data_2n7y_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n7y _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.3 t . . . . . 0 N--CA 1.449 -0.518 0 CA-C-O 120.991 0.424 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.24 133.82 45.22 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.891 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 63.0 p -109.37 146.45 34.4 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.497 ' OG ' HG13 ' A' ' 74' ' ' ILE . 37.2 t -159.07 147.08 17.81 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.538 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 17.1 p -113.27 108.93 17.94 Favored 'General case' 0 N--CA 1.418 -2.041 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 172.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.4 p -95.64 124.79 48.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.339 -177.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 54.8 ptt85 -75.46 142.56 42.92 Favored 'General case' 0 CA--C 1.505 -0.758 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.574 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 47.1 mm -115.12 119.2 61.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.6 tp -124.05 117.18 24.12 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.978 0.418 . . . . 0.0 110.474 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -175.24 154.28 17.61 Favored Glycine 0 N--CA 1.434 -1.464 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.476 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 98.8 mtp -65.35 -40.19 93.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.963 0.411 . . . . 0.0 110.9 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.0 p -111.12 84.83 2.0 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.383 0.611 . . . . 0.0 110.38 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.508 ' O ' HG23 ' A' ' 22' ' ' VAL . 42.2 t -61.38 -44.27 97.44 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.017 -177.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -61.35 -39.92 92.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.943 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.6 m -62.67 -44.2 96.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.59 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.491 ' HB3' ' CD2' ' A' ' 70' ' ' PHE . 29.6 p -73.02 -33.81 65.96 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.476 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 18' ' ' CYS . 63.0 t -62.79 -43.57 98.86 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -60.69 -44.41 96.56 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.997 177.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.0 t -61.64 -50.02 74.2 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.556 -178.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.7 tt -71.63 -36.83 61.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -61.68 -44.0 97.78 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.829 0.347 . . . . 0.0 110.693 -177.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -64.73 -47.3 78.79 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.281 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -64.58 -42.56 95.54 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.914 -176.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.63 HD11 ' SD ' ' A' ' 38' ' ' MET . 19.6 tt -69.7 -35.14 64.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.957 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 79.0 p -71.26 -22.06 62.02 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.926 0.393 . . . . 0.0 110.634 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -70.76 -27.92 64.29 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 174.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.6 mt -75.0 128.99 36.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.851 176.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.0 mtpt -86.6 153.58 21.68 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.374 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.23 8.1 57.9 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.323 -0.942 . . . . 0.0 111.862 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 33.1 pt -69.52 137.74 23.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.993 0.425 . . . . 0.0 111.819 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -96.77 -71.98 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.695 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.7 t -169.89 149.88 3.78 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-O 120.769 0.319 . . . . 0.0 111.051 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.63 ' SD ' HD11 ' A' ' 29' ' ' ILE . 28.9 ptm -153.4 159.53 42.41 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 177.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -141.1 123.45 15.78 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.989 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 79.9 t -92.52 119.29 39.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 175.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.8 m -109.21 112.07 24.02 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.042 0.448 . . . . 0.0 111.117 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.2 mt -66.2 -37.63 86.05 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.795 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -61.9 -41.81 98.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.775 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -77.22 -27.91 53.61 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.948 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.51 15.99 80.04 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -175.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 87.7 p -148.68 165.54 31.06 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.14 -0.53 . . . . 0.0 109.982 -177.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.516 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -118.5 139.44 51.43 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.708 0.289 . . . . 0.0 111.291 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.8 m -89.13 119.69 29.86 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 8' ' ' THR . 99.8 t -114.64 124.48 71.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.499 -174.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.408 ' HG2' HG22 ' A' ' 8' ' ' THR . 51.5 mtmt -126.96 103.96 7.76 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 174.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -143.86 158.71 43.51 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.587 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.8 t -82.52 114.27 50.51 Favored Pre-proline 0 N--CA 1.437 -1.125 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 173.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -61.44 -28.09 83.32 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.921 2.414 . . . . 0.0 113.787 -173.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.2 p -70.19 -39.74 75.05 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 120.809 0.338 . . . . 0.0 110.899 177.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 84.7 t -75.67 -50.81 22.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 121.128 0.49 . . . . 0.0 110.67 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 69.7 t -128.58 123.72 60.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.162 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.639 ' SG ' ' HG2' ' A' ' 60' ' ' GLN . 27.7 p -88.49 144.42 26.36 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.898 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.4 mp -68.56 -26.8 65.59 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.092 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 -60.35 -41.14 93.02 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.639 ' HG2' ' SG ' ' A' ' 57' ' ' CYS . 85.4 mm-40 -63.98 -38.43 91.07 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.387 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 71.6 t -60.98 -46.74 96.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 121.391 0.615 . . . . 0.0 109.55 178.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 43.0 t -62.55 -39.61 94.18 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.76 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -59.6 -45.17 92.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.947 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 60' ' ' GLN . 98.2 mt-30 -60.75 -44.01 97.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.65 -175.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.0 tt -81.41 -37.19 15.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.856 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.8 -41.73 99.81 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.782 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.99 -28.73 70.0 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 122.37 0.268 . . . . 0.0 111.37 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 16.1 tpt -61.75 -29.79 70.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.719 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.69 5.06 12.6 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.515 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.491 ' CD2' ' HB3' ' A' ' 21' ' ' CYS . 95.1 m-85 -111.48 152.02 27.94 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -94.97 134.69 37.37 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.37 0.605 . . . . 0.0 111.818 -176.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 12' ' ' ARG . . . -140.82 145.59 36.47 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.687 176.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.9 t -139.88 138.65 35.86 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.243 -0.583 . . . . 0.0 111.445 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.497 HG13 ' OG ' ' A' ' 9' ' ' SER . 14.7 tt -78.23 137.02 22.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.12 -0.945 . . . . 0.0 112.158 -178.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -152.11 159.48 43.64 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 176.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.308 -1.228 0 CA-C-O 118.577 -0.725 . . . . 0.0 109.976 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 N--CA 1.445 -0.687 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -120.73 140.18 52.01 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 120.979 0.418 . . . . 0.0 110.592 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 44.5 p -120.77 145.77 47.19 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.393 177.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.9 t -140.88 142.47 34.5 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.6 p -108.64 133.88 52.13 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 121.307 0.575 . . . . 0.0 110.759 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.428 HG12 ' HA ' ' A' ' 74' ' ' ILE . 33.6 m -126.85 150.53 32.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.415 ' HG2' ' HB3' ' A' ' 73' ' ' SER . 16.6 ptm180 -107.06 147.24 30.21 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.536 HG21 ' SG ' ' A' ' 21' ' ' CYS . 85.0 mt -119.56 125.86 74.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.546 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.8 tp -119.6 115.84 24.81 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -171.02 154.88 23.56 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.976 -0.63 . . . . 0.0 111.642 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 68.6 mtt -67.66 -40.14 84.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.923 0.392 . . . . 0.0 110.978 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.2 p -104.45 89.59 3.27 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.713 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 95.5 m -64.06 -40.57 96.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.238 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -64.88 -39.14 93.08 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.462 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.0 m -62.63 -43.74 98.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.712 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.536 ' SG ' HG21 ' A' ' 13' ' ' ILE . 16.0 p -70.19 -39.87 74.96 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.597 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 65.5 t -63.22 -44.13 99.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-O 121.087 0.47 . . . . 0.0 110.108 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -64.46 -40.88 96.54 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.41 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.5 m -62.36 -42.9 99.77 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.978 -0.556 . . . . 0.0 112.012 -178.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.541 ' CG2' ' HB ' ' A' ' 65' ' ' ILE . 47.1 pt -72.02 -34.94 52.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 C-N-CA 120.064 -0.655 . . . . 0.0 110.161 178.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -60.97 -44.43 97.36 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.909 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -61.82 -50.06 73.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.082 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -68.67 -41.86 78.7 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.165 -0.471 . . . . 0.0 112.192 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 94.0 mt -64.41 -42.61 95.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-O 120.668 0.27 . . . . 0.0 111.035 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 41.4 t -60.24 -41.5 93.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.023 0.44 . . . . 0.0 110.26 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -68.49 -27.9 66.54 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.094 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.5 tp -70.33 131.95 44.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.705 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -86.1 152.55 22.77 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.69 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.89 5.98 73.0 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.687 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 46.4 pt -72.55 138.19 21.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.908 0.385 . . . . 0.0 111.316 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.2 mm -96.79 -67.05 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.481 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.7 t -162.39 152.83 16.9 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.279 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -139.27 148.22 42.73 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -134.79 142.47 46.71 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.68 140.05 50.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 120.967 0.413 . . . . 0.0 111.134 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.9 m -119.38 101.75 8.18 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.67 -44.83 95.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.845 -176.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -61.68 -44.28 97.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.462 -178.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -76.93 -24.82 52.39 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.742 -178.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.13 17.53 79.53 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.326 -177.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 60.1 m -125.17 151.61 45.58 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 120.882 0.372 . . . . 0.0 110.591 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -128.71 149.14 50.82 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.047 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.6 m -116.2 125.41 52.23 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 63.1 t -114.47 124.97 71.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 120.84 0.352 . . . . 0.0 110.545 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -105.88 107.7 18.83 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.636 ' CE1' ' HB ' ' A' ' 56' ' ' VAL . 34.4 t80 -152.93 152.74 31.81 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -175.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.4 t -80.64 114.02 44.51 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -66.26 -22.28 53.62 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.066 2.511 . . . . 0.0 113.852 -174.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 79.8 p -65.28 -33.36 75.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.718 0.294 . . . . 0.0 111.271 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.9 t -84.06 -61.9 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.907 0.384 . . . . 0.0 110.174 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.636 ' HB ' ' CE1' ' A' ' 51' ' ' TYR . 88.7 t -128.76 127.49 66.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.096 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 30.3 p -76.81 155.79 32.79 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.343 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.35 -16.13 61.87 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.838 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -61.5 -42.2 98.44 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.195 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.501 ' OE1' HG13 ' A' ' 56' ' ' VAL . 98.6 mt-30 -65.13 -37.94 89.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.531 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 77.8 t -61.28 -40.95 87.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-O 121.352 0.596 . . . . 0.0 109.728 177.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.513 ' SG ' ' HB ' ' A' ' 74' ' ' ILE . 92.7 m -61.08 -38.96 88.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.569 177.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -67.94 -28.77 67.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.452 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -61.93 -42.18 98.8 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.739 0.304 . . . . 0.0 110.503 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.541 ' HB ' ' CG2' ' A' ' 25' ' ' ILE . 18.8 tt -79.7 -38.94 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 120.754 0.311 . . . . 0.0 111.565 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -62.39 -39.08 97.31 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.156 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -59.09 -39.0 80.85 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.152 0.501 . . . . 0.0 110.472 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 17.0 tpt -62.01 -29.09 70.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.127 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.15 8.54 10.38 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.677 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.506 ' CG ' ' HB3' ' A' ' 21' ' ' CYS . 97.5 m-85 -106.29 150.02 26.36 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.687 0.28 . . . . 0.0 110.286 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -93.13 138.87 31.16 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.584 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.88 149.13 31.7 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.642 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.415 ' HB3' ' HG2' ' A' ' 12' ' ' ARG . 48.3 t -127.86 138.93 52.86 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.513 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 13.5 tt -100.27 139.21 22.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.226 0.536 . . . . 0.0 111.681 -176.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.45 159.45 44.02 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.42 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 . . . . . 0 C--N 1.3 -1.575 0 CA-C-O 118.47 -0.776 . . . . 0.0 109.709 177.444 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 68.2 t . . . . . 0 N--CA 1.442 -0.844 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.62 128.53 45.73 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.004 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 76.3 p -118.47 147.45 43.6 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.699 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.9 p -159.98 168.09 26.44 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.336 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.6 p -113.0 129.59 56.44 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.5 p -109.57 123.34 65.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-O 121.026 0.441 . . . . 0.0 110.364 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -83.26 147.45 27.97 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.647 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 85.9 mt -114.68 123.6 70.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.891 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 69.6 tp -117.92 118.47 32.08 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.938 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -175.45 157.95 24.87 Favored Glycine 0 N--CA 1.432 -1.617 0 C-N-CA 119.692 -1.242 . . . . 0.0 113.151 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 66.4 ttp -61.93 -47.16 86.14 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 120.915 0.388 . . . . 0.0 110.202 177.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.6 m -118.21 107.23 13.68 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.415 ' O ' HG21 ' A' ' 22' ' ' VAL . 47.9 t -64.22 -40.19 95.54 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.09 -178.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -60.35 -39.83 88.57 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.757 -176.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 63.7 m -62.3 -46.29 89.4 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 120.959 0.409 . . . . 0.0 111.518 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.589 ' HB3' ' CD2' ' A' ' 70' ' ' PHE . 16.4 p -73.64 -36.36 65.41 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.926 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.415 HG21 ' O ' ' A' ' 18' ' ' CYS . 57.0 t -62.18 -42.79 96.56 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.541 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -60.56 -40.61 92.25 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.518 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.3 t -59.99 -48.66 80.79 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.875 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.3 tt -76.49 -39.42 33.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.018 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.1 tp10 -60.33 -47.59 85.4 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.914 0.388 . . . . 0.0 111.281 -175.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.64 -51.15 66.43 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.978 -177.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.508 ' HD2' ' HG2' ' A' ' 64' ' ' GLN . 44.4 ttm180 -63.89 -45.42 89.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.852 -177.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 15.3 tt -68.53 -31.22 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.312 -176.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 73.7 m -63.78 -38.77 92.33 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.081 0.467 . . . . 0.0 110.076 176.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -68.18 -27.8 66.72 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.877 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.4 mt -84.68 137.32 33.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.755 0.788 . . . . 0.0 112.753 -178.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.547 ' HD2' ' N ' ' A' ' 33' ' ' LYS . 9.9 mptt -87.75 155.04 20.1 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.39 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.53 7.4 39.73 Favored Glycine 0 C--O 1.239 0.422 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.94 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.2 pt -91.39 132.91 34.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 86.3 mt -97.63 -59.45 3.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.935 0.398 . . . . 0.0 110.728 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.3 t -152.34 141.21 21.08 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.162 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.432 ' HB3' ' HH ' ' A' ' 51' ' ' TYR . 28.5 ptm -145.27 146.96 31.87 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.759 177.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -135.52 124.7 24.49 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.908 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 65.7 t -106.6 116.05 49.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 176.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.8 m -109.64 104.68 13.73 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.083 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.8 mt -64.4 -36.65 84.84 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.72 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.7 mp0 -63.61 -41.29 98.32 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.74 -178.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -83.85 -27.34 28.76 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.316 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.86 20.64 77.73 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -177.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.7 m -137.63 155.91 48.64 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 122.371 0.268 . . . . 0.0 110.592 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -121.92 141.8 50.93 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.398 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.1 m -85.38 124.36 31.9 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.652 HG11 ' CE2' ' A' ' 51' ' ' TYR . 97.4 t -107.26 119.29 56.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.053 -176.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -145.56 102.83 3.74 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 173.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.652 ' CE2' HG11 ' A' ' 49' ' ' VAL . 24.7 m-85 -141.69 165.78 26.54 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -177.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.6 t -78.1 114.22 40.3 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 175.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -62.87 -25.91 74.46 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.894 2.396 . . . . 0.0 112.861 -175.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.3 m -64.46 -39.08 93.14 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.925 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.6 t -94.84 -49.43 12.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.125 -178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.1 t -114.45 126.63 72.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.328 -177.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 25.2 p -103.89 149.9 24.67 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.651 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.5 mp -64.32 -38.06 89.71 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.507 -176.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -62.6 -40.79 98.05 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -176.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.597 ' O ' ' HG3' ' A' ' 64' ' ' GLN . 85.4 mm-40 -64.72 -37.1 86.44 Favored 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 121.119 -0.233 . . . . 0.0 111.18 176.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 77.2 t -59.29 -43.43 89.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-O 121.17 0.509 . . . . 0.0 109.636 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 96.3 m -62.49 -39.09 92.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.97 177.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 63.8 m170 -67.3 -36.35 81.32 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.157 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.597 ' HG3' ' O ' ' A' ' 60' ' ' GLN . 99.2 mt-30 -60.02 -42.91 95.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.536 -176.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.8 tt -81.11 -35.07 14.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.114 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -67.14 -24.2 73.24 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.935 -0.575 . . . . 0.0 113.629 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.1 -36.59 77.78 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.847 0.356 . . . . 0.0 111.087 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 16.5 tpt -62.41 -28.93 70.13 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.533 178.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.89 5.13 18.29 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.38 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.589 ' CD2' ' HB3' ' A' ' 21' ' ' CYS . 99.0 m-85 -104.83 142.67 34.32 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.776 0.322 . . . . 0.0 110.661 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -80.88 147.81 30.2 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.404 -177.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.97 148.93 31.29 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.197 176.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 39.8 t -143.61 142.11 30.91 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.38 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 88.7 mt -86.27 128.58 39.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.198 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -138.35 148.43 44.54 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.481 177.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 . . . . . 0 C--N 1.307 -1.282 0 CA-C-O 118.393 -0.813 . . . . 0.0 110.307 -179.818 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.0 t . . . . . 0 CA--C 1.516 -0.342 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -112.31 143.58 43.16 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.954 0.406 . . . . 0.0 111.388 -176.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.544 HG23 ' HG2' ' A' ' 50' ' ' LYS . 71.7 p -109.32 140.86 42.46 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.9 t -150.64 143.02 24.32 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.048 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 71.3 p -115.09 122.99 47.83 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.8 m -107.21 125.69 63.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.329 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 16.2 ptp180 -77.79 135.29 37.96 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 85.4 mt -117.57 127.52 74.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-O 120.977 0.418 . . . . 0.0 111.63 -174.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.0 tt -115.13 119.4 36.29 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.107 177.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -165.73 173.42 41.37 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.943 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 79.2 mtm -63.81 -44.91 91.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.32 0.581 . . . . 0.0 110.134 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.0 p -134.91 128.8 33.26 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.748 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.525 ' O ' HG23 ' A' ' 22' ' ' VAL . 51.5 t -62.61 -49.56 74.74 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -176.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -62.61 -40.88 98.35 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -174.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.6 t -62.83 -47.16 84.58 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.675 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.5 p -70.75 -33.29 70.65 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.698 0.285 . . . . 0.0 110.967 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 18' ' ' CYS . 52.7 t -61.91 -45.62 98.29 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.018 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 176.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -64.34 -36.28 83.62 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.493 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 41.1 t -59.24 -48.69 80.67 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.281 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.8 tt -78.51 -28.86 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.448 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -59.2 -46.33 88.73 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.28 -176.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -61.17 -45.09 96.03 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.962 0.41 . . . . 0.0 110.689 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -67.22 -45.75 75.87 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.505 -176.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.3 tp -72.47 -34.63 49.0 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 78.8 p -65.82 -36.32 83.15 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.817 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -70.6 -27.29 63.98 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.283 176.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -77.96 125.18 28.96 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.918 0.389 . . . . 0.0 110.169 176.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -81.51 152.48 27.29 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.316 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 115.81 -0.91 21.53 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.17 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.9 tt -108.73 124.19 65.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.25 0.547 . . . . 0.0 109.98 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 49.7 mm -71.38 -49.43 47.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.029 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.7 t -159.81 150.26 18.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.76 -177.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 26.3 ttt -127.33 119.56 26.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.143 178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -131.03 146.38 52.36 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 110.289 -0.264 . . . . 0.0 110.289 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 66.4 t -123.91 129.73 74.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 120.757 0.313 . . . . 0.0 111.67 -175.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.3 t -106.85 105.3 15.26 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 177.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 60.0 tp -64.48 -40.83 96.41 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.679 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -62.07 -40.91 97.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.732 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -76.26 -29.11 57.34 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.667 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.83 20.31 63.71 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.978 -0.629 . . . . 0.0 111.629 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 89.3 p -143.91 166.22 25.55 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 120.93 0.395 . . . . 0.0 110.542 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.579 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -117.52 133.77 55.59 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.469 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.1 m -98.88 121.24 40.57 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.6 m -127.96 149.34 32.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 CA-C-O 121.408 0.623 . . . . 0.0 111.509 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.544 ' HG2' HG23 ' A' ' 8' ' ' THR . 62.3 mttp -116.04 123.88 49.06 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 175.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -150.7 165.46 33.37 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.504 -174.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.5 t -100.16 110.28 59.18 Favored Pre-proline 0 N--CA 1.438 -1.056 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.041 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -55.82 -27.13 60.8 Favored 'Trans proline' 0 N--CA 1.483 0.866 0 C-N-CA 123.62 2.88 . . . . 0.0 112.676 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.2 m -62.03 -39.22 91.59 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.845 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 51.8 t -89.05 -47.52 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.998 -177.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 31.8 m -123.25 160.2 26.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.614 0.245 . . . . 0.0 110.904 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 31.2 p -134.89 167.32 21.12 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.948 0.404 . . . . 0.0 111.541 -176.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 68.6 tp -61.07 -44.33 97.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.856 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -60.03 -42.31 94.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.515 -177.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.553 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 64.7 tt0 -61.66 -45.81 92.41 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.609 178.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.0 t -63.97 -46.59 93.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 CA-C-O 121.2 0.524 . . . . 0.0 110.751 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 48.5 t -60.82 -40.07 91.37 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.927 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -60.36 -41.38 93.58 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.414 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.553 ' HG2' ' O ' ' A' ' 60' ' ' GLN . 87.0 mm-40 -60.56 -45.7 92.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.143 -176.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.3 tt -83.22 -35.78 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.869 0.366 . . . . 0.0 111.752 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.59 -39.8 97.86 Favored Glycine 0 CA--C 1.505 -0.536 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.42 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -60.42 -39.37 87.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.952 0.406 . . . . 0.0 110.324 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 14.8 tpt -63.47 -30.67 71.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.485 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 116.64 7.93 12.96 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.334 -0.936 . . . . 0.0 113.301 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -114.53 141.6 47.52 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -99.31 133.35 43.74 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -172.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.502 ' HA ' ' O ' ' A' ' 12' ' ' ARG . . . -130.89 139.03 50.06 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.474 176.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.6 m -127.57 143.59 51.16 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.689 0.281 . . . . 0.0 110.938 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.2 tt -74.13 142.32 14.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -175.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.422 ' HB1' ' NH2' ' A' ' 12' ' ' ARG . . . -143.05 125.63 15.83 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.45 172.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 . . . . . 0 C--N 1.307 -1.244 0 CA-C-O 118.771 -0.633 . . . . 0.0 111.435 -178.579 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 N--CA 1.441 -0.9 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -129.9 143.2 50.68 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 120.954 0.407 . . . . 0.0 111.136 -178.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.1 p -107.96 129.34 55.12 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.024 177.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.414 ' O ' HG22 ' A' ' 49' ' ' VAL . 46.8 t -140.71 143.78 35.22 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 22.4 p -109.62 119.71 40.25 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.929 177.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.428 HG11 ' HA ' ' A' ' 74' ' ' ILE . 33.5 m -102.61 135.89 37.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.1 ptt180 -83.74 150.9 25.52 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.642 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 86.4 mt -112.52 121.35 64.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 63.4 tp -122.56 108.08 12.72 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -167.23 156.19 27.8 Favored Glycine 0 N--CA 1.431 -1.656 0 C-N-CA 119.932 -1.127 . . . . 0.0 113.069 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 79.5 mtm -64.6 -40.28 95.23 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.92 0.39 . . . . 0.0 110.346 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 35.5 m -121.85 103.87 9.16 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.467 ' O ' HG22 ' A' ' 22' ' ' VAL . 91.5 m -65.4 -40.23 93.16 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.051 -177.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -62.72 -39.79 95.15 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -176.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.0 m -62.38 -44.56 96.16 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.553 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.637 ' HB3' ' CD2' ' A' ' 70' ' ' PHE . 24.7 p -71.73 -37.05 70.64 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.416 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 18' ' ' CYS . 59.4 t -62.65 -45.18 99.46 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.001 178.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 66.3 tttp -62.86 -42.73 99.86 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.275 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 74.5 m -60.78 -43.01 98.63 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.67 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.0 tt -76.52 -41.16 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.396 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -62.71 -49.36 75.4 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -63.71 -46.42 85.52 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.046 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.0 ttp180 -67.17 -42.72 83.81 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.513 HG12 ' OH ' ' A' ' 51' ' ' TYR . 11.2 tp -67.55 -36.44 76.24 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.687 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.882 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 79.0 p -73.17 -20.71 60.84 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.17 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -71.64 -27.91 63.4 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 174.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 64.1 tp -93.29 119.3 32.28 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.388 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -80.66 152.41 28.48 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 120.994 0.426 . . . . 0.0 111.069 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 115.3 1.67 21.86 Favored Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -175.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.406 HD13 ' HB2' ' A' ' 38' ' ' MET . 4.1 tt -91.92 122.25 43.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 123.132 0.573 . . . . 0.0 110.426 178.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.1 tt -82.7 -42.8 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.822 177.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.458 ' HB3' ' HD2' ' A' ' 50' ' ' LYS . 35.3 t -160.67 145.62 14.35 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 120.123 -0.631 . . . . 0.0 112.248 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.57 ' SD ' HG12 ' A' ' 49' ' ' VAL . 14.4 tpt -134.41 129.81 35.89 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.851 177.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -135.05 129.05 33.44 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.6 p -129.77 137.61 56.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 120.811 0.339 . . . . 0.0 110.862 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.1 t -117.62 117.9 30.64 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.979 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.8 tp -66.66 -41.62 87.9 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.863 176.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -61.07 -48.93 79.42 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.587 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -77.02 -25.02 52.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.69 -178.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.33 29.8 69.85 Favored Glycine 0 CA--C 1.505 -0.591 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.9 t -149.12 152.85 36.84 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -119.36 138.17 53.24 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.987 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 71.6 m -102.67 122.6 44.77 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.659 ' HB ' ' CE2' ' A' ' 51' ' ' TYR . 33.3 m -120.72 149.91 23.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -174.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.458 ' HD2' ' HB3' ' A' ' 37' ' ' SER . 69.0 mttm -125.0 108.2 11.6 Favored 'General case' 0 C--O 1.245 0.858 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.749 175.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.659 ' CE2' ' HB ' ' A' ' 49' ' ' VAL . 80.8 m-85 -136.44 148.78 47.92 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.03 0.443 . . . . 0.0 111.434 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 66.5 t -87.61 115.41 62.8 Favored Pre-proline 0 N--CA 1.438 -1.049 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 171.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -59.4 -28.62 88.04 Favored 'Trans proline' 0 N--CA 1.475 0.398 0 C-N-CA 122.819 2.346 . . . . 0.0 113.765 -173.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.0 p -77.05 -14.29 59.84 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.907 0.384 . . . . 0.0 111.473 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 49.0 t -104.4 -59.19 3.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.105 0.479 . . . . 0.0 109.892 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 66.7 t -126.3 124.16 65.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.495 ' SG ' ' HG3' ' A' ' 60' ' ' GLN . 31.2 p -93.48 159.28 15.31 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.208 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.8 mt -62.91 -36.67 84.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.66 -178.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -61.11 -40.03 92.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.734 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.495 ' HG3' ' SG ' ' A' ' 57' ' ' CYS . 95.5 mt-30 -63.08 -41.25 99.38 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.074 0.464 . . . . 0.0 110.369 177.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 70.2 t -63.26 -44.24 99.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.119 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 92.5 m -62.59 -39.51 93.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.967 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -61.75 -39.67 92.4 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.547 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 60' ' ' GLN . 99.1 mt-30 -60.3 -42.34 95.32 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.41 -176.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.2 tt -81.77 -40.73 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-O 120.787 0.327 . . . . 0.0 111.604 178.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.31 -37.01 93.88 Favored Glycine 0 C--N 1.335 0.473 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.626 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -56.35 -36.14 68.44 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 123.91 0.884 . . . . 0.0 111.594 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 14.2 tpt -63.44 -28.58 70.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.246 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.81 9.62 9.83 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.495 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.637 ' CD2' ' HB3' ' A' ' 21' ' ' CYS . 98.4 m-85 -113.79 141.82 46.83 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -82.78 146.85 28.74 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.485 0.66 . . . . 0.0 112.592 -176.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.44 151.09 35.86 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.981 -1.008 . . . . 0.0 108.923 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 36.6 t -138.19 140.48 39.8 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.891 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.428 ' HA ' HG11 ' A' ' 11' ' ' VAL . 85.7 mt -81.55 128.63 38.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.066 -178.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -142.95 159.96 41.25 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.435 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 119.132 -0.461 . . . . 0.0 111.403 -179.692 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.9 t . . . . . 0 N--CA 1.449 -0.509 0 CA-C-O 120.908 0.385 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.513 ' O ' ' HA ' ' A' ' 50' ' ' LYS . . . -117.24 131.82 56.76 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 176.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.467 HG21 ' HG2' ' A' ' 50' ' ' LYS . 66.4 p -111.82 135.04 52.96 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.8 t -157.57 152.15 25.13 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.7 p -111.93 142.39 44.4 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-O 121.037 0.446 . . . . 0.0 110.042 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.3 p -133.14 127.33 54.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.137 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 40.6 ptt180 -94.53 142.61 27.24 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.595 -0.442 . . . . 0.0 109.815 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 85.3 mt -110.13 127.13 67.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.782 -177.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 63.0 tp -112.87 115.2 28.08 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.219 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -172.83 148.54 10.58 Favored Glycine 0 N--CA 1.438 -1.229 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 68.3 mtt -65.94 -41.05 91.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.972 0.415 . . . . 0.0 110.794 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.7 m -100.76 85.26 2.86 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.461 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 93.7 m -63.45 -40.13 96.32 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.495 -175.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -62.83 -42.21 99.64 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -177.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.9 m -67.34 -41.1 85.75 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.487 ' HB3' ' CG ' ' A' ' 70' ' ' PHE . 18.6 p -68.79 -39.96 79.86 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.572 -179.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.481 ' O ' ' HG3' ' A' ' 26' ' ' GLU . 67.3 t -63.07 -46.0 97.27 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.282 0 CA-C-O 121.13 0.49 . . . . 0.0 109.804 178.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.46 -44.13 97.64 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.793 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.42 ' HB3' ' HG3' ' A' ' 68' ' ' MET . 67.2 m -62.95 -46.43 87.79 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.067 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.9 tt -66.25 -33.62 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.207 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.481 ' HG3' ' O ' ' A' ' 22' ' ' VAL . 49.4 mt-10 -62.33 -44.03 97.45 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.627 178.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -65.93 -45.46 81.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.149 0.499 . . . . 0.0 110.812 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.508 ' HB3' ' HG2' ' A' ' 64' ' ' GLN . 26.5 mmt85 -64.18 -43.32 95.47 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.239 -178.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.581 HG22 ' SD ' ' A' ' 38' ' ' MET . 19.1 tt -70.62 -32.95 51.25 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.303 0 CA-C-O 120.952 0.406 . . . . 0.0 110.264 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.5 t -62.41 -38.86 91.3 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.575 176.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -66.79 -30.37 70.55 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.886 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 93.7 mt -75.82 129.12 36.51 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.164 0.507 . . . . 0.0 110.451 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -85.49 153.35 22.52 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.294 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.02 7.96 48.94 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.583 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.485 ' HA ' ' CB ' ' A' ' 51' ' ' TYR . 48.0 pt -94.78 138.68 20.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.868 0.366 . . . . 0.0 110.662 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.3 mm -99.48 -61.78 2.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.114 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.5 m -146.57 154.13 41.16 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.615 0.245 . . . . 0.0 110.965 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.581 ' SD ' HG22 ' A' ' 29' ' ' ILE . 27.8 ttt -145.6 132.45 20.12 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.583 178.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -126.26 128.34 47.02 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 176.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.8 t -107.2 123.62 62.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-O 120.79 0.329 . . . . 0.0 110.366 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.5 m -98.6 99.38 10.51 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.9 mt -64.19 -40.23 95.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.089 -175.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -69.27 -38.57 78.44 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.075 0.464 . . . . 0.0 110.91 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -74.66 -29.96 61.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.806 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.82 15.14 81.2 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -177.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 12' ' ' ARG . 49.0 m -131.48 154.25 48.93 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.39 -0.405 . . . . 0.0 110.133 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.41 143.49 50.96 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.978 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 85.1 m -102.01 125.26 48.66 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.6 m -117.69 147.28 21.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 121.023 0.439 . . . . 0.0 111.512 -177.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 99.7 mttt -133.17 112.94 12.15 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.444 177.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.485 ' CB ' ' HA ' ' A' ' 35' ' ' ILE . 35.9 p90 -159.28 170.62 21.47 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.13 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.0 t -80.61 114.94 51.84 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 38.9 Cg_endo -65.97 -23.34 54.38 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.696 2.264 . . . . 0.0 112.218 -178.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.4 m -65.77 -39.36 90.94 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.619 177.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 66.0 t -74.42 -51.11 24.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.017 0.437 . . . . 0.0 110.483 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 17.8 m -137.08 149.02 26.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.434 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.564 ' SG ' ' HB2' ' A' ' 60' ' ' GLN . 24.9 p -99.65 172.24 7.41 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.871 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.474 HD23 ' OH ' ' A' ' 51' ' ' TYR . 96.5 mt -64.84 -40.89 95.9 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.718 0.771 . . . . 0.0 110.332 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -68.27 -26.71 65.8 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.462 178.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.564 ' HB2' ' SG ' ' A' ' 57' ' ' CYS . 59.6 tp60 -60.41 -45.93 91.85 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.381 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.553 ' HA ' ' OE1' ' A' ' 64' ' ' GLN . 31.8 m -74.33 -26.43 20.49 Favored 'Isoleucine or valine' 0 C--O 1.248 0.989 0 CA-C-O 121.387 0.613 . . . . 0.0 110.722 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 98.1 m -61.64 -36.45 80.82 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.104 176.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -60.48 -40.5 91.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.933 -178.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.553 ' OE1' ' HA ' ' A' ' 61' ' ' VAL . 28.6 mp0 -64.57 -41.0 96.56 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 120.4 -0.52 . . . . 0.0 112.235 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.4 tt -72.67 -36.82 54.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.525 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.23 -38.39 96.12 Favored Glycine 0 C--N 1.339 0.702 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 176.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -57.63 -36.83 72.34 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.358 0.663 . . . . 0.0 110.896 178.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.42 ' HG3' ' HB3' ' A' ' 24' ' ' SER . 95.9 mmm -74.72 -8.05 55.2 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.526 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.57 9.91 59.65 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.617 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.487 ' CG ' ' HB3' ' A' ' 21' ' ' CYS . 98.7 m-85 -111.7 147.52 35.39 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -105.95 151.32 24.74 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.184 0.516 . . . . 0.0 111.91 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -144.72 148.62 34.4 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.456 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.7 t -123.6 132.6 53.91 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.937 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 84.4 mt -78.96 130.93 35.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.235 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -144.51 155.31 43.63 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.283 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 . . . . . 0 C--O 1.256 1.432 0 CA-C-O 118.568 -0.729 . . . . 0.0 109.377 178.388 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 CA--C 1.507 -0.702 0 CA-C-O 121.003 0.43 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -104.79 131.35 52.36 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.646 -178.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 61.2 p -117.65 142.86 46.73 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.2 t -158.89 152.55 23.1 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.274 -0.571 . . . . 0.0 110.029 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.8 p -102.43 141.23 35.58 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.3 p -134.78 135.16 53.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.522 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -95.22 151.9 18.83 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.3 pt -115.11 138.8 44.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 110.127 -0.324 . . . . 0.0 110.127 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.2 tp -126.0 117.89 24.19 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.143 0.497 . . . . 0.0 110.774 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.82 157.77 16.31 Favored Glycine 0 N--CA 1.437 -1.264 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 95.3 mmm -69.02 -39.48 79.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.145 0.498 . . . . 0.0 110.059 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.2 p -99.74 79.07 2.2 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 121.509 0.671 . . . . 0.0 109.879 176.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.549 ' O ' HG22 ' A' ' 22' ' ' VAL . 96.4 m -62.39 -43.16 99.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.986 -176.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -64.99 -38.95 92.66 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.862 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.0 t -61.23 -45.93 92.5 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.451 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 29.3 p -67.53 -32.19 72.81 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.516 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.549 HG22 ' O ' ' A' ' 18' ' ' CYS . 53.7 t -62.97 -43.63 99.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.615 176.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -61.87 -43.79 98.13 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.456 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.6 m -61.76 -44.94 95.9 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.809 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.7 tp -72.5 -35.34 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 121.171 -0.212 . . . . 0.0 111.324 178.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -59.46 -47.11 86.76 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.878 0.37 . . . . 0.0 110.955 -177.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -62.92 -51.14 68.1 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.065 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.538 ' HG3' ' NE2' ' A' ' 64' ' ' GLN . 29.9 tpt180 -68.99 -40.82 78.54 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.568 -174.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 18.9 tt -65.64 -33.83 66.28 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.086 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 73.5 m -63.64 -35.06 79.27 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.783 175.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -67.4 -26.24 66.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.097 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.415 HD11 ' NE2' ' A' ' 64' ' ' GLN . 92.1 mt -74.56 136.52 42.1 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.973 0.416 . . . . 0.0 110.852 176.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -86.75 149.92 24.52 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.393 177.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.84 7.97 54.78 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.064 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 47.7 pt -94.02 139.49 18.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 120.881 0.372 . . . . 0.0 110.22 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 89.2 mt -99.38 -58.56 3.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.819 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.1 t -158.47 147.53 19.07 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.079 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 65.5 ttp -141.74 130.04 22.32 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.115 175.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -120.12 127.0 52.11 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.3 t -111.47 119.99 61.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.1 m -100.97 106.34 17.65 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 97.0 mt -63.61 -38.68 92.03 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.979 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -63.67 -41.08 98.22 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.931 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -77.29 -27.33 52.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.174 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.27 18.78 73.42 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.216 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 78.7 p -144.69 159.03 43.49 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 120.881 0.372 . . . . 0.0 111.177 -178.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -128.33 155.65 44.32 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.23 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.9 m -113.32 127.54 56.18 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 8' ' ' THR . 35.9 m -116.99 148.28 19.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 120.826 0.346 . . . . 0.0 111.218 -178.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -142.68 114.87 8.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.459 177.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.442 ' OH ' HD23 ' A' ' 58' ' ' LEU . 39.4 p90 -158.89 166.84 30.93 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.06 -178.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.12 116.27 63.38 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.587 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 43.4 Cg_endo -65.78 -20.42 58.87 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.086 2.524 . . . . 0.0 114.053 -175.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.6 p -65.71 -38.11 88.29 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.695 0.283 . . . . 0.0 111.439 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.9 m -100.4 -26.98 3.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 79.8 t -125.35 124.86 68.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 176.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.564 ' SG ' ' HG3' ' A' ' 60' ' ' GLN . 31.2 p -103.29 168.65 9.03 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.001 -178.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.442 HD23 ' OH ' ' A' ' 51' ' ' TYR . 96.0 mt -64.18 -38.2 90.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.533 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -61.74 -41.06 97.17 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.014 -177.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.564 ' HG3' ' SG ' ' A' ' 57' ' ' CYS . 96.0 mt-30 -62.07 -45.56 92.97 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.47 -178.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 72.6 t -64.22 -46.93 92.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 CA-C-O 121.075 0.464 . . . . 0.0 111.048 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 44.6 t -62.16 -43.37 98.97 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.135 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -62.53 -41.33 98.8 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.779 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.538 ' NE2' ' HG3' ' A' ' 28' ' ' ARG . 99.6 mt-30 -61.2 -43.55 98.7 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 121.207 -0.197 . . . . 0.0 111.334 -176.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.0 tt -77.85 -38.02 24.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.119 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -62.82 -40.21 98.95 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.604 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -62.61 -26.93 68.86 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 122.989 0.516 . . . . 0.0 110.781 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.457 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 36.6 mmt -71.4 -8.97 57.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.666 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.77 5.86 58.47 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.377 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.476 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 99.1 m-85 -110.55 138.56 46.78 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -88.42 140.6 29.3 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.735 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -139.62 138.36 36.09 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.13 177.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.3 m -118.63 139.38 51.59 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.4 tt -118.56 139.91 44.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-O 121.128 0.489 . . . . 0.0 111.499 -174.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.44 160.41 42.12 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.108 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 . . . . . 0 C--O 1.252 1.214 0 CA-C-O 118.512 -0.756 . . . . 0.0 109.744 177.887 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 N--CA 1.44 -0.931 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -117.19 127.34 54.01 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 40.1 p -119.78 144.78 47.11 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.087 177.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.3 t -158.09 153.1 25.36 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.86 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 34.9 p -110.07 142.14 41.93 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 176.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.8 p -127.35 122.98 60.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-O 121.044 0.449 . . . . 0.0 110.192 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.464 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 36.3 ptt180 -91.44 146.2 24.0 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.208 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.2 pt -121.09 133.92 66.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 121.207 0.527 . . . . 0.0 112.008 -176.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 62.0 tp -135.56 129.41 32.94 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.069 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.21 -172.65 44.73 Favored Glycine 0 N--CA 1.438 -1.192 0 C-N-CA 119.58 -1.295 . . . . 0.0 112.811 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -61.8 -42.17 98.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.911 0.386 . . . . 0.0 110.913 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.453 ' HB ' ' OG ' ' A' ' 20' ' ' SER . 63.6 m -139.84 118.08 12.01 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.115 177.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.454 ' O ' HG21 ' A' ' 22' ' ' VAL . 95.1 m -67.47 -39.77 85.28 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.558 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -63.37 -41.91 98.84 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.613 -177.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.453 ' OG ' ' HB ' ' A' ' 17' ' ' THR . 78.9 p -69.71 -39.12 77.07 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.417 ' HB3' ' CG ' ' A' ' 70' ' ' PHE . 29.7 p -67.08 -34.03 76.78 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.544 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.454 HG21 ' O ' ' A' ' 18' ' ' CYS . 63.3 t -63.12 -44.84 99.68 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -63.09 -40.45 97.68 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.212 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.2 m -62.73 -46.22 89.09 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.637 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.9 tt -74.29 -35.62 40.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.012 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -60.65 -44.51 96.32 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.918 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -60.83 -51.3 69.91 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.207 -176.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -65.29 -46.35 80.74 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.444 HD11 ' SD ' ' A' ' 38' ' ' MET . 19.0 tt -65.8 -33.11 61.4 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.52 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.724 -177.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.5 m -65.55 -41.54 92.89 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.236 0.541 . . . . 0.0 110.338 177.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -71.13 -27.22 63.42 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.257 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 62.5 tp -81.86 117.23 21.96 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 121.306 0.574 . . . . 0.0 109.532 178.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -86.46 154.66 20.97 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.123 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.8 -6.3 15.9 Favored Glycine 0 C--N 1.314 -0.644 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -176.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.7 mp -102.05 112.67 36.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.3 tt -72.12 -38.45 63.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -176.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.5 m -151.34 145.31 25.21 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.838 0.352 . . . . 0.0 111.478 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.444 ' SD ' HD11 ' A' ' 29' ' ' ILE . 63.4 ttp -145.69 127.75 15.59 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -134.97 144.43 47.4 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.0 129.16 76.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 121.379 0.609 . . . . 0.0 111.428 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.6 p -100.47 98.07 8.72 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.703 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 99.4 mt -63.89 -39.16 93.54 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.371 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -65.45 -23.47 66.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.151 0.5 . . . . 0.0 111.115 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 -88.56 -27.82 21.14 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.135 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.34 19.67 71.21 Favored Glycine 0 C--O 1.236 0.272 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -176.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.0 t -145.0 154.88 43.01 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.24 -0.48 . . . . 0.0 109.733 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -118.36 149.73 40.7 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.584 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.7 m -112.86 126.83 55.88 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 8' ' ' THR . 12.7 p -123.72 137.37 57.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 121.013 0.435 . . . . 0.0 110.815 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -124.81 117.96 25.31 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 56.2 p90 -151.62 165.4 34.44 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.957 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.4 t -77.12 121.66 85.02 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 174.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -59.95 -28.38 86.99 Favored 'Trans proline' 0 N--CA 1.476 0.498 0 C-N-CA 122.814 2.343 . . . . 0.0 113.866 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.2 m -85.25 -9.43 57.74 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 120.752 0.31 . . . . 0.0 111.707 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 65.7 t -99.15 -42.33 10.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.712 0.291 . . . . 0.0 111.539 -178.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 63.5 t -125.36 137.16 58.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.746 -177.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 28.9 p -105.91 156.18 18.61 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.792 0.329 . . . . 0.0 110.872 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.73 -39.86 95.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.085 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -63.51 -36.87 85.19 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -177.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.414 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 23.8 tm0? -58.95 -45.28 90.86 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 121.224 -0.19 . . . . 0.0 110.796 -177.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.8 m -75.3 -33.47 28.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.216 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 95.4 m -63.64 -39.89 95.5 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-O 121.099 0.476 . . . . 0.0 110.179 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -63.33 -38.14 89.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.856 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.414 ' HG2' ' O ' ' A' ' 60' ' ' GLN . 19.6 mm100 -62.7 -43.52 98.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.499 -177.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.5 tt -83.0 -40.25 16.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 120.797 0.332 . . . . 0.0 111.714 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.563 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -62.89 -40.78 99.69 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 116.119 -0.491 . . . . 0.0 113.426 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -61.39 -35.3 77.11 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.974 0.416 . . . . 0.0 111.282 -178.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 35.9 mmt -68.62 -8.05 38.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.703 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.39 11.15 39.59 Favored Glycine 0 CA--C 1.506 -0.499 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.713 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.563 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 96.2 m-85 -108.03 146.16 32.94 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -102.49 131.23 49.32 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.91 0.386 . . . . 0.0 110.899 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 12' ' ' ARG . . . -143.28 144.36 32.09 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.4 p -133.9 153.72 51.56 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.306 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.8 mm -95.01 130.54 43.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.208 -174.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.0 151.5 51.47 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.134 176.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 C--N 1.309 -1.163 0 CA-C-O 119.024 -0.512 . . . . 0.0 110.595 -178.945 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 31.8 m . . . . . 0 N--CA 1.443 -0.801 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.4 134.31 55.02 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.632 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 67.9 p -117.65 147.14 43.17 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 175.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' A' ' 76' ' ' GLU . 87.4 p -158.85 158.21 33.01 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.149 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 31.9 p -115.36 114.38 25.05 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 175.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 70.7 t -107.62 123.51 63.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.2 -176.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -91.48 143.2 26.85 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.497 -177.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 82.7 mt -120.18 130.48 74.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.364 -176.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.413 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 7.4 tt -112.32 120.49 41.89 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 176.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -166.14 179.49 40.22 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.272 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 94.7 mmm -63.18 -41.41 99.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.745 0.307 . . . . 0.0 111.294 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.0 t -152.17 150.36 29.77 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 120.993 0.425 . . . . 0.0 110.652 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.433 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 93.1 m -64.01 -38.78 92.33 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.67 -178.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -59.22 -47.42 85.41 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -172.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.2 p -70.52 -40.93 73.21 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -177.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.433 ' SG ' ' HA ' ' A' ' 18' ' ' CYS . 25.4 p -72.71 -42.74 63.85 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -177.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.416 ' O ' ' HG3' ' A' ' 26' ' ' GLU . 66.9 t -64.18 -45.58 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.86 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -64.41 -38.95 92.84 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.328 -0.549 . . . . 0.0 112.061 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.6 m -62.22 -43.97 97.63 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.279 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.433 ' O ' HG21 ' A' ' 29' ' ' ILE . 10.9 tp -72.86 -37.62 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.547 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 22' ' ' VAL . 44.4 mt-10 -61.97 -41.43 98.01 Favored 'General case' 0 C--N 1.349 0.558 0 C-N-CA 120.944 -0.303 . . . . 0.0 111.513 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -61.07 -50.26 74.01 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -176.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -65.93 -44.96 83.56 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.433 HG21 ' O ' ' A' ' 25' ' ' ILE . 19.7 tt -72.17 -32.68 44.08 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 CA-C-O 120.797 0.332 . . . . 0.0 111.372 -177.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.2 t -63.66 -39.67 94.93 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -68.56 -27.09 65.77 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.377 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 98.5 mt -83.68 118.34 23.8 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.556 -0.457 . . . . 0.0 110.427 176.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -85.71 153.94 21.98 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.606 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.13 7.48 14.62 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.453 -177.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 46.7 pt -102.79 139.02 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 86.8 mt -83.82 -56.96 4.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.173 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 78.6 p -155.14 157.42 37.41 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.256 -178.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 77.9 mtm -138.03 142.35 40.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.331 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -131.3 149.52 52.53 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 175.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.9 p -138.48 131.7 40.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-O 121.187 0.518 . . . . 0.0 111.385 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.1 m -116.19 103.99 11.08 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.76 -41.63 97.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.346 -176.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -64.02 -39.93 95.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.156 0.503 . . . . 0.0 110.997 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -73.11 -29.89 63.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.323 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.35 17.66 73.28 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.749 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 88.4 p -142.2 158.58 43.57 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 120.893 0.378 . . . . 0.0 110.455 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -124.48 144.7 49.94 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.85 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.1 m -103.65 123.35 46.83 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 8' ' ' THR . 29.7 m -126.67 149.41 31.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.446 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -134.95 115.33 13.44 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.468 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -161.97 170.93 18.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.237 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.5 t -82.88 116.32 63.46 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.76 -23.88 62.41 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.71 2.273 . . . . 0.0 113.515 -176.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.5 t -64.88 -42.88 94.45 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.271 177.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 96.5 t -67.78 -49.47 69.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.137 0.494 . . . . 0.0 110.043 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 63.0 t -128.35 119.84 51.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.639 ' SG ' ' HB2' ' A' ' 60' ' ' GLN . 30.4 p -83.12 154.46 24.33 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.472 -178.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.473 ' HB3' ' CD1' ' A' ' 74' ' ' ILE . 98.9 mt -62.48 -37.99 88.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.544 -178.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -63.11 -39.43 94.66 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.535 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.639 ' HB2' ' SG ' ' A' ' 57' ' ' CYS . 14.2 tm0? -65.0 -38.89 92.44 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 77.3 t -61.58 -44.05 98.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.298 0.571 . . . . 0.0 110.171 178.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 44.0 t -60.49 -40.32 90.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.191 176.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.457 ' HB3' ' O ' ' A' ' 60' ' ' GLN . 53.7 t-80 -60.18 -39.36 86.2 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.872 177.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -59.9 -46.17 90.18 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.373 -177.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.3 tt -82.04 -33.65 11.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.09 -39.66 97.43 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.455 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -61.75 -37.94 86.14 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.838 0.351 . . . . 0.0 111.082 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 16.4 tpt -61.97 -30.04 70.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.04 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.94 6.94 18.26 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.61 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -112.55 136.92 51.51 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.413 ' HG3' ' HB3' ' A' ' 14' ' ' LEU . 12.0 pt-20 -95.88 144.55 26.12 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.009 0.433 . . . . 0.0 110.649 -178.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.89 152.36 37.46 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.381 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 78.3 p -132.1 149.36 52.42 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.45 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.473 ' CD1' ' HB3' ' A' ' 58' ' ' LEU . 81.6 mt -94.4 125.26 47.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.891 -175.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -126.33 149.83 48.91 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.008 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.502 ' O ' ' HA ' ' A' ' 9' ' ' SER . 41.8 tt0 . . . . . 0 C--O 1.249 1.078 0 C-N-CA 123.167 0.587 . . . . 0.0 111.125 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 CA--C 1.508 -0.651 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -139.07 148.77 43.77 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.06 0.457 . . . . 0.0 110.614 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 72.3 p -125.34 156.18 39.11 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.7 p -156.5 159.06 38.25 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 123.266 0.354 . . . . 0.0 110.078 176.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.2 p -117.93 139.21 51.47 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 73' ' ' SER . 6.7 p -132.14 123.81 51.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.234 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -77.96 143.51 37.55 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.496 HD12 ' SG ' ' A' ' 21' ' ' CYS . 37.6 pt -115.76 123.02 70.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 60.4 tp -122.82 119.36 30.35 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.063 0.458 . . . . 0.0 111.545 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.49 167.95 37.64 Favored Glycine 0 N--CA 1.438 -1.229 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 178.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 99.0 mtp -64.51 -39.32 93.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.954 0.407 . . . . 0.0 111.208 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.6 p -109.49 113.46 26.28 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.104 0.478 . . . . 0.0 111.196 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.496 ' O ' HG22 ' A' ' 22' ' ' VAL . 23.7 p -70.93 -44.9 65.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.851 -178.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.424 ' O ' ' HG3' ' A' ' 23' ' ' LYS . 98.3 mt-30 -64.73 -37.9 89.15 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.555 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.2 t -60.55 -45.25 94.58 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.241 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.496 ' SG ' HD12 ' A' ' 13' ' ' ILE . 26.9 p -69.56 -32.57 71.44 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.836 178.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 18' ' ' CYS . 61.5 t -63.64 -43.67 98.22 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-O 121.214 0.531 . . . . 0.0 109.631 176.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' A' ' 19' ' ' GLN . 98.6 mttt -61.86 -39.34 91.53 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.752 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.9 m -62.72 -43.23 99.34 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.716 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.426 ' CG2' ' HB ' ' A' ' 65' ' ' ILE . 46.1 pt -81.63 -39.24 16.8 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.886 0 C-N-CA 120.386 -0.525 . . . . 0.0 112.292 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -62.67 -44.87 95.16 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.155 -176.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -61.85 -51.73 67.03 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.206 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.55 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 97.7 mtt180 -70.11 -41.21 74.29 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -176.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 92.1 mt -63.45 -44.19 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.683 0.278 . . . . 0.0 111.166 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 81.1 p -63.2 -33.78 76.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.833 0.349 . . . . 0.0 110.936 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -70.98 -25.76 62.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.417 176.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 28' ' ' ARG . 99.3 mt -70.43 146.61 50.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.133 0.492 . . . . 0.0 111.316 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -86.57 130.88 34.33 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.46 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.5 7.76 25.71 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.799 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.7 tp -84.88 123.39 39.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.05 0.453 . . . . 0.0 110.821 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 86.6 mt -93.58 -60.68 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.011 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 85.9 p -161.51 164.26 29.74 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.64 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 28.5 ptm -151.31 155.54 38.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.904 0.383 . . . . 0.0 110.883 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -143.73 138.67 29.0 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.692 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 67.0 t -106.9 124.33 62.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 120.941 0.4 . . . . 0.0 110.506 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.5 t -99.24 108.09 20.57 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.101 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.11 -33.47 73.53 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.426 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -61.48 -45.48 94.06 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.256 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -93.14 -12.69 29.77 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.646 -0.421 . . . . 0.0 111.686 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.83 26.95 73.78 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.1 m -135.69 158.17 45.05 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.389 -0.406 . . . . 0.0 110.447 -177.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.44 143.59 47.42 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 85.7 m -110.03 127.8 55.04 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.1 p -127.57 134.73 64.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 121.181 0.515 . . . . 0.0 111.283 -178.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -104.48 114.99 29.58 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 175.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.456 ' O ' ' HD3' ' A' ' 53' ' ' PRO . 16.1 t80 -142.79 165.27 27.85 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.612 -170.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.9 t -107.12 98.21 21.29 Favored Pre-proline 0 C--N 1.319 -0.744 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 51' ' ' TYR . 45.9 Cg_exo -60.66 -25.08 80.17 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.294 2.663 . . . . 0.0 111.971 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.8 m -62.26 -41.06 98.11 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.792 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 76.5 t -65.5 -49.69 76.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-O 121.192 0.52 . . . . 0.0 109.847 177.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.3 p -155.85 147.13 12.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.654 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 29.8 p -68.87 156.22 38.83 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.295 0.569 . . . . 0.0 112.406 -176.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.0 mt -77.2 -12.32 59.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.425 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -58.32 -37.89 76.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.954 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.517 ' O ' ' HG3' ' A' ' 64' ' ' GLN . 16.8 mm100 -61.57 -39.88 92.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.011 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.2 t -61.74 -45.11 99.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.744 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 43.0 t -60.73 -40.54 92.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.96 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 44.7 m170 -64.63 -37.16 86.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.703 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.517 ' HG3' ' O ' ' A' ' 60' ' ' GLN . 98.5 mt-30 -60.87 -44.29 97.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.119 -0.492 . . . . 0.0 112.008 -177.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.432 HD11 ' HB3' ' A' ' 72' ' ' ALA . 20.1 tt -76.32 -38.41 33.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.597 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.13 -37.89 95.24 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 177.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -58.12 -36.89 73.59 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.25 0.62 . . . . 0.0 111.132 177.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 97.8 mmm -79.91 1.93 25.36 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.87 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.31 19.39 58.86 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.871 -0.68 . . . . 0.0 113.897 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -114.64 135.79 53.76 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 177.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -83.08 140.07 32.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.721 0.296 . . . . 0.0 110.56 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.432 ' HB3' HD11 ' A' ' 65' ' ' ILE . . . -148.23 149.72 32.43 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.175 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.503 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 65.9 m -133.92 133.97 42.08 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.181 177.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 85.9 mt -100.28 125.87 53.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.258 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -138.67 148.37 43.93 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.419 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.466 -0.778 . . . . 0.0 109.313 179.239 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -129.69 128.55 42.77 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.98 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.607 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 63.0 p -126.32 136.99 53.42 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.116 177.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.4 t -159.43 162.91 35.78 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 59.3 p -106.05 136.71 45.25 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.273 0.558 . . . . 0.0 111.077 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.32 123.61 70.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 177.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -80.61 141.15 35.29 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -178.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.2 pt -109.68 126.86 66.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-O 121.332 0.586 . . . . 0.0 111.369 -177.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.4 tp -126.26 117.8 23.81 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -165.47 160.46 33.85 Favored Glycine 0 N--CA 1.422 -2.27 0 C-N-CA 120.07 -1.062 . . . . 0.0 111.495 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.6 mmt -65.41 -39.67 92.45 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.3 p -122.33 105.94 10.64 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.722 176.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.9 m -63.63 -40.15 96.16 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.712 -177.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -62.93 -40.71 98.45 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.79 0.329 . . . . 0.0 110.471 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.4 m -62.81 -44.65 95.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.79 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 27.9 p -67.14 -38.28 85.25 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.128 -178.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 78.8 t -64.86 -45.02 96.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-O 121.128 0.489 . . . . 0.0 109.828 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -63.52 -43.14 98.03 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.925 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.459 ' HB3' ' HG3' ' A' ' 68' ' ' MET . 68.8 m -62.44 -42.79 99.71 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.825 -178.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.402 HD13 ' HB ' ' A' ' 65' ' ' ILE . 17.9 tt -72.56 -37.65 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.41 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -60.83 -45.94 92.49 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.228 0.537 . . . . 0.0 109.956 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -60.7 -49.71 76.43 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.366 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 44.4 ttt180 -66.02 -43.69 86.91 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.237 -177.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 87.9 mt -63.68 -39.87 86.97 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.799 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.861 177.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 69.3 m -59.72 -37.24 78.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.98 0.419 . . . . 0.0 110.384 178.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -68.59 -26.5 65.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.994 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.0 mp -97.71 150.01 21.67 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.31 0.576 . . . . 0.0 112.105 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -75.58 154.66 36.61 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.793 178.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.95 2.05 45.59 Favored Glycine 0 CA--C 1.505 -0.543 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.971 177.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.8 tt -72.62 108.13 3.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.253 0.549 . . . . 0.0 110.794 178.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.449 ' HB ' ' O ' ' A' ' 50' ' ' LYS . 46.0 mm -101.88 -71.47 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.816 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 52.2 m -155.65 158.41 38.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.752 0.31 . . . . 0.0 111.242 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.8 ptm -148.74 148.53 30.11 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.242 175.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.499 ' HB3' ' HB ' ' A' ' 48' ' ' THR . 55.1 tttp -117.36 112.0 20.11 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.317 176.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.7 p -118.79 114.43 44.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-O 121.409 0.623 . . . . 0.0 110.008 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.7 m -124.98 127.01 46.36 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.02 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 93.8 mt -63.29 -39.07 93.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.225 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -61.75 -39.32 91.19 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.258 0.552 . . . . 0.0 110.365 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -72.56 -30.11 64.14 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.465 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.66 14.94 80.87 Favored Glycine 0 C--O 1.236 0.255 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.036 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 89.7 p -156.17 164.4 38.42 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.56 134.78 55.07 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.926 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.499 ' HB ' ' HB3' ' A' ' 39' ' ' LYS . 53.4 m -94.54 124.32 38.5 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 177.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' A' ' 8' ' ' THR . 28.9 m -107.86 142.0 21.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.457 -177.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.449 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 87.7 tttt -131.58 104.58 7.03 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.478 -0.783 . . . . 0.0 108.926 178.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.518 ' CE2' ' HB ' ' A' ' 49' ' ' VAL . 64.5 m-85 -140.25 160.38 40.09 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.967 -177.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.0 t -80.44 117.08 66.08 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 30.1 Cg_endo -62.28 -25.83 76.92 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.142 2.561 . . . . 0.0 113.096 -176.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.8 t -62.94 -41.57 99.53 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.054 0.454 . . . . 0.0 110.334 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.1 t -87.53 -49.81 14.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.3 -177.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 28.5 m -132.82 161.68 41.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.484 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 31.1 p -133.74 169.72 16.63 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 120.679 0.276 . . . . 0.0 110.899 -178.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.1 mt -62.6 -38.59 90.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.51 -177.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -60.32 -44.49 95.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.43 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.491 ' O ' ' HG3' ' A' ' 64' ' ' GLN . 97.0 mt-30 -64.42 -41.06 96.82 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.104 178.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 73.6 t -62.08 -46.13 97.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 CA-C-O 121.133 0.492 . . . . 0.0 110.353 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.499 ' SG ' ' HB ' ' A' ' 74' ' ' ILE . 93.8 m -62.78 -39.71 95.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.848 178.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -62.47 -41.64 98.92 Favored 'General case' 0 C--O 1.206 -1.226 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.052 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.491 ' HG3' ' O ' ' A' ' 60' ' ' GLN . 78.5 mt-30 -60.39 -42.42 95.87 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -175.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.402 ' HB ' HD13 ' A' ' 25' ' ' ILE . 17.4 tt -76.77 -40.95 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.571 178.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.571 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -63.33 -38.33 96.26 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 121.334 -0.46 . . . . 0.0 112.381 178.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -58.72 -33.59 70.38 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 124.261 1.024 . . . . 0.0 110.509 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.459 ' HG3' ' HB3' ' A' ' 24' ' ' SER . 96.6 mmm -79.09 -1.32 35.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.936 -178.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.17 15.55 44.26 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.149 -1.024 . . . . 0.0 113.589 177.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.571 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 99.3 m-85 -113.8 145.86 40.79 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.788 0.328 . . . . 0.0 110.354 178.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -88.52 130.75 35.16 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 120.983 0.421 . . . . 0.0 111.028 -178.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.46 140.2 24.85 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.644 178.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.7 m -127.0 141.49 51.78 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.1 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.499 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 10.2 tp -98.33 136.32 29.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 120.859 0.361 . . . . 0.0 110.498 -177.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -154.43 159.35 41.02 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.23 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 . . . . . 0 C--O 1.252 1.198 0 CA-C-O 118.152 -0.928 . . . . 0.0 110.721 179.094 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.7 t . . . . . 0 N--CA 1.439 -1.006 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.01 134.11 44.5 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.137 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 69.8 p -123.73 137.52 54.68 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.855 178.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 72.7 m -147.11 157.3 43.56 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.448 178.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 38.4 p -110.01 139.23 45.35 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 177.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.444 ' CG2' ' HB2' ' A' ' 72' ' ' ALA . 7.0 p -129.74 119.69 48.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-O 120.967 0.413 . . . . 0.0 110.205 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.502 ' HG2' ' HB2' ' A' ' 73' ' ' SER . 9.2 ptm180 -82.21 148.79 28.24 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.9 pt -112.81 142.66 24.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 121.278 0.561 . . . . 0.0 111.123 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 67.1 tp -132.69 119.74 20.78 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.166 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 178.41 174.41 44.64 Favored Glycine 0 N--CA 1.436 -1.305 0 C-N-CA 119.27 -1.443 . . . . 0.0 113.831 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 28.1 ttt -62.06 -48.13 81.6 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 122.987 0.515 . . . . 0.0 111.426 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.4 p -128.86 119.34 24.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.066 0.46 . . . . 0.0 111.297 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.8 m -65.47 -39.02 91.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.118 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -63.42 -39.47 94.58 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.449 -177.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.8 m -62.67 -43.73 98.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.543 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.0 p -71.83 -39.65 69.64 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -178.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.7 m -69.99 -33.02 53.57 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 120.291 -0.563 . . . . 0.0 111.051 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -71.09 -42.28 69.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.111 0.482 . . . . 0.0 110.863 177.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.5 m -62.73 -43.55 98.51 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.041 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.561 ' HB ' ' CG2' ' A' ' 65' ' ' ILE . 19.3 tt -71.56 -29.71 35.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.618 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -59.63 -45.16 92.8 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.559 -177.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -61.97 -50.8 70.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.795 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.491 HH11 ' HA ' ' A' ' 64' ' ' GLN . 99.4 mtt180 -65.47 -39.95 92.57 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -177.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 27.6 mm -60.99 -44.56 98.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.99 0.424 . . . . 0.0 110.328 176.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.7 t -62.54 -39.93 95.18 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.385 178.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -68.56 -28.78 67.26 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.006 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 64.4 tp -100.38 118.13 35.99 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.133 0.492 . . . . 0.0 111.478 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -83.22 153.05 24.92 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.056 178.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.29 -11.4 12.86 Favored Glycine 0 CA--C 1.499 -0.91 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -176.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.6 tt -108.42 110.43 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 173.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.14 -47.03 95.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.864 -174.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 85.0 p -158.85 160.57 36.33 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.479 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 28.0 ttt -146.69 129.87 16.54 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.554 177.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -121.3 139.76 52.98 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.6 m -116.52 140.27 39.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 120.873 0.368 . . . . 0.0 110.894 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.6 t -119.64 106.81 12.53 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.778 178.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.8 mp -64.65 -39.72 94.17 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.271 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -62.3 -44.98 95.26 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.501 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -75.71 -28.68 58.68 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.048 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.21 25.62 65.83 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -176.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 12' ' ' ARG . 45.4 t -145.32 150.98 37.59 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.079 -0.56 . . . . 0.0 110.034 -176.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.04 145.88 45.51 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.361 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 87.2 m -105.82 126.02 51.67 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 8' ' ' THR . 23.7 m -110.6 138.3 39.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-O 120.966 0.412 . . . . 0.0 110.382 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -128.43 108.08 10.26 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -149.19 165.99 30.17 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.029 0.442 . . . . 0.0 112.035 -171.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 52.1 t -79.72 119.8 77.99 Favored Pre-proline 0 C--N 1.319 -0.741 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 174.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -60.68 -32.21 92.92 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.649 2.232 . . . . 0.0 113.281 -174.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.6 t -65.06 -41.93 94.67 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.001 0.429 . . . . 0.0 110.934 178.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.0 t -81.42 -46.04 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -175.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 74.0 t -114.75 133.88 59.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -173.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 29.1 p -109.25 147.95 31.77 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.285 177.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.402 HD11 HG23 ' A' ' 74' ' ' ILE . 87.1 mt -64.56 -40.3 95.32 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -176.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -62.6 -39.72 94.65 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -177.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -61.85 -41.6 98.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.961 0.41 . . . . 0.0 109.999 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.4 t -63.31 -44.49 99.12 Favored 'Isoleucine or valine' 0 C--O 1.247 0.924 0 CA-C-O 121.47 0.652 . . . . 0.0 110.403 177.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 97.2 m -61.65 -38.31 87.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.15 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 61.4 m170 -66.87 -26.17 66.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.088 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.491 ' HA ' HH11 ' A' ' 28' ' ' ARG . 78.8 mt-30 -60.73 -43.65 97.63 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 120.79 0.328 . . . . 0.0 110.432 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.561 ' CG2' ' HB ' ' A' ' 25' ' ' ILE . 36.6 pt -87.65 -25.89 5.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.251 176.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -61.5 -35.96 91.86 Favored Glycine 0 N--CA 1.453 -0.22 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.467 178.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -58.83 -37.43 76.41 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.856 0.36 . . . . 0.0 110.935 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 26.4 mmt -79.63 1.2 27.08 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.733 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.9 10.3 60.1 Favored Glycine 0 CA--C 1.508 -0.404 0 C-N-CA 120.604 -0.808 . . . . 0.0 113.035 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.458 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 72.2 m-85 -98.84 139.14 34.95 Favored 'General case' 0 C--N 1.315 -0.901 0 O-C-N 122.645 -0.326 . . . . 0.0 110.235 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -100.75 151.15 22.01 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.353 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.471 ' HB1' HD11 ' A' ' 65' ' ' ILE . . . -144.93 156.69 44.12 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 120.782 0.325 . . . . 0.0 111.242 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.502 ' HB2' ' HG2' ' A' ' 12' ' ' ARG . 40.4 m -129.19 146.8 51.04 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.402 HG23 HD11 ' A' ' 58' ' ' LEU . 84.2 mt -101.95 127.18 55.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.238 0.542 . . . . 0.0 111.947 -174.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -128.52 157.14 42.0 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.135 177.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 . . . . . 0 C--O 1.242 0.678 0 C-N-CA 123.37 0.668 . . . . 0.0 110.283 -176.985 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.408 HG12 HD12 ' A' ' 36' ' ' ILE . 61.8 t . . . . . 0 N--CA 1.433 -1.295 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.78 148.05 25.36 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.768 -175.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.8 p -100.64 136.05 41.11 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.174 176.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.3 m -126.8 145.86 50.47 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 120.704 0.288 . . . . 0.0 110.227 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 46.5 p -117.16 140.1 49.94 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.347 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.91 126.76 38.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.447 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.456 ' HG2' ' HB3' ' A' ' 73' ' ' SER . 14.7 ptm180 -83.42 149.17 26.84 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.714 HG23 ' SG ' ' A' ' 21' ' ' CYS . 86.0 mt -123.1 130.51 74.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -176.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.7 tp -131.61 119.07 20.93 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -173.42 -177.27 42.53 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.247 -0.977 . . . . 0.0 112.403 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 66.8 mtt -63.78 -43.22 97.01 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.6 m -136.6 116.91 13.58 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.633 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.41 ' O ' HG23 ' A' ' 22' ' ' VAL . 94.1 m -65.57 -40.23 92.56 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.729 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -62.82 -40.87 98.74 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -177.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.9 m -62.5 -44.27 96.79 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -177.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.714 ' SG ' HG23 ' A' ' 13' ' ' ILE . 24.5 p -71.38 -35.73 71.18 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.64 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 18' ' ' CYS . 59.0 t -62.76 -44.22 99.33 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 177.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.96 -40.25 97.14 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.114 177.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.7 t -60.63 -47.64 85.32 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.295 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.6 pt -74.25 -29.4 24.63 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.899 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -59.53 -48.83 80.13 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -65.41 -51.18 62.09 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.306 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -62.27 -50.71 70.61 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-O 121.192 0.52 . . . . 0.0 111.631 -174.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.407 ' CG2' HD11 ' A' ' 35' ' ' ILE . 37.4 mm -62.83 -41.98 94.63 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.929 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.752 179.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 73.2 m -60.56 -38.81 85.74 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -68.52 -27.17 65.87 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.035 177.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 60.5 tp -87.25 129.69 34.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.148 0.499 . . . . 0.0 110.966 177.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -70.81 151.88 44.33 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.354 177.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.95 -4.97 18.55 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.881 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.407 HD11 ' CG2' ' A' ' 29' ' ' ILE . 9.3 tt -96.14 138.32 21.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.84 0.353 . . . . 0.0 110.899 178.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.408 HD12 HG12 ' A' ' 6' ' ' VAL . 86.4 mt -113.02 -53.31 5.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.793 176.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.9 m -137.52 151.72 48.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.889 0.376 . . . . 0.0 111.694 -177.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.41 ' HG3' HG12 ' A' ' 49' ' ' VAL . 60.6 ttm -139.14 131.21 27.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.394 176.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -128.79 124.54 35.7 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.9 m -126.61 140.0 50.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.381 -179.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.4 t -134.74 108.3 7.91 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.973 177.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.5 mp -66.5 -32.57 74.01 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.643 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -61.74 -39.92 93.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.283 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -75.41 -27.39 59.01 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.06 0.457 . . . . 0.0 110.14 176.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.2 15.47 81.0 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 -177.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 12' ' ' ARG . 51.1 m -135.13 153.69 51.91 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 121.085 0.469 . . . . 0.0 110.627 -178.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.66 139.19 51.91 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.498 178.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 79.6 m -115.18 125.5 53.48 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.41 HG12 ' HG3' ' A' ' 38' ' ' MET . 31.5 m -125.58 148.05 30.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.977 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -124.1 116.53 22.92 Favored 'General case' 0 C--O 1.245 0.838 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.57 ' CD2' ' HB ' ' A' ' 56' ' ' VAL . 55.3 p90 -152.61 166.15 32.99 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.474 -173.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.8 t -77.5 117.99 69.09 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.03 -30.37 82.85 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.769 2.313 . . . . 0.0 113.546 -175.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.3 t -64.78 -44.19 90.8 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.039 0.447 . . . . 0.0 110.828 178.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 90.9 t -72.7 -47.17 51.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.71 -177.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.57 ' HB ' ' CD2' ' A' ' 51' ' ' TYR . 58.3 t -112.63 126.3 70.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.093 -177.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.466 ' SG ' ' HB2' ' A' ' 60' ' ' GLN . 28.6 p -100.92 158.35 16.05 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 120.989 0.423 . . . . 0.0 111.473 -178.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.3 mt -63.41 -39.12 93.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.576 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -62.19 -39.93 94.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.671 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.494 ' O ' ' HG3' ' A' ' 64' ' ' GLN . 64.9 tt0 -61.16 -46.55 90.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.627 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.5 t -61.93 -44.44 98.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.625 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 93.3 m -61.66 -41.46 97.56 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.089 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -66.04 -41.13 91.28 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.759 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 60' ' ' GLN . 95.6 mt-30 -60.87 -42.24 97.51 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.985 -175.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.0 tt -84.04 -41.23 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.98 -40.18 98.99 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 116.303 -0.408 . . . . 0.0 113.501 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -60.51 -35.82 76.88 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.936 0.398 . . . . 0.0 110.571 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 26.5 mmt -69.76 -11.95 61.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.468 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.98 12.21 32.44 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.394 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.52 ' CG ' ' HB3' ' A' ' 21' ' ' CYS . 94.9 m-85 -110.32 125.48 53.22 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -76.96 139.11 40.02 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.624 -178.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.13 155.18 41.94 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 120.889 0.376 . . . . 0.0 111.603 -177.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.456 ' HB3' ' HG2' ' A' ' 12' ' ' ARG . 42.0 t -137.29 139.95 41.24 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 36.4 pt -105.67 151.82 7.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -173.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.543 ' O ' ' HB2' ' A' ' 76' ' ' GLU . . . -151.35 160.26 43.86 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.7 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.543 ' HB2' ' O ' ' A' ' 75' ' ' ALA . 39.5 mm-40 . . . . . 0 C--O 1.251 1.148 0 C-N-CA 123.3 0.64 . . . . 0.0 110.879 -178.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.5 m . . . . . 0 N--CA 1.439 -0.979 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.98 147.27 42.44 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.103 0.478 . . . . 0.0 111.885 -175.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 53.9 p -119.35 150.15 40.64 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.715 176.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.446 ' OG ' HD22 ' A' ' 58' ' ' LEU . 87.5 p -155.34 160.35 40.66 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.314 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 41.2 p -127.77 146.09 50.7 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.538 176.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.5 m -128.92 146.19 34.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.45 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 38.5 ptt180 -106.67 140.99 38.65 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.528 HG12 ' SG ' ' A' ' 21' ' ' CYS . 7.8 tp -120.08 131.51 72.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-O 121.679 0.752 . . . . 0.0 112.424 -173.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 65.7 tp -124.67 118.19 25.93 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.52 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -170.01 169.32 42.09 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 119.938 -1.125 . . . . 0.0 112.733 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 79.3 mtm -64.09 -42.81 96.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.786 0.327 . . . . 0.0 111.377 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.7 p -132.52 122.54 25.01 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.193 0.52 . . . . 0.0 111.57 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.1 t -63.6 -41.9 98.28 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.141 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.8 mp0 -61.51 -40.42 94.54 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.295 -176.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.7 m -62.84 -45.59 91.9 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -177.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.528 ' SG ' HG12 ' A' ' 13' ' ' ILE . 26.7 p -68.71 -35.66 77.46 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.178 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 67.6 t -62.91 -44.32 99.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-O 121.114 0.483 . . . . 0.0 109.759 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -64.81 -40.13 94.71 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.012 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.6 m -62.74 -46.65 87.08 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.376 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.533 ' HB ' ' CG2' ' A' ' 65' ' ' ILE . 8.1 tp -69.9 -31.94 49.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.009 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -58.84 -42.81 90.16 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.316 -178.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -59.3 -53.57 56.75 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.406 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 24.0 ttm180 -67.14 -47.15 71.93 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.118 -178.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.59 ' O ' HD11 ' A' ' 35' ' ' ILE . 18.5 tt -65.76 -41.43 90.29 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.987 -175.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 86.6 p -66.33 -30.09 70.42 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-O 121.062 0.458 . . . . 0.0 110.488 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -70.62 -27.09 63.81 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.841 177.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 28' ' ' ARG . 89.9 mt -91.72 137.63 32.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.189 0.518 . . . . 0.0 111.775 -178.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -86.72 151.62 23.24 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.841 177.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.58 8.22 12.71 Favored Glycine 0 C--O 1.238 0.369 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.658 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.59 HD11 ' O ' ' A' ' 29' ' ' ILE . 79.8 mt -81.67 121.98 35.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 83.6 mt -94.24 -54.77 6.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.0 t -149.06 124.21 10.12 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.97 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.418 ' SD ' HD12 ' A' ' 29' ' ' ILE . 27.2 ttt -121.24 113.58 20.16 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.125 177.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -133.29 145.68 50.69 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.139 178.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.45 126.51 74.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.222 0.534 . . . . 0.0 110.089 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.8 m -93.65 91.99 7.31 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.152 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.8 mt -63.54 -35.98 82.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.603 0.716 . . . . 0.0 109.235 178.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -62.84 -40.28 96.95 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.844 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -90.33 -12.19 38.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.046 -177.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.5 29.69 69.64 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.379 -0.915 . . . . 0.0 111.471 -177.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 90.1 p -151.06 163.66 38.25 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -119.07 145.83 45.59 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.533 0.206 . . . . 0.0 110.82 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.3 m -112.93 121.95 46.18 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.0 t -120.49 123.19 69.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-O 120.884 0.373 . . . . 0.0 110.371 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -109.2 119.38 39.35 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 176.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -150.77 166.68 29.72 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.697 -170.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.9 t -92.05 110.82 46.62 Favored Pre-proline 0 N--CA 1.444 -0.755 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 173.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.27 -21.72 67.02 Favored 'Trans proline' 0 N--CA 1.475 0.427 0 C-N-CA 122.88 2.387 . . . . 0.0 113.467 -175.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.5 t -64.37 -42.71 96.04 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.173 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.8 p -95.11 -35.71 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.2 p -130.14 149.89 34.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -177.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 29.6 p -134.01 163.06 30.39 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.19 0.519 . . . . 0.0 111.663 -175.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.446 HD22 ' OG ' ' A' ' 9' ' ' SER . 98.6 mt -70.8 -22.53 62.34 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.982 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -61.73 -42.3 98.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.07 0.462 . . . . 0.0 110.14 -179.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -65.15 -40.89 95.01 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.182 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.433 ' HB ' HD12 ' A' ' 25' ' ' ILE . 32.7 m -72.71 -36.4 52.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.53 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 95.6 m -64.18 -39.51 94.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.665 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 66.3 m170 -64.31 -39.94 94.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.314 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -60.83 -43.79 97.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.606 -177.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.533 ' CG2' ' HB ' ' A' ' 25' ' ' ILE . 27.2 pt -87.04 -37.87 11.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -178.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -62.94 -40.71 99.62 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.888 -0.673 . . . . 0.0 113.137 -178.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -70.13 -14.91 62.86 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 26.3 mmt -85.11 2.34 43.88 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.907 0.384 . . . . 0.0 110.817 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.48 -9.2 71.73 Favored Glycine 0 CA--C 1.507 -0.407 0 C-N-CA 121.066 -0.587 . . . . 0.0 112.188 179.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.459 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 96.8 m-85 -80.89 143.57 32.61 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -106.25 128.31 53.87 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.643 -177.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 12' ' ' ARG . . . -147.31 151.23 36.24 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.466 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.8 p -136.77 153.63 50.78 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.903 0.382 . . . . 0.0 111.341 178.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 81.3 mt -90.98 131.86 37.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.908 -174.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -133.67 126.54 31.02 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.454 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 . . . . . 0 C--N 1.314 -0.97 0 CA-C-O 118.062 -0.97 . . . . 0.0 110.657 179.691 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.455 -0.212 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -108.77 134.55 51.32 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.287 0.565 . . . . 0.0 112.27 -173.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 50.5 p -123.97 140.5 52.92 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.976 174.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 91.3 p -158.46 166.85 31.2 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.019 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 2.1 p -110.32 148.48 31.85 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 175.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 91.1 t -131.01 126.89 60.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.418 ' NE ' ' HB2' ' A' ' 73' ' ' SER . 37.9 ptt180 -87.8 144.62 26.51 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.589 HG12 ' SG ' ' A' ' 21' ' ' CYS . 7.4 tp -129.61 130.3 66.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-O 121.163 0.506 . . . . 0.0 111.134 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 62.0 tp -129.47 124.22 33.48 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.478 178.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -165.18 176.25 40.9 Favored Glycine 0 N--CA 1.435 -1.425 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.157 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 61.0 tpp -61.52 -47.91 83.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.884 0.373 . . . . 0.0 111.024 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 65.9 m -130.4 125.16 33.84 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.119 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.8 t -63.23 -43.59 97.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.396 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -61.52 -38.76 88.57 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.528 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.0 m -60.47 -44.21 96.12 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -177.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.589 ' SG ' HG12 ' A' ' 13' ' ' ILE . 25.6 p -70.99 -36.95 72.68 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.235 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.9 t -63.18 -44.53 99.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-O 121.123 0.487 . . . . 0.0 109.764 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -64.41 -40.38 95.67 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.878 178.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.622 ' O ' ' HD3' ' A' ' 28' ' ' ARG . 68.9 m -62.11 -45.04 95.23 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.38 -178.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.447 ' HB ' ' HB ' ' A' ' 65' ' ' ILE . 17.9 tt -70.93 -33.77 53.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.849 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -60.22 -48.01 83.54 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.934 -177.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -61.55 -46.69 88.86 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.887 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.622 ' HD3' ' O ' ' A' ' 24' ' ' SER . 10.9 mpt_? -70.41 -41.75 72.53 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.754 -177.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.593 ' O ' HD12 ' A' ' 35' ' ' ILE . 16.6 tt -70.66 -39.81 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.163 -177.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 79.5 p -66.06 -28.33 68.76 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 120.988 0.423 . . . . 0.0 110.515 178.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -67.96 -28.76 67.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.793 175.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.4 tp -86.95 118.66 26.48 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.655 177.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -78.58 142.9 36.94 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.949 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.22 8.86 11.03 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.815 -178.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.593 HD12 ' O ' ' A' ' 29' ' ' ILE . 90.0 mt -70.75 125.12 28.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.633 ' HB ' ' O ' ' A' ' 50' ' ' LYS . 47.9 mm -88.21 -63.85 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.1 t -161.82 140.11 9.21 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.805 177.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 18.8 tmm? -137.27 126.37 24.46 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 176.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -125.14 115.68 20.84 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.2 p -103.16 122.32 55.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-O 121.172 0.51 . . . . 0.0 110.296 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.4 m -96.89 99.95 11.49 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 97.1 mt -63.9 -38.89 92.75 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.937 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -63.69 -40.25 96.32 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.978 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -77.1 -30.01 55.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.9 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.68 20.17 71.8 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -175.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.0 t -146.5 150.36 35.43 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -178.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -119.53 148.77 42.9 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 120.804 0.335 . . . . 0.0 111.735 -177.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.2 m -108.35 124.48 50.41 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.684 ' HB ' ' CE2' ' A' ' 51' ' ' TYR . 33.6 m -119.32 149.6 21.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.621 -176.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.633 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 65.3 tttm -140.05 106.36 5.27 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.684 ' CE2' ' HB ' ' A' ' 49' ' ' VAL . 42.2 m-85 -138.37 161.92 35.73 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -177.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 64.8 t -88.34 110.41 36.09 Favored Pre-proline 0 N--CA 1.439 -1.0 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 172.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 36.2 Cg_endo -64.21 -23.48 66.35 Favored 'Trans proline' 0 CA--C 1.514 -0.489 0 C-N-CA 122.592 2.195 . . . . 0.0 112.341 -176.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 61.9 m -62.95 -42.0 99.68 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 177.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.5 t -75.1 -48.42 32.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.826 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 7.5 p -146.68 139.54 19.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.954 -178.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 26.5 p -83.51 153.71 24.26 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.107 0.479 . . . . 0.0 111.196 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.1 mt -66.06 -37.26 85.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.759 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -60.04 -40.61 89.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.436 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.406 HE21 ' HB3' ' A' ' 60' ' ' GLN . 1.0 OUTLIER -62.14 -41.02 97.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.192 0.52 . . . . 0.0 109.633 179.12 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 73.9 t -63.41 -44.24 98.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.084 178.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 49.6 t -60.42 -41.52 94.14 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.146 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -61.07 -41.4 96.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.367 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -61.08 -41.65 97.04 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 -176.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.447 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 20.3 tt -76.89 -38.25 28.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.94 178.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.593 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -64.35 -38.49 95.9 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-N 115.699 -0.682 . . . . 0.0 113.702 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -58.1 -35.8 71.97 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.275 0.63 . . . . 0.0 112.081 -175.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 15.7 tpt -57.76 -25.82 61.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.786 -178.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 123.66 6.19 7.36 Favored Glycine 0 CA--C 1.5 -0.901 0 C-N-CA 120.229 -0.986 . . . . 0.0 112.188 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.593 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 65.2 m-85 -110.16 135.96 50.13 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -89.33 121.59 31.75 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.236 0.541 . . . . 0.0 111.751 -174.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.54 135.72 54.16 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.126 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.418 ' HB2' ' NE ' ' A' ' 12' ' ' ARG . 45.5 m -131.62 144.78 51.3 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.6 tt -69.45 128.18 32.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 121.47 0.652 . . . . 0.0 110.902 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -97.74 134.51 40.81 Favored 'General case' 0 C--O 1.261 1.673 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.657 177.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 . . . . . 0 C--O 1.249 1.058 0 O-C-N 124.832 1.333 . . . . 0.0 110.658 -176.155 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.9 t . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -113.58 139.57 48.89 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 120.893 0.378 . . . . 0.0 111.23 -177.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 67.6 p -121.61 148.21 44.84 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.097 178.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.2 t -158.31 157.0 31.61 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 73.5 p -117.1 142.06 47.48 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 120.799 0.333 . . . . 0.0 110.335 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.9 m -131.89 145.8 34.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.364 178.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 45.8 ptt85 -108.86 142.95 38.71 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 175.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.7 pt -118.26 142.98 30.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-O 121.458 0.647 . . . . 0.0 112.006 -175.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.2 tp -110.12 118.44 36.41 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.728 177.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.44 140.04 4.15 Favored Glycine 0 N--CA 1.434 -1.495 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.349 179.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 95.9 mmm -67.97 -37.71 81.85 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.233 0.539 . . . . 0.0 109.924 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.0 p -111.22 58.16 0.62 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.883 177.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 26.3 p -59.56 -30.66 68.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.767 -175.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -64.49 -33.99 77.18 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.741 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.3 t -66.41 -45.34 80.29 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.439 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.514 ' HB3' ' CD1' ' A' ' 70' ' ' PHE . 28.4 p -66.05 -35.06 79.51 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.267 -177.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 69.9 t -61.81 -45.71 98.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -65.43 -42.24 92.66 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.947 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.3 m -63.97 -42.9 97.12 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.287 -178.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 21' ' ' CYS . 46.9 pt -78.56 -27.12 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.401 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -61.77 -39.45 91.68 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -59.98 -43.13 95.32 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.693 176.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -64.26 -43.31 95.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.185 0.517 . . . . 0.0 110.277 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.41 -46.25 96.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.603 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 88.1 p -64.62 -28.38 69.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.71 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -72.78 -27.35 61.94 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.927 0.394 . . . . 0.0 110.573 177.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.3 tt -81.74 123.88 29.13 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -83.38 147.48 27.87 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.778 0.323 . . . . 0.0 111.417 -177.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.31 7.67 56.93 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.774 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.8 pt -75.0 139.29 19.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.772 0.32 . . . . 0.0 111.176 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.611 ' HB ' ' O ' ' A' ' 50' ' ' LYS . 42.1 mm -89.19 -79.84 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.954 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 82.2 p -168.61 166.68 11.82 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.788 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -156.99 159.11 37.72 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 175.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -129.69 132.78 46.75 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 69.8 t -116.21 125.68 73.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 120.827 0.346 . . . . 0.0 110.789 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.6 t -103.34 102.48 12.43 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 177.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.6 tp -62.4 -42.72 99.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.765 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.2 -45.45 94.54 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.459 -178.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -74.96 -29.69 61.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.411 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.65 16.14 78.15 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.0 m -129.48 152.39 49.07 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.342 -0.429 . . . . 0.0 110.144 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -128.39 149.35 50.57 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.544 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.7 m -113.41 126.6 55.53 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.482 ' HB ' ' CE2' ' A' ' 51' ' ' TYR . 27.5 m -114.29 146.39 18.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.466 -177.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.611 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 87.6 tttt -132.2 104.17 6.63 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.482 ' CE2' ' HB ' ' A' ' 49' ' ' VAL . 84.5 m-85 -141.52 160.11 40.84 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 120.995 0.426 . . . . 0.0 111.853 -176.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.8 m -98.66 112.45 62.6 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.518 176.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -56.17 -26.62 61.54 Favored 'Trans proline' 0 N--CA 1.48 0.686 0 C-N-CA 123.265 2.643 . . . . 0.0 112.162 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.2 t -61.08 -42.27 98.2 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.274 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.9 t -101.22 -40.28 7.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -177.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -130.2 139.65 50.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.162 0.506 . . . . 0.0 111.488 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.405 ' SG ' ' HB3' ' A' ' 59' ' ' GLN . 42.6 t -93.16 121.89 34.98 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.434 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.3 mp -63.76 -37.45 87.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.607 178.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.405 ' HB3' ' SG ' ' A' ' 57' ' ' CYS . 57.5 tp60 -60.76 -39.31 88.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.679 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.401 ' HG2' ' HG ' ' A' ' 57' ' ' CYS . 15.7 mm100 -62.89 -38.56 91.39 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.32 178.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 75.6 t -60.83 -42.68 93.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.675 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 42.6 t -60.22 -39.61 87.23 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.937 176.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -64.15 -35.12 79.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.383 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -60.57 -42.24 96.25 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.484 -178.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.428 ' HB ' HG22 ' A' ' 25' ' ' ILE . 20.2 tt -76.55 -37.55 29.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 120.294 -0.563 . . . . 0.0 111.318 178.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.48 -44.24 97.88 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.452 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -67.18 -31.48 71.91 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.284 0.564 . . . . 0.0 110.297 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 50.1 tpp -59.23 -29.18 67.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.217 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 119.35 5.39 11.44 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.479 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.514 ' CD1' ' HB3' ' A' ' 21' ' ' CYS . 89.5 m-85 -112.78 131.04 55.86 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 120.977 0.418 . . . . 0.0 110.577 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -85.55 134.99 34.0 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.191 -177.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -133.19 147.6 52.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.836 0.35 . . . . 0.0 111.337 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.6 t -119.14 132.67 56.01 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 15.2 tt -103.49 134.19 45.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.502 0.668 . . . . 0.0 111.977 -175.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.4 ' O ' ' HB3' ' A' ' 76' ' ' GLU . . . -135.22 157.5 46.75 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.867 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' A' ' 75' ' ' ALA . 43.2 tt0 . . . . . 0 C--O 1.245 0.854 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.628 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.6 t . . . . . 0 N--CA 1.443 -0.811 0 CA-C-O 120.895 0.379 . . . . 0.0 110.107 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 50' ' ' LYS . . . -121.43 123.94 43.3 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.494 179.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.8 p -125.62 151.82 45.99 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.055 0.455 . . . . 0.0 110.684 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.5 t -158.27 146.35 18.53 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.9 178.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 41.9 p -111.5 109.95 20.14 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 175.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.7 p -92.34 115.43 31.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 40.1 ptt180 -82.22 148.04 28.64 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.223 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.8 131.07 70.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-O 121.049 0.452 . . . . 0.0 110.861 -176.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.9 tt -115.16 115.11 26.21 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -171.25 151.91 16.79 Favored Glycine 0 N--CA 1.434 -1.492 0 C-N-CA 120.211 -0.995 . . . . 0.0 112.596 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 23.0 ptt? -74.98 -23.99 58.37 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 122.756 0.422 . . . . 0.0 111.295 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.5 p -122.48 85.57 2.44 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.284 0.564 . . . . 0.0 109.636 177.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.4 m -63.83 -39.98 95.52 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.303 -176.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.429 ' HA ' HG13 ' A' ' 22' ' ' VAL . 98.7 mt-30 -64.38 -41.0 96.93 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -175.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.0 p -64.9 -41.43 95.61 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.776 -177.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.584 ' HB3' ' CD2' ' A' ' 70' ' ' PHE . 20.3 p -74.46 -39.16 62.7 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.429 HG13 ' HA ' ' A' ' 19' ' ' GLN . 9.0 p -68.5 -37.68 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.61 -178.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -64.36 -40.76 96.5 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.978 0.418 . . . . 0.0 110.052 176.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.2 m -61.9 -44.72 96.22 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.671 -178.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.454 HD12 ' HB ' ' A' ' 65' ' ' ILE . 16.2 tt -74.19 -38.65 48.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.726 -0.389 . . . . 0.0 111.425 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.07 -44.29 96.99 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 120.85 0.357 . . . . 0.0 110.948 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -60.73 -44.08 97.1 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.586 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.573 ' HD3' ' NE2' ' A' ' 64' ' ' GLN . 99.4 mtt180 -65.33 -46.07 81.77 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.169 -177.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.423 HG22 HD12 ' A' ' 35' ' ' ILE . 98.0 mt -65.96 -44.8 92.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.092 -178.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 77.8 p -64.03 -34.58 78.32 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.032 -179.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -71.81 -26.78 62.55 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.094 0.473 . . . . 0.0 110.74 177.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 28' ' ' ARG . 93.3 mt -82.9 142.32 31.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.543 178.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -76.79 141.21 40.83 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.16 -8.04 18.59 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.876 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.423 HD12 HG22 ' A' ' 29' ' ' ILE . 7.2 tt -75.24 110.1 9.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 176.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.9 mt -84.27 -51.19 14.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.278 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.9 t -160.38 145.75 14.89 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.522 177.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.3 ttt -135.85 132.16 36.26 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.088 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -130.34 130.82 44.94 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 178.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.1 t -103.92 120.36 53.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 120.836 0.35 . . . . 0.0 110.397 -178.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 51.0 m -119.73 96.46 5.2 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-O 121.467 0.651 . . . . 0.0 110.63 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.4 -35.41 80.82 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.259 -178.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -61.65 -39.63 92.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.535 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -76.76 -22.68 53.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.139 176.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.56 21.75 68.66 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 89.9 p -149.33 164.93 33.49 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 121.058 0.456 . . . . 0.0 111.326 -177.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.55 137.44 52.58 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 65.3 m -104.56 125.64 50.91 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.806 -177.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.0 m -129.25 150.03 34.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-O 120.883 0.373 . . . . 0.0 111.369 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 14.3 ptmm? -131.45 135.71 47.36 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 173.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -157.2 171.45 20.41 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.95 -169.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.6 t -94.16 114.25 62.77 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 173.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -52.99 -39.1 80.36 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 C-N-CA 123.628 2.886 . . . . 0.0 114.97 -174.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.8 m -69.02 -41.98 77.01 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.898 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.9 t -70.71 -43.51 77.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.708 -176.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 30.9 m -128.65 148.65 33.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.047 0.451 . . . . 0.0 110.766 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.534 ' SG ' ' HB2' ' A' ' 59' ' ' GLN . 43.5 t -102.23 128.32 48.8 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.563 -177.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.7 tp -61.51 -38.12 86.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.317 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.534 ' HB2' ' SG ' ' A' ' 57' ' ' CYS . 80.6 mt-30 -60.33 -39.53 87.4 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.524 178.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.692 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 97.8 mt-30 -61.75 -39.39 91.42 Favored 'General case' 0 C--O 1.214 -0.783 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.879 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 73.2 t -59.4 -46.3 92.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.243 -178.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 42.3 t -61.12 -42.36 98.4 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.089 177.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -67.42 -37.58 83.26 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.3 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.692 ' HG2' ' O ' ' A' ' 60' ' ' GLN . 13.6 mm100 -61.0 -41.46 96.55 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.958 0.409 . . . . 0.0 111.013 -175.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.454 ' HB ' HD12 ' A' ' 25' ' ' ILE . 18.8 tt -82.52 -33.11 10.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.664 177.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.85 -40.84 98.78 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.798 -0.637 . . . . 0.0 114.025 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -72.8 -11.4 60.59 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 117.797 0.799 . . . . 0.0 110.961 -177.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 16.4 tpt -66.02 -28.6 68.99 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.764 176.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 116.52 9.14 11.69 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.806 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.584 ' CD2' ' HB3' ' A' ' 21' ' ' CYS . 98.3 m-85 -117.79 145.29 44.63 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -84.71 133.16 34.39 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.48 -177.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 12' ' ' ARG . . . -147.71 150.2 33.86 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.934 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 86.0 p -140.69 158.92 43.27 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.615 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 91.4 mt -91.2 122.69 42.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.053 -177.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -133.17 160.93 35.79 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 C--N 1.305 -1.35 0 CA-C-O 118.133 -0.937 . . . . 0.0 110.595 178.663 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.0 m . . . . . 0 N--CA 1.449 -0.521 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -143.79 152.85 41.75 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.76 0.314 . . . . 0.0 110.61 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 82.7 p -127.3 154.91 44.34 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.613 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.416 ' HB3' HG12 ' A' ' 49' ' ' VAL . 14.8 t -159.02 164.2 35.72 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 53.1 p -118.11 144.68 45.45 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.5 p -143.71 129.47 15.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 120.921 0.391 . . . . 0.0 111.098 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -89.06 146.92 24.53 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.6 mp -111.43 120.63 62.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 59.5 tp -114.71 112.71 23.26 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.991 0.424 . . . . 0.0 110.559 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -167.41 157.59 30.06 Favored Glycine 0 N--CA 1.44 -1.068 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.197 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 59.6 ttm -64.6 -43.02 95.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.992 0.425 . . . . 0.0 110.813 178.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.1 p -113.01 108.33 17.19 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.792 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 23.8 p -69.88 -41.23 75.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.105 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -63.94 -41.53 97.59 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.836 0.351 . . . . 0.0 111.035 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.6 t -61.5 -46.37 90.25 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.835 -177.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.445 ' HB3' ' CG ' ' A' ' 70' ' ' PHE . 20.1 p -67.33 -44.11 79.9 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.565 -178.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 73.7 t -62.79 -46.09 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.557 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.66 -44.86 95.19 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.2 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.4 m -63.49 -43.4 97.38 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.254 -177.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.41 HG23 ' HB ' ' A' ' 65' ' ' ILE . 46.3 pt -74.32 -29.18 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.765 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -60.78 -41.98 96.63 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.052 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -60.99 -45.26 95.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.264 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -63.09 -42.37 99.61 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.181 0.515 . . . . 0.0 109.9 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.544 ' O ' HD13 ' A' ' 35' ' ' ILE . 92.9 mt -61.44 -46.22 97.04 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.716 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.693 178.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 85.2 p -63.97 -23.21 67.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.856 0.36 . . . . 0.0 111.539 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -92.46 -6.08 50.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.892 0.377 . . . . 0.0 110.768 177.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 67.7 tp -103.3 128.04 50.46 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.159 178.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -85.44 153.94 22.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.689 0.28 . . . . 0.0 111.09 176.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.42 8.83 22.64 Favored Glycine 0 C--O 1.239 0.427 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -177.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.544 HD13 ' O ' ' A' ' 29' ' ' ILE . 74.9 mt -72.65 123.63 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 115.19 -0.505 . . . . 0.0 110.871 -177.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.435 HG22 ' HZ1' ' A' ' 50' ' ' LYS . 80.5 mt -101.23 -68.15 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 172.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.534 ' O ' ' HB3' ' A' ' 50' ' ' LYS . 34.7 t -166.1 140.14 4.36 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.748 177.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.7 ttt -136.23 127.69 28.58 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 176.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.485 ' HE3' ' OG ' ' A' ' 37' ' ' SER . 34.4 mmtp -119.53 129.47 54.7 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.3 t -106.47 118.47 54.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.5 m -98.86 98.12 9.24 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.921 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.1 tp -62.49 -42.05 99.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.393 -179.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -62.0 -41.19 97.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.281 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -75.83 -30.33 58.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.591 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.45 15.05 79.11 Favored Glycine 0 N--CA 1.454 -0.142 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -176.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.8 t -145.12 150.59 37.07 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.57 151.44 47.92 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.808 0.337 . . . . 0.0 111.043 -177.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.4 p -95.15 125.44 39.8 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.295 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.416 HG12 ' HB3' ' A' ' 9' ' ' SER . 3.0 p -105.91 118.66 53.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.281 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.534 ' HB3' ' O ' ' A' ' 37' ' ' SER . 60.1 tttm -136.33 104.3 5.57 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.621 0.724 . . . . 0.0 109.968 -176.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.517 ' CD2' ' HA ' ' A' ' 35' ' ' ILE . 87.0 m-85 -139.43 162.96 33.77 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.329 -176.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 54.6 t -74.94 114.85 38.84 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 37.2 Cg_endo -65.02 -18.59 62.47 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.081 2.521 . . . . 0.0 112.327 -177.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 61.4 m -61.6 -39.36 90.92 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.659 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.412 HG23 HG21 ' A' ' 56' ' ' VAL . 18.8 m -116.69 -25.76 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -178.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 96.9 t -127.28 128.93 70.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.728 0.299 . . . . 0.0 110.77 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.507 ' HG ' ' HB2' ' A' ' 60' ' ' GLN . 25.9 p -105.96 161.55 14.36 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 178.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.59 -40.24 96.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.446 -177.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -63.27 -37.4 87.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.281 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.507 ' HB2' ' HG ' ' A' ' 57' ' ' CYS . 54.7 tt0 -59.92 -45.78 91.49 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.287 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.454 ' HA ' ' OE1' ' A' ' 64' ' ' GLN . 75.1 t -63.14 -42.34 96.18 Favored 'Isoleucine or valine' 0 C--O 1.25 1.128 0 CA-C-O 121.768 0.794 . . . . 0.0 110.309 178.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 43.3 t -58.47 -35.49 72.25 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.191 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.404 ' HB2' ' O ' ' A' ' 60' ' ' GLN . 58.8 m170 -60.24 -43.98 95.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.182 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.454 ' OE1' ' HA ' ' A' ' 61' ' ' VAL . 25.7 mp0 -63.05 -42.23 99.68 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.929 -177.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.41 ' HB ' HG23 ' A' ' 25' ' ' ILE . 19.9 tt -71.3 -37.83 67.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.072 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.32 -39.85 98.29 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.9 -0.591 . . . . 0.0 113.36 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -80.15 -5.99 56.98 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 117.446 0.623 . . . . 0.0 111.555 -177.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.454 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 23.1 mmt -83.72 -3.16 57.56 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.038 0.447 . . . . 0.0 110.447 176.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.67 8.1 62.52 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.282 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.445 ' CG ' ' HB3' ' A' ' 21' ' ' CYS . 99.2 m-85 -113.4 143.06 45.12 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 120.979 0.419 . . . . 0.0 110.292 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -101.1 148.04 25.53 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.99 -175.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.92 151.48 35.92 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.114 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 60.7 m -123.53 141.51 51.93 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 176.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.0 tt -117.33 141.27 36.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 121.111 0.481 . . . . 0.0 111.337 -174.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' A' ' 76' ' ' GLU . . . -138.08 154.71 49.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.604 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' A' ' 75' ' ' ALA . 34.8 tt0 . . . . . 0 N--CA 1.474 0.758 0 C-N-CA 123.636 0.775 . . . . 0.0 109.926 -175.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 70.4 t . . . . . 0 N--CA 1.432 -1.329 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -127.59 149.6 50.09 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.005 0.431 . . . . 0.0 111.21 -177.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 56.4 p -103.57 156.02 18.09 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.821 178.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.6 t -154.34 143.95 21.55 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 62.5 p -118.59 144.02 46.4 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.12 123.22 55.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-O 120.91 0.386 . . . . 0.0 110.489 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 39.7 ptt180 -90.08 151.2 21.73 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.084 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.9 pt -126.58 144.5 36.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-O 121.187 0.517 . . . . 0.0 111.775 -177.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.9 tp -131.21 113.66 14.12 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.331 177.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -176.23 160.3 28.02 Favored Glycine 0 N--CA 1.439 -1.135 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 96.1 mmm -68.17 -40.24 82.36 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.854 0.359 . . . . 0.0 110.857 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.8 p -110.14 80.25 1.29 Allowed 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.448 0.642 . . . . 0.0 110.478 177.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.404 ' O ' HG23 ' A' ' 22' ' ' VAL . 21.8 p -67.02 -34.55 77.96 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.479 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -63.28 -39.44 94.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.11 0.481 . . . . 0.0 110.295 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.0 t -60.67 -45.73 93.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.579 -178.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 27.7 p -70.01 -33.29 71.82 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.365 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 18' ' ' CYS . 67.1 t -63.27 -45.11 99.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-O 121.412 0.625 . . . . 0.0 109.464 177.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -67.14 -35.18 79.17 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.327 177.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.3 t -60.19 -46.59 89.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.619 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.8 tt -70.99 -29.25 36.29 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.892 177.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -57.85 -49.35 76.98 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.214 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -62.52 -42.83 99.77 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.121 178.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.5 tpt180 -64.27 -47.61 78.88 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.496 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.55 HG21 ' SD ' ' A' ' 38' ' ' MET . 19.5 tt -71.01 -36.71 64.6 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.696 -177.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 77.6 p -67.72 -25.41 65.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.36 . . . . 0.0 111.257 177.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -85.37 -12.05 53.08 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.12 0.486 . . . . 0.0 110.231 175.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 64.9 tp -84.18 122.93 29.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.511 175.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -83.38 152.98 24.79 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 120.994 0.425 . . . . 0.0 111.587 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.51 6.01 64.59 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.441 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 39.7 pt -69.15 126.79 29.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 121.337 0.589 . . . . 0.0 111.576 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.434 ' HB ' ' O ' ' A' ' 50' ' ' LYS . 86.3 mt -82.09 -61.81 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.492 -179.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.402 ' OG ' ' HE2' ' A' ' 50' ' ' LYS . 87.1 p -159.43 154.34 24.78 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.993 178.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.55 ' SD ' HG21 ' A' ' 29' ' ' ILE . 27.0 ttt -140.79 134.45 30.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.843 177.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -133.59 148.94 51.62 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.1 p -126.31 134.01 67.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 C-N-CA 119.796 -0.762 . . . . 0.0 111.792 -178.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.5 m -108.66 85.75 2.16 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.327 -0.852 . . . . 0.0 108.843 177.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.9 tp -61.64 -43.09 99.5 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.32 -176.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -70.11 -28.18 65.18 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.063 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -84.92 -12.42 53.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.649 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.4 28.03 71.84 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.88 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 79.6 p -148.2 161.02 42.31 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.076 0.465 . . . . 0.0 111.454 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.75 149.2 42.41 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.839 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.7 m -117.12 126.39 52.75 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.3 p -129.32 139.31 52.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 120.868 0.366 . . . . 0.0 110.761 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.434 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 39.6 ttpt -119.07 119.14 33.35 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -153.91 164.02 39.09 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.992 -173.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.7 t -84.87 112.28 41.75 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 177.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.43 -22.2 65.89 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.797 2.331 . . . . 0.0 112.656 -176.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.5 t -63.89 -42.99 97.34 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.655 178.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.9 t -73.39 -51.59 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.909 -178.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.6 t -131.56 130.65 62.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.331 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 31.5 p -73.76 159.47 32.9 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.634 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.3 mp -68.62 -24.32 64.55 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.839 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -61.02 -42.41 98.41 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.102 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.536 ' O ' ' HG3' ' A' ' 64' ' ' GLN . 87.3 mm-40 -65.69 -39.25 91.08 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.342 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.83 -45.6 98.34 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 CA-C-O 121.245 0.545 . . . . 0.0 110.06 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 47.5 t -60.74 -41.96 96.42 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.188 177.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -61.67 -38.29 87.23 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.025 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.536 ' HG3' ' O ' ' A' ' 60' ' ' GLN . 98.7 mt-30 -59.35 -42.73 92.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.465 0.174 . . . . 0.0 111.269 -176.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 21.2 tt -85.95 -38.68 12.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.874 178.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.94 -35.54 92.2 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.911 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -54.44 -28.14 42.07 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.879 0.872 . . . . 0.0 111.658 -178.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 15.8 tpt -59.62 -29.23 67.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.076 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 119.13 8.13 9.7 Favored Glycine 0 CA--C 1.506 -0.511 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.492 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -114.84 145.11 42.51 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -72.94 135.94 45.12 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.087 0.47 . . . . 0.0 111.12 -178.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' A' ' 12' ' ' ARG . . . -146.94 146.54 30.15 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.141 178.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 39.6 t -142.12 140.5 32.5 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.761 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 42.9 pt -91.58 145.06 7.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.522 -177.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.48 145.64 29.22 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.267 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 . . . . . 0 C--O 1.251 1.162 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.085 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.9 t . . . . . 0 N--CA 1.45 -0.465 0 CA-C-O 120.931 0.396 . . . . 0.0 110.684 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -133.82 147.56 51.23 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.09 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 54.9 p -123.08 143.23 50.11 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 175.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 87.7 p -155.63 162.03 40.69 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.333 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.1 p -109.03 125.51 52.16 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.59 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.92 122.58 70.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 17.8 ptp180 -78.99 141.94 37.05 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.208 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.759 ' HB ' ' SG ' ' A' ' 21' ' ' CYS . 19.8 pt -116.06 106.51 20.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-O 121.672 0.749 . . . . 0.0 110.519 -178.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.8 tp -114.1 128.74 56.52 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.826 -175.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 176.25 -149.29 9.73 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.213 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 66.5 mtt -60.88 -43.18 98.81 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.472 0.654 . . . . 0.0 109.272 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.52 HG23 ' H ' ' A' ' 20' ' ' SER . 11.5 t -163.82 159.41 21.16 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.411 177.04 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.473 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 98.3 m -63.55 -39.03 93.35 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 120.645 0.26 . . . . 0.0 111.487 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -59.6 -45.2 92.62 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -177.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.52 ' H ' HG23 ' A' ' 17' ' ' THR . 81.0 p -69.11 -41.61 77.18 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.95 -177.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.759 ' SG ' ' HB ' ' A' ' 13' ' ' ILE . 26.0 p -72.26 -35.35 68.74 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.3 p -69.78 -33.92 58.34 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.556 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.625 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -62.28 -42.16 99.1 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.454 0.645 . . . . 0.0 109.319 176.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.6 t -59.58 -49.78 76.42 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.401 -177.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.8 tt -74.55 -32.8 30.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.811 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.4 tm-20 -60.84 -47.68 85.28 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.342 -175.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -62.54 -44.4 96.45 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.502 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.466 ' HA ' ' NE ' ' A' ' 28' ' ' ARG . 4.2 mmp_? -67.52 -43.72 80.11 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.266 -177.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 16.9 tt -72.9 -32.77 41.34 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.6 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.998 -177.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.8 t -64.76 -41.49 95.85 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 120.938 0.399 . . . . 0.0 110.404 177.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -68.64 -26.22 65.22 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.788 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.7 tp -96.23 122.18 38.82 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.025 0.441 . . . . 0.0 110.962 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -68.73 150.01 48.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.871 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.43 -1.97 16.08 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 121.065 -0.588 . . . . 0.0 111.973 -178.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.8 tt -95.82 130.22 44.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 175.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 83.9 mt -92.52 -57.7 4.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 81.5 p -163.71 164.4 23.85 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.281 178.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -154.12 147.7 25.17 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 120.925 0.393 . . . . 0.0 110.271 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -128.87 141.57 51.24 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.5 t -110.05 128.73 66.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -174.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.1 t -113.54 102.03 9.91 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 121.17 0.51 . . . . 0.0 109.998 177.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.97 -36.48 83.43 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.089 178.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -60.62 -44.56 96.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.141 -178.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -85.85 -12.63 50.28 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.11 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.14 26.9 73.64 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.333 -179.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 87.1 p -146.01 161.98 38.88 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.046 0.451 . . . . 0.0 110.823 -177.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.1 142.72 50.08 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.336 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 87.4 m -95.8 119.14 33.78 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 65.7 t -114.77 126.74 72.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 120.997 0.427 . . . . 0.0 111.394 -176.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -103.11 106.43 16.95 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 176.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -135.63 166.34 23.45 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.027 -170.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.5 t -106.07 101.67 35.37 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.027 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.51 -25.87 80.14 Favored 'Trans proline' 0 N--CA 1.48 0.68 0 C-N-CA 123.369 2.713 . . . . 0.0 112.565 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 43.9 t -61.76 -41.33 97.54 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.941 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.421 HG13 HG12 ' A' ' 56' ' ' VAL . 77.8 t -65.51 -62.11 1.39 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.421 HG12 HG13 ' A' ' 55' ' ' VAL . 34.7 m -140.04 159.64 26.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.65 175.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.44 ' SG ' ' HG3' ' A' ' 60' ' ' GLN . 31.8 p -76.07 154.48 35.58 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.029 0.442 . . . . 0.0 110.313 178.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.6 mt -70.97 -19.19 62.58 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.223 179.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -61.45 -42.15 98.31 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.374 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.44 ' HG3' ' SG ' ' A' ' 57' ' ' CYS . 97.7 mt-30 -64.28 -39.51 94.08 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.999 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 78.6 t -62.01 -45.48 98.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 CA-C-O 121.265 0.555 . . . . 0.0 109.768 178.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 42.6 t -61.92 -38.73 89.51 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.882 176.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 58.3 m170 -63.07 -36.86 84.97 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.191 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 60' ' ' GLN . 86.5 mm-40 -59.52 -43.55 93.41 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.808 0.337 . . . . 0.0 110.919 -178.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.451 HD11 ' HB2' ' A' ' 21' ' ' CYS . 18.0 tt -76.69 -36.19 26.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.901 178.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -62.81 -42.25 99.72 Favored Glycine 0 CA--C 1.522 0.514 0 CA-C-N 116.07 -0.514 . . . . 0.0 113.478 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -66.47 -22.05 66.19 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 26.4 mmt -83.52 0.56 45.99 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.527 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.45 9.33 57.9 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.513 -0.851 . . . . 0.0 113.531 177.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.491 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 90.2 m-85 -112.51 140.68 47.06 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.985 0.393 . . . . 0.0 110.092 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -90.47 140.24 29.91 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.886 0.374 . . . . 0.0 110.856 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 12' ' ' ARG . . . -147.27 150.41 34.76 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.135 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.8 t -143.64 136.46 27.43 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.142 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 83.8 mt -91.4 127.1 43.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.457 -178.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.03 160.67 37.03 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.113 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.534 -0.746 . . . . 0.0 110.941 178.856 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.474 0 CA-C-O 120.551 0.215 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -61.97 -40.62 99.13 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 121.295 -0.479 . . . . 0.0 112.811 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -71.71 136.6 47.28 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 78.7 mtm -64.08 -42.03 97.09 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -175.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.415 ' O ' ' HD2' ' A' ' 53' ' ' PRO . 60.9 tp60 -140.0 -71.9 0.38 Allowed 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.799 -177.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.3 t -109.26 127.57 65.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 120.991 0.424 . . . . 0.0 110.663 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.24 133.82 45.22 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.891 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 63.0 p -109.37 146.45 34.4 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.497 ' OG ' HG13 ' A' ' 74' ' ' ILE . 37.2 t -159.07 147.08 17.81 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.538 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 17.1 p -113.27 108.93 17.94 Favored 'General case' 0 N--CA 1.418 -2.041 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 172.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.4 p -95.64 124.79 48.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.339 -177.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 54.8 ptt85 -75.46 142.56 42.92 Favored 'General case' 0 CA--C 1.505 -0.758 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.574 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 47.1 mm -115.12 119.2 61.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.6 tp -124.05 117.18 24.12 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.978 0.418 . . . . 0.0 110.474 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -175.24 154.28 17.61 Favored Glycine 0 N--CA 1.434 -1.464 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.476 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 98.8 mtp -65.35 -40.19 93.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.963 0.411 . . . . 0.0 110.9 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.0 p -111.12 84.83 2.0 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.383 0.611 . . . . 0.0 110.38 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.508 ' O ' HG23 ' A' ' 22' ' ' VAL . 42.2 t -61.38 -44.27 97.44 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.017 -177.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -61.35 -39.92 92.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.943 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.6 m -62.67 -44.2 96.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.59 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.491 ' HB3' ' CD2' ' A' ' 70' ' ' PHE . 29.6 p -73.02 -33.81 65.96 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.476 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 18' ' ' CYS . 63.0 t -62.79 -43.57 98.86 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -60.69 -44.41 96.56 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.997 177.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.0 t -61.64 -50.02 74.2 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.556 -178.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.7 tt -71.63 -36.83 61.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -61.68 -44.0 97.78 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.829 0.347 . . . . 0.0 110.693 -177.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -64.73 -47.3 78.79 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.281 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -64.58 -42.56 95.54 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.914 -176.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.63 HD11 ' SD ' ' A' ' 38' ' ' MET . 19.6 tt -69.7 -35.14 64.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.957 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 79.0 p -71.26 -22.06 62.02 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.926 0.393 . . . . 0.0 110.634 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -70.76 -27.92 64.29 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 174.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.6 mt -75.0 128.99 36.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.851 176.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.0 mtpt -86.6 153.58 21.68 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.374 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.23 8.1 57.9 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.323 -0.942 . . . . 0.0 111.862 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 33.1 pt -69.52 137.74 23.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.993 0.425 . . . . 0.0 111.819 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -96.77 -71.98 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.695 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.7 t -169.89 149.88 3.78 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-O 120.769 0.319 . . . . 0.0 111.051 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.63 ' SD ' HD11 ' A' ' 29' ' ' ILE . 28.9 ptm -153.4 159.53 42.41 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 177.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -141.1 123.45 15.78 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.989 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 79.9 t -92.52 119.29 39.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 175.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.8 m -109.21 112.07 24.02 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.042 0.448 . . . . 0.0 111.117 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.2 mt -66.2 -37.63 86.05 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.795 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -61.9 -41.81 98.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.775 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -77.22 -27.91 53.61 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.948 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.51 15.99 80.04 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -175.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 87.7 p -148.68 165.54 31.06 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.14 -0.53 . . . . 0.0 109.982 -177.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.516 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -118.5 139.44 51.43 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.708 0.289 . . . . 0.0 111.291 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.8 m -89.13 119.69 29.86 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 8' ' ' THR . 99.8 t -114.64 124.48 71.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.499 -174.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.408 ' HG2' HG22 ' A' ' 8' ' ' THR . 51.5 mtmt -126.96 103.96 7.76 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 174.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -143.86 158.71 43.51 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.587 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.8 t -82.52 114.27 50.51 Favored Pre-proline 0 N--CA 1.437 -1.125 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 173.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.415 ' HD2' ' O ' ' A' ' 5' ' ' GLN . 29.0 Cg_endo -61.44 -28.09 83.32 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.921 2.414 . . . . 0.0 113.787 -173.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.2 p -70.19 -39.74 75.05 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 120.809 0.338 . . . . 0.0 110.899 177.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 84.7 t -75.67 -50.81 22.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 121.128 0.49 . . . . 0.0 110.67 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 69.7 t -128.58 123.72 60.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.162 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.639 ' SG ' ' HG2' ' A' ' 60' ' ' GLN . 27.7 p -88.49 144.42 26.36 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.898 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.4 mp -68.56 -26.8 65.59 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.092 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 -60.35 -41.14 93.02 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.639 ' HG2' ' SG ' ' A' ' 57' ' ' CYS . 85.4 mm-40 -63.98 -38.43 91.07 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.387 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 71.6 t -60.98 -46.74 96.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 121.391 0.615 . . . . 0.0 109.55 178.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 43.0 t -62.55 -39.61 94.18 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.76 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -59.6 -45.17 92.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.947 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 60' ' ' GLN . 98.2 mt-30 -60.75 -44.01 97.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.65 -175.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.0 tt -81.41 -37.19 15.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.856 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.8 -41.73 99.81 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.782 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.99 -28.73 70.0 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 122.37 0.268 . . . . 0.0 111.37 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 16.1 tpt -61.75 -29.79 70.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.719 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.69 5.06 12.6 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.515 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.491 ' CD2' ' HB3' ' A' ' 21' ' ' CYS . 95.1 m-85 -111.48 152.02 27.94 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -94.97 134.69 37.37 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.37 0.605 . . . . 0.0 111.818 -176.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 12' ' ' ARG . . . -140.82 145.59 36.47 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.687 176.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.9 t -139.88 138.65 35.86 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.243 -0.583 . . . . 0.0 111.445 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.497 HG13 ' OG ' ' A' ' 9' ' ' SER . 14.7 tt -78.23 137.02 22.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.12 -0.945 . . . . 0.0 112.158 -178.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -152.11 159.48 43.64 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 176.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.308 -1.228 0 CA-C-O 118.577 -0.725 . . . . 0.0 109.976 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.769 0 CA-C-O 120.961 0.41 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -87.48 -173.03 48.14 Favored Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.544 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -89.96 126.81 35.88 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 43.4 tpp -63.37 -41.69 98.83 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.136 0.493 . . . . 0.0 110.063 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -94.65 122.27 37.07 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.572 177.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.1 m -128.01 150.5 33.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.142 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -120.73 140.18 52.01 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 120.979 0.418 . . . . 0.0 110.592 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 44.5 p -120.77 145.77 47.19 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.393 177.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.9 t -140.88 142.47 34.5 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.6 p -108.64 133.88 52.13 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 121.307 0.575 . . . . 0.0 110.759 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.428 HG12 ' HA ' ' A' ' 74' ' ' ILE . 33.6 m -126.85 150.53 32.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.415 ' HG2' ' HB3' ' A' ' 73' ' ' SER . 16.6 ptm180 -107.06 147.24 30.21 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.536 HG21 ' SG ' ' A' ' 21' ' ' CYS . 85.0 mt -119.56 125.86 74.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.546 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.8 tp -119.6 115.84 24.81 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -171.02 154.88 23.56 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.976 -0.63 . . . . 0.0 111.642 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 68.6 mtt -67.66 -40.14 84.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.923 0.392 . . . . 0.0 110.978 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.2 p -104.45 89.59 3.27 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.713 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 95.5 m -64.06 -40.57 96.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.238 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -64.88 -39.14 93.08 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.462 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.0 m -62.63 -43.74 98.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.712 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.536 ' SG ' HG21 ' A' ' 13' ' ' ILE . 16.0 p -70.19 -39.87 74.96 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.597 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 65.5 t -63.22 -44.13 99.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-O 121.087 0.47 . . . . 0.0 110.108 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -64.46 -40.88 96.54 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.41 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.5 m -62.36 -42.9 99.77 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.978 -0.556 . . . . 0.0 112.012 -178.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.541 ' CG2' ' HB ' ' A' ' 65' ' ' ILE . 47.1 pt -72.02 -34.94 52.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 C-N-CA 120.064 -0.655 . . . . 0.0 110.161 178.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -60.97 -44.43 97.36 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.909 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -61.82 -50.06 73.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.082 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -68.67 -41.86 78.7 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.165 -0.471 . . . . 0.0 112.192 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 94.0 mt -64.41 -42.61 95.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-O 120.668 0.27 . . . . 0.0 111.035 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 41.4 t -60.24 -41.5 93.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.023 0.44 . . . . 0.0 110.26 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -68.49 -27.9 66.54 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.094 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.5 tp -70.33 131.95 44.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.705 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -86.1 152.55 22.77 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.69 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.89 5.98 73.0 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.687 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 46.4 pt -72.55 138.19 21.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.908 0.385 . . . . 0.0 111.316 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.2 mm -96.79 -67.05 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.481 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.7 t -162.39 152.83 16.9 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.279 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -139.27 148.22 42.73 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -134.79 142.47 46.71 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.68 140.05 50.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 120.967 0.413 . . . . 0.0 111.134 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.9 m -119.38 101.75 8.18 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.67 -44.83 95.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.845 -176.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -61.68 -44.28 97.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.462 -178.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -76.93 -24.82 52.39 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.742 -178.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.13 17.53 79.53 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.326 -177.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 60.1 m -125.17 151.61 45.58 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 120.882 0.372 . . . . 0.0 110.591 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -128.71 149.14 50.82 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.047 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.6 m -116.2 125.41 52.23 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 63.1 t -114.47 124.97 71.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 120.84 0.352 . . . . 0.0 110.545 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -105.88 107.7 18.83 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.636 ' CE1' ' HB ' ' A' ' 56' ' ' VAL . 34.4 t80 -152.93 152.74 31.81 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -175.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.4 t -80.64 114.02 44.51 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -66.26 -22.28 53.62 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.066 2.511 . . . . 0.0 113.852 -174.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 79.8 p -65.28 -33.36 75.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.718 0.294 . . . . 0.0 111.271 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.9 t -84.06 -61.9 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.907 0.384 . . . . 0.0 110.174 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.636 ' HB ' ' CE1' ' A' ' 51' ' ' TYR . 88.7 t -128.76 127.49 66.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.096 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 30.3 p -76.81 155.79 32.79 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.343 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.35 -16.13 61.87 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.838 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -61.5 -42.2 98.44 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.195 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.501 ' OE1' HG13 ' A' ' 56' ' ' VAL . 98.6 mt-30 -65.13 -37.94 89.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.531 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 77.8 t -61.28 -40.95 87.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-O 121.352 0.596 . . . . 0.0 109.728 177.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.513 ' SG ' ' HB ' ' A' ' 74' ' ' ILE . 92.7 m -61.08 -38.96 88.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.569 177.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -67.94 -28.77 67.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.452 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -61.93 -42.18 98.8 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.739 0.304 . . . . 0.0 110.503 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.541 ' HB ' ' CG2' ' A' ' 25' ' ' ILE . 18.8 tt -79.7 -38.94 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 120.754 0.311 . . . . 0.0 111.565 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -62.39 -39.08 97.31 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.156 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -59.09 -39.0 80.85 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.152 0.501 . . . . 0.0 110.472 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 17.0 tpt -62.01 -29.09 70.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.127 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.15 8.54 10.38 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.677 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.506 ' CG ' ' HB3' ' A' ' 21' ' ' CYS . 97.5 m-85 -106.29 150.02 26.36 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.687 0.28 . . . . 0.0 110.286 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -93.13 138.87 31.16 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.584 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.88 149.13 31.7 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.642 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.415 ' HB3' ' HG2' ' A' ' 12' ' ' ARG . 48.3 t -127.86 138.93 52.86 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.513 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 13.5 tt -100.27 139.21 22.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.226 0.536 . . . . 0.0 111.681 -176.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.45 159.45 44.02 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.42 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 . . . . . 0 C--N 1.3 -1.575 0 CA-C-O 118.47 -0.776 . . . . 0.0 109.709 177.444 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.578 0 CA-C-O 120.756 0.313 . . . . 0.0 110.482 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -138.59 148.87 20.25 Favored Glycine 0 N--CA 1.433 -1.566 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.901 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -71.63 137.52 47.99 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 71.9 mtm -94.92 107.25 19.28 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -78.89 117.7 20.23 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 68.2 t -117.79 127.15 75.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.618 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.62 128.53 45.73 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.004 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 76.3 p -118.47 147.45 43.6 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.699 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.9 p -159.98 168.09 26.44 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.336 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.6 p -113.0 129.59 56.44 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.5 p -109.57 123.34 65.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-O 121.026 0.441 . . . . 0.0 110.364 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -83.26 147.45 27.97 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.647 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 85.9 mt -114.68 123.6 70.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.891 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 69.6 tp -117.92 118.47 32.08 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.938 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -175.45 157.95 24.87 Favored Glycine 0 N--CA 1.432 -1.617 0 C-N-CA 119.692 -1.242 . . . . 0.0 113.151 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 66.4 ttp -61.93 -47.16 86.14 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 120.915 0.388 . . . . 0.0 110.202 177.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.6 m -118.21 107.23 13.68 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.415 ' O ' HG21 ' A' ' 22' ' ' VAL . 47.9 t -64.22 -40.19 95.54 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.09 -178.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -60.35 -39.83 88.57 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.757 -176.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 63.7 m -62.3 -46.29 89.4 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 120.959 0.409 . . . . 0.0 111.518 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.589 ' HB3' ' CD2' ' A' ' 70' ' ' PHE . 16.4 p -73.64 -36.36 65.41 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.926 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.415 HG21 ' O ' ' A' ' 18' ' ' CYS . 57.0 t -62.18 -42.79 96.56 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.541 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -60.56 -40.61 92.25 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.518 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.3 t -59.99 -48.66 80.79 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.875 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.3 tt -76.49 -39.42 33.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.018 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.1 tp10 -60.33 -47.59 85.4 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.914 0.388 . . . . 0.0 111.281 -175.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.64 -51.15 66.43 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.978 -177.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.508 ' HD2' ' HG2' ' A' ' 64' ' ' GLN . 44.4 ttm180 -63.89 -45.42 89.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.852 -177.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 15.3 tt -68.53 -31.22 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.312 -176.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 73.7 m -63.78 -38.77 92.33 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.081 0.467 . . . . 0.0 110.076 176.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -68.18 -27.8 66.72 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.877 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.4 mt -84.68 137.32 33.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.755 0.788 . . . . 0.0 112.753 -178.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.547 ' HD2' ' N ' ' A' ' 33' ' ' LYS . 9.9 mptt -87.75 155.04 20.1 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.39 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.53 7.4 39.73 Favored Glycine 0 C--O 1.239 0.422 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.94 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.2 pt -91.39 132.91 34.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 86.3 mt -97.63 -59.45 3.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.935 0.398 . . . . 0.0 110.728 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.3 t -152.34 141.21 21.08 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.162 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.432 ' HB3' ' HH ' ' A' ' 51' ' ' TYR . 28.5 ptm -145.27 146.96 31.87 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.759 177.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -135.52 124.7 24.49 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.908 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 65.7 t -106.6 116.05 49.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 176.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.8 m -109.64 104.68 13.73 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.083 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.8 mt -64.4 -36.65 84.84 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.72 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.7 mp0 -63.61 -41.29 98.32 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.74 -178.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -83.85 -27.34 28.76 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.316 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.86 20.64 77.73 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -177.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.7 m -137.63 155.91 48.64 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 122.371 0.268 . . . . 0.0 110.592 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -121.92 141.8 50.93 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.398 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.1 m -85.38 124.36 31.9 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.652 HG11 ' CE2' ' A' ' 51' ' ' TYR . 97.4 t -107.26 119.29 56.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.053 -176.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -145.56 102.83 3.74 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 173.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.652 ' CE2' HG11 ' A' ' 49' ' ' VAL . 24.7 m-85 -141.69 165.78 26.54 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -177.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.6 t -78.1 114.22 40.3 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 175.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -62.87 -25.91 74.46 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.894 2.396 . . . . 0.0 112.861 -175.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.3 m -64.46 -39.08 93.14 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.925 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.6 t -94.84 -49.43 12.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.125 -178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.1 t -114.45 126.63 72.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.328 -177.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 25.2 p -103.89 149.9 24.67 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.651 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.5 mp -64.32 -38.06 89.71 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.507 -176.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -62.6 -40.79 98.05 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -176.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.597 ' O ' ' HG3' ' A' ' 64' ' ' GLN . 85.4 mm-40 -64.72 -37.1 86.44 Favored 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 121.119 -0.233 . . . . 0.0 111.18 176.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 77.2 t -59.29 -43.43 89.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-O 121.17 0.509 . . . . 0.0 109.636 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 96.3 m -62.49 -39.09 92.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.97 177.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 63.8 m170 -67.3 -36.35 81.32 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.157 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.597 ' HG3' ' O ' ' A' ' 60' ' ' GLN . 99.2 mt-30 -60.02 -42.91 95.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.536 -176.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.8 tt -81.11 -35.07 14.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.114 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -67.14 -24.2 73.24 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.935 -0.575 . . . . 0.0 113.629 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.1 -36.59 77.78 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.847 0.356 . . . . 0.0 111.087 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 16.5 tpt -62.41 -28.93 70.13 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.533 178.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.89 5.13 18.29 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.38 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.589 ' CD2' ' HB3' ' A' ' 21' ' ' CYS . 99.0 m-85 -104.83 142.67 34.32 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.776 0.322 . . . . 0.0 110.661 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -80.88 147.81 30.2 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.404 -177.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.97 148.93 31.29 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.197 176.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 39.8 t -143.61 142.11 30.91 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.38 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 88.7 mt -86.27 128.58 39.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.198 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -138.35 148.43 44.54 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.481 177.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 . . . . . 0 C--N 1.307 -1.282 0 CA-C-O 118.393 -0.813 . . . . 0.0 110.307 -179.818 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.656 0 CA-C-O 120.765 0.317 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 155.24 -161.99 30.74 Favored Glycine 0 N--CA 1.436 -1.309 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.604 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.8 m170 -68.97 137.09 53.46 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.3 mtt -70.72 -27.97 64.38 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.758 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -66.59 -40.73 89.05 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.853 0.359 . . . . 0.0 110.772 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.0 t -130.7 108.7 15.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 175.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -112.31 143.58 43.16 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.954 0.406 . . . . 0.0 111.388 -176.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.544 HG23 ' HG2' ' A' ' 50' ' ' LYS . 71.7 p -109.32 140.86 42.46 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.9 t -150.64 143.02 24.32 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.048 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 71.3 p -115.09 122.99 47.83 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.8 m -107.21 125.69 63.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.329 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 16.2 ptp180 -77.79 135.29 37.96 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 85.4 mt -117.57 127.52 74.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-O 120.977 0.418 . . . . 0.0 111.63 -174.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.0 tt -115.13 119.4 36.29 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.107 177.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -165.73 173.42 41.37 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.943 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 79.2 mtm -63.81 -44.91 91.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.32 0.581 . . . . 0.0 110.134 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.0 p -134.91 128.8 33.26 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.748 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.525 ' O ' HG23 ' A' ' 22' ' ' VAL . 51.5 t -62.61 -49.56 74.74 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -176.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -62.61 -40.88 98.35 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -174.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.6 t -62.83 -47.16 84.58 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.675 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.5 p -70.75 -33.29 70.65 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.698 0.285 . . . . 0.0 110.967 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 18' ' ' CYS . 52.7 t -61.91 -45.62 98.29 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.018 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 176.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -64.34 -36.28 83.62 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.493 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 41.1 t -59.24 -48.69 80.67 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.281 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.8 tt -78.51 -28.86 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.448 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -59.2 -46.33 88.73 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.28 -176.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -61.17 -45.09 96.03 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.962 0.41 . . . . 0.0 110.689 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -67.22 -45.75 75.87 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.505 -176.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.3 tp -72.47 -34.63 49.0 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 78.8 p -65.82 -36.32 83.15 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.817 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -70.6 -27.29 63.98 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.283 176.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -77.96 125.18 28.96 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.918 0.389 . . . . 0.0 110.169 176.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -81.51 152.48 27.29 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.316 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 115.81 -0.91 21.53 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.17 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.9 tt -108.73 124.19 65.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.25 0.547 . . . . 0.0 109.98 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 49.7 mm -71.38 -49.43 47.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.029 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.7 t -159.81 150.26 18.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.76 -177.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 26.3 ttt -127.33 119.56 26.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.143 178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -131.03 146.38 52.36 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 110.289 -0.264 . . . . 0.0 110.289 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 66.4 t -123.91 129.73 74.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 120.757 0.313 . . . . 0.0 111.67 -175.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.3 t -106.85 105.3 15.26 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 177.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 60.0 tp -64.48 -40.83 96.41 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.679 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -62.07 -40.91 97.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.732 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -76.26 -29.11 57.34 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.667 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.83 20.31 63.71 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.978 -0.629 . . . . 0.0 111.629 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 89.3 p -143.91 166.22 25.55 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 120.93 0.395 . . . . 0.0 110.542 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.579 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -117.52 133.77 55.59 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.469 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.1 m -98.88 121.24 40.57 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.6 m -127.96 149.34 32.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 CA-C-O 121.408 0.623 . . . . 0.0 111.509 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.544 ' HG2' HG23 ' A' ' 8' ' ' THR . 62.3 mttp -116.04 123.88 49.06 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 175.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -150.7 165.46 33.37 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.504 -174.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.5 t -100.16 110.28 59.18 Favored Pre-proline 0 N--CA 1.438 -1.056 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.041 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -55.82 -27.13 60.8 Favored 'Trans proline' 0 N--CA 1.483 0.866 0 C-N-CA 123.62 2.88 . . . . 0.0 112.676 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.2 m -62.03 -39.22 91.59 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.845 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 51.8 t -89.05 -47.52 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.998 -177.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 31.8 m -123.25 160.2 26.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.614 0.245 . . . . 0.0 110.904 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 31.2 p -134.89 167.32 21.12 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.948 0.404 . . . . 0.0 111.541 -176.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 68.6 tp -61.07 -44.33 97.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.856 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -60.03 -42.31 94.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.515 -177.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.553 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 64.7 tt0 -61.66 -45.81 92.41 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.609 178.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.0 t -63.97 -46.59 93.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 CA-C-O 121.2 0.524 . . . . 0.0 110.751 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 48.5 t -60.82 -40.07 91.37 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.927 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -60.36 -41.38 93.58 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.414 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.553 ' HG2' ' O ' ' A' ' 60' ' ' GLN . 87.0 mm-40 -60.56 -45.7 92.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.143 -176.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.3 tt -83.22 -35.78 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.869 0.366 . . . . 0.0 111.752 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.59 -39.8 97.86 Favored Glycine 0 CA--C 1.505 -0.536 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.42 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -60.42 -39.37 87.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.952 0.406 . . . . 0.0 110.324 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 14.8 tpt -63.47 -30.67 71.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.485 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 116.64 7.93 12.96 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.334 -0.936 . . . . 0.0 113.301 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -114.53 141.6 47.52 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -99.31 133.35 43.74 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -172.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.502 ' HA ' ' O ' ' A' ' 12' ' ' ARG . . . -130.89 139.03 50.06 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.474 176.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.6 m -127.57 143.59 51.16 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.689 0.281 . . . . 0.0 110.938 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.2 tt -74.13 142.32 14.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -175.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.422 ' HB1' ' NH2' ' A' ' 12' ' ' ARG . . . -143.05 125.63 15.83 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.45 172.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 . . . . . 0 C--N 1.307 -1.244 0 CA-C-O 118.771 -0.633 . . . . 0.0 111.435 -178.579 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.671 0 CA-C-O 120.404 0.145 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 57.52 -131.03 51.85 Favored Glycine 0 C--N 1.338 0.642 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -90.1 129.43 36.39 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.0 mtt -103.08 120.07 40.01 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.193 0.521 . . . . 0.0 111.194 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -116.19 126.64 53.92 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.507 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.7 p -141.51 138.37 32.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 176.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -129.9 143.2 50.68 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 120.954 0.407 . . . . 0.0 111.136 -178.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.1 p -107.96 129.34 55.12 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.024 177.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.414 ' O ' HG22 ' A' ' 49' ' ' VAL . 46.8 t -140.71 143.78 35.22 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 22.4 p -109.62 119.71 40.25 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.929 177.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.428 HG11 ' HA ' ' A' ' 74' ' ' ILE . 33.5 m -102.61 135.89 37.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.1 ptt180 -83.74 150.9 25.52 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.642 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 86.4 mt -112.52 121.35 64.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 63.4 tp -122.56 108.08 12.72 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -167.23 156.19 27.8 Favored Glycine 0 N--CA 1.431 -1.656 0 C-N-CA 119.932 -1.127 . . . . 0.0 113.069 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 79.5 mtm -64.6 -40.28 95.23 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.92 0.39 . . . . 0.0 110.346 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 35.5 m -121.85 103.87 9.16 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.467 ' O ' HG22 ' A' ' 22' ' ' VAL . 91.5 m -65.4 -40.23 93.16 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.051 -177.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -62.72 -39.79 95.15 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -176.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.0 m -62.38 -44.56 96.16 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.553 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.637 ' HB3' ' CD2' ' A' ' 70' ' ' PHE . 24.7 p -71.73 -37.05 70.64 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.416 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 18' ' ' CYS . 59.4 t -62.65 -45.18 99.46 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.001 178.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 66.3 tttp -62.86 -42.73 99.86 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.275 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 74.5 m -60.78 -43.01 98.63 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.67 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.0 tt -76.52 -41.16 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.396 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -62.71 -49.36 75.4 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -63.71 -46.42 85.52 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.046 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.0 ttp180 -67.17 -42.72 83.81 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.513 HG12 ' OH ' ' A' ' 51' ' ' TYR . 11.2 tp -67.55 -36.44 76.24 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.687 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.882 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 79.0 p -73.17 -20.71 60.84 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.17 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -71.64 -27.91 63.4 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 174.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 64.1 tp -93.29 119.3 32.28 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.388 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -80.66 152.41 28.48 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 120.994 0.426 . . . . 0.0 111.069 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 115.3 1.67 21.86 Favored Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -175.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.406 HD13 ' HB2' ' A' ' 38' ' ' MET . 4.1 tt -91.92 122.25 43.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 123.132 0.573 . . . . 0.0 110.426 178.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.1 tt -82.7 -42.8 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.822 177.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.458 ' HB3' ' HD2' ' A' ' 50' ' ' LYS . 35.3 t -160.67 145.62 14.35 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 120.123 -0.631 . . . . 0.0 112.248 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.57 ' SD ' HG12 ' A' ' 49' ' ' VAL . 14.4 tpt -134.41 129.81 35.89 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.851 177.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -135.05 129.05 33.44 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.6 p -129.77 137.61 56.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 120.811 0.339 . . . . 0.0 110.862 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.1 t -117.62 117.9 30.64 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.979 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.8 tp -66.66 -41.62 87.9 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.863 176.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -61.07 -48.93 79.42 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.587 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -77.02 -25.02 52.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.69 -178.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.33 29.8 69.85 Favored Glycine 0 CA--C 1.505 -0.591 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.9 t -149.12 152.85 36.84 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -119.36 138.17 53.24 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.987 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 71.6 m -102.67 122.6 44.77 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.659 ' HB ' ' CE2' ' A' ' 51' ' ' TYR . 33.3 m -120.72 149.91 23.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -174.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.458 ' HD2' ' HB3' ' A' ' 37' ' ' SER . 69.0 mttm -125.0 108.2 11.6 Favored 'General case' 0 C--O 1.245 0.858 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.749 175.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.659 ' CE2' ' HB ' ' A' ' 49' ' ' VAL . 80.8 m-85 -136.44 148.78 47.92 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.03 0.443 . . . . 0.0 111.434 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 66.5 t -87.61 115.41 62.8 Favored Pre-proline 0 N--CA 1.438 -1.049 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 171.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -59.4 -28.62 88.04 Favored 'Trans proline' 0 N--CA 1.475 0.398 0 C-N-CA 122.819 2.346 . . . . 0.0 113.765 -173.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.0 p -77.05 -14.29 59.84 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.907 0.384 . . . . 0.0 111.473 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 49.0 t -104.4 -59.19 3.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.105 0.479 . . . . 0.0 109.892 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 66.7 t -126.3 124.16 65.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.495 ' SG ' ' HG3' ' A' ' 60' ' ' GLN . 31.2 p -93.48 159.28 15.31 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.208 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.8 mt -62.91 -36.67 84.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.66 -178.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -61.11 -40.03 92.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.734 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.495 ' HG3' ' SG ' ' A' ' 57' ' ' CYS . 95.5 mt-30 -63.08 -41.25 99.38 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.074 0.464 . . . . 0.0 110.369 177.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 70.2 t -63.26 -44.24 99.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.119 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 92.5 m -62.59 -39.51 93.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.967 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -61.75 -39.67 92.4 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.547 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 60' ' ' GLN . 99.1 mt-30 -60.3 -42.34 95.32 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.41 -176.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.2 tt -81.77 -40.73 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-O 120.787 0.327 . . . . 0.0 111.604 178.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.31 -37.01 93.88 Favored Glycine 0 C--N 1.335 0.473 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.626 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -56.35 -36.14 68.44 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 123.91 0.884 . . . . 0.0 111.594 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 14.2 tpt -63.44 -28.58 70.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.246 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.81 9.62 9.83 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.495 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.637 ' CD2' ' HB3' ' A' ' 21' ' ' CYS . 98.4 m-85 -113.79 141.82 46.83 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -82.78 146.85 28.74 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.485 0.66 . . . . 0.0 112.592 -176.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.44 151.09 35.86 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.981 -1.008 . . . . 0.0 108.923 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 36.6 t -138.19 140.48 39.8 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.891 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.428 ' HA ' HG11 ' A' ' 11' ' ' VAL . 85.7 mt -81.55 128.63 38.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.066 -178.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -142.95 159.96 41.25 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.435 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 119.132 -0.461 . . . . 0.0 111.403 -179.692 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.86 0 CA-C-O 120.744 0.307 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 136.74 -20.34 3.46 Favored Glycine 0 C--N 1.316 -0.532 0 C-N-CA 120.913 -0.661 . . . . 0.0 111.508 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -90.76 137.88 32.02 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 98.4 mmm 68.43 177.12 0.26 Allowed 'General case' 0 N--CA 1.471 0.588 0 O-C-N 123.716 0.635 . . . . 0.0 110.668 -176.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 62.9 18.95 11.22 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.071 0.548 . . . . 0.0 111.579 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.9 t -126.35 122.78 62.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 120.908 0.385 . . . . 0.0 110.957 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.513 ' O ' ' HA ' ' A' ' 50' ' ' LYS . . . -117.24 131.82 56.76 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 176.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.467 HG21 ' HG2' ' A' ' 50' ' ' LYS . 66.4 p -111.82 135.04 52.96 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.8 t -157.57 152.15 25.13 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.7 p -111.93 142.39 44.4 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-O 121.037 0.446 . . . . 0.0 110.042 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.3 p -133.14 127.33 54.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.137 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 40.6 ptt180 -94.53 142.61 27.24 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.595 -0.442 . . . . 0.0 109.815 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 85.3 mt -110.13 127.13 67.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.782 -177.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 63.0 tp -112.87 115.2 28.08 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.219 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -172.83 148.54 10.58 Favored Glycine 0 N--CA 1.438 -1.229 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 68.3 mtt -65.94 -41.05 91.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.972 0.415 . . . . 0.0 110.794 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.7 m -100.76 85.26 2.86 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.461 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 93.7 m -63.45 -40.13 96.32 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.495 -175.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -62.83 -42.21 99.64 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -177.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.9 m -67.34 -41.1 85.75 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.487 ' HB3' ' CG ' ' A' ' 70' ' ' PHE . 18.6 p -68.79 -39.96 79.86 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.572 -179.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.481 ' O ' ' HG3' ' A' ' 26' ' ' GLU . 67.3 t -63.07 -46.0 97.27 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.282 0 CA-C-O 121.13 0.49 . . . . 0.0 109.804 178.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.46 -44.13 97.64 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.793 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.42 ' HB3' ' HG3' ' A' ' 68' ' ' MET . 67.2 m -62.95 -46.43 87.79 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.067 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.9 tt -66.25 -33.62 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.207 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.481 ' HG3' ' O ' ' A' ' 22' ' ' VAL . 49.4 mt-10 -62.33 -44.03 97.45 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.627 178.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -65.93 -45.46 81.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.149 0.499 . . . . 0.0 110.812 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.508 ' HB3' ' HG2' ' A' ' 64' ' ' GLN . 26.5 mmt85 -64.18 -43.32 95.47 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.239 -178.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.581 HG22 ' SD ' ' A' ' 38' ' ' MET . 19.1 tt -70.62 -32.95 51.25 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.303 0 CA-C-O 120.952 0.406 . . . . 0.0 110.264 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.5 t -62.41 -38.86 91.3 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.575 176.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -66.79 -30.37 70.55 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.886 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 93.7 mt -75.82 129.12 36.51 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.164 0.507 . . . . 0.0 110.451 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -85.49 153.35 22.52 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.294 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.02 7.96 48.94 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.583 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.485 ' HA ' ' CB ' ' A' ' 51' ' ' TYR . 48.0 pt -94.78 138.68 20.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.868 0.366 . . . . 0.0 110.662 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.3 mm -99.48 -61.78 2.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.114 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.5 m -146.57 154.13 41.16 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.615 0.245 . . . . 0.0 110.965 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.581 ' SD ' HG22 ' A' ' 29' ' ' ILE . 27.8 ttt -145.6 132.45 20.12 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.583 178.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -126.26 128.34 47.02 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 176.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.8 t -107.2 123.62 62.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-O 120.79 0.329 . . . . 0.0 110.366 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.5 m -98.6 99.38 10.51 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.9 mt -64.19 -40.23 95.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.089 -175.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -69.27 -38.57 78.44 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.075 0.464 . . . . 0.0 110.91 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -74.66 -29.96 61.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.806 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.82 15.14 81.2 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -177.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 12' ' ' ARG . 49.0 m -131.48 154.25 48.93 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.39 -0.405 . . . . 0.0 110.133 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.41 143.49 50.96 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.978 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 85.1 m -102.01 125.26 48.66 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.6 m -117.69 147.28 21.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 121.023 0.439 . . . . 0.0 111.512 -177.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 99.7 mttt -133.17 112.94 12.15 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.444 177.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.485 ' CB ' ' HA ' ' A' ' 35' ' ' ILE . 35.9 p90 -159.28 170.62 21.47 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.13 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.0 t -80.61 114.94 51.84 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 38.9 Cg_endo -65.97 -23.34 54.38 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.696 2.264 . . . . 0.0 112.218 -178.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.4 m -65.77 -39.36 90.94 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.619 177.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 66.0 t -74.42 -51.11 24.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.017 0.437 . . . . 0.0 110.483 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 17.8 m -137.08 149.02 26.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.434 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.564 ' SG ' ' HB2' ' A' ' 60' ' ' GLN . 24.9 p -99.65 172.24 7.41 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.871 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.474 HD23 ' OH ' ' A' ' 51' ' ' TYR . 96.5 mt -64.84 -40.89 95.9 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.718 0.771 . . . . 0.0 110.332 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -68.27 -26.71 65.8 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.462 178.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.564 ' HB2' ' SG ' ' A' ' 57' ' ' CYS . 59.6 tp60 -60.41 -45.93 91.85 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.381 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.553 ' HA ' ' OE1' ' A' ' 64' ' ' GLN . 31.8 m -74.33 -26.43 20.49 Favored 'Isoleucine or valine' 0 C--O 1.248 0.989 0 CA-C-O 121.387 0.613 . . . . 0.0 110.722 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 98.1 m -61.64 -36.45 80.82 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.104 176.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -60.48 -40.5 91.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.933 -178.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.553 ' OE1' ' HA ' ' A' ' 61' ' ' VAL . 28.6 mp0 -64.57 -41.0 96.56 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 120.4 -0.52 . . . . 0.0 112.235 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.4 tt -72.67 -36.82 54.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.525 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.23 -38.39 96.12 Favored Glycine 0 C--N 1.339 0.702 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 176.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -57.63 -36.83 72.34 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.358 0.663 . . . . 0.0 110.896 178.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.42 ' HG3' ' HB3' ' A' ' 24' ' ' SER . 95.9 mmm -74.72 -8.05 55.2 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.526 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.57 9.91 59.65 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.617 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.487 ' CG ' ' HB3' ' A' ' 21' ' ' CYS . 98.7 m-85 -111.7 147.52 35.39 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -105.95 151.32 24.74 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.184 0.516 . . . . 0.0 111.91 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -144.72 148.62 34.4 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.456 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.7 t -123.6 132.6 53.91 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.937 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 84.4 mt -78.96 130.93 35.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.235 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -144.51 155.31 43.63 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.283 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 . . . . . 0 C--O 1.256 1.432 0 CA-C-O 118.568 -0.729 . . . . 0.0 109.377 178.388 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.825 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.23 173.87 52.49 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.219 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.7 p80 -69.56 147.73 50.38 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 117.128 0.464 . . . . 0.0 111.198 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -107.15 130.23 54.73 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.379 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 89.7 mm-40 -105.66 131.28 53.22 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.4 m -117.16 150.39 19.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-O 121.003 0.43 . . . . 0.0 111.075 -175.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -104.79 131.35 52.36 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.646 -178.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 61.2 p -117.65 142.86 46.73 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.2 t -158.89 152.55 23.1 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.274 -0.571 . . . . 0.0 110.029 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.8 p -102.43 141.23 35.58 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.3 p -134.78 135.16 53.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.522 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -95.22 151.9 18.83 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.3 pt -115.11 138.8 44.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 110.127 -0.324 . . . . 0.0 110.127 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.2 tp -126.0 117.89 24.19 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.143 0.497 . . . . 0.0 110.774 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.82 157.77 16.31 Favored Glycine 0 N--CA 1.437 -1.264 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 95.3 mmm -69.02 -39.48 79.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.145 0.498 . . . . 0.0 110.059 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.2 p -99.74 79.07 2.2 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 121.509 0.671 . . . . 0.0 109.879 176.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.549 ' O ' HG22 ' A' ' 22' ' ' VAL . 96.4 m -62.39 -43.16 99.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.986 -176.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -64.99 -38.95 92.66 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.862 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.0 t -61.23 -45.93 92.5 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.451 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 29.3 p -67.53 -32.19 72.81 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.516 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.549 HG22 ' O ' ' A' ' 18' ' ' CYS . 53.7 t -62.97 -43.63 99.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.615 176.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -61.87 -43.79 98.13 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.456 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.6 m -61.76 -44.94 95.9 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.809 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.7 tp -72.5 -35.34 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 121.171 -0.212 . . . . 0.0 111.324 178.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -59.46 -47.11 86.76 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.878 0.37 . . . . 0.0 110.955 -177.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -62.92 -51.14 68.1 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.065 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.538 ' HG3' ' NE2' ' A' ' 64' ' ' GLN . 29.9 tpt180 -68.99 -40.82 78.54 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.568 -174.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 18.9 tt -65.64 -33.83 66.28 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.086 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 73.5 m -63.64 -35.06 79.27 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.783 175.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -67.4 -26.24 66.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.097 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.415 HD11 ' NE2' ' A' ' 64' ' ' GLN . 92.1 mt -74.56 136.52 42.1 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.973 0.416 . . . . 0.0 110.852 176.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -86.75 149.92 24.52 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.393 177.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.84 7.97 54.78 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.064 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 47.7 pt -94.02 139.49 18.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 120.881 0.372 . . . . 0.0 110.22 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 89.2 mt -99.38 -58.56 3.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.819 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.1 t -158.47 147.53 19.07 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.079 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 65.5 ttp -141.74 130.04 22.32 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.115 175.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -120.12 127.0 52.11 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.3 t -111.47 119.99 61.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.1 m -100.97 106.34 17.65 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 97.0 mt -63.61 -38.68 92.03 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.979 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -63.67 -41.08 98.22 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.931 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -77.29 -27.33 52.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.174 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.27 18.78 73.42 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.216 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 78.7 p -144.69 159.03 43.49 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 120.881 0.372 . . . . 0.0 111.177 -178.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -128.33 155.65 44.32 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.23 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.9 m -113.32 127.54 56.18 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 8' ' ' THR . 35.9 m -116.99 148.28 19.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 120.826 0.346 . . . . 0.0 111.218 -178.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -142.68 114.87 8.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.459 177.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.442 ' OH ' HD23 ' A' ' 58' ' ' LEU . 39.4 p90 -158.89 166.84 30.93 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.06 -178.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.12 116.27 63.38 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.587 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 43.4 Cg_endo -65.78 -20.42 58.87 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.086 2.524 . . . . 0.0 114.053 -175.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.6 p -65.71 -38.11 88.29 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.695 0.283 . . . . 0.0 111.439 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.9 m -100.4 -26.98 3.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 79.8 t -125.35 124.86 68.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 176.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.564 ' SG ' ' HG3' ' A' ' 60' ' ' GLN . 31.2 p -103.29 168.65 9.03 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.001 -178.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.442 HD23 ' OH ' ' A' ' 51' ' ' TYR . 96.0 mt -64.18 -38.2 90.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.533 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -61.74 -41.06 97.17 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.014 -177.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.564 ' HG3' ' SG ' ' A' ' 57' ' ' CYS . 96.0 mt-30 -62.07 -45.56 92.97 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.47 -178.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 72.6 t -64.22 -46.93 92.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 CA-C-O 121.075 0.464 . . . . 0.0 111.048 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 44.6 t -62.16 -43.37 98.97 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.135 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -62.53 -41.33 98.8 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.779 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.538 ' NE2' ' HG3' ' A' ' 28' ' ' ARG . 99.6 mt-30 -61.2 -43.55 98.7 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 121.207 -0.197 . . . . 0.0 111.334 -176.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.0 tt -77.85 -38.02 24.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.119 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -62.82 -40.21 98.95 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.604 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -62.61 -26.93 68.86 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 122.989 0.516 . . . . 0.0 110.781 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.457 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 36.6 mmt -71.4 -8.97 57.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.666 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.77 5.86 58.47 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.377 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.476 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 99.1 m-85 -110.55 138.56 46.78 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -88.42 140.6 29.3 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.735 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -139.62 138.36 36.09 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.13 177.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.3 m -118.63 139.38 51.59 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.4 tt -118.56 139.91 44.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-O 121.128 0.489 . . . . 0.0 111.499 -174.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.44 160.41 42.12 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.108 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 . . . . . 0 C--O 1.252 1.214 0 CA-C-O 118.512 -0.756 . . . . 0.0 109.744 177.887 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.553 0 CA-C-O 120.63 0.253 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.61 -56.33 4.47 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 121.234 -0.508 . . . . 0.0 114.111 176.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 65.1 m170 -65.21 127.35 31.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.741 0.305 . . . . 0.0 111.447 -175.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 67.3 mtt 54.49 29.47 11.27 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.52 0.728 . . . . 0.0 112.62 177.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -64.68 -33.34 75.73 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.326 0.584 . . . . 0.0 110.327 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.1 m -134.03 150.79 31.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.031 177.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -117.19 127.34 54.01 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 40.1 p -119.78 144.78 47.11 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.087 177.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.3 t -158.09 153.1 25.36 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.86 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 34.9 p -110.07 142.14 41.93 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 176.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.8 p -127.35 122.98 60.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-O 121.044 0.449 . . . . 0.0 110.192 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.464 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 36.3 ptt180 -91.44 146.2 24.0 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.208 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.2 pt -121.09 133.92 66.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 121.207 0.527 . . . . 0.0 112.008 -176.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 62.0 tp -135.56 129.41 32.94 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.069 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.21 -172.65 44.73 Favored Glycine 0 N--CA 1.438 -1.192 0 C-N-CA 119.58 -1.295 . . . . 0.0 112.811 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -61.8 -42.17 98.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.911 0.386 . . . . 0.0 110.913 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.453 ' HB ' ' OG ' ' A' ' 20' ' ' SER . 63.6 m -139.84 118.08 12.01 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.115 177.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.454 ' O ' HG21 ' A' ' 22' ' ' VAL . 95.1 m -67.47 -39.77 85.28 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.558 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -63.37 -41.91 98.84 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.613 -177.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.453 ' OG ' ' HB ' ' A' ' 17' ' ' THR . 78.9 p -69.71 -39.12 77.07 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.417 ' HB3' ' CG ' ' A' ' 70' ' ' PHE . 29.7 p -67.08 -34.03 76.78 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.544 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.454 HG21 ' O ' ' A' ' 18' ' ' CYS . 63.3 t -63.12 -44.84 99.68 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -63.09 -40.45 97.68 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.212 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.2 m -62.73 -46.22 89.09 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.637 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.9 tt -74.29 -35.62 40.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.012 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -60.65 -44.51 96.32 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.918 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -60.83 -51.3 69.91 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.207 -176.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -65.29 -46.35 80.74 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.444 HD11 ' SD ' ' A' ' 38' ' ' MET . 19.0 tt -65.8 -33.11 61.4 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.52 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.724 -177.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.5 m -65.55 -41.54 92.89 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.236 0.541 . . . . 0.0 110.338 177.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -71.13 -27.22 63.42 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.257 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 62.5 tp -81.86 117.23 21.96 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 121.306 0.574 . . . . 0.0 109.532 178.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -86.46 154.66 20.97 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.123 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.8 -6.3 15.9 Favored Glycine 0 C--N 1.314 -0.644 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -176.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.7 mp -102.05 112.67 36.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.3 tt -72.12 -38.45 63.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -176.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.5 m -151.34 145.31 25.21 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.838 0.352 . . . . 0.0 111.478 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.444 ' SD ' HD11 ' A' ' 29' ' ' ILE . 63.4 ttp -145.69 127.75 15.59 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -134.97 144.43 47.4 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.0 129.16 76.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 121.379 0.609 . . . . 0.0 111.428 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.6 p -100.47 98.07 8.72 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.703 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 99.4 mt -63.89 -39.16 93.54 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.371 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -65.45 -23.47 66.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.151 0.5 . . . . 0.0 111.115 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 -88.56 -27.82 21.14 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.135 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.34 19.67 71.21 Favored Glycine 0 C--O 1.236 0.272 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -176.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.0 t -145.0 154.88 43.01 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.24 -0.48 . . . . 0.0 109.733 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -118.36 149.73 40.7 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.584 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.7 m -112.86 126.83 55.88 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 8' ' ' THR . 12.7 p -123.72 137.37 57.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 121.013 0.435 . . . . 0.0 110.815 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -124.81 117.96 25.31 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 56.2 p90 -151.62 165.4 34.44 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.957 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.4 t -77.12 121.66 85.02 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 174.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -59.95 -28.38 86.99 Favored 'Trans proline' 0 N--CA 1.476 0.498 0 C-N-CA 122.814 2.343 . . . . 0.0 113.866 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.2 m -85.25 -9.43 57.74 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 120.752 0.31 . . . . 0.0 111.707 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 65.7 t -99.15 -42.33 10.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.712 0.291 . . . . 0.0 111.539 -178.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 63.5 t -125.36 137.16 58.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.746 -177.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 28.9 p -105.91 156.18 18.61 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.792 0.329 . . . . 0.0 110.872 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.73 -39.86 95.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.085 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -63.51 -36.87 85.19 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -177.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.414 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 23.8 tm0? -58.95 -45.28 90.86 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 121.224 -0.19 . . . . 0.0 110.796 -177.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.8 m -75.3 -33.47 28.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.216 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 95.4 m -63.64 -39.89 95.5 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-O 121.099 0.476 . . . . 0.0 110.179 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -63.33 -38.14 89.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.856 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.414 ' HG2' ' O ' ' A' ' 60' ' ' GLN . 19.6 mm100 -62.7 -43.52 98.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.499 -177.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.5 tt -83.0 -40.25 16.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 120.797 0.332 . . . . 0.0 111.714 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.563 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -62.89 -40.78 99.69 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 116.119 -0.491 . . . . 0.0 113.426 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -61.39 -35.3 77.11 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.974 0.416 . . . . 0.0 111.282 -178.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 35.9 mmt -68.62 -8.05 38.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.703 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.39 11.15 39.59 Favored Glycine 0 CA--C 1.506 -0.499 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.713 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.563 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 96.2 m-85 -108.03 146.16 32.94 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -102.49 131.23 49.32 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.91 0.386 . . . . 0.0 110.899 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 12' ' ' ARG . . . -143.28 144.36 32.09 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.4 p -133.9 153.72 51.56 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.306 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.8 mm -95.01 130.54 43.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.208 -174.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.0 151.5 51.47 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.134 176.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 C--N 1.309 -1.163 0 CA-C-O 119.024 -0.512 . . . . 0.0 110.595 -178.945 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.796 0 CA-C-O 120.739 0.304 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -137.04 147.52 19.28 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.386 -0.911 . . . . 0.0 111.94 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -88.41 130.06 35.27 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.007 0.432 . . . . 0.0 111.166 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 98.2 mmm -67.47 -39.17 85.26 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.489 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -98.98 105.57 17.73 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.426 0.631 . . . . 0.0 111.944 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 31.8 m -132.68 150.76 33.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.075 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.4 134.31 55.02 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.632 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 67.9 p -117.65 147.14 43.17 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 175.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' A' ' 76' ' ' GLU . 87.4 p -158.85 158.21 33.01 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.149 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 31.9 p -115.36 114.38 25.05 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 175.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 70.7 t -107.62 123.51 63.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.2 -176.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -91.48 143.2 26.85 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.497 -177.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 82.7 mt -120.18 130.48 74.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.364 -176.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.413 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 7.4 tt -112.32 120.49 41.89 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 176.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -166.14 179.49 40.22 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.272 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 94.7 mmm -63.18 -41.41 99.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.745 0.307 . . . . 0.0 111.294 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.0 t -152.17 150.36 29.77 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 120.993 0.425 . . . . 0.0 110.652 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.433 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 93.1 m -64.01 -38.78 92.33 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.67 -178.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -59.22 -47.42 85.41 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -172.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.2 p -70.52 -40.93 73.21 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -177.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.433 ' SG ' ' HA ' ' A' ' 18' ' ' CYS . 25.4 p -72.71 -42.74 63.85 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -177.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.416 ' O ' ' HG3' ' A' ' 26' ' ' GLU . 66.9 t -64.18 -45.58 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.86 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -64.41 -38.95 92.84 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.328 -0.549 . . . . 0.0 112.061 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.6 m -62.22 -43.97 97.63 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.279 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.433 ' O ' HG21 ' A' ' 29' ' ' ILE . 10.9 tp -72.86 -37.62 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.547 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 22' ' ' VAL . 44.4 mt-10 -61.97 -41.43 98.01 Favored 'General case' 0 C--N 1.349 0.558 0 C-N-CA 120.944 -0.303 . . . . 0.0 111.513 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -61.07 -50.26 74.01 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -176.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -65.93 -44.96 83.56 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.433 HG21 ' O ' ' A' ' 25' ' ' ILE . 19.7 tt -72.17 -32.68 44.08 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 CA-C-O 120.797 0.332 . . . . 0.0 111.372 -177.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.2 t -63.66 -39.67 94.93 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -68.56 -27.09 65.77 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.377 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 98.5 mt -83.68 118.34 23.8 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.556 -0.457 . . . . 0.0 110.427 176.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -85.71 153.94 21.98 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.606 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.13 7.48 14.62 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.453 -177.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 46.7 pt -102.79 139.02 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 86.8 mt -83.82 -56.96 4.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.173 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 78.6 p -155.14 157.42 37.41 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.256 -178.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 77.9 mtm -138.03 142.35 40.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.331 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -131.3 149.52 52.53 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 175.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.9 p -138.48 131.7 40.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-O 121.187 0.518 . . . . 0.0 111.385 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.1 m -116.19 103.99 11.08 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.76 -41.63 97.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.346 -176.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -64.02 -39.93 95.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.156 0.503 . . . . 0.0 110.997 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -73.11 -29.89 63.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.323 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.35 17.66 73.28 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.749 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 88.4 p -142.2 158.58 43.57 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 120.893 0.378 . . . . 0.0 110.455 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -124.48 144.7 49.94 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.85 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.1 m -103.65 123.35 46.83 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 8' ' ' THR . 29.7 m -126.67 149.41 31.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.446 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -134.95 115.33 13.44 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.468 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -161.97 170.93 18.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.237 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.5 t -82.88 116.32 63.46 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.76 -23.88 62.41 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.71 2.273 . . . . 0.0 113.515 -176.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.5 t -64.88 -42.88 94.45 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.271 177.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 96.5 t -67.78 -49.47 69.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.137 0.494 . . . . 0.0 110.043 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 63.0 t -128.35 119.84 51.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.639 ' SG ' ' HB2' ' A' ' 60' ' ' GLN . 30.4 p -83.12 154.46 24.33 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.472 -178.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.473 ' HB3' ' CD1' ' A' ' 74' ' ' ILE . 98.9 mt -62.48 -37.99 88.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.544 -178.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -63.11 -39.43 94.66 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.535 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.639 ' HB2' ' SG ' ' A' ' 57' ' ' CYS . 14.2 tm0? -65.0 -38.89 92.44 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 77.3 t -61.58 -44.05 98.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.298 0.571 . . . . 0.0 110.171 178.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 44.0 t -60.49 -40.32 90.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.191 176.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.457 ' HB3' ' O ' ' A' ' 60' ' ' GLN . 53.7 t-80 -60.18 -39.36 86.2 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.872 177.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -59.9 -46.17 90.18 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.373 -177.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.3 tt -82.04 -33.65 11.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.09 -39.66 97.43 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.455 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -61.75 -37.94 86.14 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.838 0.351 . . . . 0.0 111.082 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 16.4 tpt -61.97 -30.04 70.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.04 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.94 6.94 18.26 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.61 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -112.55 136.92 51.51 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.413 ' HG3' ' HB3' ' A' ' 14' ' ' LEU . 12.0 pt-20 -95.88 144.55 26.12 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.009 0.433 . . . . 0.0 110.649 -178.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.89 152.36 37.46 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.381 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 78.3 p -132.1 149.36 52.42 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.45 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.473 ' CD1' ' HB3' ' A' ' 58' ' ' LEU . 81.6 mt -94.4 125.26 47.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.891 -175.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -126.33 149.83 48.91 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.008 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.502 ' O ' ' HA ' ' A' ' 9' ' ' SER . 41.8 tt0 . . . . . 0 C--O 1.249 1.078 0 C-N-CA 123.167 0.587 . . . . 0.0 111.125 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.636 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.03 137.1 13.68 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.518 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -90.49 127.85 36.36 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.07 0.462 . . . . 0.0 111.622 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.453 ' HG3' HG12 ' A' ' 6' ' ' VAL . 15.0 tpt -140.96 128.89 21.84 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.481 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -91.37 103.33 15.98 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.233 0.54 . . . . 0.0 111.218 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.453 HG12 ' HG3' ' A' ' 4' ' ' MET . 27.6 m -133.17 150.41 32.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.511 177.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -139.07 148.77 43.77 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.06 0.457 . . . . 0.0 110.614 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 72.3 p -125.34 156.18 39.11 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.7 p -156.5 159.06 38.25 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 123.266 0.354 . . . . 0.0 110.078 176.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.2 p -117.93 139.21 51.47 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 73' ' ' SER . 6.7 p -132.14 123.81 51.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.234 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -77.96 143.51 37.55 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.496 HD12 ' SG ' ' A' ' 21' ' ' CYS . 37.6 pt -115.76 123.02 70.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 60.4 tp -122.82 119.36 30.35 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.063 0.458 . . . . 0.0 111.545 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.49 167.95 37.64 Favored Glycine 0 N--CA 1.438 -1.229 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 178.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 99.0 mtp -64.51 -39.32 93.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.954 0.407 . . . . 0.0 111.208 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.6 p -109.49 113.46 26.28 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.104 0.478 . . . . 0.0 111.196 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.496 ' O ' HG22 ' A' ' 22' ' ' VAL . 23.7 p -70.93 -44.9 65.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.851 -178.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.424 ' O ' ' HG3' ' A' ' 23' ' ' LYS . 98.3 mt-30 -64.73 -37.9 89.15 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.555 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.2 t -60.55 -45.25 94.58 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.241 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.496 ' SG ' HD12 ' A' ' 13' ' ' ILE . 26.9 p -69.56 -32.57 71.44 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.836 178.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 18' ' ' CYS . 61.5 t -63.64 -43.67 98.22 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-O 121.214 0.531 . . . . 0.0 109.631 176.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' A' ' 19' ' ' GLN . 98.6 mttt -61.86 -39.34 91.53 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.752 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.9 m -62.72 -43.23 99.34 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.716 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.426 ' CG2' ' HB ' ' A' ' 65' ' ' ILE . 46.1 pt -81.63 -39.24 16.8 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.886 0 C-N-CA 120.386 -0.525 . . . . 0.0 112.292 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -62.67 -44.87 95.16 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.155 -176.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -61.85 -51.73 67.03 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.206 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.55 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 97.7 mtt180 -70.11 -41.21 74.29 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -176.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 92.1 mt -63.45 -44.19 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.683 0.278 . . . . 0.0 111.166 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 81.1 p -63.2 -33.78 76.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.833 0.349 . . . . 0.0 110.936 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -70.98 -25.76 62.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.417 176.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 28' ' ' ARG . 99.3 mt -70.43 146.61 50.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.133 0.492 . . . . 0.0 111.316 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -86.57 130.88 34.33 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.46 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.5 7.76 25.71 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.799 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.7 tp -84.88 123.39 39.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.05 0.453 . . . . 0.0 110.821 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 86.6 mt -93.58 -60.68 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.011 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 85.9 p -161.51 164.26 29.74 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.64 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 28.5 ptm -151.31 155.54 38.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.904 0.383 . . . . 0.0 110.883 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -143.73 138.67 29.0 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.692 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 67.0 t -106.9 124.33 62.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 120.941 0.4 . . . . 0.0 110.506 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.5 t -99.24 108.09 20.57 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.101 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.11 -33.47 73.53 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.426 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -61.48 -45.48 94.06 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.256 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -93.14 -12.69 29.77 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.646 -0.421 . . . . 0.0 111.686 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.83 26.95 73.78 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.1 m -135.69 158.17 45.05 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.389 -0.406 . . . . 0.0 110.447 -177.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.44 143.59 47.42 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 85.7 m -110.03 127.8 55.04 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.1 p -127.57 134.73 64.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 121.181 0.515 . . . . 0.0 111.283 -178.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -104.48 114.99 29.58 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 175.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.456 ' O ' ' HD3' ' A' ' 53' ' ' PRO . 16.1 t80 -142.79 165.27 27.85 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.612 -170.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.9 t -107.12 98.21 21.29 Favored Pre-proline 0 C--N 1.319 -0.744 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 51' ' ' TYR . 45.9 Cg_exo -60.66 -25.08 80.17 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.294 2.663 . . . . 0.0 111.971 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.8 m -62.26 -41.06 98.11 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.792 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 76.5 t -65.5 -49.69 76.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-O 121.192 0.52 . . . . 0.0 109.847 177.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.3 p -155.85 147.13 12.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.654 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 29.8 p -68.87 156.22 38.83 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.295 0.569 . . . . 0.0 112.406 -176.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.0 mt -77.2 -12.32 59.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.425 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -58.32 -37.89 76.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.954 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.517 ' O ' ' HG3' ' A' ' 64' ' ' GLN . 16.8 mm100 -61.57 -39.88 92.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.011 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.2 t -61.74 -45.11 99.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.744 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 43.0 t -60.73 -40.54 92.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.96 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 44.7 m170 -64.63 -37.16 86.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.703 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.517 ' HG3' ' O ' ' A' ' 60' ' ' GLN . 98.5 mt-30 -60.87 -44.29 97.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.119 -0.492 . . . . 0.0 112.008 -177.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.432 HD11 ' HB3' ' A' ' 72' ' ' ALA . 20.1 tt -76.32 -38.41 33.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.597 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.13 -37.89 95.24 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 177.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -58.12 -36.89 73.59 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.25 0.62 . . . . 0.0 111.132 177.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 97.8 mmm -79.91 1.93 25.36 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.87 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.31 19.39 58.86 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.871 -0.68 . . . . 0.0 113.897 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -114.64 135.79 53.76 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 177.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -83.08 140.07 32.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.721 0.296 . . . . 0.0 110.56 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.432 ' HB3' HD11 ' A' ' 65' ' ' ILE . . . -148.23 149.72 32.43 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.175 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.503 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 65.9 m -133.92 133.97 42.08 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.181 177.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 85.9 mt -100.28 125.87 53.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.258 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -138.67 148.37 43.93 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.419 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.466 -0.778 . . . . 0.0 109.313 179.239 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -62.0 -44.88 97.19 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 121.039 -0.6 . . . . 0.0 113.3 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.8 p80 -90.23 164.91 14.22 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.453 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.9 tpt -122.17 91.14 3.44 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.807 0.336 . . . . 0.0 110.812 177.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 52.86 28.46 6.5 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.2 p -145.63 135.58 18.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -129.69 128.55 42.77 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.98 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.607 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 63.0 p -126.32 136.99 53.42 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.116 177.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.4 t -159.43 162.91 35.78 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 59.3 p -106.05 136.71 45.25 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.273 0.558 . . . . 0.0 111.077 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.32 123.61 70.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 177.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -80.61 141.15 35.29 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -178.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.2 pt -109.68 126.86 66.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-O 121.332 0.586 . . . . 0.0 111.369 -177.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.4 tp -126.26 117.8 23.81 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -165.47 160.46 33.85 Favored Glycine 0 N--CA 1.422 -2.27 0 C-N-CA 120.07 -1.062 . . . . 0.0 111.495 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.6 mmt -65.41 -39.67 92.45 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.3 p -122.33 105.94 10.64 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.722 176.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.9 m -63.63 -40.15 96.16 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.712 -177.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -62.93 -40.71 98.45 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.79 0.329 . . . . 0.0 110.471 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.4 m -62.81 -44.65 95.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.79 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 27.9 p -67.14 -38.28 85.25 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.128 -178.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 78.8 t -64.86 -45.02 96.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-O 121.128 0.489 . . . . 0.0 109.828 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -63.52 -43.14 98.03 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.925 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.459 ' HB3' ' HG3' ' A' ' 68' ' ' MET . 68.8 m -62.44 -42.79 99.71 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.825 -178.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.402 HD13 ' HB ' ' A' ' 65' ' ' ILE . 17.9 tt -72.56 -37.65 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.41 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -60.83 -45.94 92.49 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.228 0.537 . . . . 0.0 109.956 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -60.7 -49.71 76.43 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.366 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 44.4 ttt180 -66.02 -43.69 86.91 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.237 -177.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 87.9 mt -63.68 -39.87 86.97 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.799 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.861 177.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 69.3 m -59.72 -37.24 78.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.98 0.419 . . . . 0.0 110.384 178.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -68.59 -26.5 65.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.994 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.0 mp -97.71 150.01 21.67 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.31 0.576 . . . . 0.0 112.105 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -75.58 154.66 36.61 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.793 178.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.95 2.05 45.59 Favored Glycine 0 CA--C 1.505 -0.543 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.971 177.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.8 tt -72.62 108.13 3.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.253 0.549 . . . . 0.0 110.794 178.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.449 ' HB ' ' O ' ' A' ' 50' ' ' LYS . 46.0 mm -101.88 -71.47 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.816 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 52.2 m -155.65 158.41 38.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.752 0.31 . . . . 0.0 111.242 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.8 ptm -148.74 148.53 30.11 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.242 175.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.499 ' HB3' ' HB ' ' A' ' 48' ' ' THR . 55.1 tttp -117.36 112.0 20.11 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.317 176.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.7 p -118.79 114.43 44.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-O 121.409 0.623 . . . . 0.0 110.008 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.7 m -124.98 127.01 46.36 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.02 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 93.8 mt -63.29 -39.07 93.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.225 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -61.75 -39.32 91.19 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.258 0.552 . . . . 0.0 110.365 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -72.56 -30.11 64.14 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.465 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.66 14.94 80.87 Favored Glycine 0 C--O 1.236 0.255 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.036 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 89.7 p -156.17 164.4 38.42 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.56 134.78 55.07 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.926 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.499 ' HB ' ' HB3' ' A' ' 39' ' ' LYS . 53.4 m -94.54 124.32 38.5 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 177.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' A' ' 8' ' ' THR . 28.9 m -107.86 142.0 21.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.457 -177.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.449 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 87.7 tttt -131.58 104.58 7.03 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.478 -0.783 . . . . 0.0 108.926 178.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.518 ' CE2' ' HB ' ' A' ' 49' ' ' VAL . 64.5 m-85 -140.25 160.38 40.09 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.967 -177.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.0 t -80.44 117.08 66.08 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 30.1 Cg_endo -62.28 -25.83 76.92 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.142 2.561 . . . . 0.0 113.096 -176.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.8 t -62.94 -41.57 99.53 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.054 0.454 . . . . 0.0 110.334 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.1 t -87.53 -49.81 14.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.3 -177.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 28.5 m -132.82 161.68 41.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.484 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 31.1 p -133.74 169.72 16.63 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 120.679 0.276 . . . . 0.0 110.899 -178.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.1 mt -62.6 -38.59 90.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.51 -177.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -60.32 -44.49 95.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.43 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.491 ' O ' ' HG3' ' A' ' 64' ' ' GLN . 97.0 mt-30 -64.42 -41.06 96.82 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.104 178.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 73.6 t -62.08 -46.13 97.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 CA-C-O 121.133 0.492 . . . . 0.0 110.353 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.499 ' SG ' ' HB ' ' A' ' 74' ' ' ILE . 93.8 m -62.78 -39.71 95.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.848 178.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -62.47 -41.64 98.92 Favored 'General case' 0 C--O 1.206 -1.226 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.052 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.491 ' HG3' ' O ' ' A' ' 60' ' ' GLN . 78.5 mt-30 -60.39 -42.42 95.87 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -175.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.402 ' HB ' HD13 ' A' ' 25' ' ' ILE . 17.4 tt -76.77 -40.95 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.571 178.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.571 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -63.33 -38.33 96.26 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 121.334 -0.46 . . . . 0.0 112.381 178.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -58.72 -33.59 70.38 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 124.261 1.024 . . . . 0.0 110.509 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.459 ' HG3' ' HB3' ' A' ' 24' ' ' SER . 96.6 mmm -79.09 -1.32 35.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.936 -178.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.17 15.55 44.26 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.149 -1.024 . . . . 0.0 113.589 177.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.571 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 99.3 m-85 -113.8 145.86 40.79 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.788 0.328 . . . . 0.0 110.354 178.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -88.52 130.75 35.16 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 120.983 0.421 . . . . 0.0 111.028 -178.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.46 140.2 24.85 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.644 178.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.7 m -127.0 141.49 51.78 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.1 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.499 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 10.2 tp -98.33 136.32 29.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 120.859 0.361 . . . . 0.0 110.498 -177.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -154.43 159.35 41.02 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.23 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 . . . . . 0 C--O 1.252 1.198 0 CA-C-O 118.152 -0.928 . . . . 0.0 110.721 179.094 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.559 ' HA ' ' OE1' ' A' ' 5' ' ' GLN . . . . . . . . 0 N--CA 1.467 0.39 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -157.86 174.91 35.21 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.117 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -83.69 129.0 34.95 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.7 ttt 55.04 48.66 19.29 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -176.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.559 ' OE1' ' HA ' ' A' ' 1' ' ' ALA . 53.6 tt0 -70.67 123.79 22.73 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.576 -177.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.7 t -126.7 129.27 71.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.875 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.01 134.11 44.5 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.137 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 69.8 p -123.73 137.52 54.68 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.855 178.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 72.7 m -147.11 157.3 43.56 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.448 178.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 38.4 p -110.01 139.23 45.35 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 177.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.444 ' CG2' ' HB2' ' A' ' 72' ' ' ALA . 7.0 p -129.74 119.69 48.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-O 120.967 0.413 . . . . 0.0 110.205 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.502 ' HG2' ' HB2' ' A' ' 73' ' ' SER . 9.2 ptm180 -82.21 148.79 28.24 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.9 pt -112.81 142.66 24.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 121.278 0.561 . . . . 0.0 111.123 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 67.1 tp -132.69 119.74 20.78 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.166 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 178.41 174.41 44.64 Favored Glycine 0 N--CA 1.436 -1.305 0 C-N-CA 119.27 -1.443 . . . . 0.0 113.831 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 28.1 ttt -62.06 -48.13 81.6 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 122.987 0.515 . . . . 0.0 111.426 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.4 p -128.86 119.34 24.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.066 0.46 . . . . 0.0 111.297 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.8 m -65.47 -39.02 91.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.118 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -63.42 -39.47 94.58 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.449 -177.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.8 m -62.67 -43.73 98.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.543 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.0 p -71.83 -39.65 69.64 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -178.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.7 m -69.99 -33.02 53.57 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 120.291 -0.563 . . . . 0.0 111.051 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -71.09 -42.28 69.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.111 0.482 . . . . 0.0 110.863 177.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.5 m -62.73 -43.55 98.51 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.041 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.561 ' HB ' ' CG2' ' A' ' 65' ' ' ILE . 19.3 tt -71.56 -29.71 35.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.618 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -59.63 -45.16 92.8 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.559 -177.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -61.97 -50.8 70.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.795 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.491 HH11 ' HA ' ' A' ' 64' ' ' GLN . 99.4 mtt180 -65.47 -39.95 92.57 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -177.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 27.6 mm -60.99 -44.56 98.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.99 0.424 . . . . 0.0 110.328 176.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.7 t -62.54 -39.93 95.18 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.385 178.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -68.56 -28.78 67.26 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.006 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 64.4 tp -100.38 118.13 35.99 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.133 0.492 . . . . 0.0 111.478 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -83.22 153.05 24.92 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.056 178.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.29 -11.4 12.86 Favored Glycine 0 CA--C 1.499 -0.91 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -176.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.6 tt -108.42 110.43 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 173.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.14 -47.03 95.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.864 -174.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 85.0 p -158.85 160.57 36.33 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.479 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 28.0 ttt -146.69 129.87 16.54 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.554 177.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -121.3 139.76 52.98 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.6 m -116.52 140.27 39.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 120.873 0.368 . . . . 0.0 110.894 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.6 t -119.64 106.81 12.53 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.778 178.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.8 mp -64.65 -39.72 94.17 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.271 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -62.3 -44.98 95.26 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.501 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -75.71 -28.68 58.68 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.048 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.21 25.62 65.83 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -176.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 12' ' ' ARG . 45.4 t -145.32 150.98 37.59 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.079 -0.56 . . . . 0.0 110.034 -176.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.04 145.88 45.51 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.361 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 87.2 m -105.82 126.02 51.67 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 8' ' ' THR . 23.7 m -110.6 138.3 39.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-O 120.966 0.412 . . . . 0.0 110.382 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -128.43 108.08 10.26 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -149.19 165.99 30.17 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.029 0.442 . . . . 0.0 112.035 -171.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 52.1 t -79.72 119.8 77.99 Favored Pre-proline 0 C--N 1.319 -0.741 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 174.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -60.68 -32.21 92.92 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.649 2.232 . . . . 0.0 113.281 -174.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.6 t -65.06 -41.93 94.67 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.001 0.429 . . . . 0.0 110.934 178.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.0 t -81.42 -46.04 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -175.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 74.0 t -114.75 133.88 59.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -173.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 29.1 p -109.25 147.95 31.77 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.285 177.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.402 HD11 HG23 ' A' ' 74' ' ' ILE . 87.1 mt -64.56 -40.3 95.32 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -176.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -62.6 -39.72 94.65 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -177.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -61.85 -41.6 98.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.961 0.41 . . . . 0.0 109.999 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.4 t -63.31 -44.49 99.12 Favored 'Isoleucine or valine' 0 C--O 1.247 0.924 0 CA-C-O 121.47 0.652 . . . . 0.0 110.403 177.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 97.2 m -61.65 -38.31 87.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.15 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 61.4 m170 -66.87 -26.17 66.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.088 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.491 ' HA ' HH11 ' A' ' 28' ' ' ARG . 78.8 mt-30 -60.73 -43.65 97.63 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 120.79 0.328 . . . . 0.0 110.432 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.561 ' CG2' ' HB ' ' A' ' 25' ' ' ILE . 36.6 pt -87.65 -25.89 5.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.251 176.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -61.5 -35.96 91.86 Favored Glycine 0 N--CA 1.453 -0.22 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.467 178.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -58.83 -37.43 76.41 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.856 0.36 . . . . 0.0 110.935 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 26.4 mmt -79.63 1.2 27.08 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.733 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.9 10.3 60.1 Favored Glycine 0 CA--C 1.508 -0.404 0 C-N-CA 120.604 -0.808 . . . . 0.0 113.035 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.458 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 72.2 m-85 -98.84 139.14 34.95 Favored 'General case' 0 C--N 1.315 -0.901 0 O-C-N 122.645 -0.326 . . . . 0.0 110.235 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -100.75 151.15 22.01 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.353 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.471 ' HB1' HD11 ' A' ' 65' ' ' ILE . . . -144.93 156.69 44.12 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 120.782 0.325 . . . . 0.0 111.242 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.502 ' HB2' ' HG2' ' A' ' 12' ' ' ARG . 40.4 m -129.19 146.8 51.04 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.402 HG23 HD11 ' A' ' 58' ' ' LEU . 84.2 mt -101.95 127.18 55.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.238 0.542 . . . . 0.0 111.947 -174.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -128.52 157.14 42.0 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.135 177.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 . . . . . 0 C--O 1.242 0.678 0 C-N-CA 123.37 0.668 . . . . 0.0 110.283 -176.985 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.01 137.13 29.5 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.233 -0.984 . . . . 0.0 110.896 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -91.78 124.35 35.85 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.997 0.427 . . . . 0.0 111.12 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 98.5 mmm -89.51 138.14 31.72 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.263 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -85.34 137.27 33.06 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.629 -0.429 . . . . 0.0 110.263 178.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.408 HG12 HD12 ' A' ' 36' ' ' ILE . 61.8 t -95.29 120.31 44.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.78 148.05 25.36 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.768 -175.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.8 p -100.64 136.05 41.11 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.174 176.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.3 m -126.8 145.86 50.47 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 120.704 0.288 . . . . 0.0 110.227 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 46.5 p -117.16 140.1 49.94 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.347 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.91 126.76 38.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.447 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.456 ' HG2' ' HB3' ' A' ' 73' ' ' SER . 14.7 ptm180 -83.42 149.17 26.84 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.714 HG23 ' SG ' ' A' ' 21' ' ' CYS . 86.0 mt -123.1 130.51 74.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -176.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.7 tp -131.61 119.07 20.93 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -173.42 -177.27 42.53 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.247 -0.977 . . . . 0.0 112.403 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 66.8 mtt -63.78 -43.22 97.01 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.6 m -136.6 116.91 13.58 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.633 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.41 ' O ' HG23 ' A' ' 22' ' ' VAL . 94.1 m -65.57 -40.23 92.56 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.729 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -62.82 -40.87 98.74 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -177.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.9 m -62.5 -44.27 96.79 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -177.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.714 ' SG ' HG23 ' A' ' 13' ' ' ILE . 24.5 p -71.38 -35.73 71.18 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.64 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 18' ' ' CYS . 59.0 t -62.76 -44.22 99.33 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 177.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.96 -40.25 97.14 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.114 177.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.7 t -60.63 -47.64 85.32 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.295 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.6 pt -74.25 -29.4 24.63 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.899 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -59.53 -48.83 80.13 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -65.41 -51.18 62.09 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.306 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -62.27 -50.71 70.61 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-O 121.192 0.52 . . . . 0.0 111.631 -174.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.407 ' CG2' HD11 ' A' ' 35' ' ' ILE . 37.4 mm -62.83 -41.98 94.63 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.929 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.752 179.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 73.2 m -60.56 -38.81 85.74 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -68.52 -27.17 65.87 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.035 177.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 60.5 tp -87.25 129.69 34.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.148 0.499 . . . . 0.0 110.966 177.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -70.81 151.88 44.33 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.354 177.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.95 -4.97 18.55 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.881 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.407 HD11 ' CG2' ' A' ' 29' ' ' ILE . 9.3 tt -96.14 138.32 21.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.84 0.353 . . . . 0.0 110.899 178.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.408 HD12 HG12 ' A' ' 6' ' ' VAL . 86.4 mt -113.02 -53.31 5.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.793 176.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.9 m -137.52 151.72 48.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.889 0.376 . . . . 0.0 111.694 -177.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.41 ' HG3' HG12 ' A' ' 49' ' ' VAL . 60.6 ttm -139.14 131.21 27.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.394 176.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -128.79 124.54 35.7 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.9 m -126.61 140.0 50.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.381 -179.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.4 t -134.74 108.3 7.91 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.973 177.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.5 mp -66.5 -32.57 74.01 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.643 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -61.74 -39.92 93.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.283 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -75.41 -27.39 59.01 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.06 0.457 . . . . 0.0 110.14 176.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.2 15.47 81.0 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 -177.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 12' ' ' ARG . 51.1 m -135.13 153.69 51.91 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 121.085 0.469 . . . . 0.0 110.627 -178.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.66 139.19 51.91 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.498 178.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 79.6 m -115.18 125.5 53.48 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.41 HG12 ' HG3' ' A' ' 38' ' ' MET . 31.5 m -125.58 148.05 30.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.977 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -124.1 116.53 22.92 Favored 'General case' 0 C--O 1.245 0.838 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.57 ' CD2' ' HB ' ' A' ' 56' ' ' VAL . 55.3 p90 -152.61 166.15 32.99 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.474 -173.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.8 t -77.5 117.99 69.09 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.03 -30.37 82.85 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.769 2.313 . . . . 0.0 113.546 -175.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.3 t -64.78 -44.19 90.8 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.039 0.447 . . . . 0.0 110.828 178.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 90.9 t -72.7 -47.17 51.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.71 -177.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.57 ' HB ' ' CD2' ' A' ' 51' ' ' TYR . 58.3 t -112.63 126.3 70.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.093 -177.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.466 ' SG ' ' HB2' ' A' ' 60' ' ' GLN . 28.6 p -100.92 158.35 16.05 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 120.989 0.423 . . . . 0.0 111.473 -178.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.3 mt -63.41 -39.12 93.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.576 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -62.19 -39.93 94.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.671 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.494 ' O ' ' HG3' ' A' ' 64' ' ' GLN . 64.9 tt0 -61.16 -46.55 90.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.627 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.5 t -61.93 -44.44 98.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.625 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 93.3 m -61.66 -41.46 97.56 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.089 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -66.04 -41.13 91.28 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.759 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 60' ' ' GLN . 95.6 mt-30 -60.87 -42.24 97.51 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.985 -175.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.0 tt -84.04 -41.23 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.98 -40.18 98.99 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 116.303 -0.408 . . . . 0.0 113.501 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -60.51 -35.82 76.88 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.936 0.398 . . . . 0.0 110.571 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 26.5 mmt -69.76 -11.95 61.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.468 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.98 12.21 32.44 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.394 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.52 ' CG ' ' HB3' ' A' ' 21' ' ' CYS . 94.9 m-85 -110.32 125.48 53.22 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -76.96 139.11 40.02 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.624 -178.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.13 155.18 41.94 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 120.889 0.376 . . . . 0.0 111.603 -177.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.456 ' HB3' ' HG2' ' A' ' 12' ' ' ARG . 42.0 t -137.29 139.95 41.24 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 36.4 pt -105.67 151.82 7.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -173.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.543 ' O ' ' HB2' ' A' ' 76' ' ' GLU . . . -151.35 160.26 43.86 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.7 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.543 ' HB2' ' O ' ' A' ' 75' ' ' ALA . 39.5 mm-40 . . . . . 0 C--O 1.251 1.148 0 C-N-CA 123.3 0.64 . . . . 0.0 110.879 -178.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.622 0 CA-C-O 120.632 0.253 . . . . 0.0 110.375 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -123.56 166.29 16.08 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.524 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -67.64 149.74 49.66 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.622 0.248 . . . . 0.0 110.356 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -66.71 116.88 8.1 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.021 0.438 . . . . 0.0 110.966 -178.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -65.24 -37.84 88.49 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.663 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.5 m -107.77 150.58 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.587 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.98 147.27 42.44 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.103 0.478 . . . . 0.0 111.885 -175.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 53.9 p -119.35 150.15 40.64 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.715 176.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.446 ' OG ' HD22 ' A' ' 58' ' ' LEU . 87.5 p -155.34 160.35 40.66 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.314 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 41.2 p -127.77 146.09 50.7 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.538 176.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.5 m -128.92 146.19 34.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.45 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 38.5 ptt180 -106.67 140.99 38.65 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.528 HG12 ' SG ' ' A' ' 21' ' ' CYS . 7.8 tp -120.08 131.51 72.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-O 121.679 0.752 . . . . 0.0 112.424 -173.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 65.7 tp -124.67 118.19 25.93 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.52 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -170.01 169.32 42.09 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 119.938 -1.125 . . . . 0.0 112.733 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 79.3 mtm -64.09 -42.81 96.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.786 0.327 . . . . 0.0 111.377 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.7 p -132.52 122.54 25.01 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.193 0.52 . . . . 0.0 111.57 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.1 t -63.6 -41.9 98.28 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.141 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.8 mp0 -61.51 -40.42 94.54 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.295 -176.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.7 m -62.84 -45.59 91.9 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -177.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.528 ' SG ' HG12 ' A' ' 13' ' ' ILE . 26.7 p -68.71 -35.66 77.46 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.178 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 67.6 t -62.91 -44.32 99.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-O 121.114 0.483 . . . . 0.0 109.759 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -64.81 -40.13 94.71 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.012 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.6 m -62.74 -46.65 87.08 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.376 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.533 ' HB ' ' CG2' ' A' ' 65' ' ' ILE . 8.1 tp -69.9 -31.94 49.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.009 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -58.84 -42.81 90.16 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.316 -178.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -59.3 -53.57 56.75 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.406 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 24.0 ttm180 -67.14 -47.15 71.93 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.118 -178.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.59 ' O ' HD11 ' A' ' 35' ' ' ILE . 18.5 tt -65.76 -41.43 90.29 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.987 -175.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 86.6 p -66.33 -30.09 70.42 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-O 121.062 0.458 . . . . 0.0 110.488 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -70.62 -27.09 63.81 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.841 177.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 28' ' ' ARG . 89.9 mt -91.72 137.63 32.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.189 0.518 . . . . 0.0 111.775 -178.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -86.72 151.62 23.24 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.841 177.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.58 8.22 12.71 Favored Glycine 0 C--O 1.238 0.369 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.658 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.59 HD11 ' O ' ' A' ' 29' ' ' ILE . 79.8 mt -81.67 121.98 35.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 83.6 mt -94.24 -54.77 6.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.0 t -149.06 124.21 10.12 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.97 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.418 ' SD ' HD12 ' A' ' 29' ' ' ILE . 27.2 ttt -121.24 113.58 20.16 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.125 177.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -133.29 145.68 50.69 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.139 178.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.45 126.51 74.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.222 0.534 . . . . 0.0 110.089 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.8 m -93.65 91.99 7.31 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.152 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.8 mt -63.54 -35.98 82.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.603 0.716 . . . . 0.0 109.235 178.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -62.84 -40.28 96.95 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.844 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -90.33 -12.19 38.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.046 -177.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.5 29.69 69.64 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.379 -0.915 . . . . 0.0 111.471 -177.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 90.1 p -151.06 163.66 38.25 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -119.07 145.83 45.59 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.533 0.206 . . . . 0.0 110.82 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.3 m -112.93 121.95 46.18 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.0 t -120.49 123.19 69.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-O 120.884 0.373 . . . . 0.0 110.371 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -109.2 119.38 39.35 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 176.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -150.77 166.68 29.72 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.697 -170.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.9 t -92.05 110.82 46.62 Favored Pre-proline 0 N--CA 1.444 -0.755 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 173.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.27 -21.72 67.02 Favored 'Trans proline' 0 N--CA 1.475 0.427 0 C-N-CA 122.88 2.387 . . . . 0.0 113.467 -175.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.5 t -64.37 -42.71 96.04 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.173 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.8 p -95.11 -35.71 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.2 p -130.14 149.89 34.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -177.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 29.6 p -134.01 163.06 30.39 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.19 0.519 . . . . 0.0 111.663 -175.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.446 HD22 ' OG ' ' A' ' 9' ' ' SER . 98.6 mt -70.8 -22.53 62.34 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.982 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -61.73 -42.3 98.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.07 0.462 . . . . 0.0 110.14 -179.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -65.15 -40.89 95.01 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.182 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.433 ' HB ' HD12 ' A' ' 25' ' ' ILE . 32.7 m -72.71 -36.4 52.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.53 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 95.6 m -64.18 -39.51 94.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.665 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 66.3 m170 -64.31 -39.94 94.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.314 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -60.83 -43.79 97.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.606 -177.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.533 ' CG2' ' HB ' ' A' ' 25' ' ' ILE . 27.2 pt -87.04 -37.87 11.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -178.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -62.94 -40.71 99.62 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.888 -0.673 . . . . 0.0 113.137 -178.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -70.13 -14.91 62.86 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 26.3 mmt -85.11 2.34 43.88 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.907 0.384 . . . . 0.0 110.817 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.48 -9.2 71.73 Favored Glycine 0 CA--C 1.507 -0.407 0 C-N-CA 121.066 -0.587 . . . . 0.0 112.188 179.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.459 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 96.8 m-85 -80.89 143.57 32.61 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -106.25 128.31 53.87 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.643 -177.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 12' ' ' ARG . . . -147.31 151.23 36.24 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.466 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.8 p -136.77 153.63 50.78 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.903 0.382 . . . . 0.0 111.341 178.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 81.3 mt -90.98 131.86 37.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.908 -174.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -133.67 126.54 31.02 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.454 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 . . . . . 0 C--N 1.314 -0.97 0 CA-C-O 118.062 -0.97 . . . . 0.0 110.657 179.691 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.615 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.6 -130.74 46.33 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.14 -177.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.424 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 63.0 m170 -90.11 152.67 21.02 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.84 0.352 . . . . 0.0 110.247 -179.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 96.2 mmm -70.84 -37.9 73.18 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.911 0.386 . . . . 0.0 111.026 175.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -67.0 -40.01 87.26 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.087 178.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.424 ' O ' ' HB2' ' A' ' 3' ' ' HIS . 7.6 p -139.45 125.89 23.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -108.77 134.55 51.32 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.287 0.565 . . . . 0.0 112.27 -173.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 50.5 p -123.97 140.5 52.92 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.976 174.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 91.3 p -158.46 166.85 31.2 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.019 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 2.1 p -110.32 148.48 31.85 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 175.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 91.1 t -131.01 126.89 60.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.418 ' NE ' ' HB2' ' A' ' 73' ' ' SER . 37.9 ptt180 -87.8 144.62 26.51 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.589 HG12 ' SG ' ' A' ' 21' ' ' CYS . 7.4 tp -129.61 130.3 66.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-O 121.163 0.506 . . . . 0.0 111.134 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 62.0 tp -129.47 124.22 33.48 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.478 178.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -165.18 176.25 40.9 Favored Glycine 0 N--CA 1.435 -1.425 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.157 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 61.0 tpp -61.52 -47.91 83.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.884 0.373 . . . . 0.0 111.024 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 65.9 m -130.4 125.16 33.84 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.119 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.8 t -63.23 -43.59 97.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.396 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -61.52 -38.76 88.57 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.528 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.0 m -60.47 -44.21 96.12 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -177.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.589 ' SG ' HG12 ' A' ' 13' ' ' ILE . 25.6 p -70.99 -36.95 72.68 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.235 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.9 t -63.18 -44.53 99.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-O 121.123 0.487 . . . . 0.0 109.764 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -64.41 -40.38 95.67 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.878 178.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.622 ' O ' ' HD3' ' A' ' 28' ' ' ARG . 68.9 m -62.11 -45.04 95.23 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.38 -178.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.447 ' HB ' ' HB ' ' A' ' 65' ' ' ILE . 17.9 tt -70.93 -33.77 53.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.849 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -60.22 -48.01 83.54 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.934 -177.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -61.55 -46.69 88.86 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.887 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.622 ' HD3' ' O ' ' A' ' 24' ' ' SER . 10.9 mpt_? -70.41 -41.75 72.53 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.754 -177.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.593 ' O ' HD12 ' A' ' 35' ' ' ILE . 16.6 tt -70.66 -39.81 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.163 -177.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 79.5 p -66.06 -28.33 68.76 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 120.988 0.423 . . . . 0.0 110.515 178.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -67.96 -28.76 67.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.793 175.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.4 tp -86.95 118.66 26.48 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.655 177.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -78.58 142.9 36.94 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.949 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.22 8.86 11.03 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.815 -178.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.593 HD12 ' O ' ' A' ' 29' ' ' ILE . 90.0 mt -70.75 125.12 28.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.633 ' HB ' ' O ' ' A' ' 50' ' ' LYS . 47.9 mm -88.21 -63.85 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.1 t -161.82 140.11 9.21 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.805 177.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 18.8 tmm? -137.27 126.37 24.46 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 176.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -125.14 115.68 20.84 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.2 p -103.16 122.32 55.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-O 121.172 0.51 . . . . 0.0 110.296 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.4 m -96.89 99.95 11.49 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 97.1 mt -63.9 -38.89 92.75 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.937 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -63.69 -40.25 96.32 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.978 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -77.1 -30.01 55.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.9 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.68 20.17 71.8 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -175.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.0 t -146.5 150.36 35.43 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -178.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -119.53 148.77 42.9 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 120.804 0.335 . . . . 0.0 111.735 -177.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.2 m -108.35 124.48 50.41 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.684 ' HB ' ' CE2' ' A' ' 51' ' ' TYR . 33.6 m -119.32 149.6 21.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.621 -176.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.633 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 65.3 tttm -140.05 106.36 5.27 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.684 ' CE2' ' HB ' ' A' ' 49' ' ' VAL . 42.2 m-85 -138.37 161.92 35.73 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -177.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 64.8 t -88.34 110.41 36.09 Favored Pre-proline 0 N--CA 1.439 -1.0 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 172.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 36.2 Cg_endo -64.21 -23.48 66.35 Favored 'Trans proline' 0 CA--C 1.514 -0.489 0 C-N-CA 122.592 2.195 . . . . 0.0 112.341 -176.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 61.9 m -62.95 -42.0 99.68 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 177.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.5 t -75.1 -48.42 32.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.826 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 7.5 p -146.68 139.54 19.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.954 -178.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 26.5 p -83.51 153.71 24.26 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.107 0.479 . . . . 0.0 111.196 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.1 mt -66.06 -37.26 85.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.759 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -60.04 -40.61 89.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.436 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.406 HE21 ' HB3' ' A' ' 60' ' ' GLN . 1.0 OUTLIER -62.14 -41.02 97.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.192 0.52 . . . . 0.0 109.633 179.12 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 73.9 t -63.41 -44.24 98.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.084 178.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 49.6 t -60.42 -41.52 94.14 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.146 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -61.07 -41.4 96.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.367 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -61.08 -41.65 97.04 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 -176.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.447 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 20.3 tt -76.89 -38.25 28.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.94 178.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.593 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -64.35 -38.49 95.9 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-N 115.699 -0.682 . . . . 0.0 113.702 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -58.1 -35.8 71.97 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.275 0.63 . . . . 0.0 112.081 -175.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 15.7 tpt -57.76 -25.82 61.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.786 -178.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 123.66 6.19 7.36 Favored Glycine 0 CA--C 1.5 -0.901 0 C-N-CA 120.229 -0.986 . . . . 0.0 112.188 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.593 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 65.2 m-85 -110.16 135.96 50.13 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -89.33 121.59 31.75 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.236 0.541 . . . . 0.0 111.751 -174.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.54 135.72 54.16 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.126 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.418 ' HB2' ' NE ' ' A' ' 12' ' ' ARG . 45.5 m -131.62 144.78 51.3 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.6 tt -69.45 128.18 32.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 121.47 0.652 . . . . 0.0 110.902 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -97.74 134.51 40.81 Favored 'General case' 0 C--O 1.261 1.673 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.657 177.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 . . . . . 0 C--O 1.249 1.058 0 O-C-N 124.832 1.333 . . . . 0.0 110.658 -176.155 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.702 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.86 32.14 73.51 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.663 -0.78 . . . . 0.0 111.358 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -61.75 132.15 52.23 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.041 0.448 . . . . 0.0 111.339 -176.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -139.21 155.1 48.04 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.94 178.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -64.8 -38.74 92.01 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -176.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.9 t -102.47 120.77 52.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -113.58 139.57 48.89 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 120.893 0.378 . . . . 0.0 111.23 -177.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 67.6 p -121.61 148.21 44.84 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.097 178.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.2 t -158.31 157.0 31.61 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 73.5 p -117.1 142.06 47.48 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 120.799 0.333 . . . . 0.0 110.335 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.9 m -131.89 145.8 34.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.364 178.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 45.8 ptt85 -108.86 142.95 38.71 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 175.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.7 pt -118.26 142.98 30.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-O 121.458 0.647 . . . . 0.0 112.006 -175.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.2 tp -110.12 118.44 36.41 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.728 177.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.44 140.04 4.15 Favored Glycine 0 N--CA 1.434 -1.495 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.349 179.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 95.9 mmm -67.97 -37.71 81.85 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.233 0.539 . . . . 0.0 109.924 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.0 p -111.22 58.16 0.62 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.883 177.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 26.3 p -59.56 -30.66 68.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.767 -175.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -64.49 -33.99 77.18 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.741 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.3 t -66.41 -45.34 80.29 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.439 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.514 ' HB3' ' CD1' ' A' ' 70' ' ' PHE . 28.4 p -66.05 -35.06 79.51 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.267 -177.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 69.9 t -61.81 -45.71 98.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -65.43 -42.24 92.66 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.947 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.3 m -63.97 -42.9 97.12 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.287 -178.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 21' ' ' CYS . 46.9 pt -78.56 -27.12 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.401 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -61.77 -39.45 91.68 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -59.98 -43.13 95.32 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.693 176.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -64.26 -43.31 95.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.185 0.517 . . . . 0.0 110.277 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.41 -46.25 96.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.603 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 88.1 p -64.62 -28.38 69.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.71 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -72.78 -27.35 61.94 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.927 0.394 . . . . 0.0 110.573 177.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.3 tt -81.74 123.88 29.13 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -83.38 147.48 27.87 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.778 0.323 . . . . 0.0 111.417 -177.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.31 7.67 56.93 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.774 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.8 pt -75.0 139.29 19.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.772 0.32 . . . . 0.0 111.176 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.611 ' HB ' ' O ' ' A' ' 50' ' ' LYS . 42.1 mm -89.19 -79.84 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.954 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 82.2 p -168.61 166.68 11.82 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.788 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -156.99 159.11 37.72 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 175.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -129.69 132.78 46.75 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 69.8 t -116.21 125.68 73.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 120.827 0.346 . . . . 0.0 110.789 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.6 t -103.34 102.48 12.43 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 177.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.6 tp -62.4 -42.72 99.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.765 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.2 -45.45 94.54 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.459 -178.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -74.96 -29.69 61.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.411 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.65 16.14 78.15 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.0 m -129.48 152.39 49.07 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.342 -0.429 . . . . 0.0 110.144 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -128.39 149.35 50.57 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.544 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.7 m -113.41 126.6 55.53 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.482 ' HB ' ' CE2' ' A' ' 51' ' ' TYR . 27.5 m -114.29 146.39 18.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.466 -177.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.611 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 87.6 tttt -132.2 104.17 6.63 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.482 ' CE2' ' HB ' ' A' ' 49' ' ' VAL . 84.5 m-85 -141.52 160.11 40.84 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 120.995 0.426 . . . . 0.0 111.853 -176.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.8 m -98.66 112.45 62.6 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.518 176.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -56.17 -26.62 61.54 Favored 'Trans proline' 0 N--CA 1.48 0.686 0 C-N-CA 123.265 2.643 . . . . 0.0 112.162 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.2 t -61.08 -42.27 98.2 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.274 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.9 t -101.22 -40.28 7.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -177.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -130.2 139.65 50.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.162 0.506 . . . . 0.0 111.488 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.405 ' SG ' ' HB3' ' A' ' 59' ' ' GLN . 42.6 t -93.16 121.89 34.98 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.434 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.3 mp -63.76 -37.45 87.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.607 178.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.405 ' HB3' ' SG ' ' A' ' 57' ' ' CYS . 57.5 tp60 -60.76 -39.31 88.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.679 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.401 ' HG2' ' HG ' ' A' ' 57' ' ' CYS . 15.7 mm100 -62.89 -38.56 91.39 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.32 178.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 75.6 t -60.83 -42.68 93.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.675 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 42.6 t -60.22 -39.61 87.23 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.937 176.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -64.15 -35.12 79.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.383 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -60.57 -42.24 96.25 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.484 -178.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.428 ' HB ' HG22 ' A' ' 25' ' ' ILE . 20.2 tt -76.55 -37.55 29.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 120.294 -0.563 . . . . 0.0 111.318 178.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.48 -44.24 97.88 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.452 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -67.18 -31.48 71.91 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.284 0.564 . . . . 0.0 110.297 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 50.1 tpp -59.23 -29.18 67.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.217 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 119.35 5.39 11.44 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.479 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.514 ' CD1' ' HB3' ' A' ' 21' ' ' CYS . 89.5 m-85 -112.78 131.04 55.86 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 120.977 0.418 . . . . 0.0 110.577 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -85.55 134.99 34.0 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.191 -177.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -133.19 147.6 52.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.836 0.35 . . . . 0.0 111.337 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.6 t -119.14 132.67 56.01 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 15.2 tt -103.49 134.19 45.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.502 0.668 . . . . 0.0 111.977 -175.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.4 ' O ' ' HB3' ' A' ' 76' ' ' GLU . . . -135.22 157.5 46.75 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.867 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' A' ' 75' ' ' ALA . 43.2 tt0 . . . . . 0 C--O 1.245 0.854 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.628 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.919 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.24 -129.97 48.31 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.993 -0.623 . . . . 0.0 112.066 -178.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -81.77 124.81 29.96 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 63.3 mtt -87.13 97.29 10.67 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.172 0.51 . . . . 0.0 110.327 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.1 pm0 -77.28 161.02 28.44 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.377 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.6 t -105.32 119.3 54.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 120.895 0.379 . . . . 0.0 110.107 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 50' ' ' LYS . . . -121.43 123.94 43.3 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.494 179.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.8 p -125.62 151.82 45.99 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.055 0.455 . . . . 0.0 110.684 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.5 t -158.27 146.35 18.53 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.9 178.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 41.9 p -111.5 109.95 20.14 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 175.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.7 p -92.34 115.43 31.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 40.1 ptt180 -82.22 148.04 28.64 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.223 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.8 131.07 70.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-O 121.049 0.452 . . . . 0.0 110.861 -176.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.9 tt -115.16 115.11 26.21 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -171.25 151.91 16.79 Favored Glycine 0 N--CA 1.434 -1.492 0 C-N-CA 120.211 -0.995 . . . . 0.0 112.596 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 23.0 ptt? -74.98 -23.99 58.37 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 122.756 0.422 . . . . 0.0 111.295 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.5 p -122.48 85.57 2.44 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.284 0.564 . . . . 0.0 109.636 177.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.4 m -63.83 -39.98 95.52 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.303 -176.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.429 ' HA ' HG13 ' A' ' 22' ' ' VAL . 98.7 mt-30 -64.38 -41.0 96.93 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -175.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.0 p -64.9 -41.43 95.61 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.776 -177.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.584 ' HB3' ' CD2' ' A' ' 70' ' ' PHE . 20.3 p -74.46 -39.16 62.7 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.429 HG13 ' HA ' ' A' ' 19' ' ' GLN . 9.0 p -68.5 -37.68 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.61 -178.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -64.36 -40.76 96.5 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.978 0.418 . . . . 0.0 110.052 176.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.2 m -61.9 -44.72 96.22 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.671 -178.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.454 HD12 ' HB ' ' A' ' 65' ' ' ILE . 16.2 tt -74.19 -38.65 48.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.726 -0.389 . . . . 0.0 111.425 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.07 -44.29 96.99 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 120.85 0.357 . . . . 0.0 110.948 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -60.73 -44.08 97.1 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.586 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.573 ' HD3' ' NE2' ' A' ' 64' ' ' GLN . 99.4 mtt180 -65.33 -46.07 81.77 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.169 -177.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.423 HG22 HD12 ' A' ' 35' ' ' ILE . 98.0 mt -65.96 -44.8 92.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.092 -178.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 77.8 p -64.03 -34.58 78.32 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.032 -179.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -71.81 -26.78 62.55 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.094 0.473 . . . . 0.0 110.74 177.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 28' ' ' ARG . 93.3 mt -82.9 142.32 31.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.543 178.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -76.79 141.21 40.83 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.16 -8.04 18.59 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.876 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.423 HD12 HG22 ' A' ' 29' ' ' ILE . 7.2 tt -75.24 110.1 9.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 176.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.9 mt -84.27 -51.19 14.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.278 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.9 t -160.38 145.75 14.89 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.522 177.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.3 ttt -135.85 132.16 36.26 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.088 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -130.34 130.82 44.94 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 178.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.1 t -103.92 120.36 53.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 120.836 0.35 . . . . 0.0 110.397 -178.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 51.0 m -119.73 96.46 5.2 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-O 121.467 0.651 . . . . 0.0 110.63 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.4 -35.41 80.82 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.259 -178.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -61.65 -39.63 92.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.535 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -76.76 -22.68 53.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.139 176.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.56 21.75 68.66 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 89.9 p -149.33 164.93 33.49 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 121.058 0.456 . . . . 0.0 111.326 -177.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.55 137.44 52.58 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 65.3 m -104.56 125.64 50.91 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.806 -177.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.0 m -129.25 150.03 34.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-O 120.883 0.373 . . . . 0.0 111.369 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 14.3 ptmm? -131.45 135.71 47.36 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 173.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -157.2 171.45 20.41 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.95 -169.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.6 t -94.16 114.25 62.77 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 173.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -52.99 -39.1 80.36 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 C-N-CA 123.628 2.886 . . . . 0.0 114.97 -174.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.8 m -69.02 -41.98 77.01 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.898 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.9 t -70.71 -43.51 77.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.708 -176.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 30.9 m -128.65 148.65 33.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.047 0.451 . . . . 0.0 110.766 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.534 ' SG ' ' HB2' ' A' ' 59' ' ' GLN . 43.5 t -102.23 128.32 48.8 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.563 -177.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.7 tp -61.51 -38.12 86.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.317 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.534 ' HB2' ' SG ' ' A' ' 57' ' ' CYS . 80.6 mt-30 -60.33 -39.53 87.4 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.524 178.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.692 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 97.8 mt-30 -61.75 -39.39 91.42 Favored 'General case' 0 C--O 1.214 -0.783 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.879 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 73.2 t -59.4 -46.3 92.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.243 -178.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 42.3 t -61.12 -42.36 98.4 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.089 177.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -67.42 -37.58 83.26 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.3 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.692 ' HG2' ' O ' ' A' ' 60' ' ' GLN . 13.6 mm100 -61.0 -41.46 96.55 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.958 0.409 . . . . 0.0 111.013 -175.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.454 ' HB ' HD12 ' A' ' 25' ' ' ILE . 18.8 tt -82.52 -33.11 10.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.664 177.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.85 -40.84 98.78 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.798 -0.637 . . . . 0.0 114.025 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -72.8 -11.4 60.59 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 117.797 0.799 . . . . 0.0 110.961 -177.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 16.4 tpt -66.02 -28.6 68.99 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.764 176.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 116.52 9.14 11.69 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.806 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.584 ' CD2' ' HB3' ' A' ' 21' ' ' CYS . 98.3 m-85 -117.79 145.29 44.63 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -84.71 133.16 34.39 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.48 -177.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 12' ' ' ARG . . . -147.71 150.2 33.86 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.934 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 86.0 p -140.69 158.92 43.27 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.615 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 91.4 mt -91.2 122.69 42.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.053 -177.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -133.17 160.93 35.79 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 C--N 1.305 -1.35 0 CA-C-O 118.133 -0.937 . . . . 0.0 110.595 178.663 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.741 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 91.61 -1.72 76.05 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.668 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -89.73 143.79 26.51 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 110.27 -0.271 . . . . 0.0 110.27 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.8 mmt -99.11 154.28 18.24 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.072 0.463 . . . . 0.0 112.243 -175.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.479 ' O ' ' HD2' ' A' ' 53' ' ' PRO . 30.0 pt20 -63.74 -18.95 64.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.458 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.427 HG11 ' HG3' ' A' ' 5' ' ' GLN . 25.0 m -128.66 150.85 34.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.006 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -143.79 152.85 41.75 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.76 0.314 . . . . 0.0 110.61 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 82.7 p -127.3 154.91 44.34 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.613 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.416 ' HB3' HG12 ' A' ' 49' ' ' VAL . 14.8 t -159.02 164.2 35.72 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 53.1 p -118.11 144.68 45.45 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.5 p -143.71 129.47 15.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 120.921 0.391 . . . . 0.0 111.098 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -89.06 146.92 24.53 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.6 mp -111.43 120.63 62.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 59.5 tp -114.71 112.71 23.26 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.991 0.424 . . . . 0.0 110.559 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -167.41 157.59 30.06 Favored Glycine 0 N--CA 1.44 -1.068 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.197 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 59.6 ttm -64.6 -43.02 95.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.992 0.425 . . . . 0.0 110.813 178.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.1 p -113.01 108.33 17.19 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.792 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 23.8 p -69.88 -41.23 75.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.105 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -63.94 -41.53 97.59 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.836 0.351 . . . . 0.0 111.035 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.6 t -61.5 -46.37 90.25 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.835 -177.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.445 ' HB3' ' CG ' ' A' ' 70' ' ' PHE . 20.1 p -67.33 -44.11 79.9 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.565 -178.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 73.7 t -62.79 -46.09 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.557 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.66 -44.86 95.19 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.2 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.4 m -63.49 -43.4 97.38 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.254 -177.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.41 HG23 ' HB ' ' A' ' 65' ' ' ILE . 46.3 pt -74.32 -29.18 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.765 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -60.78 -41.98 96.63 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.052 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -60.99 -45.26 95.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.264 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -63.09 -42.37 99.61 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.181 0.515 . . . . 0.0 109.9 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.544 ' O ' HD13 ' A' ' 35' ' ' ILE . 92.9 mt -61.44 -46.22 97.04 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.716 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.693 178.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 85.2 p -63.97 -23.21 67.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.856 0.36 . . . . 0.0 111.539 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -92.46 -6.08 50.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.892 0.377 . . . . 0.0 110.768 177.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 67.7 tp -103.3 128.04 50.46 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.159 178.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -85.44 153.94 22.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.689 0.28 . . . . 0.0 111.09 176.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.42 8.83 22.64 Favored Glycine 0 C--O 1.239 0.427 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -177.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.544 HD13 ' O ' ' A' ' 29' ' ' ILE . 74.9 mt -72.65 123.63 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 115.19 -0.505 . . . . 0.0 110.871 -177.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.435 HG22 ' HZ1' ' A' ' 50' ' ' LYS . 80.5 mt -101.23 -68.15 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 172.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.534 ' O ' ' HB3' ' A' ' 50' ' ' LYS . 34.7 t -166.1 140.14 4.36 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.748 177.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.7 ttt -136.23 127.69 28.58 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 176.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.485 ' HE3' ' OG ' ' A' ' 37' ' ' SER . 34.4 mmtp -119.53 129.47 54.7 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.3 t -106.47 118.47 54.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.5 m -98.86 98.12 9.24 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.921 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.1 tp -62.49 -42.05 99.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.393 -179.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -62.0 -41.19 97.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.281 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -75.83 -30.33 58.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.591 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.45 15.05 79.11 Favored Glycine 0 N--CA 1.454 -0.142 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -176.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.8 t -145.12 150.59 37.07 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.57 151.44 47.92 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.808 0.337 . . . . 0.0 111.043 -177.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.4 p -95.15 125.44 39.8 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.295 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.416 HG12 ' HB3' ' A' ' 9' ' ' SER . 3.0 p -105.91 118.66 53.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.281 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.534 ' HB3' ' O ' ' A' ' 37' ' ' SER . 60.1 tttm -136.33 104.3 5.57 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.621 0.724 . . . . 0.0 109.968 -176.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.517 ' CD2' ' HA ' ' A' ' 35' ' ' ILE . 87.0 m-85 -139.43 162.96 33.77 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.329 -176.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 54.6 t -74.94 114.85 38.84 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 37.2 Cg_endo -65.02 -18.59 62.47 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.081 2.521 . . . . 0.0 112.327 -177.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 61.4 m -61.6 -39.36 90.92 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.659 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.412 HG23 HG21 ' A' ' 56' ' ' VAL . 18.8 m -116.69 -25.76 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -178.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 96.9 t -127.28 128.93 70.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.728 0.299 . . . . 0.0 110.77 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.507 ' HG ' ' HB2' ' A' ' 60' ' ' GLN . 25.9 p -105.96 161.55 14.36 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 178.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.59 -40.24 96.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.446 -177.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -63.27 -37.4 87.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.281 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.507 ' HB2' ' HG ' ' A' ' 57' ' ' CYS . 54.7 tt0 -59.92 -45.78 91.49 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.287 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.454 ' HA ' ' OE1' ' A' ' 64' ' ' GLN . 75.1 t -63.14 -42.34 96.18 Favored 'Isoleucine or valine' 0 C--O 1.25 1.128 0 CA-C-O 121.768 0.794 . . . . 0.0 110.309 178.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 43.3 t -58.47 -35.49 72.25 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.191 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.404 ' HB2' ' O ' ' A' ' 60' ' ' GLN . 58.8 m170 -60.24 -43.98 95.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.182 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.454 ' OE1' ' HA ' ' A' ' 61' ' ' VAL . 25.7 mp0 -63.05 -42.23 99.68 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.929 -177.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.41 ' HB ' HG23 ' A' ' 25' ' ' ILE . 19.9 tt -71.3 -37.83 67.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.072 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.32 -39.85 98.29 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.9 -0.591 . . . . 0.0 113.36 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -80.15 -5.99 56.98 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 117.446 0.623 . . . . 0.0 111.555 -177.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.454 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 23.1 mmt -83.72 -3.16 57.56 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.038 0.447 . . . . 0.0 110.447 176.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.67 8.1 62.52 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.282 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.445 ' CG ' ' HB3' ' A' ' 21' ' ' CYS . 99.2 m-85 -113.4 143.06 45.12 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 120.979 0.419 . . . . 0.0 110.292 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -101.1 148.04 25.53 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.99 -175.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.92 151.48 35.92 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.114 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 60.7 m -123.53 141.51 51.93 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 176.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.0 tt -117.33 141.27 36.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 121.111 0.481 . . . . 0.0 111.337 -174.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' A' ' 76' ' ' GLU . . . -138.08 154.71 49.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.604 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' A' ' 75' ' ' ALA . 34.8 tt0 . . . . . 0 N--CA 1.474 0.758 0 C-N-CA 123.636 0.775 . . . . 0.0 109.926 -175.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.757 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -78.91 171.46 55.11 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.576 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -73.56 141.75 46.66 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.549 0.214 . . . . 0.0 110.693 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 64.3 mtt 57.48 27.03 13.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.399 -178.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 -75.09 112.95 11.86 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 121.213 0.53 . . . . 0.0 110.096 178.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 70.4 t -101.99 118.78 49.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -127.59 149.6 50.09 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.005 0.431 . . . . 0.0 111.21 -177.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 56.4 p -103.57 156.02 18.09 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.821 178.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.6 t -154.34 143.95 21.55 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 62.5 p -118.59 144.02 46.4 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.12 123.22 55.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-O 120.91 0.386 . . . . 0.0 110.489 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 39.7 ptt180 -90.08 151.2 21.73 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.084 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.9 pt -126.58 144.5 36.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-O 121.187 0.517 . . . . 0.0 111.775 -177.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.9 tp -131.21 113.66 14.12 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.331 177.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -176.23 160.3 28.02 Favored Glycine 0 N--CA 1.439 -1.135 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 96.1 mmm -68.17 -40.24 82.36 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.854 0.359 . . . . 0.0 110.857 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.8 p -110.14 80.25 1.29 Allowed 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.448 0.642 . . . . 0.0 110.478 177.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.404 ' O ' HG23 ' A' ' 22' ' ' VAL . 21.8 p -67.02 -34.55 77.96 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.479 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -63.28 -39.44 94.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.11 0.481 . . . . 0.0 110.295 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.0 t -60.67 -45.73 93.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.579 -178.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 27.7 p -70.01 -33.29 71.82 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.365 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 18' ' ' CYS . 67.1 t -63.27 -45.11 99.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-O 121.412 0.625 . . . . 0.0 109.464 177.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -67.14 -35.18 79.17 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.327 177.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.3 t -60.19 -46.59 89.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.619 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.8 tt -70.99 -29.25 36.29 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.892 177.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -57.85 -49.35 76.98 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.214 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -62.52 -42.83 99.77 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.121 178.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.5 tpt180 -64.27 -47.61 78.88 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.496 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.55 HG21 ' SD ' ' A' ' 38' ' ' MET . 19.5 tt -71.01 -36.71 64.6 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.696 -177.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 77.6 p -67.72 -25.41 65.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.36 . . . . 0.0 111.257 177.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -85.37 -12.05 53.08 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.12 0.486 . . . . 0.0 110.231 175.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 64.9 tp -84.18 122.93 29.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.511 175.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -83.38 152.98 24.79 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 120.994 0.425 . . . . 0.0 111.587 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.51 6.01 64.59 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.441 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 39.7 pt -69.15 126.79 29.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 121.337 0.589 . . . . 0.0 111.576 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.434 ' HB ' ' O ' ' A' ' 50' ' ' LYS . 86.3 mt -82.09 -61.81 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.492 -179.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.402 ' OG ' ' HE2' ' A' ' 50' ' ' LYS . 87.1 p -159.43 154.34 24.78 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.993 178.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.55 ' SD ' HG21 ' A' ' 29' ' ' ILE . 27.0 ttt -140.79 134.45 30.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.843 177.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -133.59 148.94 51.62 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.1 p -126.31 134.01 67.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 C-N-CA 119.796 -0.762 . . . . 0.0 111.792 -178.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.5 m -108.66 85.75 2.16 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.327 -0.852 . . . . 0.0 108.843 177.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.9 tp -61.64 -43.09 99.5 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.32 -176.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -70.11 -28.18 65.18 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.063 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -84.92 -12.42 53.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.649 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.4 28.03 71.84 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.88 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 79.6 p -148.2 161.02 42.31 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.076 0.465 . . . . 0.0 111.454 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.75 149.2 42.41 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.839 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.7 m -117.12 126.39 52.75 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.3 p -129.32 139.31 52.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 120.868 0.366 . . . . 0.0 110.761 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.434 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 39.6 ttpt -119.07 119.14 33.35 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -153.91 164.02 39.09 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.992 -173.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.7 t -84.87 112.28 41.75 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 177.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.43 -22.2 65.89 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.797 2.331 . . . . 0.0 112.656 -176.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.5 t -63.89 -42.99 97.34 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.655 178.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.9 t -73.39 -51.59 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.909 -178.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.6 t -131.56 130.65 62.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.331 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 31.5 p -73.76 159.47 32.9 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.634 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.3 mp -68.62 -24.32 64.55 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.839 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -61.02 -42.41 98.41 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.102 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.536 ' O ' ' HG3' ' A' ' 64' ' ' GLN . 87.3 mm-40 -65.69 -39.25 91.08 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.342 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.83 -45.6 98.34 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 CA-C-O 121.245 0.545 . . . . 0.0 110.06 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 47.5 t -60.74 -41.96 96.42 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.188 177.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -61.67 -38.29 87.23 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.025 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.536 ' HG3' ' O ' ' A' ' 60' ' ' GLN . 98.7 mt-30 -59.35 -42.73 92.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.465 0.174 . . . . 0.0 111.269 -176.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 21.2 tt -85.95 -38.68 12.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.874 178.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.94 -35.54 92.2 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.911 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -54.44 -28.14 42.07 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.879 0.872 . . . . 0.0 111.658 -178.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 15.8 tpt -59.62 -29.23 67.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.076 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 119.13 8.13 9.7 Favored Glycine 0 CA--C 1.506 -0.511 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.492 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -114.84 145.11 42.51 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -72.94 135.94 45.12 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.087 0.47 . . . . 0.0 111.12 -178.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' A' ' 12' ' ' ARG . . . -146.94 146.54 30.15 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.141 178.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 39.6 t -142.12 140.5 32.5 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.761 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 42.9 pt -91.58 145.06 7.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.522 -177.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.48 145.64 29.22 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.267 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 . . . . . 0 C--O 1.251 1.162 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.085 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.674 0 CA-C-O 120.799 0.333 . . . . 0.0 110.386 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -133.3 169.37 22.69 Favored Glycine 0 N--CA 1.438 -1.182 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.607 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -90.66 130.91 36.62 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 120.873 0.368 . . . . 0.0 110.499 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 67.4 ttp -60.73 -48.76 80.35 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.878 -176.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -151.4 -50.26 0.12 Allowed 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.469 -0.493 . . . . 0.0 111.945 -177.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.9 t -108.52 126.45 65.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-O 120.931 0.396 . . . . 0.0 110.684 -177.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -133.82 147.56 51.23 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.09 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 54.9 p -123.08 143.23 50.11 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 175.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 87.7 p -155.63 162.03 40.69 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.333 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.1 p -109.03 125.51 52.16 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.59 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.92 122.58 70.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 17.8 ptp180 -78.99 141.94 37.05 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.208 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.759 ' HB ' ' SG ' ' A' ' 21' ' ' CYS . 19.8 pt -116.06 106.51 20.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-O 121.672 0.749 . . . . 0.0 110.519 -178.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.8 tp -114.1 128.74 56.52 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.826 -175.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 176.25 -149.29 9.73 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.213 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 66.5 mtt -60.88 -43.18 98.81 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.472 0.654 . . . . 0.0 109.272 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.52 HG23 ' H ' ' A' ' 20' ' ' SER . 11.5 t -163.82 159.41 21.16 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.411 177.04 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.473 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 98.3 m -63.55 -39.03 93.35 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 120.645 0.26 . . . . 0.0 111.487 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -59.6 -45.2 92.62 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -177.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.52 ' H ' HG23 ' A' ' 17' ' ' THR . 81.0 p -69.11 -41.61 77.18 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.95 -177.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.759 ' SG ' ' HB ' ' A' ' 13' ' ' ILE . 26.0 p -72.26 -35.35 68.74 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.3 p -69.78 -33.92 58.34 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.556 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.625 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -62.28 -42.16 99.1 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.454 0.645 . . . . 0.0 109.319 176.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.6 t -59.58 -49.78 76.42 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.401 -177.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.8 tt -74.55 -32.8 30.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.811 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.4 tm-20 -60.84 -47.68 85.28 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.342 -175.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -62.54 -44.4 96.45 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.502 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.466 ' HA ' ' NE ' ' A' ' 28' ' ' ARG . 4.2 mmp_? -67.52 -43.72 80.11 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.266 -177.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 16.9 tt -72.9 -32.77 41.34 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.6 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.998 -177.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.8 t -64.76 -41.49 95.85 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 120.938 0.399 . . . . 0.0 110.404 177.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -68.64 -26.22 65.22 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.788 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.7 tp -96.23 122.18 38.82 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.025 0.441 . . . . 0.0 110.962 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -68.73 150.01 48.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.871 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.43 -1.97 16.08 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 121.065 -0.588 . . . . 0.0 111.973 -178.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.8 tt -95.82 130.22 44.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 175.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 83.9 mt -92.52 -57.7 4.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 81.5 p -163.71 164.4 23.85 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.281 178.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -154.12 147.7 25.17 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 120.925 0.393 . . . . 0.0 110.271 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -128.87 141.57 51.24 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.5 t -110.05 128.73 66.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -174.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.1 t -113.54 102.03 9.91 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 121.17 0.51 . . . . 0.0 109.998 177.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.97 -36.48 83.43 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.089 178.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -60.62 -44.56 96.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.141 -178.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -85.85 -12.63 50.28 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.11 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.14 26.9 73.64 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.333 -179.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 87.1 p -146.01 161.98 38.88 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.046 0.451 . . . . 0.0 110.823 -177.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.1 142.72 50.08 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.336 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 87.4 m -95.8 119.14 33.78 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 65.7 t -114.77 126.74 72.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 120.997 0.427 . . . . 0.0 111.394 -176.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -103.11 106.43 16.95 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 176.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -135.63 166.34 23.45 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.027 -170.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.5 t -106.07 101.67 35.37 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.027 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.51 -25.87 80.14 Favored 'Trans proline' 0 N--CA 1.48 0.68 0 C-N-CA 123.369 2.713 . . . . 0.0 112.565 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 43.9 t -61.76 -41.33 97.54 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.941 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.421 HG13 HG12 ' A' ' 56' ' ' VAL . 77.8 t -65.51 -62.11 1.39 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.421 HG12 HG13 ' A' ' 55' ' ' VAL . 34.7 m -140.04 159.64 26.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.65 175.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.44 ' SG ' ' HG3' ' A' ' 60' ' ' GLN . 31.8 p -76.07 154.48 35.58 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.029 0.442 . . . . 0.0 110.313 178.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.6 mt -70.97 -19.19 62.58 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.223 179.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -61.45 -42.15 98.31 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.374 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.44 ' HG3' ' SG ' ' A' ' 57' ' ' CYS . 97.7 mt-30 -64.28 -39.51 94.08 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.999 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 78.6 t -62.01 -45.48 98.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 CA-C-O 121.265 0.555 . . . . 0.0 109.768 178.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 42.6 t -61.92 -38.73 89.51 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.882 176.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 58.3 m170 -63.07 -36.86 84.97 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.191 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 60' ' ' GLN . 86.5 mm-40 -59.52 -43.55 93.41 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.808 0.337 . . . . 0.0 110.919 -178.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.451 HD11 ' HB2' ' A' ' 21' ' ' CYS . 18.0 tt -76.69 -36.19 26.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.901 178.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -62.81 -42.25 99.72 Favored Glycine 0 CA--C 1.522 0.514 0 CA-C-N 116.07 -0.514 . . . . 0.0 113.478 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -66.47 -22.05 66.19 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 26.4 mmt -83.52 0.56 45.99 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.527 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.45 9.33 57.9 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.513 -0.851 . . . . 0.0 113.531 177.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.491 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 90.2 m-85 -112.51 140.68 47.06 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.985 0.393 . . . . 0.0 110.092 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -90.47 140.24 29.91 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.886 0.374 . . . . 0.0 110.856 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 12' ' ' ARG . . . -147.27 150.41 34.76 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.135 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.8 t -143.64 136.46 27.43 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.142 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 83.8 mt -91.4 127.1 43.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.457 -178.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.03 160.67 37.03 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.113 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.534 -0.746 . . . . 0.0 110.941 178.856 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.3 t . . . . . 0 N--CA 1.449 -0.518 0 CA-C-O 120.991 0.424 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.24 133.82 45.22 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.891 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 63.0 p -109.37 146.45 34.4 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.512 ' OG ' HG13 ' A' ' 74' ' ' ILE . 37.2 t -159.07 147.08 17.81 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.538 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 17.1 p -113.27 108.93 17.94 Favored 'General case' 0 N--CA 1.418 -2.041 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 172.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.4 p -95.64 124.79 48.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.339 -177.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 54.8 ptt85 -75.46 142.56 42.92 Favored 'General case' 0 CA--C 1.505 -0.758 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.574 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 47.1 mm -115.12 119.2 61.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.6 tp -124.05 117.18 24.12 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.978 0.418 . . . . 0.0 110.474 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -175.24 154.28 17.61 Favored Glycine 0 N--CA 1.434 -1.464 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.476 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 98.8 mtp -65.35 -40.19 93.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.963 0.411 . . . . 0.0 110.9 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.0 p -111.12 84.83 2.0 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.383 0.611 . . . . 0.0 110.38 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.507 ' O ' HG23 ' A' ' 22' ' ' VAL . 42.2 t -61.38 -44.27 97.44 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.017 -177.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -61.35 -39.92 92.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.943 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.6 m -62.67 -44.2 96.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.59 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.505 ' HB3' ' CD2' ' A' ' 70' ' ' PHE . 29.6 p -73.02 -33.81 65.96 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.476 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 18' ' ' CYS . 63.0 t -62.79 -43.57 98.86 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -60.69 -44.41 96.56 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.997 177.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.0 t -61.64 -50.02 74.2 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.556 -178.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.7 tt -71.63 -36.83 61.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -61.68 -44.0 97.78 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.829 0.347 . . . . 0.0 110.693 -177.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -64.73 -47.3 78.79 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.281 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -64.58 -42.56 95.54 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.914 -176.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.639 HD13 ' SD ' ' A' ' 38' ' ' MET . 19.6 tt -69.7 -35.14 64.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.957 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 79.0 p -71.26 -22.06 62.02 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.926 0.393 . . . . 0.0 110.634 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -70.76 -27.92 64.29 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 174.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.6 mt -75.0 128.99 36.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.851 176.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.0 mtpt -86.6 153.58 21.68 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.374 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.23 8.1 57.9 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.323 -0.942 . . . . 0.0 111.862 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 33.1 pt -69.52 137.74 23.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.993 0.425 . . . . 0.0 111.819 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -96.77 -71.98 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.695 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.7 t -169.89 149.88 3.78 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-O 120.769 0.319 . . . . 0.0 111.051 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.639 ' SD ' HD13 ' A' ' 29' ' ' ILE . 28.9 ptm -153.4 159.53 42.41 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 177.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -141.1 123.45 15.78 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.989 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 79.9 t -92.52 119.29 39.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 175.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.8 m -109.21 112.07 24.02 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.042 0.448 . . . . 0.0 111.117 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.2 mt -66.2 -37.63 86.05 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.795 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -61.9 -41.81 98.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.775 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -77.22 -27.91 53.61 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.948 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.51 15.99 80.04 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -175.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 87.7 p -148.68 165.54 31.06 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.14 -0.53 . . . . 0.0 109.982 -177.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.515 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -118.5 139.44 51.43 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.708 0.289 . . . . 0.0 111.291 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.8 m -89.13 119.69 29.86 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 8' ' ' THR . 99.8 t -114.64 124.48 71.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.499 -174.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.428 ' HG2' HG22 ' A' ' 8' ' ' THR . 51.5 mtmt -126.96 103.96 7.76 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 174.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -143.86 158.71 43.51 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.587 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.8 t -82.52 114.27 50.51 Favored Pre-proline 0 N--CA 1.437 -1.125 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 173.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -61.44 -28.09 83.32 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.921 2.414 . . . . 0.0 113.787 -173.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.2 p -70.19 -39.74 75.05 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 120.809 0.338 . . . . 0.0 110.899 177.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 84.7 t -75.67 -50.81 22.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 121.128 0.49 . . . . 0.0 110.67 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 69.7 t -128.58 123.72 60.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.162 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.66 ' SG ' ' HG2' ' A' ' 60' ' ' GLN . 27.7 p -88.49 144.42 26.36 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.898 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.4 mp -68.56 -26.8 65.59 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.092 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 -60.35 -41.14 93.02 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.66 ' HG2' ' SG ' ' A' ' 57' ' ' CYS . 85.4 mm-40 -63.98 -38.43 91.07 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.387 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 71.6 t -60.98 -46.74 96.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 121.391 0.615 . . . . 0.0 109.55 178.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 43.0 t -62.55 -39.61 94.18 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.76 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -59.6 -45.17 92.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.947 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 60' ' ' GLN . 98.2 mt-30 -60.75 -44.01 97.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.65 -175.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.0 tt -81.41 -37.19 15.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.856 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.8 -41.73 99.81 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.782 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.99 -28.73 70.0 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 122.37 0.268 . . . . 0.0 111.37 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 16.1 tpt -61.75 -29.79 70.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.719 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.69 5.06 12.6 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.515 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.505 ' CD2' ' HB3' ' A' ' 21' ' ' CYS . 95.1 m-85 -111.48 152.02 27.94 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -94.97 134.69 37.37 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.37 0.605 . . . . 0.0 111.818 -176.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 12' ' ' ARG . . . -140.82 145.59 36.47 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.687 176.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.9 t -139.88 138.65 35.86 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.243 -0.583 . . . . 0.0 111.445 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.512 HG13 ' OG ' ' A' ' 9' ' ' SER . 14.7 tt -78.23 137.02 22.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.12 -0.945 . . . . 0.0 112.158 -178.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -152.11 159.48 43.64 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 176.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.308 -1.228 0 CA-C-O 118.577 -0.725 . . . . 0.0 109.976 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 N--CA 1.445 -0.687 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.453 ' HB3' ' HD3' ' A' ' 53' ' ' PRO . . . -120.73 140.18 52.01 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 120.979 0.418 . . . . 0.0 110.592 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 44.5 p -120.77 145.77 47.19 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.393 177.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.9 t -140.88 142.47 34.5 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.6 p -108.64 133.88 52.13 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 121.307 0.575 . . . . 0.0 110.759 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.445 HG12 ' HA ' ' A' ' 74' ' ' ILE . 33.6 m -126.85 150.53 32.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.457 ' HG2' ' HB3' ' A' ' 73' ' ' SER . 16.6 ptm180 -107.06 147.24 30.21 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.55 HG21 ' SG ' ' A' ' 21' ' ' CYS . 85.0 mt -119.56 125.86 74.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.546 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.8 tp -119.6 115.84 24.81 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -171.02 154.88 23.56 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.976 -0.63 . . . . 0.0 111.642 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 68.6 mtt -67.66 -40.14 84.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.923 0.392 . . . . 0.0 110.978 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.2 p -104.45 89.59 3.27 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.713 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 95.5 m -64.06 -40.57 96.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.238 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -64.88 -39.14 93.08 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.462 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.0 m -62.63 -43.74 98.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.712 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.55 ' SG ' HG21 ' A' ' 13' ' ' ILE . 16.0 p -70.19 -39.87 74.96 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.597 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 65.5 t -63.22 -44.13 99.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-O 121.087 0.47 . . . . 0.0 110.108 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -64.46 -40.88 96.54 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.41 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.5 m -62.36 -42.9 99.77 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.978 -0.556 . . . . 0.0 112.012 -178.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.552 ' CG2' ' HB ' ' A' ' 65' ' ' ILE . 47.1 pt -72.02 -34.94 52.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 C-N-CA 120.064 -0.655 . . . . 0.0 110.161 178.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -60.97 -44.43 97.36 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.909 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -61.82 -50.06 73.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.082 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -68.67 -41.86 78.7 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.165 -0.471 . . . . 0.0 112.192 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 94.0 mt -64.41 -42.61 95.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-O 120.668 0.27 . . . . 0.0 111.035 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 41.4 t -60.24 -41.5 93.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.023 0.44 . . . . 0.0 110.26 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -68.49 -27.9 66.54 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.094 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.5 tp -70.33 131.95 44.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.705 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -86.1 152.55 22.77 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.69 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.89 5.98 73.0 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.687 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.407 ' HA ' ' CD2' ' A' ' 51' ' ' TYR . 46.4 pt -72.55 138.19 21.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.908 0.385 . . . . 0.0 111.316 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.2 mm -96.79 -67.05 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.481 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.7 t -162.39 152.83 16.9 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.279 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -139.27 148.22 42.73 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -134.79 142.47 46.71 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.68 140.05 50.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 120.967 0.413 . . . . 0.0 111.134 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.9 m -119.38 101.75 8.18 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.67 -44.83 95.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.845 -176.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -61.68 -44.28 97.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.462 -178.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -76.93 -24.82 52.39 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.742 -178.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.13 17.53 79.53 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.326 -177.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 60.1 m -125.17 151.61 45.58 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 120.882 0.372 . . . . 0.0 110.591 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -128.71 149.14 50.82 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.047 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.6 m -116.2 125.41 52.23 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 63.1 t -114.47 124.97 71.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 120.84 0.352 . . . . 0.0 110.545 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -105.88 107.7 18.83 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.65 ' CE1' ' HB ' ' A' ' 56' ' ' VAL . 34.4 t80 -152.93 152.74 31.81 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -175.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.4 t -80.64 114.02 44.51 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.453 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 46.9 Cg_endo -66.26 -22.28 53.62 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.066 2.511 . . . . 0.0 113.852 -174.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 79.8 p -65.28 -33.36 75.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.718 0.294 . . . . 0.0 111.271 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.446 HG12 HG23 ' A' ' 56' ' ' VAL . 45.9 t -84.06 -61.9 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.907 0.384 . . . . 0.0 110.174 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.65 ' HB ' ' CE1' ' A' ' 51' ' ' TYR . 88.7 t -128.76 127.49 66.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.096 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 30.3 p -76.81 155.79 32.79 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.343 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.35 -16.13 61.87 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.838 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -61.5 -42.2 98.44 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.195 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.511 ' OE1' HG13 ' A' ' 56' ' ' VAL . 98.6 mt-30 -65.13 -37.94 89.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.531 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 77.8 t -61.28 -40.95 87.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-O 121.352 0.596 . . . . 0.0 109.728 177.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.523 ' SG ' ' HB ' ' A' ' 74' ' ' ILE . 92.7 m -61.08 -38.96 88.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.569 177.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -67.94 -28.77 67.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.452 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -61.93 -42.18 98.8 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.739 0.304 . . . . 0.0 110.503 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.552 ' HB ' ' CG2' ' A' ' 25' ' ' ILE . 18.8 tt -79.7 -38.94 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 120.754 0.311 . . . . 0.0 111.565 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -62.39 -39.08 97.31 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.156 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -59.09 -39.0 80.85 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.152 0.501 . . . . 0.0 110.472 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 17.0 tpt -62.01 -29.09 70.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.127 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.15 8.54 10.38 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.677 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.52 ' CG ' ' HB3' ' A' ' 21' ' ' CYS . 97.5 m-85 -106.29 150.02 26.36 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.687 0.28 . . . . 0.0 110.286 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -93.13 138.87 31.16 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.584 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.88 149.13 31.7 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.642 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.457 ' HB3' ' HG2' ' A' ' 12' ' ' ARG . 48.3 t -127.86 138.93 52.86 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.523 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 13.5 tt -100.27 139.21 22.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.226 0.536 . . . . 0.0 111.681 -176.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.45 159.45 44.02 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.42 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.442 ' H ' ' CD ' ' A' ' 76' ' ' GLU . 1.2 pm0 . . . . . 0 C--N 1.3 -1.575 0 CA-C-O 118.47 -0.776 . . . . 0.0 109.709 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 68.2 t . . . . . 0 N--CA 1.442 -0.844 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.62 128.53 45.73 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.004 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 76.3 p -118.47 147.45 43.6 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.699 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.9 p -159.98 168.09 26.44 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.336 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.6 p -113.0 129.59 56.44 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.5 p -109.57 123.34 65.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-O 121.026 0.441 . . . . 0.0 110.364 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -83.26 147.45 27.97 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.647 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 85.9 mt -114.68 123.6 70.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.891 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 69.6 tp -117.92 118.47 32.08 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.938 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -175.45 157.95 24.87 Favored Glycine 0 N--CA 1.432 -1.617 0 C-N-CA 119.692 -1.242 . . . . 0.0 113.151 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 66.4 ttp -61.93 -47.16 86.14 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 120.915 0.388 . . . . 0.0 110.202 177.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.6 m -118.21 107.23 13.68 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.426 ' O ' HG23 ' A' ' 22' ' ' VAL . 47.9 t -64.22 -40.19 95.54 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.09 -178.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -60.35 -39.83 88.57 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.757 -176.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 63.7 m -62.3 -46.29 89.4 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 120.959 0.409 . . . . 0.0 111.518 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.595 ' HB3' ' CD2' ' A' ' 70' ' ' PHE . 16.4 p -73.64 -36.36 65.41 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.926 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 18' ' ' CYS . 57.0 t -62.18 -42.79 96.56 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.541 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -60.56 -40.61 92.25 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.518 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.3 t -59.99 -48.66 80.79 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.875 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.457 HD11 HG13 ' A' ' 61' ' ' VAL . 17.3 tt -76.49 -39.42 33.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.018 -178.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.1 tp10 -60.33 -47.59 85.4 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.914 0.388 . . . . 0.0 111.281 -175.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.64 -51.15 66.43 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.978 -177.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.558 ' HD2' ' HG2' ' A' ' 64' ' ' GLN . 44.4 ttm180 -63.89 -45.42 89.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.852 -177.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 15.3 tt -68.53 -31.22 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.312 -176.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 73.7 m -63.78 -38.77 92.33 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.081 0.467 . . . . 0.0 110.076 176.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -68.18 -27.8 66.72 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.877 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.4 mt -84.68 137.32 33.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.755 0.788 . . . . 0.0 112.753 -178.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.561 ' HD2' ' N ' ' A' ' 33' ' ' LYS . 9.9 mptt -87.75 155.04 20.1 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.39 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.53 7.4 39.73 Favored Glycine 0 C--O 1.239 0.422 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.94 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.2 pt -91.39 132.91 34.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 86.3 mt -97.63 -59.45 3.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.935 0.398 . . . . 0.0 110.728 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.3 t -152.34 141.21 21.08 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.162 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 28.5 ptm -145.27 146.96 31.87 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.759 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -135.52 124.7 24.49 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.908 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 65.7 t -106.6 116.05 49.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 176.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.8 m -109.64 104.68 13.73 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.083 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.8 mt -64.4 -36.65 84.84 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.72 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.7 mp0 -63.61 -41.29 98.32 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.74 -178.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -83.85 -27.34 28.76 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.316 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.86 20.64 77.73 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -177.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.7 m -137.63 155.91 48.64 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 122.371 0.268 . . . . 0.0 110.592 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -121.92 141.8 50.93 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.398 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.1 m -85.38 124.36 31.9 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.664 HG13 ' CE2' ' A' ' 51' ' ' TYR . 97.4 t -107.26 119.29 56.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.053 -176.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -145.56 102.83 3.74 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 173.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.664 ' CE2' HG13 ' A' ' 49' ' ' VAL . 24.7 m-85 -141.69 165.78 26.54 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -177.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.6 t -78.1 114.22 40.3 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 175.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -62.87 -25.91 74.46 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.894 2.396 . . . . 0.0 112.861 -175.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.3 m -64.46 -39.08 93.14 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.925 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.6 t -94.84 -49.43 12.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.125 -178.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.1 t -114.45 126.63 72.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.328 -177.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 25.2 p -103.89 149.9 24.67 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.651 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.5 mp -64.32 -38.06 89.71 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.507 -176.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -62.6 -40.79 98.05 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -176.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.599 ' O ' ' HG3' ' A' ' 64' ' ' GLN . 85.4 mm-40 -64.72 -37.1 86.44 Favored 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 121.119 -0.233 . . . . 0.0 111.18 176.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.457 HG13 HD11 ' A' ' 25' ' ' ILE . 77.2 t -59.29 -43.43 89.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-O 121.17 0.509 . . . . 0.0 109.636 178.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 96.3 m -62.49 -39.09 92.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.97 177.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 63.8 m170 -67.3 -36.35 81.32 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.157 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.599 ' HG3' ' O ' ' A' ' 60' ' ' GLN . 99.2 mt-30 -60.02 -42.91 95.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.536 -176.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.419 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 19.8 tt -81.11 -35.07 14.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.114 178.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -67.14 -24.2 73.24 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.935 -0.575 . . . . 0.0 113.629 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.1 -36.59 77.78 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.847 0.356 . . . . 0.0 111.087 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 16.5 tpt -62.41 -28.93 70.13 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.533 178.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.89 5.13 18.29 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.38 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.595 ' CD2' ' HB3' ' A' ' 21' ' ' CYS . 99.0 m-85 -104.83 142.67 34.32 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.776 0.322 . . . . 0.0 110.661 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -80.88 147.81 30.2 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.404 -177.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.97 148.93 31.29 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.197 176.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 39.8 t -143.61 142.11 30.91 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.38 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 88.7 mt -86.27 128.58 39.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.198 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -138.35 148.43 44.54 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.481 177.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 . . . . . 0 C--N 1.307 -1.282 0 CA-C-O 118.393 -0.813 . . . . 0.0 110.307 -179.818 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.0 t . . . . . 0 CA--C 1.516 -0.342 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -112.31 143.58 43.16 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.954 0.406 . . . . 0.0 111.388 -176.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.587 HG22 ' HG2' ' A' ' 50' ' ' LYS . 71.7 p -109.32 140.86 42.46 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.9 t -150.64 143.02 24.32 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.048 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.58 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 71.3 p -115.09 122.99 47.83 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.8 m -107.21 125.69 63.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.329 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.519 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 16.2 ptp180 -77.79 135.29 37.96 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 85.4 mt -117.57 127.52 74.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-O 120.977 0.418 . . . . 0.0 111.63 -174.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.0 tt -115.13 119.4 36.29 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.107 177.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -165.73 173.42 41.37 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.943 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 79.2 mtm -63.81 -44.91 91.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.32 0.581 . . . . 0.0 110.134 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.0 p -134.91 128.8 33.26 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.748 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.551 ' O ' HG23 ' A' ' 22' ' ' VAL . 51.5 t -62.61 -49.56 74.74 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -176.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -62.61 -40.88 98.35 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -174.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.6 t -62.83 -47.16 84.58 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.675 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.5 p -70.75 -33.29 70.65 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.698 0.285 . . . . 0.0 110.967 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 18' ' ' CYS . 52.7 t -61.91 -45.62 98.29 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.018 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 176.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -64.34 -36.28 83.62 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.493 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 41.1 t -59.24 -48.69 80.67 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.281 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.8 tt -78.51 -28.86 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.448 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -59.2 -46.33 88.73 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.28 -176.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -61.17 -45.09 96.03 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.962 0.41 . . . . 0.0 110.689 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -67.22 -45.75 75.87 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.505 -176.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.3 tp -72.47 -34.63 49.0 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 78.8 p -65.82 -36.32 83.15 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.817 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -70.6 -27.29 63.98 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.283 176.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -77.96 125.18 28.96 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.918 0.389 . . . . 0.0 110.169 176.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -81.51 152.48 27.29 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.316 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 115.81 -0.91 21.53 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.17 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.9 tt -108.73 124.19 65.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.25 0.547 . . . . 0.0 109.98 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 49.7 mm -71.38 -49.43 47.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.029 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.7 t -159.81 150.26 18.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.76 -177.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 26.3 ttt -127.33 119.56 26.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.143 178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -131.03 146.38 52.36 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 110.289 -0.264 . . . . 0.0 110.289 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.5 HG21 HG11 ' A' ' 22' ' ' VAL . 66.4 t -123.91 129.73 74.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 120.757 0.313 . . . . 0.0 111.67 -175.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.3 t -106.85 105.3 15.26 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 177.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 60.0 tp -64.48 -40.83 96.41 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.679 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -62.07 -40.91 97.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.732 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -76.26 -29.11 57.34 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.667 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.83 20.31 63.71 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.978 -0.629 . . . . 0.0 111.629 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 89.3 p -143.91 166.22 25.55 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 120.93 0.395 . . . . 0.0 110.542 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.58 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -117.52 133.77 55.59 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.469 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.1 m -98.88 121.24 40.57 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.6 m -127.96 149.34 32.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 CA-C-O 121.408 0.623 . . . . 0.0 111.509 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.587 ' HG2' HG22 ' A' ' 8' ' ' THR . 62.3 mttp -116.04 123.88 49.06 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 175.062 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -150.7 165.46 33.37 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.504 -174.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.5 t -100.16 110.28 59.18 Favored Pre-proline 0 N--CA 1.438 -1.056 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.041 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -55.82 -27.13 60.8 Favored 'Trans proline' 0 N--CA 1.483 0.866 0 C-N-CA 123.62 2.88 . . . . 0.0 112.676 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.2 m -62.03 -39.22 91.59 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.845 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 51.8 t -89.05 -47.52 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.998 -177.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 31.8 m -123.25 160.2 26.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.614 0.245 . . . . 0.0 110.904 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 31.2 p -134.89 167.32 21.12 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.948 0.404 . . . . 0.0 111.541 -176.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 68.6 tp -61.07 -44.33 97.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.856 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -60.03 -42.31 94.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.515 -177.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.563 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 64.7 tt0 -61.66 -45.81 92.41 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.609 178.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.0 t -63.97 -46.59 93.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 CA-C-O 121.2 0.524 . . . . 0.0 110.751 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 48.5 t -60.82 -40.07 91.37 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.927 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -60.36 -41.38 93.58 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.414 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.563 ' HG2' ' O ' ' A' ' 60' ' ' GLN . 87.0 mm-40 -60.56 -45.7 92.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.143 -176.079 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.3 tt -83.22 -35.78 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.869 0.366 . . . . 0.0 111.752 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.59 -39.8 97.86 Favored Glycine 0 CA--C 1.505 -0.536 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.42 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -60.42 -39.37 87.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.952 0.406 . . . . 0.0 110.324 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 14.8 tpt -63.47 -30.67 71.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.485 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 116.64 7.93 12.96 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.334 -0.936 . . . . 0.0 113.301 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -114.53 141.6 47.52 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -99.31 133.35 43.74 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -172.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 12' ' ' ARG . . . -130.89 139.03 50.06 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.474 176.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.6 m -127.57 143.59 51.16 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.689 0.281 . . . . 0.0 110.938 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.2 tt -74.13 142.32 14.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -175.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.434 ' HB2' ' NH2' ' A' ' 12' ' ' ARG . . . -143.05 125.63 15.83 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.45 172.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 . . . . . 0 C--N 1.307 -1.244 0 CA-C-O 118.771 -0.633 . . . . 0.0 111.435 -178.579 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 N--CA 1.441 -0.9 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -129.9 143.2 50.68 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 120.954 0.407 . . . . 0.0 111.136 -178.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.1 p -107.96 129.34 55.12 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.024 177.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.424 ' O ' HG22 ' A' ' 49' ' ' VAL . 46.8 t -140.71 143.78 35.22 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 22.4 p -109.62 119.71 40.25 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.929 177.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 74' ' ' ILE . 33.5 m -102.61 135.89 37.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.408 ' HG2' ' HB3' ' A' ' 73' ' ' SER . 24.1 ptt180 -83.74 150.9 25.52 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.642 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 86.4 mt -112.52 121.35 64.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 63.4 tp -122.56 108.08 12.72 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -167.23 156.19 27.8 Favored Glycine 0 N--CA 1.431 -1.656 0 C-N-CA 119.932 -1.127 . . . . 0.0 113.069 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 79.5 mtm -64.6 -40.28 95.23 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.92 0.39 . . . . 0.0 110.346 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 35.5 m -121.85 103.87 9.16 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.468 ' O ' HG23 ' A' ' 22' ' ' VAL . 91.5 m -65.4 -40.23 93.16 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.051 -177.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -62.72 -39.79 95.15 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -176.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.0 m -62.38 -44.56 96.16 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.553 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.651 ' HB3' ' CD2' ' A' ' 70' ' ' PHE . 24.7 p -71.73 -37.05 70.64 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.416 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 18' ' ' CYS . 59.4 t -62.65 -45.18 99.46 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.001 178.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 66.3 tttp -62.86 -42.73 99.86 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.275 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 74.5 m -60.78 -43.01 98.63 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.67 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.0 tt -76.52 -41.16 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.396 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -62.71 -49.36 75.4 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -63.71 -46.42 85.52 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.046 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.0 ttp180 -67.17 -42.72 83.81 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.522 HG12 ' OH ' ' A' ' 51' ' ' TYR . 11.2 tp -67.55 -36.44 76.24 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.687 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.882 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 79.0 p -73.17 -20.71 60.84 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.17 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -71.64 -27.91 63.4 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 174.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 64.1 tp -93.29 119.3 32.28 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.388 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -80.66 152.41 28.48 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 120.994 0.426 . . . . 0.0 111.069 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 115.3 1.67 21.86 Favored Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -175.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.522 HD11 ' HB2' ' A' ' 38' ' ' MET . 4.1 tt -91.92 122.25 43.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 123.132 0.573 . . . . 0.0 110.426 178.003 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.1 tt -82.7 -42.8 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.822 177.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.492 ' HB3' ' HD2' ' A' ' 50' ' ' LYS . 35.3 t -160.67 145.62 14.35 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 120.123 -0.631 . . . . 0.0 112.248 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.577 ' SD ' HG12 ' A' ' 49' ' ' VAL . 14.4 tpt -134.41 129.81 35.89 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.851 177.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -135.05 129.05 33.44 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.6 p -129.77 137.61 56.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 120.811 0.339 . . . . 0.0 110.862 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.1 t -117.62 117.9 30.64 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.979 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.8 tp -66.66 -41.62 87.9 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.863 176.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -61.07 -48.93 79.42 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.587 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -77.02 -25.02 52.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.69 -178.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.33 29.8 69.85 Favored Glycine 0 CA--C 1.505 -0.591 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.9 t -149.12 152.85 36.84 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -119.36 138.17 53.24 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.987 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 71.6 m -102.67 122.6 44.77 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.667 ' HB ' ' CE2' ' A' ' 51' ' ' TYR . 33.3 m -120.72 149.91 23.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -174.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.492 ' HD2' ' HB3' ' A' ' 37' ' ' SER . 69.0 mttm -125.0 108.2 11.6 Favored 'General case' 0 C--O 1.245 0.858 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.749 175.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.667 ' CE2' ' HB ' ' A' ' 49' ' ' VAL . 80.8 m-85 -136.44 148.78 47.92 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.03 0.443 . . . . 0.0 111.434 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 66.5 t -87.61 115.41 62.8 Favored Pre-proline 0 N--CA 1.438 -1.049 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 171.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -59.4 -28.62 88.04 Favored 'Trans proline' 0 N--CA 1.475 0.398 0 C-N-CA 122.819 2.346 . . . . 0.0 113.765 -173.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.0 p -77.05 -14.29 59.84 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.907 0.384 . . . . 0.0 111.473 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 49.0 t -104.4 -59.19 3.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.105 0.479 . . . . 0.0 109.892 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 66.7 t -126.3 124.16 65.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.491 ' SG ' ' HG3' ' A' ' 60' ' ' GLN . 31.2 p -93.48 159.28 15.31 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.208 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.8 mt -62.91 -36.67 84.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.66 -178.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -61.11 -40.03 92.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.734 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.491 ' HG3' ' SG ' ' A' ' 57' ' ' CYS . 95.5 mt-30 -63.08 -41.25 99.38 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.074 0.464 . . . . 0.0 110.369 177.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 70.2 t -63.26 -44.24 99.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.119 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 92.5 m -62.59 -39.51 93.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.967 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -61.75 -39.67 92.4 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.547 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.42 ' HG3' ' O ' ' A' ' 60' ' ' GLN . 99.1 mt-30 -60.3 -42.34 95.32 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.41 -176.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.2 tt -81.77 -40.73 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-O 120.787 0.327 . . . . 0.0 111.604 178.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -62.31 -37.01 93.88 Favored Glycine 0 C--N 1.335 0.473 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.626 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -56.35 -36.14 68.44 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 123.91 0.884 . . . . 0.0 111.594 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 14.2 tpt -63.44 -28.58 70.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.246 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.81 9.62 9.83 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.495 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.651 ' CD2' ' HB3' ' A' ' 21' ' ' CYS . 98.4 m-85 -113.79 141.82 46.83 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -82.78 146.85 28.74 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.485 0.66 . . . . 0.0 112.592 -176.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.44 151.09 35.86 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.981 -1.008 . . . . 0.0 108.923 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 36.6 t -138.19 140.48 39.8 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.891 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.455 ' HA ' HG12 ' A' ' 11' ' ' VAL . 85.7 mt -81.55 128.63 38.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.066 -178.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -142.95 159.96 41.25 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.435 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 119.132 -0.461 . . . . 0.0 111.403 -179.692 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.9 t . . . . . 0 N--CA 1.449 -0.509 0 CA-C-O 120.908 0.385 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 50' ' ' LYS . . . -117.24 131.82 56.76 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 176.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.573 HG22 ' HG2' ' A' ' 50' ' ' LYS . 66.4 p -111.82 135.04 52.96 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.8 t -157.57 152.15 25.13 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 40.7 p -111.93 142.39 44.4 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-O 121.037 0.446 . . . . 0.0 110.042 178.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.3 p -133.14 127.33 54.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.137 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 40.6 ptt180 -94.53 142.61 27.24 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.595 -0.442 . . . . 0.0 109.815 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 85.3 mt -110.13 127.13 67.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.782 -177.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 63.0 tp -112.87 115.2 28.08 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.219 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -172.83 148.54 10.58 Favored Glycine 0 N--CA 1.438 -1.229 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 68.3 mtt -65.94 -41.05 91.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.972 0.415 . . . . 0.0 110.794 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.7 m -100.76 85.26 2.86 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.489 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 93.7 m -63.45 -40.13 96.32 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.495 -175.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -62.83 -42.21 99.64 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -177.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.9 m -67.34 -41.1 85.75 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.504 ' HB3' ' CG ' ' A' ' 70' ' ' PHE . 18.6 p -68.79 -39.96 79.86 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.572 -179.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.476 ' O ' ' HG3' ' A' ' 26' ' ' GLU . 67.3 t -63.07 -46.0 97.27 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.282 0 CA-C-O 121.13 0.49 . . . . 0.0 109.804 178.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.46 -44.13 97.64 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.793 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.459 ' HB3' ' HG3' ' A' ' 68' ' ' MET . 67.2 m -62.95 -46.43 87.79 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.067 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.9 tt -66.25 -33.62 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.207 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 22' ' ' VAL . 49.4 mt-10 -62.33 -44.03 97.45 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.627 178.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -65.93 -45.46 81.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.149 0.499 . . . . 0.0 110.812 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.534 ' HB3' ' HG2' ' A' ' 64' ' ' GLN . 26.5 mmt85 -64.18 -43.32 95.47 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.239 -178.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.591 HG21 ' SD ' ' A' ' 38' ' ' MET . 19.1 tt -70.62 -32.95 51.25 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.303 0 CA-C-O 120.952 0.406 . . . . 0.0 110.264 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.5 t -62.41 -38.86 91.3 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.575 176.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -66.79 -30.37 70.55 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.886 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 93.7 mt -75.82 129.12 36.51 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.164 0.507 . . . . 0.0 110.451 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -85.49 153.35 22.52 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.294 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.02 7.96 48.94 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.583 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.497 ' HA ' ' CB ' ' A' ' 51' ' ' TYR . 48.0 pt -94.78 138.68 20.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.868 0.366 . . . . 0.0 110.662 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.3 mm -99.48 -61.78 2.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.114 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.5 m -146.57 154.13 41.16 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.615 0.245 . . . . 0.0 110.965 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.591 ' SD ' HG21 ' A' ' 29' ' ' ILE . 27.8 ttt -145.6 132.45 20.12 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.583 178.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -126.26 128.34 47.02 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 176.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.8 t -107.2 123.62 62.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-O 120.79 0.329 . . . . 0.0 110.366 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.5 m -98.6 99.38 10.51 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.9 mt -64.19 -40.23 95.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.089 -175.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -69.27 -38.57 78.44 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.075 0.464 . . . . 0.0 110.91 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -74.66 -29.96 61.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.806 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.82 15.14 81.2 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -177.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 12' ' ' ARG . 49.0 m -131.48 154.25 48.93 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.39 -0.405 . . . . 0.0 110.133 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -125.41 143.49 50.96 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.978 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 85.1 m -102.01 125.26 48.66 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.6 m -117.69 147.28 21.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 121.023 0.439 . . . . 0.0 111.512 -177.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.573 ' HG2' HG22 ' A' ' 8' ' ' THR . 99.7 mttt -133.17 112.94 12.15 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.444 177.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.497 ' CB ' ' HA ' ' A' ' 35' ' ' ILE . 35.9 p90 -159.28 170.62 21.47 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.13 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.0 t -80.61 114.94 51.84 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 38.9 Cg_endo -65.97 -23.34 54.38 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.696 2.264 . . . . 0.0 112.218 -178.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.4 m -65.77 -39.36 90.94 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.619 177.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 66.0 t -74.42 -51.11 24.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.017 0.437 . . . . 0.0 110.483 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 17.8 m -137.08 149.02 26.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.434 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.582 ' SG ' ' HB2' ' A' ' 60' ' ' GLN . 24.9 p -99.65 172.24 7.41 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.871 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.484 HD23 ' OH ' ' A' ' 51' ' ' TYR . 96.5 mt -64.84 -40.89 95.9 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.718 0.771 . . . . 0.0 110.332 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -68.27 -26.71 65.8 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.462 178.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.582 ' HB2' ' SG ' ' A' ' 57' ' ' CYS . 59.6 tp60 -60.41 -45.93 91.85 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.381 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.54 ' HA ' ' OE1' ' A' ' 64' ' ' GLN . 31.8 m -74.33 -26.43 20.49 Favored 'Isoleucine or valine' 0 C--O 1.248 0.989 0 CA-C-O 121.387 0.613 . . . . 0.0 110.722 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 98.1 m -61.64 -36.45 80.82 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.104 176.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -60.48 -40.5 91.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.933 -178.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.54 ' OE1' ' HA ' ' A' ' 61' ' ' VAL . 28.6 mp0 -64.57 -41.0 96.56 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 120.4 -0.52 . . . . 0.0 112.235 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.4 tt -72.67 -36.82 54.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.525 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.23 -38.39 96.12 Favored Glycine 0 C--N 1.339 0.702 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 176.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -57.63 -36.83 72.34 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.358 0.663 . . . . 0.0 110.896 178.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.459 ' HG3' ' HB3' ' A' ' 24' ' ' SER . 95.9 mmm -74.72 -8.05 55.2 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.526 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.57 9.91 59.65 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.617 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.504 ' CG ' ' HB3' ' A' ' 21' ' ' CYS . 98.7 m-85 -111.7 147.52 35.39 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -105.95 151.32 24.74 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.184 0.516 . . . . 0.0 111.91 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -144.72 148.62 34.4 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.456 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.7 t -123.6 132.6 53.91 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.937 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 84.4 mt -78.96 130.93 35.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.235 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -144.51 155.31 43.63 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.283 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 . . . . . 0 C--O 1.256 1.432 0 CA-C-O 118.568 -0.729 . . . . 0.0 109.377 178.388 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 CA--C 1.507 -0.702 0 CA-C-O 121.003 0.43 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -104.79 131.35 52.36 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.646 -178.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 61.2 p -117.65 142.86 46.73 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.2 t -158.89 152.55 23.1 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.274 -0.571 . . . . 0.0 110.029 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 20.8 p -102.43 141.23 35.58 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 177.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.3 p -134.78 135.16 53.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.522 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -95.22 151.9 18.83 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.3 pt -115.11 138.8 44.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 110.127 -0.324 . . . . 0.0 110.127 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.2 tp -126.0 117.89 24.19 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.143 0.497 . . . . 0.0 110.774 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.82 157.77 16.31 Favored Glycine 0 N--CA 1.437 -1.264 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 95.3 mmm -69.02 -39.48 79.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.145 0.498 . . . . 0.0 110.059 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.2 p -99.74 79.07 2.2 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 121.509 0.671 . . . . 0.0 109.879 176.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.545 ' O ' HG23 ' A' ' 22' ' ' VAL . 96.4 m -62.39 -43.16 99.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.986 -176.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -64.99 -38.95 92.66 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.862 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.0 t -61.23 -45.93 92.5 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.451 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 29.3 p -67.53 -32.19 72.81 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.516 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 18' ' ' CYS . 53.7 t -62.97 -43.63 99.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.615 176.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -61.87 -43.79 98.13 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.456 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.6 m -61.76 -44.94 95.9 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.809 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.7 tp -72.5 -35.34 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 121.171 -0.212 . . . . 0.0 111.324 178.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -59.46 -47.11 86.76 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.878 0.37 . . . . 0.0 110.955 -177.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -62.92 -51.14 68.1 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.065 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.415 ' HG3' ' OE1' ' A' ' 64' ' ' GLN . 29.9 tpt180 -68.99 -40.82 78.54 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.568 -174.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.404 ' O ' HD13 ' A' ' 35' ' ' ILE . 18.9 tt -65.64 -33.83 66.28 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.086 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 73.5 m -63.64 -35.06 79.27 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.783 175.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -67.4 -26.24 66.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.097 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.1 mt -74.56 136.52 42.1 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.973 0.416 . . . . 0.0 110.852 176.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -86.75 149.92 24.52 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.393 177.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.84 7.97 54.78 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.064 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.404 HD13 ' O ' ' A' ' 29' ' ' ILE . 47.7 pt -94.02 139.49 18.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 120.881 0.372 . . . . 0.0 110.22 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 89.2 mt -99.38 -58.56 3.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.819 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.1 t -158.47 147.53 19.07 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.079 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.42 ' HG3' HG12 ' A' ' 49' ' ' VAL . 65.5 ttp -141.74 130.04 22.32 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.115 175.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -120.12 127.0 52.11 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.3 t -111.47 119.99 61.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.1 m -100.97 106.34 17.65 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 97.0 mt -63.61 -38.68 92.03 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.979 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -63.67 -41.08 98.22 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.931 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -77.29 -27.33 52.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.174 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.27 18.78 73.42 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.216 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 78.7 p -144.69 159.03 43.49 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 120.881 0.372 . . . . 0.0 111.177 -178.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -128.33 155.65 44.32 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.23 -178.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.9 m -113.32 127.54 56.18 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 8' ' ' THR . 35.9 m -116.99 148.28 19.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 120.826 0.346 . . . . 0.0 111.218 -178.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -142.68 114.87 8.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.459 177.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.449 ' OH ' HD23 ' A' ' 58' ' ' LEU . 39.4 p90 -158.89 166.84 30.93 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.06 -178.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.12 116.27 63.38 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.647 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 43.4 Cg_endo -65.78 -20.42 58.87 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.086 2.524 . . . . 0.0 114.053 -175.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.6 p -65.71 -38.11 88.29 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.695 0.283 . . . . 0.0 111.439 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.9 m -100.4 -26.98 3.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 79.8 t -125.35 124.86 68.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 176.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.564 ' SG ' ' HG3' ' A' ' 60' ' ' GLN . 31.2 p -103.29 168.65 9.03 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.001 -178.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.449 HD23 ' OH ' ' A' ' 51' ' ' TYR . 96.0 mt -64.18 -38.2 90.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.533 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -61.74 -41.06 97.17 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.014 -177.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.564 ' HG3' ' SG ' ' A' ' 57' ' ' CYS . 96.0 mt-30 -62.07 -45.56 92.97 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.47 -178.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 72.6 t -64.22 -46.93 92.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 CA-C-O 121.075 0.464 . . . . 0.0 111.048 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 44.6 t -62.16 -43.37 98.97 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.135 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -62.53 -41.33 98.8 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.779 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.523 ' HG3' ' O ' ' A' ' 60' ' ' GLN . 22.8 mt-30 -61.2 -43.55 98.7 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 121.207 -0.197 . . . . 0.0 111.334 -176.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.0 tt -77.85 -38.02 24.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.119 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -62.82 -40.21 98.95 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.604 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -62.61 -26.93 68.86 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 122.989 0.516 . . . . 0.0 110.781 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.476 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 36.6 mmt -71.4 -8.97 57.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.666 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.77 5.86 58.47 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.377 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.479 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 99.1 m-85 -110.55 138.56 46.78 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -88.42 140.6 29.3 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.735 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -139.62 138.36 36.09 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.13 177.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.3 m -118.63 139.38 51.59 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.4 tt -118.56 139.91 44.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-O 121.128 0.489 . . . . 0.0 111.499 -174.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.44 160.41 42.12 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.108 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 . . . . . 0 C--O 1.252 1.214 0 CA-C-O 118.512 -0.756 . . . . 0.0 109.744 177.887 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 N--CA 1.44 -0.931 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -117.19 127.34 54.01 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 40.1 p -119.78 144.78 47.11 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.087 177.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.3 t -158.09 153.1 25.36 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.86 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 34.9 p -110.07 142.14 41.93 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 176.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 73' ' ' SER . 6.8 p -127.35 122.98 60.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-O 121.044 0.449 . . . . 0.0 110.192 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 36.3 ptt180 -91.44 146.2 24.0 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.208 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.2 pt -121.09 133.92 66.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 121.207 0.527 . . . . 0.0 112.008 -176.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 62.0 tp -135.56 129.41 32.94 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.069 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.21 -172.65 44.73 Favored Glycine 0 N--CA 1.438 -1.192 0 C-N-CA 119.58 -1.295 . . . . 0.0 112.811 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -61.8 -42.17 98.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.911 0.386 . . . . 0.0 110.913 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.472 ' HB ' ' OG ' ' A' ' 20' ' ' SER . 63.6 m -139.84 118.08 12.01 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.115 177.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.463 ' O ' HG23 ' A' ' 22' ' ' VAL . 95.1 m -67.47 -39.77 85.28 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.558 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -63.37 -41.91 98.84 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.613 -177.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.472 ' OG ' ' HB ' ' A' ' 17' ' ' THR . 78.9 p -69.71 -39.12 77.07 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.437 ' HB3' ' CG ' ' A' ' 70' ' ' PHE . 29.7 p -67.08 -34.03 76.78 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.544 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 18' ' ' CYS . 63.3 t -63.12 -44.84 99.68 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.088 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -63.09 -40.45 97.68 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.212 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.2 m -62.73 -46.22 89.09 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.637 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.9 tt -74.29 -35.62 40.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.012 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -60.65 -44.51 96.32 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.918 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -60.83 -51.3 69.91 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.207 -176.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -65.29 -46.35 80.74 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.452 HD13 ' SD ' ' A' ' 38' ' ' MET . 19.0 tt -65.8 -33.11 61.4 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.52 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.724 -177.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.5 m -65.55 -41.54 92.89 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.236 0.541 . . . . 0.0 110.338 177.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -71.13 -27.22 63.42 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.257 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 62.5 tp -81.86 117.23 21.96 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 121.306 0.574 . . . . 0.0 109.532 178.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -86.46 154.66 20.97 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.123 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.415 ' HA3' HG11 ' A' ' 55' ' ' VAL . . . 117.8 -6.3 15.9 Favored Glycine 0 C--N 1.314 -0.644 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -176.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.7 mp -102.05 112.67 36.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.3 tt -72.12 -38.45 63.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -176.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.5 m -151.34 145.31 25.21 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.838 0.352 . . . . 0.0 111.478 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.452 ' SD ' HD13 ' A' ' 29' ' ' ILE . 63.4 ttp -145.69 127.75 15.59 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -134.97 144.43 47.4 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.0 129.16 76.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 121.379 0.609 . . . . 0.0 111.428 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.6 p -100.47 98.07 8.72 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.703 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 99.4 mt -63.89 -39.16 93.54 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.371 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -65.45 -23.47 66.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.151 0.5 . . . . 0.0 111.115 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 -88.56 -27.82 21.14 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.135 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.34 19.67 71.21 Favored Glycine 0 C--O 1.236 0.272 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -176.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.0 t -145.0 154.88 43.01 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.24 -0.48 . . . . 0.0 109.733 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -118.36 149.73 40.7 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.584 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.7 m -112.86 126.83 55.88 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 8' ' ' THR . 12.7 p -123.72 137.37 57.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 121.013 0.435 . . . . 0.0 110.815 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -124.81 117.96 25.31 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 56.2 p90 -151.62 165.4 34.44 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.957 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.4 t -77.12 121.66 85.02 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 174.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -59.95 -28.38 86.99 Favored 'Trans proline' 0 N--CA 1.476 0.498 0 C-N-CA 122.814 2.343 . . . . 0.0 113.866 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.2 m -85.25 -9.43 57.74 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 120.752 0.31 . . . . 0.0 111.707 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.415 HG11 ' HA3' ' A' ' 34' ' ' GLY . 65.7 t -99.15 -42.33 10.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.712 0.291 . . . . 0.0 111.539 -178.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 63.5 t -125.36 137.16 58.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.746 -177.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.403 ' SG ' ' HB2' ' A' ' 60' ' ' GLN . 28.9 p -105.91 156.18 18.61 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.792 0.329 . . . . 0.0 110.872 178.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.471 HD13 HG21 ' A' ' 74' ' ' ILE . 87.9 mt -63.73 -39.86 95.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.085 -178.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -63.51 -36.87 85.19 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -177.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.426 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 23.8 tm0? -58.95 -45.28 90.86 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 121.224 -0.19 . . . . 0.0 110.796 -177.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.8 m -75.3 -33.47 28.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.216 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 95.4 m -63.64 -39.89 95.5 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-O 121.099 0.476 . . . . 0.0 110.179 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -63.33 -38.14 89.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.856 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' A' ' 60' ' ' GLN . 89.7 mm-40 -62.7 -43.52 98.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.499 -177.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.5 tt -83.0 -40.25 16.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 120.797 0.332 . . . . 0.0 111.714 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.566 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -62.89 -40.78 99.69 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 116.119 -0.491 . . . . 0.0 113.426 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -61.39 -35.3 77.11 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.974 0.416 . . . . 0.0 111.282 -178.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 35.9 mmt -68.62 -8.05 38.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.703 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.39 11.15 39.59 Favored Glycine 0 CA--C 1.506 -0.499 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.713 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.566 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 96.2 m-85 -108.03 146.16 32.94 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -102.49 131.23 49.32 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.91 0.386 . . . . 0.0 110.899 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 12' ' ' ARG . . . -143.28 144.36 32.09 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 13.4 p -133.9 153.72 51.56 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.306 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.471 HG21 HD13 ' A' ' 58' ' ' LEU . 49.8 mm -95.01 130.54 43.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.208 -174.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.0 151.5 51.47 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.134 176.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 C--N 1.309 -1.163 0 CA-C-O 119.024 -0.512 . . . . 0.0 110.595 -178.945 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 31.8 m . . . . . 0 N--CA 1.443 -0.801 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.4 134.31 55.02 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.632 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 67.9 p -117.65 147.14 43.17 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 175.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 76' ' ' GLU . 87.4 p -158.85 158.21 33.01 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.149 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 31.9 p -115.36 114.38 25.05 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 175.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.505 HG22 HG12 ' A' ' 74' ' ' ILE . 70.7 t -107.62 123.51 63.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.2 -176.09 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -91.48 143.2 26.85 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.497 -177.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 82.7 mt -120.18 130.48 74.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.364 -176.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.46 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 7.4 tt -112.32 120.49 41.89 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 176.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -166.14 179.49 40.22 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.272 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 94.7 mmm -63.18 -41.41 99.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.745 0.307 . . . . 0.0 111.294 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.0 t -152.17 150.36 29.77 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 120.993 0.425 . . . . 0.0 110.652 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.456 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 93.1 m -64.01 -38.78 92.33 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.67 -178.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -59.22 -47.42 85.41 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -172.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.2 p -70.52 -40.93 73.21 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -177.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.456 ' SG ' ' HA ' ' A' ' 18' ' ' CYS . 25.4 p -72.71 -42.74 63.85 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -177.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.414 ' O ' ' HG3' ' A' ' 26' ' ' GLU . 66.9 t -64.18 -45.58 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.86 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 73.6 mmtt -64.41 -38.95 92.84 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.328 -0.549 . . . . 0.0 112.061 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.6 m -62.22 -43.97 97.63 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.279 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.439 ' O ' HG22 ' A' ' 29' ' ' ILE . 10.9 tp -72.86 -37.62 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.547 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 22' ' ' VAL . 44.4 mt-10 -61.97 -41.43 98.01 Favored 'General case' 0 C--N 1.349 0.558 0 C-N-CA 120.944 -0.303 . . . . 0.0 111.513 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -61.07 -50.26 74.01 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -176.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -65.93 -44.96 83.56 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.439 HG22 ' O ' ' A' ' 25' ' ' ILE . 19.7 tt -72.17 -32.68 44.08 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 CA-C-O 120.797 0.332 . . . . 0.0 111.372 -177.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.2 t -63.66 -39.67 94.93 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -68.56 -27.09 65.77 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.377 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 98.5 mt -83.68 118.34 23.8 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.556 -0.457 . . . . 0.0 110.427 176.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -85.71 153.94 21.98 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.606 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.13 7.48 14.62 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.453 -177.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.412 ' HA ' ' CB ' ' A' ' 51' ' ' TYR . 46.7 pt -102.79 139.02 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 86.8 mt -83.82 -56.96 4.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.173 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 78.6 p -155.14 157.42 37.41 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.256 -178.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 77.9 mtm -138.03 142.35 40.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.331 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -131.3 149.52 52.53 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 175.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.9 p -138.48 131.7 40.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-O 121.187 0.518 . . . . 0.0 111.385 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.1 m -116.19 103.99 11.08 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.76 -41.63 97.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.346 -176.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -64.02 -39.93 95.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.156 0.503 . . . . 0.0 110.997 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -73.11 -29.89 63.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.323 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.35 17.66 73.28 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.749 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 88.4 p -142.2 158.58 43.57 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 120.893 0.378 . . . . 0.0 110.455 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -124.48 144.7 49.94 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.85 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.1 m -103.65 123.35 46.83 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 8' ' ' THR . 29.7 m -126.67 149.41 31.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.446 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -134.95 115.33 13.44 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.468 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.412 ' CB ' ' HA ' ' A' ' 35' ' ' ILE . 51.6 p90 -161.97 170.93 18.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.237 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.5 t -82.88 116.32 63.46 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 36.7 Cg_endo -64.76 -23.88 62.41 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.71 2.273 . . . . 0.0 113.515 -176.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.5 t -64.88 -42.88 94.45 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.271 177.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 96.5 t -67.78 -49.47 69.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.137 0.494 . . . . 0.0 110.043 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 63.0 t -128.35 119.84 51.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.657 ' SG ' ' HB2' ' A' ' 60' ' ' GLN . 30.4 p -83.12 154.46 24.33 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.472 -178.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.482 ' HB3' ' CD1' ' A' ' 74' ' ' ILE . 98.9 mt -62.48 -37.99 88.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.544 -178.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -63.11 -39.43 94.66 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.535 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.657 ' HB2' ' SG ' ' A' ' 57' ' ' CYS . 14.2 tm0? -65.0 -38.89 92.44 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 77.3 t -61.58 -44.05 98.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.298 0.571 . . . . 0.0 110.171 178.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 44.0 t -60.49 -40.32 90.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.191 176.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.468 ' HB3' ' O ' ' A' ' 60' ' ' GLN . 53.7 t-80 -60.18 -39.36 86.2 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.872 177.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -59.9 -46.17 90.18 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.373 -177.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.3 tt -82.04 -33.65 11.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.09 -39.66 97.43 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.455 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -61.75 -37.94 86.14 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.838 0.351 . . . . 0.0 111.082 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 16.4 tpt -61.97 -30.04 70.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.04 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.94 6.94 18.26 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.61 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -112.55 136.92 51.51 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.46 ' HG3' ' HB3' ' A' ' 14' ' ' LEU . 12.0 pt-20 -95.88 144.55 26.12 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.009 0.433 . . . . 0.0 110.649 -178.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.89 152.36 37.46 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.381 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 78.3 p -132.1 149.36 52.42 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.45 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.505 HG12 HG22 ' A' ' 11' ' ' VAL . 81.6 mt -94.4 125.26 47.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.891 -175.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -126.33 149.83 48.91 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.008 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 9' ' ' SER . 41.8 tt0 . . . . . 0 C--O 1.249 1.078 0 C-N-CA 123.167 0.587 . . . . 0.0 111.125 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 CA--C 1.508 -0.651 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -139.07 148.77 43.77 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.06 0.457 . . . . 0.0 110.614 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 72.3 p -125.34 156.18 39.11 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.7 p -156.5 159.06 38.25 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 123.266 0.354 . . . . 0.0 110.078 176.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.2 p -117.93 139.21 51.47 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 73' ' ' SER . 6.7 p -132.14 123.81 51.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.234 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -77.96 143.51 37.55 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.503 HD12 ' SG ' ' A' ' 21' ' ' CYS . 37.6 pt -115.76 123.02 70.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 60.4 tp -122.82 119.36 30.35 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.063 0.458 . . . . 0.0 111.545 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.49 167.95 37.64 Favored Glycine 0 N--CA 1.438 -1.229 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 178.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 99.0 mtp -64.51 -39.32 93.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.954 0.407 . . . . 0.0 111.208 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.6 p -109.49 113.46 26.28 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.104 0.478 . . . . 0.0 111.196 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.509 ' O ' HG23 ' A' ' 22' ' ' VAL . 23.7 p -70.93 -44.9 65.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.851 -178.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.415 ' O ' ' HG3' ' A' ' 23' ' ' LYS . 98.3 mt-30 -64.73 -37.9 89.15 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.555 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.2 t -60.55 -45.25 94.58 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.241 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.503 ' SG ' HD12 ' A' ' 13' ' ' ILE . 26.9 p -69.56 -32.57 71.44 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.836 178.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 18' ' ' CYS . 61.5 t -63.64 -43.67 98.22 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-O 121.214 0.531 . . . . 0.0 109.631 176.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 19' ' ' GLN . 98.6 mttt -61.86 -39.34 91.53 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.752 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.403 ' HB3' ' HG3' ' A' ' 68' ' ' MET . 70.9 m -62.72 -43.23 99.34 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.716 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.439 ' CG2' ' HB ' ' A' ' 65' ' ' ILE . 46.1 pt -81.63 -39.24 16.8 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.886 0 C-N-CA 120.386 -0.525 . . . . 0.0 112.292 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -62.67 -44.87 95.16 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.155 -176.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -61.85 -51.73 67.03 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.206 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.56 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 97.7 mtt180 -70.11 -41.21 74.29 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -176.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 92.1 mt -63.45 -44.19 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.683 0.278 . . . . 0.0 111.166 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 81.1 p -63.2 -33.78 76.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.833 0.349 . . . . 0.0 110.936 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -70.98 -25.76 62.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.417 176.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 28' ' ' ARG . 99.3 mt -70.43 146.61 50.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.133 0.492 . . . . 0.0 111.316 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -86.57 130.88 34.33 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.46 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.5 7.76 25.71 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.799 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.7 tp -84.88 123.39 39.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.05 0.453 . . . . 0.0 110.821 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 86.6 mt -93.58 -60.68 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.011 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 85.9 p -161.51 164.26 29.74 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.64 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 28.5 ptm -151.31 155.54 38.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.904 0.383 . . . . 0.0 110.883 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -143.73 138.67 29.0 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.692 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 67.0 t -106.9 124.33 62.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 120.941 0.4 . . . . 0.0 110.506 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.5 t -99.24 108.09 20.57 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.101 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.11 -33.47 73.53 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.426 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -61.48 -45.48 94.06 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.256 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -93.14 -12.69 29.77 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.646 -0.421 . . . . 0.0 111.686 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.83 26.95 73.78 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.1 m -135.69 158.17 45.05 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.389 -0.406 . . . . 0.0 110.447 -177.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.44 143.59 47.42 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 85.7 m -110.03 127.8 55.04 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.1 p -127.57 134.73 64.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 121.181 0.515 . . . . 0.0 111.283 -178.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -104.48 114.99 29.58 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 175.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.473 ' O ' ' HD3' ' A' ' 53' ' ' PRO . 16.1 t80 -142.79 165.27 27.85 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.612 -170.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.9 t -107.12 98.21 21.29 Favored Pre-proline 0 C--N 1.319 -0.744 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 51' ' ' TYR . 45.9 Cg_exo -60.66 -25.08 80.17 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.294 2.663 . . . . 0.0 111.971 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.8 m -62.26 -41.06 98.11 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.792 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 76.5 t -65.5 -49.69 76.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-O 121.192 0.52 . . . . 0.0 109.847 177.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.3 p -155.85 147.13 12.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.654 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 29.8 p -68.87 156.22 38.83 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.295 0.569 . . . . 0.0 112.406 -176.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.0 mt -77.2 -12.32 59.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.425 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -58.32 -37.89 76.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.954 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.514 ' O ' ' HG3' ' A' ' 64' ' ' GLN . 16.8 mm100 -61.57 -39.88 92.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.011 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.2 t -61.74 -45.11 99.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.744 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 43.0 t -60.73 -40.54 92.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.96 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 44.7 m170 -64.63 -37.16 86.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.703 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.514 ' HG3' ' O ' ' A' ' 60' ' ' GLN . 98.5 mt-30 -60.87 -44.29 97.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.119 -0.492 . . . . 0.0 112.008 -177.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.52 HD13 ' HB2' ' A' ' 72' ' ' ALA . 20.1 tt -76.32 -38.41 33.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.597 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.13 -37.89 95.24 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 177.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -58.12 -36.89 73.59 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.25 0.62 . . . . 0.0 111.132 177.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.403 ' HG3' ' HB3' ' A' ' 24' ' ' SER . 97.8 mmm -79.91 1.93 25.36 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.87 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.31 19.39 58.86 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.871 -0.68 . . . . 0.0 113.897 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -114.64 135.79 53.76 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 177.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -83.08 140.07 32.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.721 0.296 . . . . 0.0 110.56 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.52 ' HB2' HD13 ' A' ' 65' ' ' ILE . . . -148.23 149.72 32.43 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.175 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 65.9 m -133.92 133.97 42.08 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.181 177.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 85.9 mt -100.28 125.87 53.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.258 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -138.67 148.37 43.93 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.419 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.466 -0.778 . . . . 0.0 109.313 179.239 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -129.69 128.55 42.77 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.98 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.608 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 63.0 p -126.32 136.99 53.42 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.116 177.234 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.4 t -159.43 162.91 35.78 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 59.3 p -106.05 136.71 45.25 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.273 0.558 . . . . 0.0 111.077 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.32 123.61 70.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 177.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -80.61 141.15 35.29 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -178.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.2 pt -109.68 126.86 66.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-O 121.332 0.586 . . . . 0.0 111.369 -177.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.4 tp -126.26 117.8 23.81 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -165.47 160.46 33.85 Favored Glycine 0 N--CA 1.422 -2.27 0 C-N-CA 120.07 -1.062 . . . . 0.0 111.495 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.6 mmt -65.41 -39.67 92.45 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.3 p -122.33 105.94 10.64 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.722 176.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.9 m -63.63 -40.15 96.16 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.712 -177.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -62.93 -40.71 98.45 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.79 0.329 . . . . 0.0 110.471 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.4 m -62.81 -44.65 95.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.79 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.405 ' HB3' ' CD1' ' A' ' 70' ' ' PHE . 27.9 p -67.14 -38.28 85.25 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.128 -178.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 78.8 t -64.86 -45.02 96.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-O 121.128 0.489 . . . . 0.0 109.828 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -63.52 -43.14 98.03 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.925 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.492 ' HB3' ' HG3' ' A' ' 68' ' ' MET . 68.8 m -62.44 -42.79 99.71 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.825 -178.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.428 HD12 ' HB ' ' A' ' 65' ' ' ILE . 17.9 tt -72.56 -37.65 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.41 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -60.83 -45.94 92.49 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.228 0.537 . . . . 0.0 109.956 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -60.7 -49.71 76.43 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.366 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 44.4 ttt180 -66.02 -43.69 86.91 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.237 -177.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 87.9 mt -63.68 -39.87 86.97 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.799 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.861 177.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 69.3 m -59.72 -37.24 78.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.98 0.419 . . . . 0.0 110.384 178.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -68.59 -26.5 65.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.994 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.0 mp -97.71 150.01 21.67 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.31 0.576 . . . . 0.0 112.105 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -75.58 154.66 36.61 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.793 178.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.95 2.05 45.59 Favored Glycine 0 CA--C 1.505 -0.543 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.971 177.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.8 tt -72.62 108.13 3.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.253 0.549 . . . . 0.0 110.794 178.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' A' ' 50' ' ' LYS . 46.0 mm -101.88 -71.47 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.816 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 52.2 m -155.65 158.41 38.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.752 0.31 . . . . 0.0 111.242 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.8 ptm -148.74 148.53 30.11 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.242 175.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.52 ' HB3' ' HB ' ' A' ' 48' ' ' THR . 55.1 tttp -117.36 112.0 20.11 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.317 176.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.7 p -118.79 114.43 44.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-O 121.409 0.623 . . . . 0.0 110.008 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.7 m -124.98 127.01 46.36 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.02 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 93.8 mt -63.29 -39.07 93.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.225 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -61.75 -39.32 91.19 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.258 0.552 . . . . 0.0 110.365 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -72.56 -30.11 64.14 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.465 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.66 14.94 80.87 Favored Glycine 0 C--O 1.236 0.255 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.036 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 89.7 p -156.17 164.4 38.42 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.56 134.78 55.07 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.926 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' A' ' 39' ' ' LYS . 53.4 m -94.54 124.32 38.5 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 177.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.608 ' O ' ' HA ' ' A' ' 8' ' ' THR . 28.9 m -107.86 142.0 21.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.457 -177.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.461 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 87.7 tttt -131.58 104.58 7.03 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.478 -0.783 . . . . 0.0 108.926 178.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.523 ' CE2' ' HB ' ' A' ' 49' ' ' VAL . 64.5 m-85 -140.25 160.38 40.09 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.967 -177.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.0 t -80.44 117.08 66.08 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.612 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 30.1 Cg_endo -62.28 -25.83 76.92 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.142 2.561 . . . . 0.0 113.096 -176.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.8 t -62.94 -41.57 99.53 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.054 0.454 . . . . 0.0 110.334 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.1 t -87.53 -49.81 14.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.3 -177.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.612 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 28.5 m -132.82 161.68 41.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.484 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 31.1 p -133.74 169.72 16.63 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 120.679 0.276 . . . . 0.0 110.899 -178.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.1 mt -62.6 -38.59 90.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.51 -177.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -60.32 -44.49 95.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.43 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.495 ' O ' ' HG3' ' A' ' 64' ' ' GLN . 97.0 mt-30 -64.42 -41.06 96.82 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.104 178.436 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 73.6 t -62.08 -46.13 97.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 CA-C-O 121.133 0.492 . . . . 0.0 110.353 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.504 ' SG ' ' HB ' ' A' ' 74' ' ' ILE . 93.8 m -62.78 -39.71 95.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.848 178.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -62.47 -41.64 98.92 Favored 'General case' 0 C--O 1.206 -1.226 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.052 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 60' ' ' GLN . 78.5 mt-30 -60.39 -42.42 95.87 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -175.177 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.428 ' HB ' HD12 ' A' ' 25' ' ' ILE . 17.4 tt -76.77 -40.95 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.571 178.313 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.578 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -63.33 -38.33 96.26 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 121.334 -0.46 . . . . 0.0 112.381 178.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -58.72 -33.59 70.38 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 124.261 1.024 . . . . 0.0 110.509 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.492 ' HG3' ' HB3' ' A' ' 24' ' ' SER . 96.6 mmm -79.09 -1.32 35.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.936 -178.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.17 15.55 44.26 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.149 -1.024 . . . . 0.0 113.589 177.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.578 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 99.3 m-85 -113.8 145.86 40.79 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.788 0.328 . . . . 0.0 110.354 178.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -88.52 130.75 35.16 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 120.983 0.421 . . . . 0.0 111.028 -178.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.46 140.2 24.85 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.644 178.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.7 m -127.0 141.49 51.78 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.1 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.504 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 10.2 tp -98.33 136.32 29.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 120.859 0.361 . . . . 0.0 110.498 -177.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -154.43 159.35 41.02 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.23 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 . . . . . 0 C--O 1.252 1.198 0 CA-C-O 118.152 -0.928 . . . . 0.0 110.721 179.094 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.7 t . . . . . 0 N--CA 1.439 -1.006 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.01 134.11 44.5 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.137 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 69.8 p -123.73 137.52 54.68 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.855 178.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 72.7 m -147.11 157.3 43.56 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.448 178.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 38.4 p -110.01 139.23 45.35 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 177.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.453 ' CG2' ' HB1' ' A' ' 72' ' ' ALA . 7.0 p -129.74 119.69 48.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-O 120.967 0.413 . . . . 0.0 110.205 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.526 ' HG2' ' HB2' ' A' ' 73' ' ' SER . 9.2 ptm180 -82.21 148.79 28.24 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.9 pt -112.81 142.66 24.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 121.278 0.561 . . . . 0.0 111.123 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 67.1 tp -132.69 119.74 20.78 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.166 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.414 ' HA3' ' HD1' ' A' ' 70' ' ' PHE . . . 178.41 174.41 44.64 Favored Glycine 0 N--CA 1.436 -1.305 0 C-N-CA 119.27 -1.443 . . . . 0.0 113.831 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 28.1 ttt -62.06 -48.13 81.6 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 122.987 0.515 . . . . 0.0 111.426 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.4 p -128.86 119.34 24.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.066 0.46 . . . . 0.0 111.297 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.8 m -65.47 -39.02 91.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.118 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -63.42 -39.47 94.58 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.449 -177.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.8 m -62.67 -43.73 98.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.543 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.0 p -71.83 -39.65 69.64 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -178.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.7 m -69.99 -33.02 53.57 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 120.291 -0.563 . . . . 0.0 111.051 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -71.09 -42.28 69.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.111 0.482 . . . . 0.0 110.863 177.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.5 m -62.73 -43.55 98.51 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.041 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.574 ' HB ' ' CG2' ' A' ' 65' ' ' ILE . 19.3 tt -71.56 -29.71 35.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.618 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -59.63 -45.16 92.8 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.559 -177.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -61.97 -50.8 70.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.795 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.514 HH11 ' HA ' ' A' ' 64' ' ' GLN . 99.4 mtt180 -65.47 -39.95 92.57 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -177.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.444 HG23 HG21 ' A' ' 35' ' ' ILE . 27.6 mm -60.99 -44.56 98.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.99 0.424 . . . . 0.0 110.328 176.339 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.7 t -62.54 -39.93 95.18 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.385 178.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -68.56 -28.78 67.26 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.006 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 64.4 tp -100.38 118.13 35.99 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.133 0.492 . . . . 0.0 111.478 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -83.22 153.05 24.92 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.056 178.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.501 ' HA3' HG11 ' A' ' 55' ' ' VAL . . . 118.29 -11.4 12.86 Favored Glycine 0 CA--C 1.499 -0.91 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -176.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.444 HG21 HG23 ' A' ' 29' ' ' ILE . 12.6 tt -108.42 110.43 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 173.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.14 -47.03 95.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.864 -174.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 85.0 p -158.85 160.57 36.33 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.479 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 28.0 ttt -146.69 129.87 16.54 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.554 177.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -121.3 139.76 52.98 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.6 m -116.52 140.27 39.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 120.873 0.368 . . . . 0.0 110.894 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.6 t -119.64 106.81 12.53 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.778 178.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.8 mp -64.65 -39.72 94.17 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.271 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -62.3 -44.98 95.26 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.501 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -75.71 -28.68 58.68 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.048 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.21 25.62 65.83 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -176.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 12' ' ' ARG . 45.4 t -145.32 150.98 37.59 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.079 -0.56 . . . . 0.0 110.034 -176.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.04 145.88 45.51 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.361 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 87.2 m -105.82 126.02 51.67 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 8' ' ' THR . 23.7 m -110.6 138.3 39.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-O 120.966 0.412 . . . . 0.0 110.382 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -128.43 108.08 10.26 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -149.19 165.99 30.17 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.029 0.442 . . . . 0.0 112.035 -171.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 52.1 t -79.72 119.8 77.99 Favored Pre-proline 0 C--N 1.319 -0.741 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 174.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -60.68 -32.21 92.92 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.649 2.232 . . . . 0.0 113.281 -174.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.6 t -65.06 -41.93 94.67 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.001 0.429 . . . . 0.0 110.934 178.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.501 HG11 ' HA3' ' A' ' 34' ' ' GLY . 60.0 t -81.42 -46.04 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -175.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 74.0 t -114.75 133.88 59.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -173.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 29.1 p -109.25 147.95 31.77 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.285 177.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.494 HD13 HG21 ' A' ' 74' ' ' ILE . 87.1 mt -64.56 -40.3 95.32 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -176.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -62.6 -39.72 94.65 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -177.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.446 HE21 ' HB3' ' A' ' 60' ' ' GLN . 1.1 tm0? -61.85 -41.6 98.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.961 0.41 . . . . 0.0 109.999 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.428 HG13 HD11 ' A' ' 25' ' ' ILE . 76.4 t -63.31 -44.49 99.12 Favored 'Isoleucine or valine' 0 C--O 1.247 0.924 0 CA-C-O 121.47 0.652 . . . . 0.0 110.403 177.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 97.2 m -61.65 -38.31 87.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.15 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 61.4 m170 -66.87 -26.17 66.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.088 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.514 ' HA ' HH11 ' A' ' 28' ' ' ARG . 78.8 mt-30 -60.73 -43.65 97.63 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 120.79 0.328 . . . . 0.0 110.432 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.638 HD11 ' HB2' ' A' ' 72' ' ' ALA . 36.6 pt -87.65 -25.89 5.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.251 176.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -61.5 -35.96 91.86 Favored Glycine 0 N--CA 1.453 -0.22 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.467 178.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -58.83 -37.43 76.41 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.856 0.36 . . . . 0.0 110.935 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 26.4 mmt -79.63 1.2 27.08 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.733 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.9 10.3 60.1 Favored Glycine 0 CA--C 1.508 -0.404 0 C-N-CA 120.604 -0.808 . . . . 0.0 113.035 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.458 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 72.2 m-85 -98.84 139.14 34.95 Favored 'General case' 0 C--N 1.315 -0.901 0 O-C-N 122.645 -0.326 . . . . 0.0 110.235 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -100.75 151.15 22.01 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.353 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.638 ' HB2' HD11 ' A' ' 65' ' ' ILE . . . -144.93 156.69 44.12 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 120.782 0.325 . . . . 0.0 111.242 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.526 ' HB2' ' HG2' ' A' ' 12' ' ' ARG . 40.4 m -129.19 146.8 51.04 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.494 HG21 HD13 ' A' ' 58' ' ' LEU . 84.2 mt -101.95 127.18 55.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.238 0.542 . . . . 0.0 111.947 -174.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -128.52 157.14 42.0 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.135 177.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 . . . . . 0 C--O 1.242 0.678 0 C-N-CA 123.37 0.668 . . . . 0.0 110.283 -176.985 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.473 HG11 HD12 ' A' ' 36' ' ' ILE . 61.8 t . . . . . 0 N--CA 1.433 -1.295 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.78 148.05 25.36 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.768 -175.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.8 p -100.64 136.05 41.11 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.174 176.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.3 m -126.8 145.86 50.47 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 120.704 0.288 . . . . 0.0 110.227 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 46.5 p -117.16 140.1 49.94 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.347 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.91 126.76 38.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.447 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.494 ' HG2' ' HB3' ' A' ' 73' ' ' SER . 14.7 ptm180 -83.42 149.17 26.84 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.721 HG21 ' SG ' ' A' ' 21' ' ' CYS . 86.0 mt -123.1 130.51 74.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -176.091 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.7 tp -131.61 119.07 20.93 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -173.42 -177.27 42.53 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.247 -0.977 . . . . 0.0 112.403 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 66.8 mtt -63.78 -43.22 97.01 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.6 m -136.6 116.91 13.58 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.633 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.416 ' O ' HG23 ' A' ' 22' ' ' VAL . 94.1 m -65.57 -40.23 92.56 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.729 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -62.82 -40.87 98.74 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -177.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.9 m -62.5 -44.27 96.79 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -177.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.721 ' SG ' HG21 ' A' ' 13' ' ' ILE . 24.5 p -71.38 -35.73 71.18 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.64 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 18' ' ' CYS . 59.0 t -62.76 -44.22 99.33 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 177.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.96 -40.25 97.14 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.114 177.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.7 t -60.63 -47.64 85.32 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.295 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.6 pt -74.25 -29.4 24.63 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.899 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -59.53 -48.83 80.13 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -65.41 -51.18 62.09 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.306 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -62.27 -50.71 70.61 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-O 121.192 0.52 . . . . 0.0 111.631 -174.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.448 ' CG2' HD12 ' A' ' 35' ' ' ILE . 37.4 mm -62.83 -41.98 94.63 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.929 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.752 179.179 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 73.2 m -60.56 -38.81 85.74 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -68.52 -27.17 65.87 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.035 177.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 60.5 tp -87.25 129.69 34.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.148 0.499 . . . . 0.0 110.966 177.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -70.81 151.88 44.33 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.354 177.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.95 -4.97 18.55 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.881 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.448 HD12 ' CG2' ' A' ' 29' ' ' ILE . 9.3 tt -96.14 138.32 21.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.84 0.353 . . . . 0.0 110.899 178.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.473 HD12 HG11 ' A' ' 6' ' ' VAL . 86.4 mt -113.02 -53.31 5.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.793 176.342 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.9 m -137.52 151.72 48.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.889 0.376 . . . . 0.0 111.694 -177.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.45 ' HG3' HG12 ' A' ' 49' ' ' VAL . 60.6 ttm -139.14 131.21 27.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.394 176.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -128.79 124.54 35.7 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.9 m -126.61 140.0 50.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.381 -179.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.4 t -134.74 108.3 7.91 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.973 177.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.5 mp -66.5 -32.57 74.01 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.643 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -61.74 -39.92 93.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.283 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -75.41 -27.39 59.01 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.06 0.457 . . . . 0.0 110.14 176.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.2 15.47 81.0 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 -177.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 12' ' ' ARG . 51.1 m -135.13 153.69 51.91 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 121.085 0.469 . . . . 0.0 110.627 -178.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.66 139.19 51.91 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.498 178.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 79.6 m -115.18 125.5 53.48 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.45 HG12 ' HG3' ' A' ' 38' ' ' MET . 31.5 m -125.58 148.05 30.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.977 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -124.1 116.53 22.92 Favored 'General case' 0 C--O 1.245 0.838 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.58 ' CD2' ' HB ' ' A' ' 56' ' ' VAL . 55.3 p90 -152.61 166.15 32.99 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.474 -173.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.8 t -77.5 117.99 69.09 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.03 -30.37 82.85 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.769 2.313 . . . . 0.0 113.546 -175.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.3 t -64.78 -44.19 90.8 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.039 0.447 . . . . 0.0 110.828 178.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 90.9 t -72.7 -47.17 51.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.71 -177.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.58 ' HB ' ' CD2' ' A' ' 51' ' ' TYR . 58.3 t -112.63 126.3 70.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.093 -177.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 60' ' ' GLN . 28.6 p -100.92 158.35 16.05 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 120.989 0.423 . . . . 0.0 111.473 -178.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.3 mt -63.41 -39.12 93.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.576 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -62.19 -39.93 94.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.671 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.49 ' HB2' ' SG ' ' A' ' 57' ' ' CYS . 64.9 tt0 -61.16 -46.55 90.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.627 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.5 t -61.93 -44.44 98.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.625 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 93.3 m -61.66 -41.46 97.56 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.089 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -66.04 -41.13 91.28 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.759 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.489 ' HG3' ' O ' ' A' ' 60' ' ' GLN . 95.6 mt-30 -60.87 -42.24 97.51 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.985 -175.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.0 tt -84.04 -41.23 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.98 -40.18 98.99 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 116.303 -0.408 . . . . 0.0 113.501 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -60.51 -35.82 76.88 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.936 0.398 . . . . 0.0 110.571 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 26.5 mmt -69.76 -11.95 61.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.468 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.98 12.21 32.44 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.394 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.529 ' CG ' ' HB3' ' A' ' 21' ' ' CYS . 94.9 m-85 -110.32 125.48 53.22 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -76.96 139.11 40.02 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.624 -178.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.13 155.18 41.94 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 120.889 0.376 . . . . 0.0 111.603 -177.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.494 ' HB3' ' HG2' ' A' ' 12' ' ' ARG . 42.0 t -137.29 139.95 41.24 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 36.4 pt -105.67 151.82 7.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -173.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.547 ' O ' ' HB2' ' A' ' 76' ' ' GLU . . . -151.35 160.26 43.86 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.7 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.547 ' HB2' ' O ' ' A' ' 75' ' ' ALA . 39.5 mm-40 . . . . . 0 C--O 1.251 1.148 0 C-N-CA 123.3 0.64 . . . . 0.0 110.879 -178.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.5 m . . . . . 0 N--CA 1.439 -0.979 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.98 147.27 42.44 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.103 0.478 . . . . 0.0 111.885 -175.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 53.9 p -119.35 150.15 40.64 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.715 176.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.429 ' OG ' HD21 ' A' ' 58' ' ' LEU . 87.5 p -155.34 160.35 40.66 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.314 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 41.2 p -127.77 146.09 50.7 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.538 176.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.5 m -128.92 146.19 34.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.459 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 38.5 ptt180 -106.67 140.99 38.65 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.535 HG12 ' SG ' ' A' ' 21' ' ' CYS . 7.8 tp -120.08 131.51 72.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-O 121.679 0.752 . . . . 0.0 112.424 -173.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 65.7 tp -124.67 118.19 25.93 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.52 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -170.01 169.32 42.09 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 119.938 -1.125 . . . . 0.0 112.733 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 79.3 mtm -64.09 -42.81 96.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.786 0.327 . . . . 0.0 111.377 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.7 p -132.52 122.54 25.01 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.193 0.52 . . . . 0.0 111.57 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.402 ' O ' HG23 ' A' ' 22' ' ' VAL . 44.1 t -63.6 -41.9 98.28 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.141 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.8 mp0 -61.51 -40.42 94.54 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.295 -176.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.7 m -62.84 -45.59 91.9 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -177.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.535 ' SG ' HG12 ' A' ' 13' ' ' ILE . 26.7 p -68.71 -35.66 77.46 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.178 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 18' ' ' CYS . 67.6 t -62.91 -44.32 99.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-O 121.114 0.483 . . . . 0.0 109.759 178.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -64.81 -40.13 94.71 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.012 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.6 m -62.74 -46.65 87.08 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.376 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.547 ' HB ' ' CG2' ' A' ' 65' ' ' ILE . 8.1 tp -69.9 -31.94 49.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.009 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -58.84 -42.81 90.16 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.316 -178.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -59.3 -53.57 56.75 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.418 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 24.0 ttm180 -67.14 -47.15 71.93 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.118 -178.224 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.578 ' O ' HD11 ' A' ' 35' ' ' ILE . 18.5 tt -65.76 -41.43 90.29 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.987 -175.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 86.6 p -66.33 -30.09 70.42 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-O 121.062 0.458 . . . . 0.0 110.488 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -70.62 -27.09 63.81 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.841 177.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 28' ' ' ARG . 89.9 mt -91.72 137.63 32.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.189 0.518 . . . . 0.0 111.775 -178.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -86.72 151.62 23.24 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.841 177.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.58 8.22 12.71 Favored Glycine 0 C--O 1.238 0.369 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.658 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.578 HD11 ' O ' ' A' ' 29' ' ' ILE . 79.8 mt -81.67 121.98 35.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 83.6 mt -94.24 -54.77 6.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.0 t -149.06 124.21 10.12 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.97 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.429 ' SD ' HD13 ' A' ' 29' ' ' ILE . 27.2 ttt -121.24 113.58 20.16 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.125 177.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -133.29 145.68 50.69 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.139 178.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.45 126.51 74.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.222 0.534 . . . . 0.0 110.089 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.8 m -93.65 91.99 7.31 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.152 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.8 mt -63.54 -35.98 82.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.603 0.716 . . . . 0.0 109.235 178.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -62.84 -40.28 96.95 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.844 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -90.33 -12.19 38.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.046 -177.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.5 29.69 69.64 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.379 -0.915 . . . . 0.0 111.471 -177.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 90.1 p -151.06 163.66 38.25 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.48 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -119.07 145.83 45.59 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.533 0.206 . . . . 0.0 110.82 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.3 m -112.93 121.95 46.18 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.0 t -120.49 123.19 69.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-O 120.884 0.373 . . . . 0.0 110.371 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -109.2 119.38 39.35 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 176.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -150.77 166.68 29.72 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.697 -170.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.9 t -92.05 110.82 46.62 Favored Pre-proline 0 N--CA 1.444 -0.755 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 173.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 37.6 Cg_endo -64.27 -21.72 67.02 Favored 'Trans proline' 0 N--CA 1.475 0.427 0 C-N-CA 122.88 2.387 . . . . 0.0 113.467 -175.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.5 t -64.37 -42.71 96.04 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.173 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.8 p -95.11 -35.71 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 12.2 p -130.14 149.89 34.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -177.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 29.6 p -134.01 163.06 30.39 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.19 0.519 . . . . 0.0 111.663 -175.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.446 ' HA ' HG22 ' A' ' 61' ' ' VAL . 98.6 mt -70.8 -22.53 62.34 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.982 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -61.73 -42.3 98.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.07 0.462 . . . . 0.0 110.14 -179.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -65.15 -40.89 95.01 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.182 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.497 ' HB ' HD11 ' A' ' 25' ' ' ILE . 32.7 m -72.71 -36.4 52.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.53 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 95.6 m -64.18 -39.51 94.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.665 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 66.3 m170 -64.31 -39.94 94.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.314 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -60.83 -43.79 97.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.606 -177.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.547 ' CG2' ' HB ' ' A' ' 25' ' ' ILE . 27.2 pt -87.04 -37.87 11.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -178.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -62.94 -40.71 99.62 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.888 -0.673 . . . . 0.0 113.137 -178.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -70.13 -14.91 62.86 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 26.3 mmt -85.11 2.34 43.88 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.907 0.384 . . . . 0.0 110.817 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.48 -9.2 71.73 Favored Glycine 0 CA--C 1.507 -0.407 0 C-N-CA 121.066 -0.587 . . . . 0.0 112.188 179.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.459 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 96.8 m-85 -80.89 143.57 32.61 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -106.25 128.31 53.87 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.643 -177.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 12' ' ' ARG . . . -147.31 151.23 36.24 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.466 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.8 p -136.77 153.63 50.78 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.903 0.382 . . . . 0.0 111.341 178.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 81.3 mt -90.98 131.86 37.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.908 -174.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -133.67 126.54 31.02 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.454 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 . . . . . 0 C--N 1.314 -0.97 0 CA-C-O 118.062 -0.97 . . . . 0.0 110.657 179.691 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.455 -0.212 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.409 ' H ' ' HD3' ' A' ' 53' ' ' PRO . . . -108.77 134.55 51.32 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.287 0.565 . . . . 0.0 112.27 -173.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 50.5 p -123.97 140.5 52.92 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.976 174.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 91.3 p -158.46 166.85 31.2 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.019 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 2.1 p -110.32 148.48 31.85 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 175.35 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 91.1 t -131.01 126.89 60.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.425 ' NE ' ' HB2' ' A' ' 73' ' ' SER . 37.9 ptt180 -87.8 144.62 26.51 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.6 HG12 ' SG ' ' A' ' 21' ' ' CYS . 7.4 tp -129.61 130.3 66.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-O 121.163 0.506 . . . . 0.0 111.134 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 62.0 tp -129.47 124.22 33.48 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.478 178.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -165.18 176.25 40.9 Favored Glycine 0 N--CA 1.435 -1.425 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.157 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 61.0 tpp -61.52 -47.91 83.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.884 0.373 . . . . 0.0 111.024 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 65.9 m -130.4 125.16 33.84 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.119 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.8 t -63.23 -43.59 97.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.396 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -61.52 -38.76 88.57 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.528 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.0 m -60.47 -44.21 96.12 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -177.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.6 ' SG ' HG12 ' A' ' 13' ' ' ILE . 25.6 p -70.99 -36.95 72.68 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.235 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.9 t -63.18 -44.53 99.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-O 121.123 0.487 . . . . 0.0 109.764 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -64.41 -40.38 95.67 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.878 178.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.639 ' O ' ' HD3' ' A' ' 28' ' ' ARG . 68.9 m -62.11 -45.04 95.23 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.38 -178.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.468 ' HB ' ' HB ' ' A' ' 65' ' ' ILE . 17.9 tt -70.93 -33.77 53.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.849 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -60.22 -48.01 83.54 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.934 -177.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -61.55 -46.69 88.86 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.887 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.639 ' HD3' ' O ' ' A' ' 24' ' ' SER . 10.9 mpt_? -70.41 -41.75 72.53 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.754 -177.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.6 ' O ' HD11 ' A' ' 35' ' ' ILE . 16.6 tt -70.66 -39.81 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.163 -177.342 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 79.5 p -66.06 -28.33 68.76 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 120.988 0.423 . . . . 0.0 110.515 178.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -67.96 -28.76 67.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.793 175.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.4 tp -86.95 118.66 26.48 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.655 177.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -78.58 142.9 36.94 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.949 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.22 8.86 11.03 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.815 -178.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.6 HD11 ' O ' ' A' ' 29' ' ' ILE . 90.0 mt -70.75 125.12 28.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.642 ' HB ' ' O ' ' A' ' 50' ' ' LYS . 47.9 mm -88.21 -63.85 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.1 t -161.82 140.11 9.21 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.805 177.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.435 ' HG2' HG12 ' A' ' 49' ' ' VAL . 18.8 tmm? -137.27 126.37 24.46 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 176.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -125.14 115.68 20.84 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.2 p -103.16 122.32 55.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-O 121.172 0.51 . . . . 0.0 110.296 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.4 m -96.89 99.95 11.49 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 97.1 mt -63.9 -38.89 92.75 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.937 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -63.69 -40.25 96.32 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.978 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -77.1 -30.01 55.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.9 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.68 20.17 71.8 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -175.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.0 t -146.5 150.36 35.43 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -178.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -119.53 148.77 42.9 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 120.804 0.335 . . . . 0.0 111.735 -177.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.2 m -108.35 124.48 50.41 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.691 ' HB ' ' CE2' ' A' ' 51' ' ' TYR . 33.6 m -119.32 149.6 21.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.621 -176.225 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.642 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 65.3 tttm -140.05 106.36 5.27 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.691 ' CE2' ' HB ' ' A' ' 49' ' ' VAL . 42.2 m-85 -138.37 161.92 35.73 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -177.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 64.8 t -88.34 110.41 36.09 Favored Pre-proline 0 N--CA 1.439 -1.0 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 172.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 36.2 Cg_endo -64.21 -23.48 66.35 Favored 'Trans proline' 0 CA--C 1.514 -0.489 0 C-N-CA 122.592 2.195 . . . . 0.0 112.341 -176.133 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 61.9 m -62.95 -42.0 99.68 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 177.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.5 t -75.1 -48.42 32.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.826 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 7.5 p -146.68 139.54 19.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.954 -178.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.416 ' SG ' ' HB2' ' A' ' 60' ' ' GLN . 26.5 p -83.51 153.71 24.26 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.107 0.479 . . . . 0.0 111.196 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.1 mt -66.06 -37.26 85.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.759 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -60.04 -40.61 89.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.436 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.416 ' HB2' ' SG ' ' A' ' 57' ' ' CYS . 1.0 OUTLIER -62.14 -41.02 97.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.192 0.52 . . . . 0.0 109.633 179.12 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 73.9 t -63.41 -44.24 98.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.084 178.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 49.6 t -60.42 -41.52 94.14 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.146 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -61.07 -41.4 96.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.367 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -61.08 -41.65 97.04 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 -176.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.468 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 20.3 tt -76.89 -38.25 28.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.94 178.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.6 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -64.35 -38.49 95.9 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-N 115.699 -0.682 . . . . 0.0 113.702 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -58.1 -35.8 71.97 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.275 0.63 . . . . 0.0 112.081 -175.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 15.7 tpt -57.76 -25.82 61.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.786 -178.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 123.66 6.19 7.36 Favored Glycine 0 CA--C 1.5 -0.901 0 C-N-CA 120.229 -0.986 . . . . 0.0 112.188 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.6 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 65.2 m-85 -110.16 135.96 50.13 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -89.33 121.59 31.75 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.236 0.541 . . . . 0.0 111.751 -174.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.54 135.72 54.16 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.126 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.425 ' HB2' ' NE ' ' A' ' 12' ' ' ARG . 45.5 m -131.62 144.78 51.3 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.6 tt -69.45 128.18 32.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 121.47 0.652 . . . . 0.0 110.902 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -97.74 134.51 40.81 Favored 'General case' 0 C--O 1.261 1.673 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.657 177.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 . . . . . 0 C--O 1.249 1.058 0 O-C-N 124.832 1.333 . . . . 0.0 110.658 -176.155 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.9 t . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -113.58 139.57 48.89 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 120.893 0.378 . . . . 0.0 111.23 -177.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 67.6 p -121.61 148.21 44.84 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.097 178.126 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.2 t -158.31 157.0 31.61 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 73.5 p -117.1 142.06 47.48 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 120.799 0.333 . . . . 0.0 110.335 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.9 m -131.89 145.8 34.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.364 178.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 45.8 ptt85 -108.86 142.95 38.71 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 175.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.7 pt -118.26 142.98 30.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-O 121.458 0.647 . . . . 0.0 112.006 -175.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.2 tp -110.12 118.44 36.41 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.728 177.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.44 140.04 4.15 Favored Glycine 0 N--CA 1.434 -1.495 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.349 179.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 95.9 mmm -67.97 -37.71 81.85 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.233 0.539 . . . . 0.0 109.924 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.0 p -111.22 58.16 0.62 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.883 177.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 26.3 p -59.56 -30.66 68.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.767 -175.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -64.49 -33.99 77.18 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.741 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.3 t -66.41 -45.34 80.29 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.439 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.531 ' HB3' ' CD1' ' A' ' 70' ' ' PHE . 28.4 p -66.05 -35.06 79.51 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.267 -177.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 69.9 t -61.81 -45.71 98.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -65.43 -42.24 92.66 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.947 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.3 m -63.97 -42.9 97.12 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.287 -178.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 21' ' ' CYS . 46.9 pt -78.56 -27.12 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.401 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -61.77 -39.45 91.68 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -59.98 -43.13 95.32 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.693 176.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -64.26 -43.31 95.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.185 0.517 . . . . 0.0 110.277 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.41 -46.25 96.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.603 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 88.1 p -64.62 -28.38 69.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.71 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -72.78 -27.35 61.94 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.927 0.394 . . . . 0.0 110.573 177.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.3 tt -81.74 123.88 29.13 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -83.38 147.48 27.87 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.778 0.323 . . . . 0.0 111.417 -177.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.31 7.67 56.93 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.774 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.8 pt -75.0 139.29 19.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.772 0.32 . . . . 0.0 111.176 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.621 ' HB ' ' O ' ' A' ' 50' ' ' LYS . 42.1 mm -89.19 -79.84 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.954 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 82.2 p -168.61 166.68 11.82 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.788 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -156.99 159.11 37.72 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 175.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -129.69 132.78 46.75 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 69.8 t -116.21 125.68 73.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 120.827 0.346 . . . . 0.0 110.789 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.6 t -103.34 102.48 12.43 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 177.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.6 tp -62.4 -42.72 99.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.765 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.2 -45.45 94.54 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.459 -178.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -74.96 -29.69 61.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.411 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.65 16.14 78.15 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.0 m -129.48 152.39 49.07 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.342 -0.429 . . . . 0.0 110.144 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -128.39 149.35 50.57 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.544 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.7 m -113.41 126.6 55.53 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.489 ' HB ' ' CE2' ' A' ' 51' ' ' TYR . 27.5 m -114.29 146.39 18.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.466 -177.463 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.621 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 87.6 tttt -132.2 104.17 6.63 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.489 ' CE2' ' HB ' ' A' ' 49' ' ' VAL . 84.5 m-85 -141.52 160.11 40.84 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 120.995 0.426 . . . . 0.0 111.853 -176.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.8 m -98.66 112.45 62.6 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.518 176.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -56.17 -26.62 61.54 Favored 'Trans proline' 0 N--CA 1.48 0.686 0 C-N-CA 123.265 2.643 . . . . 0.0 112.162 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.2 t -61.08 -42.27 98.2 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.274 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.9 t -101.22 -40.28 7.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -177.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.4 HG13 ' HB3' ' A' ' 51' ' ' TYR . 7.5 p -130.2 139.65 50.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.162 0.506 . . . . 0.0 111.488 -177.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.418 ' SG ' ' HB3' ' A' ' 59' ' ' GLN . 42.6 t -93.16 121.89 34.98 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.434 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.3 mp -63.76 -37.45 87.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.607 178.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.418 ' HB3' ' SG ' ' A' ' 57' ' ' CYS . 57.5 tp60 -60.76 -39.31 88.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.679 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -62.89 -38.56 91.39 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.32 178.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 75.6 t -60.83 -42.68 93.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.675 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 42.6 t -60.22 -39.61 87.23 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.937 176.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -64.15 -35.12 79.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.383 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -60.57 -42.24 96.25 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.484 -178.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.456 ' HB ' HG21 ' A' ' 25' ' ' ILE . 20.2 tt -76.55 -37.55 29.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 120.294 -0.563 . . . . 0.0 111.318 178.255 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.48 -44.24 97.88 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.452 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -67.18 -31.48 71.91 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.284 0.564 . . . . 0.0 110.297 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 50.1 tpp -59.23 -29.18 67.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.217 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 119.35 5.39 11.44 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.479 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.531 ' CD1' ' HB3' ' A' ' 21' ' ' CYS . 89.5 m-85 -112.78 131.04 55.86 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 120.977 0.418 . . . . 0.0 110.577 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -85.55 134.99 34.0 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.191 -177.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -133.19 147.6 52.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.836 0.35 . . . . 0.0 111.337 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.6 t -119.14 132.67 56.01 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 15.2 tt -103.49 134.19 45.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.502 0.668 . . . . 0.0 111.977 -175.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 76' ' ' GLU . . . -135.22 157.5 46.75 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.867 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.407 ' HB3' ' O ' ' A' ' 75' ' ' ALA . 43.2 tt0 . . . . . 0 C--O 1.245 0.854 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.628 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.6 t . . . . . 0 N--CA 1.443 -0.811 0 CA-C-O 120.895 0.379 . . . . 0.0 110.107 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 50' ' ' LYS . . . -121.43 123.94 43.3 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.494 179.211 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.8 p -125.62 151.82 45.99 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.055 0.455 . . . . 0.0 110.684 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.5 t -158.27 146.35 18.53 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.9 178.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 41.9 p -111.5 109.95 20.14 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 175.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.7 p -92.34 115.43 31.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 40.1 ptt180 -82.22 148.04 28.64 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.223 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.8 131.07 70.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-O 121.049 0.452 . . . . 0.0 110.861 -176.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.9 tt -115.16 115.11 26.21 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -171.25 151.91 16.79 Favored Glycine 0 N--CA 1.434 -1.492 0 C-N-CA 120.211 -0.995 . . . . 0.0 112.596 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 23.0 ptt? -74.98 -23.99 58.37 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 122.756 0.422 . . . . 0.0 111.295 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.5 p -122.48 85.57 2.44 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.284 0.564 . . . . 0.0 109.636 177.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.4 m -63.83 -39.98 95.52 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.303 -176.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.504 ' HA ' HG12 ' A' ' 22' ' ' VAL . 98.7 mt-30 -64.38 -41.0 96.93 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -175.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.0 p -64.9 -41.43 95.61 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.776 -177.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.598 ' HB3' ' CD2' ' A' ' 70' ' ' PHE . 20.3 p -74.46 -39.16 62.7 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.504 HG12 ' HA ' ' A' ' 19' ' ' GLN . 9.0 p -68.5 -37.68 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.61 -178.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -64.36 -40.76 96.5 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.978 0.418 . . . . 0.0 110.052 176.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.2 m -61.9 -44.72 96.22 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.671 -178.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.593 HD12 ' HB ' ' A' ' 65' ' ' ILE . 16.2 tt -74.19 -38.65 48.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.726 -0.389 . . . . 0.0 111.425 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.07 -44.29 96.99 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 120.85 0.357 . . . . 0.0 110.948 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -60.73 -44.08 97.1 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.586 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.568 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 99.4 mtt180 -65.33 -46.07 81.77 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.169 -177.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.541 HG22 HD12 ' A' ' 35' ' ' ILE . 98.0 mt -65.96 -44.8 92.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.092 -178.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.426 ' HA ' HG21 ' A' ' 35' ' ' ILE . 77.8 p -64.03 -34.58 78.32 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.032 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -71.81 -26.78 62.55 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.094 0.473 . . . . 0.0 110.74 177.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 28' ' ' ARG . 93.3 mt -82.9 142.32 31.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.543 178.118 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -76.79 141.21 40.83 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.16 -8.04 18.59 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.876 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.541 HD12 HG22 ' A' ' 29' ' ' ILE . 7.2 tt -75.24 110.1 9.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 176.043 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.9 mt -84.27 -51.19 14.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.278 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.9 t -160.38 145.75 14.89 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.522 177.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.414 ' HG3' HG12 ' A' ' 49' ' ' VAL . 27.3 ttt -135.85 132.16 36.26 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.088 179.271 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -130.34 130.82 44.94 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 178.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.1 t -103.92 120.36 53.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 120.836 0.35 . . . . 0.0 110.397 -178.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 51.0 m -119.73 96.46 5.2 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-O 121.467 0.651 . . . . 0.0 110.63 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.4 -35.41 80.82 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.259 -178.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -61.65 -39.63 92.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.535 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -76.76 -22.68 53.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.139 176.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.56 21.75 68.66 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 89.9 p -149.33 164.93 33.49 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 121.058 0.456 . . . . 0.0 111.326 -177.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.55 137.44 52.58 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 65.3 m -104.56 125.64 50.91 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.806 -177.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.414 HG12 ' HG3' ' A' ' 38' ' ' MET . 27.0 m -129.25 150.03 34.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-O 120.883 0.373 . . . . 0.0 111.369 -179.255 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 14.3 ptmm? -131.45 135.71 47.36 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 173.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -157.2 171.45 20.41 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.95 -169.048 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.6 t -94.16 114.25 62.77 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 173.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -52.99 -39.1 80.36 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 C-N-CA 123.628 2.886 . . . . 0.0 114.97 -174.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.8 m -69.02 -41.98 77.01 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.898 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.9 t -70.71 -43.51 77.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.708 -176.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 30.9 m -128.65 148.65 33.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.047 0.451 . . . . 0.0 110.766 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.533 ' SG ' ' HB2' ' A' ' 59' ' ' GLN . 43.5 t -102.23 128.32 48.8 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.563 -177.229 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.492 ' HG ' HD13 ' A' ' 74' ' ' ILE . 56.7 tp -61.51 -38.12 86.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.317 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.533 ' HB2' ' SG ' ' A' ' 57' ' ' CYS . 80.6 mt-30 -60.33 -39.53 87.4 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.524 178.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.698 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 97.8 mt-30 -61.75 -39.39 91.42 Favored 'General case' 0 C--O 1.214 -0.783 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.879 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.435 HG13 HD11 ' A' ' 25' ' ' ILE . 73.2 t -59.4 -46.3 92.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.243 -178.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 42.3 t -61.12 -42.36 98.4 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.089 177.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -67.42 -37.58 83.26 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.3 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.698 ' HG2' ' O ' ' A' ' 60' ' ' GLN . 20.0 mm-40 -61.0 -41.46 96.55 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.958 0.409 . . . . 0.0 111.013 -175.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.593 ' HB ' HD12 ' A' ' 25' ' ' ILE . 18.8 tt -82.52 -33.11 10.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.664 177.06 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.85 -40.84 98.78 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.798 -0.637 . . . . 0.0 114.025 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -72.8 -11.4 60.59 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 117.797 0.799 . . . . 0.0 110.961 -177.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 16.4 tpt -66.02 -28.6 68.99 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.764 176.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 116.52 9.14 11.69 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.806 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.598 ' CD2' ' HB3' ' A' ' 21' ' ' CYS . 98.3 m-85 -117.79 145.29 44.63 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -84.71 133.16 34.39 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.48 -177.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 12' ' ' ARG . . . -147.71 150.2 33.86 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.934 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 86.0 p -140.69 158.92 43.27 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.615 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.492 HD13 ' HG ' ' A' ' 58' ' ' LEU . 91.4 mt -91.2 122.69 42.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.053 -177.137 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -133.17 160.93 35.79 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 C--N 1.305 -1.35 0 CA-C-O 118.133 -0.937 . . . . 0.0 110.595 178.663 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.0 m . . . . . 0 N--CA 1.449 -0.521 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -143.79 152.85 41.75 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.76 0.314 . . . . 0.0 110.61 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 82.7 p -127.3 154.91 44.34 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.613 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.444 ' HB3' HG13 ' A' ' 49' ' ' VAL . 14.8 t -159.02 164.2 35.72 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 53.1 p -118.11 144.68 45.45 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.5 p -143.71 129.47 15.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 120.921 0.391 . . . . 0.0 111.098 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 15.8 ptm180 -89.06 146.92 24.53 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.6 mp -111.43 120.63 62.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 59.5 tp -114.71 112.71 23.26 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.991 0.424 . . . . 0.0 110.559 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -167.41 157.59 30.06 Favored Glycine 0 N--CA 1.44 -1.068 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.197 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 59.6 ttm -64.6 -43.02 95.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.992 0.425 . . . . 0.0 110.813 178.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.1 p -113.01 108.33 17.19 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.792 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 23.8 p -69.88 -41.23 75.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.105 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -63.94 -41.53 97.59 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.836 0.351 . . . . 0.0 111.035 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.6 t -61.5 -46.37 90.25 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.835 -177.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.461 ' HB3' ' CG ' ' A' ' 70' ' ' PHE . 20.1 p -67.33 -44.11 79.9 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.565 -178.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 73.7 t -62.79 -46.09 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.557 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.66 -44.86 95.19 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.2 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.4 m -63.49 -43.4 97.38 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.254 -177.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.464 HG21 ' HB ' ' A' ' 65' ' ' ILE . 46.3 pt -74.32 -29.18 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.765 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -60.78 -41.98 96.63 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.052 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -60.99 -45.26 95.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.264 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -63.09 -42.37 99.61 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.181 0.515 . . . . 0.0 109.9 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.556 ' O ' HD11 ' A' ' 35' ' ' ILE . 92.9 mt -61.44 -46.22 97.04 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.716 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.693 178.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 85.2 p -63.97 -23.21 67.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.856 0.36 . . . . 0.0 111.539 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -92.46 -6.08 50.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.892 0.377 . . . . 0.0 110.768 177.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 67.7 tp -103.3 128.04 50.46 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.159 178.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -85.44 153.94 22.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.689 0.28 . . . . 0.0 111.09 176.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.42 8.83 22.64 Favored Glycine 0 C--O 1.239 0.427 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -177.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.556 HD11 ' O ' ' A' ' 29' ' ' ILE . 74.9 mt -72.65 123.63 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 115.19 -0.505 . . . . 0.0 110.871 -177.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 80.5 mt -101.23 -68.15 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 172.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.541 ' O ' ' HB3' ' A' ' 50' ' ' LYS . 34.7 t -166.1 140.14 4.36 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.748 177.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.7 ttt -136.23 127.69 28.58 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 176.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.496 ' HE3' ' OG ' ' A' ' 37' ' ' SER . 34.4 mmtp -119.53 129.47 54.7 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.3 t -106.47 118.47 54.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.5 m -98.86 98.12 9.24 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.921 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.1 tp -62.49 -42.05 99.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.393 -179.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -62.0 -41.19 97.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.281 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -75.83 -30.33 58.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.591 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.45 15.05 79.11 Favored Glycine 0 N--CA 1.454 -0.142 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -176.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 12' ' ' ARG . 39.8 t -145.12 150.59 37.07 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -178.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.57 151.44 47.92 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.808 0.337 . . . . 0.0 111.043 -177.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.4 p -95.15 125.44 39.8 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.295 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.444 HG13 ' HB3' ' A' ' 9' ' ' SER . 3.0 p -105.91 118.66 53.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.281 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.541 ' HB3' ' O ' ' A' ' 37' ' ' SER . 60.1 tttm -136.33 104.3 5.57 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.621 0.724 . . . . 0.0 109.968 -176.201 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.538 ' CD2' ' HA ' ' A' ' 35' ' ' ILE . 87.0 m-85 -139.43 162.96 33.77 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.329 -176.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 54.6 t -74.94 114.85 38.84 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 37.2 Cg_endo -65.02 -18.59 62.47 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.081 2.521 . . . . 0.0 112.327 -177.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 61.4 m -61.6 -39.36 90.92 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.659 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.459 HG23 HG23 ' A' ' 56' ' ' VAL . 18.8 m -116.69 -25.76 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -178.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 96.9 t -127.28 128.93 70.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.728 0.299 . . . . 0.0 110.77 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.524 ' SG ' ' HB2' ' A' ' 60' ' ' GLN . 25.9 p -105.96 161.55 14.36 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 178.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.59 -40.24 96.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.446 -177.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -63.27 -37.4 87.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.281 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.524 ' HB2' ' SG ' ' A' ' 57' ' ' CYS . 54.7 tt0 -59.92 -45.78 91.49 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.287 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.457 ' HA ' ' OE1' ' A' ' 64' ' ' GLN . 75.1 t -63.14 -42.34 96.18 Favored 'Isoleucine or valine' 0 C--O 1.25 1.128 0 CA-C-O 121.768 0.794 . . . . 0.0 110.309 178.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 43.3 t -58.47 -35.49 72.25 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.191 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.406 ' HB2' ' O ' ' A' ' 60' ' ' GLN . 58.8 m170 -60.24 -43.98 95.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.182 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.473 ' O ' ' HG2' ' A' ' 68' ' ' MET . 25.7 mp0 -63.05 -42.23 99.68 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.929 -177.51 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.464 ' HB ' HG21 ' A' ' 25' ' ' ILE . 19.9 tt -71.3 -37.83 67.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.072 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.32 -39.85 98.29 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.9 -0.591 . . . . 0.0 113.36 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -80.15 -5.99 56.98 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 117.446 0.623 . . . . 0.0 111.555 -177.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 23.1 mmt -83.72 -3.16 57.56 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.038 0.447 . . . . 0.0 110.447 176.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.67 8.1 62.52 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.282 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.461 ' CG ' ' HB3' ' A' ' 21' ' ' CYS . 99.2 m-85 -113.4 143.06 45.12 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 120.979 0.419 . . . . 0.0 110.292 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -101.1 148.04 25.53 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.99 -175.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.92 151.48 35.92 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.114 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.41 ' HB2' ' HG2' ' A' ' 12' ' ' ARG . 60.7 m -123.53 141.51 51.93 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 176.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.0 tt -117.33 141.27 36.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 121.111 0.481 . . . . 0.0 111.337 -174.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 76' ' ' GLU . . . -138.08 154.71 49.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.604 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.446 ' HB3' ' O ' ' A' ' 75' ' ' ALA . 34.8 tt0 . . . . . 0 N--CA 1.474 0.758 0 C-N-CA 123.636 0.775 . . . . 0.0 109.926 -175.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 70.4 t . . . . . 0 N--CA 1.432 -1.329 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -127.59 149.6 50.09 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.005 0.431 . . . . 0.0 111.21 -177.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 56.4 p -103.57 156.02 18.09 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.821 178.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.6 t -154.34 143.95 21.55 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 62.5 p -118.59 144.02 46.4 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.12 123.22 55.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-O 120.91 0.386 . . . . 0.0 110.489 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.519 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 39.7 ptt180 -90.08 151.2 21.73 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.084 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.9 pt -126.58 144.5 36.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-O 121.187 0.517 . . . . 0.0 111.775 -177.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.9 tp -131.21 113.66 14.12 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.331 177.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -176.23 160.3 28.02 Favored Glycine 0 N--CA 1.439 -1.135 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 96.1 mmm -68.17 -40.24 82.36 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.854 0.359 . . . . 0.0 110.857 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.8 p -110.14 80.25 1.29 Allowed 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.448 0.642 . . . . 0.0 110.478 177.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.41 ' O ' HG23 ' A' ' 22' ' ' VAL . 21.8 p -67.02 -34.55 77.96 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.479 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -63.28 -39.44 94.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.11 0.481 . . . . 0.0 110.295 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.0 t -60.67 -45.73 93.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.579 -178.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 27.7 p -70.01 -33.29 71.82 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.365 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 18' ' ' CYS . 67.1 t -63.27 -45.11 99.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-O 121.412 0.625 . . . . 0.0 109.464 177.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -67.14 -35.18 79.17 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.327 177.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.3 t -60.19 -46.59 89.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.619 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.523 HD12 ' HB ' ' A' ' 65' ' ' ILE . 18.8 tt -70.99 -29.25 36.29 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.892 177.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -57.85 -49.35 76.98 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.214 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -62.52 -42.83 99.77 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.121 178.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.5 tpt180 -64.27 -47.61 78.88 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.496 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.561 HG21 ' SD ' ' A' ' 38' ' ' MET . 19.5 tt -71.01 -36.71 64.6 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.696 -177.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 77.6 p -67.72 -25.41 65.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.36 . . . . 0.0 111.257 177.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -85.37 -12.05 53.08 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.12 0.486 . . . . 0.0 110.231 175.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 64.9 tp -84.18 122.93 29.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.511 175.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -83.38 152.98 24.79 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 120.994 0.425 . . . . 0.0 111.587 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.51 6.01 64.59 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.441 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 39.7 pt -69.15 126.79 29.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 121.337 0.589 . . . . 0.0 111.576 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' A' ' 50' ' ' LYS . 86.3 mt -82.09 -61.81 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.492 -179.138 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.421 ' OG ' ' HE2' ' A' ' 50' ' ' LYS . 87.1 p -159.43 154.34 24.78 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.993 178.222 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.561 ' SD ' HG21 ' A' ' 29' ' ' ILE . 27.0 ttt -140.79 134.45 30.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.843 177.111 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -133.59 148.94 51.62 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.1 p -126.31 134.01 67.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 C-N-CA 119.796 -0.762 . . . . 0.0 111.792 -178.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.5 m -108.66 85.75 2.16 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.327 -0.852 . . . . 0.0 108.843 177.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.9 tp -61.64 -43.09 99.5 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.32 -176.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -70.11 -28.18 65.18 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.063 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -84.92 -12.42 53.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.649 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.4 28.03 71.84 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.88 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 79.6 p -148.2 161.02 42.31 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.076 0.465 . . . . 0.0 111.454 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.75 149.2 42.41 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.839 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.7 m -117.12 126.39 52.75 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.3 p -129.32 139.31 52.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 120.868 0.366 . . . . 0.0 110.761 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.444 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 39.6 ttpt -119.07 119.14 33.35 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -153.91 164.02 39.09 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.992 -173.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.7 t -84.87 112.28 41.75 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 177.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.43 -22.2 65.89 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.797 2.331 . . . . 0.0 112.656 -176.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.5 t -63.89 -42.99 97.34 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.655 178.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.476 HG12 HG23 ' A' ' 56' ' ' VAL . 98.9 t -73.39 -51.59 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.909 -178.54 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.476 HG23 HG12 ' A' ' 55' ' ' VAL . 98.6 t -131.56 130.65 62.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.331 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 31.5 p -73.76 159.47 32.9 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.634 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.3 mp -68.62 -24.32 64.55 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.839 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -61.02 -42.41 98.41 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.102 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.536 ' O ' ' HG3' ' A' ' 64' ' ' GLN . 87.3 mm-40 -65.69 -39.25 91.08 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.342 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.83 -45.6 98.34 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 CA-C-O 121.245 0.545 . . . . 0.0 110.06 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 47.5 t -60.74 -41.96 96.42 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.188 177.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -61.67 -38.29 87.23 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.025 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.536 ' HG3' ' O ' ' A' ' 60' ' ' GLN . 98.7 mt-30 -59.35 -42.73 92.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.465 0.174 . . . . 0.0 111.269 -176.15 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.523 ' HB ' HD12 ' A' ' 25' ' ' ILE . 21.2 tt -85.95 -38.68 12.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.874 178.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.94 -35.54 92.2 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.911 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -54.44 -28.14 42.07 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.879 0.872 . . . . 0.0 111.658 -178.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 15.8 tpt -59.62 -29.23 67.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.076 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 119.13 8.13 9.7 Favored Glycine 0 CA--C 1.506 -0.511 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.492 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -114.84 145.11 42.51 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -72.94 135.94 45.12 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.087 0.47 . . . . 0.0 111.12 -178.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 12' ' ' ARG . . . -146.94 146.54 30.15 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.141 178.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 39.6 t -142.12 140.5 32.5 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.761 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 42.9 pt -91.58 145.06 7.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.522 -177.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.48 145.64 29.22 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.267 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 . . . . . 0 C--O 1.251 1.162 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.085 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.9 t . . . . . 0 N--CA 1.45 -0.465 0 CA-C-O 120.931 0.396 . . . . 0.0 110.684 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -133.82 147.56 51.23 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.09 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 54.9 p -123.08 143.23 50.11 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 175.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 87.7 p -155.63 162.03 40.69 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.333 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.1 p -109.03 125.51 52.16 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.59 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.92 122.58 70.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 17.8 ptp180 -78.99 141.94 37.05 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.208 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.775 ' HB ' ' SG ' ' A' ' 21' ' ' CYS . 19.8 pt -116.06 106.51 20.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-O 121.672 0.749 . . . . 0.0 110.519 -178.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.8 tp -114.1 128.74 56.52 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.826 -175.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 176.25 -149.29 9.73 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.213 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 66.5 mtt -60.88 -43.18 98.81 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.472 0.654 . . . . 0.0 109.272 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.573 HG23 ' H ' ' A' ' 20' ' ' SER . 11.5 t -163.82 159.41 21.16 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.411 177.04 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.486 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 98.3 m -63.55 -39.03 93.35 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 120.645 0.26 . . . . 0.0 111.487 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -59.6 -45.2 92.62 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -177.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.573 ' H ' HG23 ' A' ' 17' ' ' THR . 81.0 p -69.11 -41.61 77.18 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.95 -177.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.775 ' SG ' ' HB ' ' A' ' 13' ' ' ILE . 26.0 p -72.26 -35.35 68.74 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.3 p -69.78 -33.92 58.34 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.556 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.625 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -62.28 -42.16 99.1 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.454 0.645 . . . . 0.0 109.319 176.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.6 t -59.58 -49.78 76.42 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.401 -177.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.8 tt -74.55 -32.8 30.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.811 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.4 tm-20 -60.84 -47.68 85.28 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.342 -175.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -62.54 -44.4 96.45 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.502 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.452 ' HA ' ' NE ' ' A' ' 28' ' ' ARG . 4.2 mmp_? -67.52 -43.72 80.11 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.266 -177.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 16.9 tt -72.9 -32.77 41.34 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.6 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.998 -177.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.8 t -64.76 -41.49 95.85 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 120.938 0.399 . . . . 0.0 110.404 177.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -68.64 -26.22 65.22 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.788 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.534 HD21 HG21 ' A' ' 56' ' ' VAL . 57.7 tp -96.23 122.18 38.82 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.025 0.441 . . . . 0.0 110.962 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -68.73 150.01 48.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.871 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.43 -1.97 16.08 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 121.065 -0.588 . . . . 0.0 111.973 -178.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.8 tt -95.82 130.22 44.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 175.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 83.9 mt -92.52 -57.7 4.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 81.5 p -163.71 164.4 23.85 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.281 178.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -154.12 147.7 25.17 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 120.925 0.393 . . . . 0.0 110.271 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -128.87 141.57 51.24 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.5 t -110.05 128.73 66.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -174.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.1 t -113.54 102.03 9.91 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 121.17 0.51 . . . . 0.0 109.998 177.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.97 -36.48 83.43 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.089 178.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -60.62 -44.56 96.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.141 -178.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -85.85 -12.63 50.28 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.11 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.14 26.9 73.64 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.333 -179.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 87.1 p -146.01 161.98 38.88 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.046 0.451 . . . . 0.0 110.823 -177.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.1 142.72 50.08 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.336 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 87.4 m -95.8 119.14 33.78 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 65.7 t -114.77 126.74 72.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 120.997 0.427 . . . . 0.0 111.394 -176.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -103.11 106.43 16.95 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 176.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -135.63 166.34 23.45 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.027 -170.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.5 t -106.07 101.67 35.37 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.027 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.51 -25.87 80.14 Favored 'Trans proline' 0 N--CA 1.48 0.68 0 C-N-CA 123.369 2.713 . . . . 0.0 112.565 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 43.9 t -61.76 -41.33 97.54 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.941 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.447 HG12 HG13 ' A' ' 56' ' ' VAL . 77.8 t -65.51 -62.11 1.39 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.534 HG21 HD21 ' A' ' 32' ' ' LEU . 34.7 m -140.04 159.64 26.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.65 175.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.432 ' SG ' ' HG3' ' A' ' 60' ' ' GLN . 31.8 p -76.07 154.48 35.58 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.029 0.442 . . . . 0.0 110.313 178.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.6 mt -70.97 -19.19 62.58 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.223 179.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -61.45 -42.15 98.31 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.374 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.446 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 97.7 mt-30 -64.28 -39.51 94.08 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.999 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 78.6 t -62.01 -45.48 98.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 CA-C-O 121.265 0.555 . . . . 0.0 109.768 178.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 42.6 t -61.92 -38.73 89.51 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.882 176.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 58.3 m170 -63.07 -36.86 84.97 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.191 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 60' ' ' GLN . 86.5 mm-40 -59.52 -43.55 93.41 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.808 0.337 . . . . 0.0 110.919 -178.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.537 HD11 ' HB2' ' A' ' 21' ' ' CYS . 18.0 tt -76.69 -36.19 26.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.901 178.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -62.81 -42.25 99.72 Favored Glycine 0 CA--C 1.522 0.514 0 CA-C-N 116.07 -0.514 . . . . 0.0 113.478 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -66.47 -22.05 66.19 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 26.4 mmt -83.52 0.56 45.99 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.527 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.45 9.33 57.9 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.513 -0.851 . . . . 0.0 113.531 177.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.491 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 90.2 m-85 -112.51 140.68 47.06 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.985 0.393 . . . . 0.0 110.092 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -90.47 140.24 29.91 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.886 0.374 . . . . 0.0 110.856 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 12' ' ' ARG . . . -147.27 150.41 34.76 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.135 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.8 t -143.64 136.46 27.43 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.142 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 83.8 mt -91.4 127.1 43.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.457 -178.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.03 160.67 37.03 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.113 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.534 -0.746 . . . . 0.0 110.941 178.856 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.474 0 CA-C-O 120.551 0.215 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -61.97 -40.62 99.13 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 121.295 -0.479 . . . . 0.0 112.811 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.402 ' HB2' ' HG3' ' A' ' 53' ' ' PRO . 86.4 m-70 -71.71 136.6 47.28 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 78.7 mtm -64.08 -42.03 97.09 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -175.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.443 ' O ' ' HD2' ' A' ' 53' ' ' PRO . 60.9 tp60 -140.0 -71.9 0.38 Allowed 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.799 -177.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.3 t -109.26 127.57 65.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 120.991 0.424 . . . . 0.0 110.663 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.24 133.82 45.22 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.891 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 63.0 p -109.37 146.45 34.4 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.512 ' OG ' HG13 ' A' ' 74' ' ' ILE . 37.2 t -159.07 147.08 17.81 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.538 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 17.1 p -113.27 108.93 17.94 Favored 'General case' 0 N--CA 1.418 -2.041 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 172.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.4 p -95.64 124.79 48.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.339 -177.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 54.8 ptt85 -75.46 142.56 42.92 Favored 'General case' 0 CA--C 1.505 -0.758 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.574 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 47.1 mm -115.12 119.2 61.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.6 tp -124.05 117.18 24.12 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.978 0.418 . . . . 0.0 110.474 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -175.24 154.28 17.61 Favored Glycine 0 N--CA 1.434 -1.464 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.476 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 98.8 mtp -65.35 -40.19 93.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.963 0.411 . . . . 0.0 110.9 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.0 p -111.12 84.83 2.0 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.383 0.611 . . . . 0.0 110.38 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.507 ' O ' HG23 ' A' ' 22' ' ' VAL . 42.2 t -61.38 -44.27 97.44 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.017 -177.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -61.35 -39.92 92.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.943 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.6 m -62.67 -44.2 96.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.59 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.505 ' HB3' ' CD2' ' A' ' 70' ' ' PHE . 29.6 p -73.02 -33.81 65.96 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.476 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 18' ' ' CYS . 63.0 t -62.79 -43.57 98.86 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -60.69 -44.41 96.56 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.997 177.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.0 t -61.64 -50.02 74.2 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.556 -178.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.7 tt -71.63 -36.83 61.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -61.68 -44.0 97.78 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.829 0.347 . . . . 0.0 110.693 -177.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -64.73 -47.3 78.79 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.281 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -64.58 -42.56 95.54 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.914 -176.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.639 HD13 ' SD ' ' A' ' 38' ' ' MET . 19.6 tt -69.7 -35.14 64.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.957 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 79.0 p -71.26 -22.06 62.02 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.926 0.393 . . . . 0.0 110.634 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -70.76 -27.92 64.29 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 174.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.6 mt -75.0 128.99 36.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.851 176.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.0 mtpt -86.6 153.58 21.68 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.374 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.23 8.1 57.9 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.323 -0.942 . . . . 0.0 111.862 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 33.1 pt -69.52 137.74 23.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.993 0.425 . . . . 0.0 111.819 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -96.77 -71.98 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.695 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.7 t -169.89 149.88 3.78 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-O 120.769 0.319 . . . . 0.0 111.051 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.639 ' SD ' HD13 ' A' ' 29' ' ' ILE . 28.9 ptm -153.4 159.53 42.41 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 177.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -141.1 123.45 15.78 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.989 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 79.9 t -92.52 119.29 39.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 175.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.8 m -109.21 112.07 24.02 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.042 0.448 . . . . 0.0 111.117 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.2 mt -66.2 -37.63 86.05 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.795 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -61.9 -41.81 98.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.775 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -77.22 -27.91 53.61 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.948 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.51 15.99 80.04 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -175.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 87.7 p -148.68 165.54 31.06 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.14 -0.53 . . . . 0.0 109.982 -177.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.515 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -118.5 139.44 51.43 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.708 0.289 . . . . 0.0 111.291 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.8 m -89.13 119.69 29.86 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 8' ' ' THR . 99.8 t -114.64 124.48 71.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.499 -174.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.428 ' HG2' HG22 ' A' ' 8' ' ' THR . 51.5 mtmt -126.96 103.96 7.76 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 174.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -143.86 158.71 43.51 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.587 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.8 t -82.52 114.27 50.51 Favored Pre-proline 0 N--CA 1.437 -1.125 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 173.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.443 ' HD2' ' O ' ' A' ' 5' ' ' GLN . 29.0 Cg_endo -61.44 -28.09 83.32 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.921 2.414 . . . . 0.0 113.787 -173.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.2 p -70.19 -39.74 75.05 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 120.809 0.338 . . . . 0.0 110.899 177.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 84.7 t -75.67 -50.81 22.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 121.128 0.49 . . . . 0.0 110.67 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 69.7 t -128.58 123.72 60.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.162 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.66 ' SG ' ' HG2' ' A' ' 60' ' ' GLN . 27.7 p -88.49 144.42 26.36 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.898 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.4 mp -68.56 -26.8 65.59 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.092 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 -60.35 -41.14 93.02 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.66 ' HG2' ' SG ' ' A' ' 57' ' ' CYS . 85.4 mm-40 -63.98 -38.43 91.07 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.387 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 71.6 t -60.98 -46.74 96.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 121.391 0.615 . . . . 0.0 109.55 178.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 43.0 t -62.55 -39.61 94.18 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.76 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -59.6 -45.17 92.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.947 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 60' ' ' GLN . 98.2 mt-30 -60.75 -44.01 97.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.65 -175.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.0 tt -81.41 -37.19 15.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.856 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.8 -41.73 99.81 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.782 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.99 -28.73 70.0 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 122.37 0.268 . . . . 0.0 111.37 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 16.1 tpt -61.75 -29.79 70.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.719 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.69 5.06 12.6 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.515 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.505 ' CD2' ' HB3' ' A' ' 21' ' ' CYS . 95.1 m-85 -111.48 152.02 27.94 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -94.97 134.69 37.37 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.37 0.605 . . . . 0.0 111.818 -176.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 12' ' ' ARG . . . -140.82 145.59 36.47 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.687 176.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.9 t -139.88 138.65 35.86 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.243 -0.583 . . . . 0.0 111.445 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.512 HG13 ' OG ' ' A' ' 9' ' ' SER . 14.7 tt -78.23 137.02 22.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.12 -0.945 . . . . 0.0 112.158 -178.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -152.11 159.48 43.64 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 176.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.308 -1.228 0 CA-C-O 118.577 -0.725 . . . . 0.0 109.976 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.769 0 CA-C-O 120.961 0.41 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -87.48 -173.03 48.14 Favored Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.544 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -89.96 126.81 35.88 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 43.4 tpp -63.37 -41.69 98.83 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.136 0.493 . . . . 0.0 110.063 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -94.65 122.27 37.07 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.572 177.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.1 m -128.01 150.5 33.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.142 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.453 ' HB3' ' HD3' ' A' ' 53' ' ' PRO . . . -120.73 140.18 52.01 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 120.979 0.418 . . . . 0.0 110.592 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 44.5 p -120.77 145.77 47.19 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.393 177.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.9 t -140.88 142.47 34.5 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.6 p -108.64 133.88 52.13 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 121.307 0.575 . . . . 0.0 110.759 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.445 HG12 ' HA ' ' A' ' 74' ' ' ILE . 33.6 m -126.85 150.53 32.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.457 ' HG2' ' HB3' ' A' ' 73' ' ' SER . 16.6 ptm180 -107.06 147.24 30.21 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.55 HG21 ' SG ' ' A' ' 21' ' ' CYS . 85.0 mt -119.56 125.86 74.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.546 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.8 tp -119.6 115.84 24.81 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -171.02 154.88 23.56 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.976 -0.63 . . . . 0.0 111.642 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 68.6 mtt -67.66 -40.14 84.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.923 0.392 . . . . 0.0 110.978 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.2 p -104.45 89.59 3.27 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.713 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 95.5 m -64.06 -40.57 96.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.238 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -64.88 -39.14 93.08 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.462 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.0 m -62.63 -43.74 98.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.712 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.55 ' SG ' HG21 ' A' ' 13' ' ' ILE . 16.0 p -70.19 -39.87 74.96 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.597 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 65.5 t -63.22 -44.13 99.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-O 121.087 0.47 . . . . 0.0 110.108 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -64.46 -40.88 96.54 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.41 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.5 m -62.36 -42.9 99.77 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.978 -0.556 . . . . 0.0 112.012 -178.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.552 ' CG2' ' HB ' ' A' ' 65' ' ' ILE . 47.1 pt -72.02 -34.94 52.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 C-N-CA 120.064 -0.655 . . . . 0.0 110.161 178.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -60.97 -44.43 97.36 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.909 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -61.82 -50.06 73.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.082 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -68.67 -41.86 78.7 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.165 -0.471 . . . . 0.0 112.192 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 94.0 mt -64.41 -42.61 95.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-O 120.668 0.27 . . . . 0.0 111.035 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 41.4 t -60.24 -41.5 93.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.023 0.44 . . . . 0.0 110.26 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -68.49 -27.9 66.54 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.094 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.5 tp -70.33 131.95 44.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.705 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -86.1 152.55 22.77 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.69 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.89 5.98 73.0 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.687 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.407 ' HA ' ' CD2' ' A' ' 51' ' ' TYR . 46.4 pt -72.55 138.19 21.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.908 0.385 . . . . 0.0 111.316 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.2 mm -96.79 -67.05 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.481 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.7 t -162.39 152.83 16.9 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.279 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -139.27 148.22 42.73 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -134.79 142.47 46.71 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.68 140.05 50.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 120.967 0.413 . . . . 0.0 111.134 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.9 m -119.38 101.75 8.18 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.67 -44.83 95.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.845 -176.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -61.68 -44.28 97.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.462 -178.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -76.93 -24.82 52.39 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.742 -178.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.13 17.53 79.53 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.326 -177.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 60.1 m -125.17 151.61 45.58 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 120.882 0.372 . . . . 0.0 110.591 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -128.71 149.14 50.82 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.047 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.6 m -116.2 125.41 52.23 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 63.1 t -114.47 124.97 71.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 120.84 0.352 . . . . 0.0 110.545 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -105.88 107.7 18.83 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.65 ' CE1' ' HB ' ' A' ' 56' ' ' VAL . 34.4 t80 -152.93 152.74 31.81 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -175.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.4 t -80.64 114.02 44.51 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.453 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 46.9 Cg_endo -66.26 -22.28 53.62 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.066 2.511 . . . . 0.0 113.852 -174.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 79.8 p -65.28 -33.36 75.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.718 0.294 . . . . 0.0 111.271 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.446 HG12 HG23 ' A' ' 56' ' ' VAL . 45.9 t -84.06 -61.9 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.907 0.384 . . . . 0.0 110.174 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.65 ' HB ' ' CE1' ' A' ' 51' ' ' TYR . 88.7 t -128.76 127.49 66.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.096 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 30.3 p -76.81 155.79 32.79 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.343 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.35 -16.13 61.87 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.838 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -61.5 -42.2 98.44 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.195 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.511 ' OE1' HG13 ' A' ' 56' ' ' VAL . 98.6 mt-30 -65.13 -37.94 89.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.531 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 77.8 t -61.28 -40.95 87.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-O 121.352 0.596 . . . . 0.0 109.728 177.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.523 ' SG ' ' HB ' ' A' ' 74' ' ' ILE . 92.7 m -61.08 -38.96 88.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.569 177.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -67.94 -28.77 67.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.452 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -61.93 -42.18 98.8 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.739 0.304 . . . . 0.0 110.503 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.552 ' HB ' ' CG2' ' A' ' 25' ' ' ILE . 18.8 tt -79.7 -38.94 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 120.754 0.311 . . . . 0.0 111.565 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -62.39 -39.08 97.31 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.156 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -59.09 -39.0 80.85 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.152 0.501 . . . . 0.0 110.472 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 17.0 tpt -62.01 -29.09 70.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.127 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.15 8.54 10.38 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.677 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.52 ' CG ' ' HB3' ' A' ' 21' ' ' CYS . 97.5 m-85 -106.29 150.02 26.36 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.687 0.28 . . . . 0.0 110.286 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -93.13 138.87 31.16 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.584 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.88 149.13 31.7 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.642 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.457 ' HB3' ' HG2' ' A' ' 12' ' ' ARG . 48.3 t -127.86 138.93 52.86 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.523 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 13.5 tt -100.27 139.21 22.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.226 0.536 . . . . 0.0 111.681 -176.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.45 159.45 44.02 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.42 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.442 ' H ' ' CD ' ' A' ' 76' ' ' GLU . 1.2 pm0 . . . . . 0 C--N 1.3 -1.575 0 CA-C-O 118.47 -0.776 . . . . 0.0 109.709 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.578 0 CA-C-O 120.756 0.313 . . . . 0.0 110.482 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -138.59 148.87 20.25 Favored Glycine 0 N--CA 1.433 -1.566 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.901 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -71.63 137.52 47.99 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 71.9 mtm -94.92 107.25 19.28 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -78.89 117.7 20.23 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 68.2 t -117.79 127.15 75.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.618 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.62 128.53 45.73 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.004 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 76.3 p -118.47 147.45 43.6 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.699 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.9 p -159.98 168.09 26.44 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.336 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.6 p -113.0 129.59 56.44 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.5 p -109.57 123.34 65.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-O 121.026 0.441 . . . . 0.0 110.364 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -83.26 147.45 27.97 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.647 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 85.9 mt -114.68 123.6 70.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.891 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 69.6 tp -117.92 118.47 32.08 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.938 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -175.45 157.95 24.87 Favored Glycine 0 N--CA 1.432 -1.617 0 C-N-CA 119.692 -1.242 . . . . 0.0 113.151 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 66.4 ttp -61.93 -47.16 86.14 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 120.915 0.388 . . . . 0.0 110.202 177.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.6 m -118.21 107.23 13.68 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.426 ' O ' HG23 ' A' ' 22' ' ' VAL . 47.9 t -64.22 -40.19 95.54 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.09 -178.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -60.35 -39.83 88.57 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.757 -176.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 63.7 m -62.3 -46.29 89.4 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 120.959 0.409 . . . . 0.0 111.518 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.595 ' HB3' ' CD2' ' A' ' 70' ' ' PHE . 16.4 p -73.64 -36.36 65.41 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.926 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 18' ' ' CYS . 57.0 t -62.18 -42.79 96.56 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.541 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -60.56 -40.61 92.25 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.518 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.3 t -59.99 -48.66 80.79 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.875 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.457 HD11 HG13 ' A' ' 61' ' ' VAL . 17.3 tt -76.49 -39.42 33.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.018 -178.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.1 tp10 -60.33 -47.59 85.4 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.914 0.388 . . . . 0.0 111.281 -175.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.64 -51.15 66.43 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.978 -177.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.558 ' HD2' ' HG2' ' A' ' 64' ' ' GLN . 44.4 ttm180 -63.89 -45.42 89.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.852 -177.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 15.3 tt -68.53 -31.22 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.312 -176.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 73.7 m -63.78 -38.77 92.33 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.081 0.467 . . . . 0.0 110.076 176.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -68.18 -27.8 66.72 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.877 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.4 mt -84.68 137.32 33.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.755 0.788 . . . . 0.0 112.753 -178.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.561 ' HD2' ' N ' ' A' ' 33' ' ' LYS . 9.9 mptt -87.75 155.04 20.1 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.39 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.53 7.4 39.73 Favored Glycine 0 C--O 1.239 0.422 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.94 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.2 pt -91.39 132.91 34.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 86.3 mt -97.63 -59.45 3.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.935 0.398 . . . . 0.0 110.728 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.3 t -152.34 141.21 21.08 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.162 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 28.5 ptm -145.27 146.96 31.87 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.759 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -135.52 124.7 24.49 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.908 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 65.7 t -106.6 116.05 49.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 176.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.8 m -109.64 104.68 13.73 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.083 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.8 mt -64.4 -36.65 84.84 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.72 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.7 mp0 -63.61 -41.29 98.32 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.74 -178.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -83.85 -27.34 28.76 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.316 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.86 20.64 77.73 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -177.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.7 m -137.63 155.91 48.64 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 122.371 0.268 . . . . 0.0 110.592 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -121.92 141.8 50.93 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.398 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.1 m -85.38 124.36 31.9 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.664 HG13 ' CE2' ' A' ' 51' ' ' TYR . 97.4 t -107.26 119.29 56.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.053 -176.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -145.56 102.83 3.74 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 173.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.664 ' CE2' HG13 ' A' ' 49' ' ' VAL . 24.7 m-85 -141.69 165.78 26.54 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -177.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.6 t -78.1 114.22 40.3 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 175.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -62.87 -25.91 74.46 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.894 2.396 . . . . 0.0 112.861 -175.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.3 m -64.46 -39.08 93.14 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.925 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.6 t -94.84 -49.43 12.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.125 -178.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.1 t -114.45 126.63 72.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.328 -177.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 25.2 p -103.89 149.9 24.67 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.651 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.5 mp -64.32 -38.06 89.71 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.507 -176.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -62.6 -40.79 98.05 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -176.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.599 ' O ' ' HG3' ' A' ' 64' ' ' GLN . 85.4 mm-40 -64.72 -37.1 86.44 Favored 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 121.119 -0.233 . . . . 0.0 111.18 176.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.457 HG13 HD11 ' A' ' 25' ' ' ILE . 77.2 t -59.29 -43.43 89.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-O 121.17 0.509 . . . . 0.0 109.636 178.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 96.3 m -62.49 -39.09 92.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.97 177.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 63.8 m170 -67.3 -36.35 81.32 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.157 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.599 ' HG3' ' O ' ' A' ' 60' ' ' GLN . 99.2 mt-30 -60.02 -42.91 95.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.536 -176.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.419 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 19.8 tt -81.11 -35.07 14.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.114 178.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -67.14 -24.2 73.24 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.935 -0.575 . . . . 0.0 113.629 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.1 -36.59 77.78 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.847 0.356 . . . . 0.0 111.087 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 16.5 tpt -62.41 -28.93 70.13 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.533 178.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.89 5.13 18.29 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.38 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.595 ' CD2' ' HB3' ' A' ' 21' ' ' CYS . 99.0 m-85 -104.83 142.67 34.32 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.776 0.322 . . . . 0.0 110.661 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -80.88 147.81 30.2 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.404 -177.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.97 148.93 31.29 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.197 176.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 39.8 t -143.61 142.11 30.91 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.38 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 88.7 mt -86.27 128.58 39.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.198 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -138.35 148.43 44.54 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.481 177.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 . . . . . 0 C--N 1.307 -1.282 0 CA-C-O 118.393 -0.813 . . . . 0.0 110.307 -179.818 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.656 0 CA-C-O 120.765 0.317 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 155.24 -161.99 30.74 Favored Glycine 0 N--CA 1.436 -1.309 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.604 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.8 m170 -68.97 137.09 53.46 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.3 mtt -70.72 -27.97 64.38 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.758 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -66.59 -40.73 89.05 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.853 0.359 . . . . 0.0 110.772 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.0 t -130.7 108.7 15.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 175.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -112.31 143.58 43.16 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.954 0.406 . . . . 0.0 111.388 -176.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.587 HG22 ' HG2' ' A' ' 50' ' ' LYS . 71.7 p -109.32 140.86 42.46 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.9 t -150.64 143.02 24.32 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.048 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.58 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 71.3 p -115.09 122.99 47.83 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.8 m -107.21 125.69 63.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.329 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.519 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 16.2 ptp180 -77.79 135.29 37.96 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 85.4 mt -117.57 127.52 74.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-O 120.977 0.418 . . . . 0.0 111.63 -174.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.0 tt -115.13 119.4 36.29 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.107 177.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -165.73 173.42 41.37 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.943 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 79.2 mtm -63.81 -44.91 91.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.32 0.581 . . . . 0.0 110.134 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.0 p -134.91 128.8 33.26 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.748 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.551 ' O ' HG23 ' A' ' 22' ' ' VAL . 51.5 t -62.61 -49.56 74.74 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -176.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -62.61 -40.88 98.35 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -174.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.6 t -62.83 -47.16 84.58 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.675 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.5 p -70.75 -33.29 70.65 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.698 0.285 . . . . 0.0 110.967 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 18' ' ' CYS . 52.7 t -61.91 -45.62 98.29 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.018 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 176.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -64.34 -36.28 83.62 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.493 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 41.1 t -59.24 -48.69 80.67 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.281 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.8 tt -78.51 -28.86 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.448 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -59.2 -46.33 88.73 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.28 -176.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -61.17 -45.09 96.03 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.962 0.41 . . . . 0.0 110.689 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -67.22 -45.75 75.87 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.505 -176.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.3 tp -72.47 -34.63 49.0 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 78.8 p -65.82 -36.32 83.15 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.817 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -70.6 -27.29 63.98 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.283 176.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -77.96 125.18 28.96 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.918 0.389 . . . . 0.0 110.169 176.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -81.51 152.48 27.29 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.316 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 115.81 -0.91 21.53 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.17 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.9 tt -108.73 124.19 65.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.25 0.547 . . . . 0.0 109.98 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 49.7 mm -71.38 -49.43 47.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.029 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.7 t -159.81 150.26 18.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.76 -177.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 26.3 ttt -127.33 119.56 26.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.143 178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -131.03 146.38 52.36 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 110.289 -0.264 . . . . 0.0 110.289 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.5 HG21 HG11 ' A' ' 22' ' ' VAL . 66.4 t -123.91 129.73 74.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 120.757 0.313 . . . . 0.0 111.67 -175.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.3 t -106.85 105.3 15.26 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 177.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 60.0 tp -64.48 -40.83 96.41 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.679 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -62.07 -40.91 97.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.732 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -76.26 -29.11 57.34 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.667 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.83 20.31 63.71 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.978 -0.629 . . . . 0.0 111.629 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 89.3 p -143.91 166.22 25.55 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 120.93 0.395 . . . . 0.0 110.542 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.58 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -117.52 133.77 55.59 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.469 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.1 m -98.88 121.24 40.57 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.6 m -127.96 149.34 32.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 CA-C-O 121.408 0.623 . . . . 0.0 111.509 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.587 ' HG2' HG22 ' A' ' 8' ' ' THR . 62.3 mttp -116.04 123.88 49.06 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 175.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -150.7 165.46 33.37 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.504 -174.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.5 t -100.16 110.28 59.18 Favored Pre-proline 0 N--CA 1.438 -1.056 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.041 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -55.82 -27.13 60.8 Favored 'Trans proline' 0 N--CA 1.483 0.866 0 C-N-CA 123.62 2.88 . . . . 0.0 112.676 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.2 m -62.03 -39.22 91.59 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.845 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 51.8 t -89.05 -47.52 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.998 -177.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 31.8 m -123.25 160.2 26.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.614 0.245 . . . . 0.0 110.904 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 31.2 p -134.89 167.32 21.12 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.948 0.404 . . . . 0.0 111.541 -176.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 68.6 tp -61.07 -44.33 97.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.856 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -60.03 -42.31 94.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.515 -177.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.563 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 64.7 tt0 -61.66 -45.81 92.41 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.609 178.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.0 t -63.97 -46.59 93.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 CA-C-O 121.2 0.524 . . . . 0.0 110.751 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 48.5 t -60.82 -40.07 91.37 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.927 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -60.36 -41.38 93.58 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.414 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.563 ' HG2' ' O ' ' A' ' 60' ' ' GLN . 87.0 mm-40 -60.56 -45.7 92.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.143 -176.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.3 tt -83.22 -35.78 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.869 0.366 . . . . 0.0 111.752 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.59 -39.8 97.86 Favored Glycine 0 CA--C 1.505 -0.536 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.42 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -60.42 -39.37 87.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.952 0.406 . . . . 0.0 110.324 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 14.8 tpt -63.47 -30.67 71.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.485 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 116.64 7.93 12.96 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.334 -0.936 . . . . 0.0 113.301 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -114.53 141.6 47.52 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -99.31 133.35 43.74 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -172.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 12' ' ' ARG . . . -130.89 139.03 50.06 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.474 176.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.6 m -127.57 143.59 51.16 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.689 0.281 . . . . 0.0 110.938 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.2 tt -74.13 142.32 14.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -175.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.434 ' HB2' ' NH2' ' A' ' 12' ' ' ARG . . . -143.05 125.63 15.83 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.45 172.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 . . . . . 0 C--N 1.307 -1.244 0 CA-C-O 118.771 -0.633 . . . . 0.0 111.435 -178.579 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.671 0 CA-C-O 120.404 0.145 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 57.52 -131.03 51.85 Favored Glycine 0 C--N 1.338 0.642 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -90.1 129.43 36.39 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.0 mtt -103.08 120.07 40.01 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.193 0.521 . . . . 0.0 111.194 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -116.19 126.64 53.92 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.507 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.7 p -141.51 138.37 32.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 176.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -129.9 143.2 50.68 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 120.954 0.407 . . . . 0.0 111.136 -178.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.1 p -107.96 129.34 55.12 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.024 177.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.424 ' O ' HG22 ' A' ' 49' ' ' VAL . 46.8 t -140.71 143.78 35.22 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 22.4 p -109.62 119.71 40.25 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.929 177.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 74' ' ' ILE . 33.5 m -102.61 135.89 37.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.408 ' HG2' ' HB3' ' A' ' 73' ' ' SER . 24.1 ptt180 -83.74 150.9 25.52 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.642 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 86.4 mt -112.52 121.35 64.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 63.4 tp -122.56 108.08 12.72 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -167.23 156.19 27.8 Favored Glycine 0 N--CA 1.431 -1.656 0 C-N-CA 119.932 -1.127 . . . . 0.0 113.069 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 79.5 mtm -64.6 -40.28 95.23 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.92 0.39 . . . . 0.0 110.346 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 35.5 m -121.85 103.87 9.16 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.468 ' O ' HG23 ' A' ' 22' ' ' VAL . 91.5 m -65.4 -40.23 93.16 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.051 -177.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -62.72 -39.79 95.15 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -176.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.0 m -62.38 -44.56 96.16 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.553 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.651 ' HB3' ' CD2' ' A' ' 70' ' ' PHE . 24.7 p -71.73 -37.05 70.64 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.416 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 18' ' ' CYS . 59.4 t -62.65 -45.18 99.46 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.001 178.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 66.3 tttp -62.86 -42.73 99.86 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.275 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 74.5 m -60.78 -43.01 98.63 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.67 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.0 tt -76.52 -41.16 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.396 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -62.71 -49.36 75.4 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -63.71 -46.42 85.52 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.046 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.0 ttp180 -67.17 -42.72 83.81 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.522 HG12 ' OH ' ' A' ' 51' ' ' TYR . 11.2 tp -67.55 -36.44 76.24 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.687 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.882 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 79.0 p -73.17 -20.71 60.84 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.17 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -71.64 -27.91 63.4 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 174.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 64.1 tp -93.29 119.3 32.28 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.388 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -80.66 152.41 28.48 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 120.994 0.426 . . . . 0.0 111.069 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 115.3 1.67 21.86 Favored Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -175.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.522 HD11 ' HB2' ' A' ' 38' ' ' MET . 4.1 tt -91.92 122.25 43.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 123.132 0.573 . . . . 0.0 110.426 178.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.1 tt -82.7 -42.8 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.822 177.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.492 ' HB3' ' HD2' ' A' ' 50' ' ' LYS . 35.3 t -160.67 145.62 14.35 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 120.123 -0.631 . . . . 0.0 112.248 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.577 ' SD ' HG12 ' A' ' 49' ' ' VAL . 14.4 tpt -134.41 129.81 35.89 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.851 177.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -135.05 129.05 33.44 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.6 p -129.77 137.61 56.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 120.811 0.339 . . . . 0.0 110.862 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.1 t -117.62 117.9 30.64 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.979 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.8 tp -66.66 -41.62 87.9 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.863 176.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -61.07 -48.93 79.42 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.587 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -77.02 -25.02 52.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.69 -178.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.33 29.8 69.85 Favored Glycine 0 CA--C 1.505 -0.591 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.9 t -149.12 152.85 36.84 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -119.36 138.17 53.24 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.987 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 71.6 m -102.67 122.6 44.77 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.667 ' HB ' ' CE2' ' A' ' 51' ' ' TYR . 33.3 m -120.72 149.91 23.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -174.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.492 ' HD2' ' HB3' ' A' ' 37' ' ' SER . 69.0 mttm -125.0 108.2 11.6 Favored 'General case' 0 C--O 1.245 0.858 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.749 175.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.667 ' CE2' ' HB ' ' A' ' 49' ' ' VAL . 80.8 m-85 -136.44 148.78 47.92 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.03 0.443 . . . . 0.0 111.434 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 66.5 t -87.61 115.41 62.8 Favored Pre-proline 0 N--CA 1.438 -1.049 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 171.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -59.4 -28.62 88.04 Favored 'Trans proline' 0 N--CA 1.475 0.398 0 C-N-CA 122.819 2.346 . . . . 0.0 113.765 -173.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.0 p -77.05 -14.29 59.84 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.907 0.384 . . . . 0.0 111.473 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 49.0 t -104.4 -59.19 3.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.105 0.479 . . . . 0.0 109.892 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 66.7 t -126.3 124.16 65.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.491 ' SG ' ' HG3' ' A' ' 60' ' ' GLN . 31.2 p -93.48 159.28 15.31 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.208 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.8 mt -62.91 -36.67 84.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.66 -178.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -61.11 -40.03 92.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.734 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.491 ' HG3' ' SG ' ' A' ' 57' ' ' CYS . 95.5 mt-30 -63.08 -41.25 99.38 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.074 0.464 . . . . 0.0 110.369 177.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 70.2 t -63.26 -44.24 99.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.119 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 92.5 m -62.59 -39.51 93.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.967 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -61.75 -39.67 92.4 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.547 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.42 ' HG3' ' O ' ' A' ' 60' ' ' GLN . 99.1 mt-30 -60.3 -42.34 95.32 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.41 -176.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.2 tt -81.77 -40.73 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-O 120.787 0.327 . . . . 0.0 111.604 178.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -62.31 -37.01 93.88 Favored Glycine 0 C--N 1.335 0.473 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.626 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -56.35 -36.14 68.44 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 123.91 0.884 . . . . 0.0 111.594 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 14.2 tpt -63.44 -28.58 70.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.246 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.81 9.62 9.83 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.495 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.651 ' CD2' ' HB3' ' A' ' 21' ' ' CYS . 98.4 m-85 -113.79 141.82 46.83 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -82.78 146.85 28.74 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.485 0.66 . . . . 0.0 112.592 -176.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.44 151.09 35.86 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.981 -1.008 . . . . 0.0 108.923 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 36.6 t -138.19 140.48 39.8 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.891 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.455 ' HA ' HG12 ' A' ' 11' ' ' VAL . 85.7 mt -81.55 128.63 38.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.066 -178.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -142.95 159.96 41.25 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.435 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 119.132 -0.461 . . . . 0.0 111.403 -179.692 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.86 0 CA-C-O 120.744 0.307 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 136.74 -20.34 3.46 Favored Glycine 0 C--N 1.316 -0.532 0 C-N-CA 120.913 -0.661 . . . . 0.0 111.508 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -90.76 137.88 32.02 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 98.4 mmm 68.43 177.12 0.26 Allowed 'General case' 0 N--CA 1.471 0.588 0 O-C-N 123.716 0.635 . . . . 0.0 110.668 -176.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 62.9 18.95 11.22 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.071 0.548 . . . . 0.0 111.579 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.9 t -126.35 122.78 62.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 120.908 0.385 . . . . 0.0 110.957 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 50' ' ' LYS . . . -117.24 131.82 56.76 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 176.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.573 HG22 ' HG2' ' A' ' 50' ' ' LYS . 66.4 p -111.82 135.04 52.96 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.8 t -157.57 152.15 25.13 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 40.7 p -111.93 142.39 44.4 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-O 121.037 0.446 . . . . 0.0 110.042 178.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.3 p -133.14 127.33 54.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.137 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 40.6 ptt180 -94.53 142.61 27.24 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.595 -0.442 . . . . 0.0 109.815 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 85.3 mt -110.13 127.13 67.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.782 -177.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 63.0 tp -112.87 115.2 28.08 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.219 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -172.83 148.54 10.58 Favored Glycine 0 N--CA 1.438 -1.229 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 68.3 mtt -65.94 -41.05 91.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.972 0.415 . . . . 0.0 110.794 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.7 m -100.76 85.26 2.86 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.489 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 93.7 m -63.45 -40.13 96.32 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.495 -175.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -62.83 -42.21 99.64 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -177.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.9 m -67.34 -41.1 85.75 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.504 ' HB3' ' CG ' ' A' ' 70' ' ' PHE . 18.6 p -68.79 -39.96 79.86 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.572 -179.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.476 ' O ' ' HG3' ' A' ' 26' ' ' GLU . 67.3 t -63.07 -46.0 97.27 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.282 0 CA-C-O 121.13 0.49 . . . . 0.0 109.804 178.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.46 -44.13 97.64 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.793 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.459 ' HB3' ' HG3' ' A' ' 68' ' ' MET . 67.2 m -62.95 -46.43 87.79 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.067 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.9 tt -66.25 -33.62 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.207 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 22' ' ' VAL . 49.4 mt-10 -62.33 -44.03 97.45 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.627 178.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -65.93 -45.46 81.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.149 0.499 . . . . 0.0 110.812 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.534 ' HB3' ' HG2' ' A' ' 64' ' ' GLN . 26.5 mmt85 -64.18 -43.32 95.47 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.239 -178.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.591 HG21 ' SD ' ' A' ' 38' ' ' MET . 19.1 tt -70.62 -32.95 51.25 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.303 0 CA-C-O 120.952 0.406 . . . . 0.0 110.264 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.5 t -62.41 -38.86 91.3 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.575 176.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -66.79 -30.37 70.55 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.886 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 93.7 mt -75.82 129.12 36.51 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.164 0.507 . . . . 0.0 110.451 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -85.49 153.35 22.52 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.294 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.02 7.96 48.94 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.583 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.497 ' HA ' ' CB ' ' A' ' 51' ' ' TYR . 48.0 pt -94.78 138.68 20.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.868 0.366 . . . . 0.0 110.662 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.3 mm -99.48 -61.78 2.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.114 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.5 m -146.57 154.13 41.16 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.615 0.245 . . . . 0.0 110.965 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.591 ' SD ' HG21 ' A' ' 29' ' ' ILE . 27.8 ttt -145.6 132.45 20.12 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.583 178.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -126.26 128.34 47.02 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 176.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.8 t -107.2 123.62 62.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-O 120.79 0.329 . . . . 0.0 110.366 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.5 m -98.6 99.38 10.51 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.9 mt -64.19 -40.23 95.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.089 -175.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -69.27 -38.57 78.44 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.075 0.464 . . . . 0.0 110.91 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -74.66 -29.96 61.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.806 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.82 15.14 81.2 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -177.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 12' ' ' ARG . 49.0 m -131.48 154.25 48.93 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.39 -0.405 . . . . 0.0 110.133 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -125.41 143.49 50.96 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.978 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 85.1 m -102.01 125.26 48.66 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.6 m -117.69 147.28 21.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 121.023 0.439 . . . . 0.0 111.512 -177.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.573 ' HG2' HG22 ' A' ' 8' ' ' THR . 99.7 mttt -133.17 112.94 12.15 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.444 177.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.497 ' CB ' ' HA ' ' A' ' 35' ' ' ILE . 35.9 p90 -159.28 170.62 21.47 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.13 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.0 t -80.61 114.94 51.84 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 38.9 Cg_endo -65.97 -23.34 54.38 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.696 2.264 . . . . 0.0 112.218 -178.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.4 m -65.77 -39.36 90.94 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.619 177.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 66.0 t -74.42 -51.11 24.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.017 0.437 . . . . 0.0 110.483 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 17.8 m -137.08 149.02 26.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.434 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.582 ' SG ' ' HB2' ' A' ' 60' ' ' GLN . 24.9 p -99.65 172.24 7.41 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.871 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.484 HD23 ' OH ' ' A' ' 51' ' ' TYR . 96.5 mt -64.84 -40.89 95.9 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.718 0.771 . . . . 0.0 110.332 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -68.27 -26.71 65.8 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.462 178.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.582 ' HB2' ' SG ' ' A' ' 57' ' ' CYS . 59.6 tp60 -60.41 -45.93 91.85 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.381 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.54 ' HA ' ' OE1' ' A' ' 64' ' ' GLN . 31.8 m -74.33 -26.43 20.49 Favored 'Isoleucine or valine' 0 C--O 1.248 0.989 0 CA-C-O 121.387 0.613 . . . . 0.0 110.722 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 98.1 m -61.64 -36.45 80.82 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.104 176.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -60.48 -40.5 91.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.933 -178.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.54 ' OE1' ' HA ' ' A' ' 61' ' ' VAL . 28.6 mp0 -64.57 -41.0 96.56 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 120.4 -0.52 . . . . 0.0 112.235 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.4 tt -72.67 -36.82 54.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.525 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.23 -38.39 96.12 Favored Glycine 0 C--N 1.339 0.702 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 176.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -57.63 -36.83 72.34 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.358 0.663 . . . . 0.0 110.896 178.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.459 ' HG3' ' HB3' ' A' ' 24' ' ' SER . 95.9 mmm -74.72 -8.05 55.2 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.526 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.57 9.91 59.65 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.617 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.504 ' CG ' ' HB3' ' A' ' 21' ' ' CYS . 98.7 m-85 -111.7 147.52 35.39 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -105.95 151.32 24.74 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.184 0.516 . . . . 0.0 111.91 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -144.72 148.62 34.4 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.456 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.7 t -123.6 132.6 53.91 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.937 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 84.4 mt -78.96 130.93 35.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.235 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -144.51 155.31 43.63 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.283 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 . . . . . 0 C--O 1.256 1.432 0 CA-C-O 118.568 -0.729 . . . . 0.0 109.377 178.388 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.825 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.23 173.87 52.49 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.219 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.7 p80 -69.56 147.73 50.38 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 117.128 0.464 . . . . 0.0 111.198 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -107.15 130.23 54.73 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.379 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 89.7 mm-40 -105.66 131.28 53.22 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.4 m -117.16 150.39 19.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-O 121.003 0.43 . . . . 0.0 111.075 -175.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -104.79 131.35 52.36 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.646 -178.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 61.2 p -117.65 142.86 46.73 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.2 t -158.89 152.55 23.1 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.274 -0.571 . . . . 0.0 110.029 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 20.8 p -102.43 141.23 35.58 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 177.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.3 p -134.78 135.16 53.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.522 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -95.22 151.9 18.83 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.3 pt -115.11 138.8 44.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 110.127 -0.324 . . . . 0.0 110.127 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.2 tp -126.0 117.89 24.19 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.143 0.497 . . . . 0.0 110.774 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.82 157.77 16.31 Favored Glycine 0 N--CA 1.437 -1.264 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 95.3 mmm -69.02 -39.48 79.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.145 0.498 . . . . 0.0 110.059 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.2 p -99.74 79.07 2.2 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 121.509 0.671 . . . . 0.0 109.879 176.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.545 ' O ' HG23 ' A' ' 22' ' ' VAL . 96.4 m -62.39 -43.16 99.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.986 -176.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -64.99 -38.95 92.66 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.862 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.0 t -61.23 -45.93 92.5 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.451 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 29.3 p -67.53 -32.19 72.81 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.516 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 18' ' ' CYS . 53.7 t -62.97 -43.63 99.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.615 176.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -61.87 -43.79 98.13 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.456 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.6 m -61.76 -44.94 95.9 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.809 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.7 tp -72.5 -35.34 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 121.171 -0.212 . . . . 0.0 111.324 178.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -59.46 -47.11 86.76 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.878 0.37 . . . . 0.0 110.955 -177.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -62.92 -51.14 68.1 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.065 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.415 ' HG3' ' OE1' ' A' ' 64' ' ' GLN . 29.9 tpt180 -68.99 -40.82 78.54 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.568 -174.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.404 ' O ' HD13 ' A' ' 35' ' ' ILE . 18.9 tt -65.64 -33.83 66.28 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.086 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 73.5 m -63.64 -35.06 79.27 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.783 175.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -67.4 -26.24 66.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.097 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.1 mt -74.56 136.52 42.1 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.973 0.416 . . . . 0.0 110.852 176.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -86.75 149.92 24.52 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.393 177.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.84 7.97 54.78 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.064 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.404 HD13 ' O ' ' A' ' 29' ' ' ILE . 47.7 pt -94.02 139.49 18.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 120.881 0.372 . . . . 0.0 110.22 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 89.2 mt -99.38 -58.56 3.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.819 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.1 t -158.47 147.53 19.07 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.079 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.42 ' HG3' HG12 ' A' ' 49' ' ' VAL . 65.5 ttp -141.74 130.04 22.32 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.115 175.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -120.12 127.0 52.11 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.3 t -111.47 119.99 61.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.1 m -100.97 106.34 17.65 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 97.0 mt -63.61 -38.68 92.03 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.979 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -63.67 -41.08 98.22 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.931 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -77.29 -27.33 52.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.174 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.27 18.78 73.42 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.216 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 78.7 p -144.69 159.03 43.49 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 120.881 0.372 . . . . 0.0 111.177 -178.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -128.33 155.65 44.32 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.23 -178.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.9 m -113.32 127.54 56.18 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 8' ' ' THR . 35.9 m -116.99 148.28 19.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 120.826 0.346 . . . . 0.0 111.218 -178.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -142.68 114.87 8.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.459 177.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.449 ' OH ' HD23 ' A' ' 58' ' ' LEU . 39.4 p90 -158.89 166.84 30.93 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.06 -178.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.12 116.27 63.38 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.647 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 43.4 Cg_endo -65.78 -20.42 58.87 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.086 2.524 . . . . 0.0 114.053 -175.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.6 p -65.71 -38.11 88.29 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.695 0.283 . . . . 0.0 111.439 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.9 m -100.4 -26.98 3.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 79.8 t -125.35 124.86 68.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 176.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.564 ' SG ' ' HG3' ' A' ' 60' ' ' GLN . 31.2 p -103.29 168.65 9.03 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.001 -178.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.449 HD23 ' OH ' ' A' ' 51' ' ' TYR . 96.0 mt -64.18 -38.2 90.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.533 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -61.74 -41.06 97.17 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.014 -177.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.564 ' HG3' ' SG ' ' A' ' 57' ' ' CYS . 96.0 mt-30 -62.07 -45.56 92.97 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.47 -178.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 72.6 t -64.22 -46.93 92.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 CA-C-O 121.075 0.464 . . . . 0.0 111.048 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 44.6 t -62.16 -43.37 98.97 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.135 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -62.53 -41.33 98.8 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.779 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.523 ' HG3' ' O ' ' A' ' 60' ' ' GLN . 22.8 mt-30 -61.2 -43.55 98.7 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 121.207 -0.197 . . . . 0.0 111.334 -176.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.0 tt -77.85 -38.02 24.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.119 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -62.82 -40.21 98.95 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.604 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -62.61 -26.93 68.86 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 122.989 0.516 . . . . 0.0 110.781 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.476 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 36.6 mmt -71.4 -8.97 57.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.666 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.77 5.86 58.47 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.377 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.479 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 99.1 m-85 -110.55 138.56 46.78 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -88.42 140.6 29.3 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.735 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -139.62 138.36 36.09 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.13 177.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.3 m -118.63 139.38 51.59 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.4 tt -118.56 139.91 44.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-O 121.128 0.489 . . . . 0.0 111.499 -174.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.44 160.41 42.12 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.108 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 . . . . . 0 C--O 1.252 1.214 0 CA-C-O 118.512 -0.756 . . . . 0.0 109.744 177.887 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.553 0 CA-C-O 120.63 0.253 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.61 -56.33 4.47 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 121.234 -0.508 . . . . 0.0 114.111 176.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 65.1 m170 -65.21 127.35 31.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.741 0.305 . . . . 0.0 111.447 -175.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 67.3 mtt 54.49 29.47 11.27 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.52 0.728 . . . . 0.0 112.62 177.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -64.68 -33.34 75.73 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.326 0.584 . . . . 0.0 110.327 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.1 m -134.03 150.79 31.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.031 177.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -117.19 127.34 54.01 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 40.1 p -119.78 144.78 47.11 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.087 177.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.3 t -158.09 153.1 25.36 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.86 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 34.9 p -110.07 142.14 41.93 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 176.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 73' ' ' SER . 6.8 p -127.35 122.98 60.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-O 121.044 0.449 . . . . 0.0 110.192 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 36.3 ptt180 -91.44 146.2 24.0 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.208 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.2 pt -121.09 133.92 66.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 121.207 0.527 . . . . 0.0 112.008 -176.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 62.0 tp -135.56 129.41 32.94 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.069 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.21 -172.65 44.73 Favored Glycine 0 N--CA 1.438 -1.192 0 C-N-CA 119.58 -1.295 . . . . 0.0 112.811 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -61.8 -42.17 98.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.911 0.386 . . . . 0.0 110.913 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.472 ' HB ' ' OG ' ' A' ' 20' ' ' SER . 63.6 m -139.84 118.08 12.01 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.115 177.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.463 ' O ' HG23 ' A' ' 22' ' ' VAL . 95.1 m -67.47 -39.77 85.28 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.558 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -63.37 -41.91 98.84 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.613 -177.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.472 ' OG ' ' HB ' ' A' ' 17' ' ' THR . 78.9 p -69.71 -39.12 77.07 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.437 ' HB3' ' CG ' ' A' ' 70' ' ' PHE . 29.7 p -67.08 -34.03 76.78 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.544 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 18' ' ' CYS . 63.3 t -63.12 -44.84 99.68 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -63.09 -40.45 97.68 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.212 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.2 m -62.73 -46.22 89.09 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.637 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.9 tt -74.29 -35.62 40.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.012 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -60.65 -44.51 96.32 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.918 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -60.83 -51.3 69.91 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.207 -176.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -65.29 -46.35 80.74 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.452 HD13 ' SD ' ' A' ' 38' ' ' MET . 19.0 tt -65.8 -33.11 61.4 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.52 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.724 -177.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.5 m -65.55 -41.54 92.89 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.236 0.541 . . . . 0.0 110.338 177.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -71.13 -27.22 63.42 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.257 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 62.5 tp -81.86 117.23 21.96 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 121.306 0.574 . . . . 0.0 109.532 178.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -86.46 154.66 20.97 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.123 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.415 ' HA3' HG11 ' A' ' 55' ' ' VAL . . . 117.8 -6.3 15.9 Favored Glycine 0 C--N 1.314 -0.644 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -176.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.7 mp -102.05 112.67 36.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.3 tt -72.12 -38.45 63.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -176.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.5 m -151.34 145.31 25.21 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.838 0.352 . . . . 0.0 111.478 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.452 ' SD ' HD13 ' A' ' 29' ' ' ILE . 63.4 ttp -145.69 127.75 15.59 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -134.97 144.43 47.4 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.0 129.16 76.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 121.379 0.609 . . . . 0.0 111.428 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.6 p -100.47 98.07 8.72 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.703 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 99.4 mt -63.89 -39.16 93.54 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.371 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -65.45 -23.47 66.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.151 0.5 . . . . 0.0 111.115 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 -88.56 -27.82 21.14 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.135 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.34 19.67 71.21 Favored Glycine 0 C--O 1.236 0.272 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -176.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.0 t -145.0 154.88 43.01 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.24 -0.48 . . . . 0.0 109.733 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -118.36 149.73 40.7 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.584 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.7 m -112.86 126.83 55.88 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 8' ' ' THR . 12.7 p -123.72 137.37 57.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 121.013 0.435 . . . . 0.0 110.815 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -124.81 117.96 25.31 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 56.2 p90 -151.62 165.4 34.44 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.957 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.4 t -77.12 121.66 85.02 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 174.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -59.95 -28.38 86.99 Favored 'Trans proline' 0 N--CA 1.476 0.498 0 C-N-CA 122.814 2.343 . . . . 0.0 113.866 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.2 m -85.25 -9.43 57.74 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 120.752 0.31 . . . . 0.0 111.707 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.415 HG11 ' HA3' ' A' ' 34' ' ' GLY . 65.7 t -99.15 -42.33 10.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.712 0.291 . . . . 0.0 111.539 -178.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 63.5 t -125.36 137.16 58.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.746 -177.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.403 ' SG ' ' HB2' ' A' ' 60' ' ' GLN . 28.9 p -105.91 156.18 18.61 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.792 0.329 . . . . 0.0 110.872 178.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.471 HD13 HG21 ' A' ' 74' ' ' ILE . 87.9 mt -63.73 -39.86 95.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.085 -178.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -63.51 -36.87 85.19 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -177.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.426 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 23.8 tm0? -58.95 -45.28 90.86 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 121.224 -0.19 . . . . 0.0 110.796 -177.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.8 m -75.3 -33.47 28.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.216 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 95.4 m -63.64 -39.89 95.5 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-O 121.099 0.476 . . . . 0.0 110.179 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -63.33 -38.14 89.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.856 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' A' ' 60' ' ' GLN . 89.7 mm-40 -62.7 -43.52 98.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.499 -177.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.5 tt -83.0 -40.25 16.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 120.797 0.332 . . . . 0.0 111.714 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.566 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -62.89 -40.78 99.69 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 116.119 -0.491 . . . . 0.0 113.426 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -61.39 -35.3 77.11 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.974 0.416 . . . . 0.0 111.282 -178.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 35.9 mmt -68.62 -8.05 38.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.703 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.39 11.15 39.59 Favored Glycine 0 CA--C 1.506 -0.499 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.713 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.566 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 96.2 m-85 -108.03 146.16 32.94 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -102.49 131.23 49.32 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.91 0.386 . . . . 0.0 110.899 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 12' ' ' ARG . . . -143.28 144.36 32.09 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 13.4 p -133.9 153.72 51.56 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.306 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.471 HG21 HD13 ' A' ' 58' ' ' LEU . 49.8 mm -95.01 130.54 43.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.208 -174.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.0 151.5 51.47 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.134 176.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 C--N 1.309 -1.163 0 CA-C-O 119.024 -0.512 . . . . 0.0 110.595 -178.945 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.796 0 CA-C-O 120.739 0.304 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -137.04 147.52 19.28 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.386 -0.911 . . . . 0.0 111.94 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -88.41 130.06 35.27 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.007 0.432 . . . . 0.0 111.166 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 98.2 mmm -67.47 -39.17 85.26 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.489 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -98.98 105.57 17.73 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.426 0.631 . . . . 0.0 111.944 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 31.8 m -132.68 150.76 33.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.075 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.4 134.31 55.02 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.632 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 67.9 p -117.65 147.14 43.17 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 175.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 76' ' ' GLU . 87.4 p -158.85 158.21 33.01 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.149 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 31.9 p -115.36 114.38 25.05 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 175.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.505 HG22 HG12 ' A' ' 74' ' ' ILE . 70.7 t -107.62 123.51 63.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.2 -176.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -91.48 143.2 26.85 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.497 -177.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 82.7 mt -120.18 130.48 74.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.364 -176.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.46 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 7.4 tt -112.32 120.49 41.89 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 176.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -166.14 179.49 40.22 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.272 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 94.7 mmm -63.18 -41.41 99.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.745 0.307 . . . . 0.0 111.294 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.0 t -152.17 150.36 29.77 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 120.993 0.425 . . . . 0.0 110.652 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.456 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 93.1 m -64.01 -38.78 92.33 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.67 -178.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -59.22 -47.42 85.41 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -172.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.2 p -70.52 -40.93 73.21 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -177.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.456 ' SG ' ' HA ' ' A' ' 18' ' ' CYS . 25.4 p -72.71 -42.74 63.85 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -177.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.414 ' O ' ' HG3' ' A' ' 26' ' ' GLU . 66.9 t -64.18 -45.58 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.86 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 73.6 mmtt -64.41 -38.95 92.84 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.328 -0.549 . . . . 0.0 112.061 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.6 m -62.22 -43.97 97.63 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.279 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.439 ' O ' HG22 ' A' ' 29' ' ' ILE . 10.9 tp -72.86 -37.62 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.547 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 22' ' ' VAL . 44.4 mt-10 -61.97 -41.43 98.01 Favored 'General case' 0 C--N 1.349 0.558 0 C-N-CA 120.944 -0.303 . . . . 0.0 111.513 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -61.07 -50.26 74.01 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -176.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -65.93 -44.96 83.56 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.439 HG22 ' O ' ' A' ' 25' ' ' ILE . 19.7 tt -72.17 -32.68 44.08 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 CA-C-O 120.797 0.332 . . . . 0.0 111.372 -177.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.2 t -63.66 -39.67 94.93 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -68.56 -27.09 65.77 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.377 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 98.5 mt -83.68 118.34 23.8 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.556 -0.457 . . . . 0.0 110.427 176.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -85.71 153.94 21.98 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.606 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.13 7.48 14.62 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.453 -177.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.412 ' HA ' ' CB ' ' A' ' 51' ' ' TYR . 46.7 pt -102.79 139.02 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 86.8 mt -83.82 -56.96 4.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.173 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 78.6 p -155.14 157.42 37.41 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.256 -178.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 77.9 mtm -138.03 142.35 40.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.331 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -131.3 149.52 52.53 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 175.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.9 p -138.48 131.7 40.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-O 121.187 0.518 . . . . 0.0 111.385 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.1 m -116.19 103.99 11.08 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.76 -41.63 97.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.346 -176.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -64.02 -39.93 95.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.156 0.503 . . . . 0.0 110.997 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -73.11 -29.89 63.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.323 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.35 17.66 73.28 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.749 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 88.4 p -142.2 158.58 43.57 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 120.893 0.378 . . . . 0.0 110.455 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -124.48 144.7 49.94 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.85 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.1 m -103.65 123.35 46.83 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 8' ' ' THR . 29.7 m -126.67 149.41 31.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.446 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -134.95 115.33 13.44 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.468 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.412 ' CB ' ' HA ' ' A' ' 35' ' ' ILE . 51.6 p90 -161.97 170.93 18.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.237 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.5 t -82.88 116.32 63.46 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 36.7 Cg_endo -64.76 -23.88 62.41 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.71 2.273 . . . . 0.0 113.515 -176.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.5 t -64.88 -42.88 94.45 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.271 177.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 96.5 t -67.78 -49.47 69.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.137 0.494 . . . . 0.0 110.043 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 63.0 t -128.35 119.84 51.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.657 ' SG ' ' HB2' ' A' ' 60' ' ' GLN . 30.4 p -83.12 154.46 24.33 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.472 -178.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.482 ' HB3' ' CD1' ' A' ' 74' ' ' ILE . 98.9 mt -62.48 -37.99 88.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.544 -178.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -63.11 -39.43 94.66 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.535 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.657 ' HB2' ' SG ' ' A' ' 57' ' ' CYS . 14.2 tm0? -65.0 -38.89 92.44 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 77.3 t -61.58 -44.05 98.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.298 0.571 . . . . 0.0 110.171 178.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 44.0 t -60.49 -40.32 90.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.191 176.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.468 ' HB3' ' O ' ' A' ' 60' ' ' GLN . 53.7 t-80 -60.18 -39.36 86.2 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.872 177.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -59.9 -46.17 90.18 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.373 -177.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.3 tt -82.04 -33.65 11.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.09 -39.66 97.43 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.455 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -61.75 -37.94 86.14 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.838 0.351 . . . . 0.0 111.082 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 16.4 tpt -61.97 -30.04 70.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.04 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.94 6.94 18.26 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.61 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -112.55 136.92 51.51 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.46 ' HG3' ' HB3' ' A' ' 14' ' ' LEU . 12.0 pt-20 -95.88 144.55 26.12 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.009 0.433 . . . . 0.0 110.649 -178.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.89 152.36 37.46 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.381 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 78.3 p -132.1 149.36 52.42 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.45 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.505 HG12 HG22 ' A' ' 11' ' ' VAL . 81.6 mt -94.4 125.26 47.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.891 -175.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -126.33 149.83 48.91 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.008 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 9' ' ' SER . 41.8 tt0 . . . . . 0 C--O 1.249 1.078 0 C-N-CA 123.167 0.587 . . . . 0.0 111.125 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.636 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.03 137.1 13.68 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.518 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -90.49 127.85 36.36 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.07 0.462 . . . . 0.0 111.622 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.55 ' HG3' HG13 ' A' ' 6' ' ' VAL . 15.0 tpt -140.96 128.89 21.84 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.481 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -91.37 103.33 15.98 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.233 0.54 . . . . 0.0 111.218 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.55 HG13 ' HG3' ' A' ' 4' ' ' MET . 27.6 m -133.17 150.41 32.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.511 177.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -139.07 148.77 43.77 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.06 0.457 . . . . 0.0 110.614 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 72.3 p -125.34 156.18 39.11 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.7 p -156.5 159.06 38.25 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 123.266 0.354 . . . . 0.0 110.078 176.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.2 p -117.93 139.21 51.47 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 73' ' ' SER . 6.7 p -132.14 123.81 51.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.234 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -77.96 143.51 37.55 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.503 HD12 ' SG ' ' A' ' 21' ' ' CYS . 37.6 pt -115.76 123.02 70.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 60.4 tp -122.82 119.36 30.35 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.063 0.458 . . . . 0.0 111.545 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.49 167.95 37.64 Favored Glycine 0 N--CA 1.438 -1.229 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 178.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 99.0 mtp -64.51 -39.32 93.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.954 0.407 . . . . 0.0 111.208 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.6 p -109.49 113.46 26.28 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.104 0.478 . . . . 0.0 111.196 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.509 ' O ' HG23 ' A' ' 22' ' ' VAL . 23.7 p -70.93 -44.9 65.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.851 -178.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.415 ' O ' ' HG3' ' A' ' 23' ' ' LYS . 98.3 mt-30 -64.73 -37.9 89.15 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.555 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.2 t -60.55 -45.25 94.58 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.241 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.503 ' SG ' HD12 ' A' ' 13' ' ' ILE . 26.9 p -69.56 -32.57 71.44 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.836 178.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 18' ' ' CYS . 61.5 t -63.64 -43.67 98.22 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-O 121.214 0.531 . . . . 0.0 109.631 176.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 19' ' ' GLN . 98.6 mttt -61.86 -39.34 91.53 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.752 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.403 ' HB3' ' HG3' ' A' ' 68' ' ' MET . 70.9 m -62.72 -43.23 99.34 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.716 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.439 ' CG2' ' HB ' ' A' ' 65' ' ' ILE . 46.1 pt -81.63 -39.24 16.8 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.886 0 C-N-CA 120.386 -0.525 . . . . 0.0 112.292 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -62.67 -44.87 95.16 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.155 -176.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -61.85 -51.73 67.03 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.206 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.56 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 97.7 mtt180 -70.11 -41.21 74.29 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -176.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 92.1 mt -63.45 -44.19 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.683 0.278 . . . . 0.0 111.166 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 81.1 p -63.2 -33.78 76.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.833 0.349 . . . . 0.0 110.936 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -70.98 -25.76 62.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.417 176.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 28' ' ' ARG . 99.3 mt -70.43 146.61 50.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.133 0.492 . . . . 0.0 111.316 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -86.57 130.88 34.33 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.46 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.5 7.76 25.71 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.799 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.7 tp -84.88 123.39 39.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.05 0.453 . . . . 0.0 110.821 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 86.6 mt -93.58 -60.68 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.011 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 85.9 p -161.51 164.26 29.74 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.64 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 28.5 ptm -151.31 155.54 38.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.904 0.383 . . . . 0.0 110.883 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -143.73 138.67 29.0 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.692 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 67.0 t -106.9 124.33 62.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 120.941 0.4 . . . . 0.0 110.506 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.5 t -99.24 108.09 20.57 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.101 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.11 -33.47 73.53 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.426 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -61.48 -45.48 94.06 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.256 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -93.14 -12.69 29.77 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.646 -0.421 . . . . 0.0 111.686 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.83 26.95 73.78 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.1 m -135.69 158.17 45.05 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.389 -0.406 . . . . 0.0 110.447 -177.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.44 143.59 47.42 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 85.7 m -110.03 127.8 55.04 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.1 p -127.57 134.73 64.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 121.181 0.515 . . . . 0.0 111.283 -178.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -104.48 114.99 29.58 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 175.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.473 ' O ' ' HD3' ' A' ' 53' ' ' PRO . 16.1 t80 -142.79 165.27 27.85 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.612 -170.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.9 t -107.12 98.21 21.29 Favored Pre-proline 0 C--N 1.319 -0.744 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 51' ' ' TYR . 45.9 Cg_exo -60.66 -25.08 80.17 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.294 2.663 . . . . 0.0 111.971 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.8 m -62.26 -41.06 98.11 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.792 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 76.5 t -65.5 -49.69 76.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-O 121.192 0.52 . . . . 0.0 109.847 177.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.3 p -155.85 147.13 12.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.654 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 29.8 p -68.87 156.22 38.83 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.295 0.569 . . . . 0.0 112.406 -176.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.0 mt -77.2 -12.32 59.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.425 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -58.32 -37.89 76.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.954 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.514 ' O ' ' HG3' ' A' ' 64' ' ' GLN . 16.8 mm100 -61.57 -39.88 92.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.011 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.2 t -61.74 -45.11 99.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.744 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 43.0 t -60.73 -40.54 92.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.96 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 44.7 m170 -64.63 -37.16 86.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.703 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.514 ' HG3' ' O ' ' A' ' 60' ' ' GLN . 98.5 mt-30 -60.87 -44.29 97.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.119 -0.492 . . . . 0.0 112.008 -177.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.52 HD13 ' HB2' ' A' ' 72' ' ' ALA . 20.1 tt -76.32 -38.41 33.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.597 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.13 -37.89 95.24 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 177.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -58.12 -36.89 73.59 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.25 0.62 . . . . 0.0 111.132 177.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.403 ' HG3' ' HB3' ' A' ' 24' ' ' SER . 97.8 mmm -79.91 1.93 25.36 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.87 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.31 19.39 58.86 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.871 -0.68 . . . . 0.0 113.897 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -114.64 135.79 53.76 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 177.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -83.08 140.07 32.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.721 0.296 . . . . 0.0 110.56 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.52 ' HB2' HD13 ' A' ' 65' ' ' ILE . . . -148.23 149.72 32.43 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.175 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 65.9 m -133.92 133.97 42.08 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.181 177.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 85.9 mt -100.28 125.87 53.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.258 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -138.67 148.37 43.93 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.419 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.466 -0.778 . . . . 0.0 109.313 179.239 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -62.0 -44.88 97.19 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 121.039 -0.6 . . . . 0.0 113.3 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.8 p80 -90.23 164.91 14.22 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.453 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.9 tpt -122.17 91.14 3.44 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.807 0.336 . . . . 0.0 110.812 177.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 52.86 28.46 6.5 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.2 p -145.63 135.58 18.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -129.69 128.55 42.77 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.98 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.608 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 63.0 p -126.32 136.99 53.42 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.116 177.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.4 t -159.43 162.91 35.78 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 59.3 p -106.05 136.71 45.25 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.273 0.558 . . . . 0.0 111.077 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.32 123.61 70.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 177.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -80.61 141.15 35.29 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -178.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.2 pt -109.68 126.86 66.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-O 121.332 0.586 . . . . 0.0 111.369 -177.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.4 tp -126.26 117.8 23.81 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -165.47 160.46 33.85 Favored Glycine 0 N--CA 1.422 -2.27 0 C-N-CA 120.07 -1.062 . . . . 0.0 111.495 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.6 mmt -65.41 -39.67 92.45 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.3 p -122.33 105.94 10.64 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.722 176.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.9 m -63.63 -40.15 96.16 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.712 -177.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -62.93 -40.71 98.45 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.79 0.329 . . . . 0.0 110.471 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.4 m -62.81 -44.65 95.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.79 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.405 ' HB3' ' CD1' ' A' ' 70' ' ' PHE . 27.9 p -67.14 -38.28 85.25 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.128 -178.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 78.8 t -64.86 -45.02 96.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-O 121.128 0.489 . . . . 0.0 109.828 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -63.52 -43.14 98.03 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.925 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.492 ' HB3' ' HG3' ' A' ' 68' ' ' MET . 68.8 m -62.44 -42.79 99.71 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.825 -178.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.428 HD12 ' HB ' ' A' ' 65' ' ' ILE . 17.9 tt -72.56 -37.65 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.41 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -60.83 -45.94 92.49 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.228 0.537 . . . . 0.0 109.956 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -60.7 -49.71 76.43 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.366 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 44.4 ttt180 -66.02 -43.69 86.91 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.237 -177.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 87.9 mt -63.68 -39.87 86.97 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.799 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.861 177.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 69.3 m -59.72 -37.24 78.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.98 0.419 . . . . 0.0 110.384 178.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -68.59 -26.5 65.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.994 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.0 mp -97.71 150.01 21.67 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.31 0.576 . . . . 0.0 112.105 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -75.58 154.66 36.61 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.793 178.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.95 2.05 45.59 Favored Glycine 0 CA--C 1.505 -0.543 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.971 177.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.8 tt -72.62 108.13 3.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.253 0.549 . . . . 0.0 110.794 178.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' A' ' 50' ' ' LYS . 46.0 mm -101.88 -71.47 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.816 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 52.2 m -155.65 158.41 38.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.752 0.31 . . . . 0.0 111.242 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.8 ptm -148.74 148.53 30.11 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.242 175.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.52 ' HB3' ' HB ' ' A' ' 48' ' ' THR . 55.1 tttp -117.36 112.0 20.11 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.317 176.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.7 p -118.79 114.43 44.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-O 121.409 0.623 . . . . 0.0 110.008 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.7 m -124.98 127.01 46.36 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.02 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 93.8 mt -63.29 -39.07 93.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.225 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -61.75 -39.32 91.19 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.258 0.552 . . . . 0.0 110.365 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -72.56 -30.11 64.14 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.465 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.66 14.94 80.87 Favored Glycine 0 C--O 1.236 0.255 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.036 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 89.7 p -156.17 164.4 38.42 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.56 134.78 55.07 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.926 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' A' ' 39' ' ' LYS . 53.4 m -94.54 124.32 38.5 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 177.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.608 ' O ' ' HA ' ' A' ' 8' ' ' THR . 28.9 m -107.86 142.0 21.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.457 -177.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.461 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 87.7 tttt -131.58 104.58 7.03 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.478 -0.783 . . . . 0.0 108.926 178.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.523 ' CE2' ' HB ' ' A' ' 49' ' ' VAL . 64.5 m-85 -140.25 160.38 40.09 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.967 -177.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.0 t -80.44 117.08 66.08 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.612 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 30.1 Cg_endo -62.28 -25.83 76.92 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.142 2.561 . . . . 0.0 113.096 -176.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.8 t -62.94 -41.57 99.53 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.054 0.454 . . . . 0.0 110.334 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.1 t -87.53 -49.81 14.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.3 -177.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.612 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 28.5 m -132.82 161.68 41.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.484 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 31.1 p -133.74 169.72 16.63 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 120.679 0.276 . . . . 0.0 110.899 -178.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.1 mt -62.6 -38.59 90.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.51 -177.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -60.32 -44.49 95.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.43 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.495 ' O ' ' HG3' ' A' ' 64' ' ' GLN . 97.0 mt-30 -64.42 -41.06 96.82 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.104 178.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 73.6 t -62.08 -46.13 97.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 CA-C-O 121.133 0.492 . . . . 0.0 110.353 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.504 ' SG ' ' HB ' ' A' ' 74' ' ' ILE . 93.8 m -62.78 -39.71 95.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.848 178.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -62.47 -41.64 98.92 Favored 'General case' 0 C--O 1.206 -1.226 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.052 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 60' ' ' GLN . 78.5 mt-30 -60.39 -42.42 95.87 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -175.177 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.428 ' HB ' HD12 ' A' ' 25' ' ' ILE . 17.4 tt -76.77 -40.95 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.571 178.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.578 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -63.33 -38.33 96.26 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 121.334 -0.46 . . . . 0.0 112.381 178.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -58.72 -33.59 70.38 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 124.261 1.024 . . . . 0.0 110.509 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.492 ' HG3' ' HB3' ' A' ' 24' ' ' SER . 96.6 mmm -79.09 -1.32 35.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.936 -178.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.17 15.55 44.26 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.149 -1.024 . . . . 0.0 113.589 177.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.578 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 99.3 m-85 -113.8 145.86 40.79 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.788 0.328 . . . . 0.0 110.354 178.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -88.52 130.75 35.16 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 120.983 0.421 . . . . 0.0 111.028 -178.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.46 140.2 24.85 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.644 178.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.7 m -127.0 141.49 51.78 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.1 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.504 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 10.2 tp -98.33 136.32 29.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 120.859 0.361 . . . . 0.0 110.498 -177.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -154.43 159.35 41.02 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.23 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 . . . . . 0 C--O 1.252 1.198 0 CA-C-O 118.152 -0.928 . . . . 0.0 110.721 179.094 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.569 ' HA ' ' OE1' ' A' ' 5' ' ' GLN . . . . . . . . 0 N--CA 1.467 0.39 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -157.86 174.91 35.21 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.117 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -83.69 129.0 34.95 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.7 ttt 55.04 48.66 19.29 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -176.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.569 ' OE1' ' HA ' ' A' ' 1' ' ' ALA . 53.6 tt0 -70.67 123.79 22.73 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.576 -177.108 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.7 t -126.7 129.27 71.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.875 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.01 134.11 44.5 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.137 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 69.8 p -123.73 137.52 54.68 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.855 178.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 72.7 m -147.11 157.3 43.56 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.448 178.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 38.4 p -110.01 139.23 45.35 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 177.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.453 ' CG2' ' HB1' ' A' ' 72' ' ' ALA . 7.0 p -129.74 119.69 48.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-O 120.967 0.413 . . . . 0.0 110.205 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.526 ' HG2' ' HB2' ' A' ' 73' ' ' SER . 9.2 ptm180 -82.21 148.79 28.24 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.9 pt -112.81 142.66 24.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 121.278 0.561 . . . . 0.0 111.123 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 67.1 tp -132.69 119.74 20.78 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.166 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.414 ' HA3' ' HD1' ' A' ' 70' ' ' PHE . . . 178.41 174.41 44.64 Favored Glycine 0 N--CA 1.436 -1.305 0 C-N-CA 119.27 -1.443 . . . . 0.0 113.831 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 28.1 ttt -62.06 -48.13 81.6 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 122.987 0.515 . . . . 0.0 111.426 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.4 p -128.86 119.34 24.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.066 0.46 . . . . 0.0 111.297 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.8 m -65.47 -39.02 91.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.118 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -63.42 -39.47 94.58 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.449 -177.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.8 m -62.67 -43.73 98.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.543 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.0 p -71.83 -39.65 69.64 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -178.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.7 m -69.99 -33.02 53.57 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 120.291 -0.563 . . . . 0.0 111.051 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -71.09 -42.28 69.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.111 0.482 . . . . 0.0 110.863 177.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.5 m -62.73 -43.55 98.51 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.041 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.574 ' HB ' ' CG2' ' A' ' 65' ' ' ILE . 19.3 tt -71.56 -29.71 35.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.618 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -59.63 -45.16 92.8 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.559 -177.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -61.97 -50.8 70.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.795 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.514 HH11 ' HA ' ' A' ' 64' ' ' GLN . 99.4 mtt180 -65.47 -39.95 92.57 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -177.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.444 HG23 HG21 ' A' ' 35' ' ' ILE . 27.6 mm -60.99 -44.56 98.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.99 0.424 . . . . 0.0 110.328 176.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.7 t -62.54 -39.93 95.18 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.385 178.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -68.56 -28.78 67.26 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.006 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 64.4 tp -100.38 118.13 35.99 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.133 0.492 . . . . 0.0 111.478 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -83.22 153.05 24.92 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.056 178.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.501 ' HA3' HG11 ' A' ' 55' ' ' VAL . . . 118.29 -11.4 12.86 Favored Glycine 0 CA--C 1.499 -0.91 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -176.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.444 HG21 HG23 ' A' ' 29' ' ' ILE . 12.6 tt -108.42 110.43 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 173.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.14 -47.03 95.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.864 -174.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 85.0 p -158.85 160.57 36.33 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.479 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 28.0 ttt -146.69 129.87 16.54 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.554 177.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -121.3 139.76 52.98 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.6 m -116.52 140.27 39.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 120.873 0.368 . . . . 0.0 110.894 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.6 t -119.64 106.81 12.53 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.778 178.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.8 mp -64.65 -39.72 94.17 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.271 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -62.3 -44.98 95.26 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.501 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -75.71 -28.68 58.68 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.048 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.21 25.62 65.83 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -176.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 12' ' ' ARG . 45.4 t -145.32 150.98 37.59 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.079 -0.56 . . . . 0.0 110.034 -176.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.04 145.88 45.51 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.361 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 87.2 m -105.82 126.02 51.67 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 8' ' ' THR . 23.7 m -110.6 138.3 39.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-O 120.966 0.412 . . . . 0.0 110.382 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -128.43 108.08 10.26 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -149.19 165.99 30.17 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.029 0.442 . . . . 0.0 112.035 -171.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 52.1 t -79.72 119.8 77.99 Favored Pre-proline 0 C--N 1.319 -0.741 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 174.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -60.68 -32.21 92.92 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.649 2.232 . . . . 0.0 113.281 -174.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.6 t -65.06 -41.93 94.67 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.001 0.429 . . . . 0.0 110.934 178.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.501 HG11 ' HA3' ' A' ' 34' ' ' GLY . 60.0 t -81.42 -46.04 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -175.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 74.0 t -114.75 133.88 59.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -173.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 29.1 p -109.25 147.95 31.77 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.285 177.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.494 HD13 HG21 ' A' ' 74' ' ' ILE . 87.1 mt -64.56 -40.3 95.32 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -176.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -62.6 -39.72 94.65 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -177.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.446 HE21 ' HB3' ' A' ' 60' ' ' GLN . 1.1 tm0? -61.85 -41.6 98.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.961 0.41 . . . . 0.0 109.999 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.428 HG13 HD11 ' A' ' 25' ' ' ILE . 76.4 t -63.31 -44.49 99.12 Favored 'Isoleucine or valine' 0 C--O 1.247 0.924 0 CA-C-O 121.47 0.652 . . . . 0.0 110.403 177.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 97.2 m -61.65 -38.31 87.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.15 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 61.4 m170 -66.87 -26.17 66.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.088 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.514 ' HA ' HH11 ' A' ' 28' ' ' ARG . 78.8 mt-30 -60.73 -43.65 97.63 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 120.79 0.328 . . . . 0.0 110.432 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.638 HD11 ' HB2' ' A' ' 72' ' ' ALA . 36.6 pt -87.65 -25.89 5.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.251 176.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -61.5 -35.96 91.86 Favored Glycine 0 N--CA 1.453 -0.22 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.467 178.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -58.83 -37.43 76.41 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.856 0.36 . . . . 0.0 110.935 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 26.4 mmt -79.63 1.2 27.08 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.733 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.9 10.3 60.1 Favored Glycine 0 CA--C 1.508 -0.404 0 C-N-CA 120.604 -0.808 . . . . 0.0 113.035 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.458 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 72.2 m-85 -98.84 139.14 34.95 Favored 'General case' 0 C--N 1.315 -0.901 0 O-C-N 122.645 -0.326 . . . . 0.0 110.235 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -100.75 151.15 22.01 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.353 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.638 ' HB2' HD11 ' A' ' 65' ' ' ILE . . . -144.93 156.69 44.12 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 120.782 0.325 . . . . 0.0 111.242 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.526 ' HB2' ' HG2' ' A' ' 12' ' ' ARG . 40.4 m -129.19 146.8 51.04 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.494 HG21 HD13 ' A' ' 58' ' ' LEU . 84.2 mt -101.95 127.18 55.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.238 0.542 . . . . 0.0 111.947 -174.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -128.52 157.14 42.0 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.135 177.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 . . . . . 0 C--O 1.242 0.678 0 C-N-CA 123.37 0.668 . . . . 0.0 110.283 -176.985 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.01 137.13 29.5 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.233 -0.984 . . . . 0.0 110.896 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -91.78 124.35 35.85 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.997 0.427 . . . . 0.0 111.12 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 98.5 mmm -89.51 138.14 31.72 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.263 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -85.34 137.27 33.06 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.629 -0.429 . . . . 0.0 110.263 178.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.473 HG11 HD12 ' A' ' 36' ' ' ILE . 61.8 t -95.29 120.31 44.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.78 148.05 25.36 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.768 -175.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.8 p -100.64 136.05 41.11 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.174 176.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.3 m -126.8 145.86 50.47 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 120.704 0.288 . . . . 0.0 110.227 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 46.5 p -117.16 140.1 49.94 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.347 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.91 126.76 38.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.447 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.494 ' HG2' ' HB3' ' A' ' 73' ' ' SER . 14.7 ptm180 -83.42 149.17 26.84 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.721 HG21 ' SG ' ' A' ' 21' ' ' CYS . 86.0 mt -123.1 130.51 74.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -176.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.7 tp -131.61 119.07 20.93 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -173.42 -177.27 42.53 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.247 -0.977 . . . . 0.0 112.403 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 66.8 mtt -63.78 -43.22 97.01 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.6 m -136.6 116.91 13.58 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.633 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.416 ' O ' HG23 ' A' ' 22' ' ' VAL . 94.1 m -65.57 -40.23 92.56 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.729 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -62.82 -40.87 98.74 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -177.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.9 m -62.5 -44.27 96.79 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -177.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.721 ' SG ' HG21 ' A' ' 13' ' ' ILE . 24.5 p -71.38 -35.73 71.18 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.64 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 18' ' ' CYS . 59.0 t -62.76 -44.22 99.33 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 177.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.96 -40.25 97.14 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.114 177.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.7 t -60.63 -47.64 85.32 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.295 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.6 pt -74.25 -29.4 24.63 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.899 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -59.53 -48.83 80.13 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -65.41 -51.18 62.09 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.306 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -62.27 -50.71 70.61 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-O 121.192 0.52 . . . . 0.0 111.631 -174.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.448 ' CG2' HD12 ' A' ' 35' ' ' ILE . 37.4 mm -62.83 -41.98 94.63 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.929 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.752 179.179 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 73.2 m -60.56 -38.81 85.74 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -68.52 -27.17 65.87 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.035 177.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 60.5 tp -87.25 129.69 34.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.148 0.499 . . . . 0.0 110.966 177.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -70.81 151.88 44.33 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.354 177.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.95 -4.97 18.55 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.881 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.448 HD12 ' CG2' ' A' ' 29' ' ' ILE . 9.3 tt -96.14 138.32 21.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.84 0.353 . . . . 0.0 110.899 178.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.473 HD12 HG11 ' A' ' 6' ' ' VAL . 86.4 mt -113.02 -53.31 5.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.793 176.342 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.9 m -137.52 151.72 48.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.889 0.376 . . . . 0.0 111.694 -177.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.45 ' HG3' HG12 ' A' ' 49' ' ' VAL . 60.6 ttm -139.14 131.21 27.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.394 176.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -128.79 124.54 35.7 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.9 m -126.61 140.0 50.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.381 -179.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.4 t -134.74 108.3 7.91 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.973 177.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.5 mp -66.5 -32.57 74.01 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.643 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -61.74 -39.92 93.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.283 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -75.41 -27.39 59.01 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.06 0.457 . . . . 0.0 110.14 176.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.2 15.47 81.0 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 -177.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 12' ' ' ARG . 51.1 m -135.13 153.69 51.91 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 121.085 0.469 . . . . 0.0 110.627 -178.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.66 139.19 51.91 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.498 178.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 79.6 m -115.18 125.5 53.48 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.45 HG12 ' HG3' ' A' ' 38' ' ' MET . 31.5 m -125.58 148.05 30.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.977 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -124.1 116.53 22.92 Favored 'General case' 0 C--O 1.245 0.838 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.58 ' CD2' ' HB ' ' A' ' 56' ' ' VAL . 55.3 p90 -152.61 166.15 32.99 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.474 -173.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.8 t -77.5 117.99 69.09 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.03 -30.37 82.85 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.769 2.313 . . . . 0.0 113.546 -175.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.3 t -64.78 -44.19 90.8 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.039 0.447 . . . . 0.0 110.828 178.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 90.9 t -72.7 -47.17 51.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.71 -177.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.58 ' HB ' ' CD2' ' A' ' 51' ' ' TYR . 58.3 t -112.63 126.3 70.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.093 -177.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 60' ' ' GLN . 28.6 p -100.92 158.35 16.05 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 120.989 0.423 . . . . 0.0 111.473 -178.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.3 mt -63.41 -39.12 93.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.576 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -62.19 -39.93 94.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.671 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.49 ' HB2' ' SG ' ' A' ' 57' ' ' CYS . 64.9 tt0 -61.16 -46.55 90.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.627 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.5 t -61.93 -44.44 98.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.625 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 93.3 m -61.66 -41.46 97.56 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.089 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -66.04 -41.13 91.28 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.759 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.489 ' HG3' ' O ' ' A' ' 60' ' ' GLN . 95.6 mt-30 -60.87 -42.24 97.51 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.985 -175.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.0 tt -84.04 -41.23 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.98 -40.18 98.99 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 116.303 -0.408 . . . . 0.0 113.501 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -60.51 -35.82 76.88 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.936 0.398 . . . . 0.0 110.571 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 26.5 mmt -69.76 -11.95 61.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.468 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.98 12.21 32.44 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.394 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.529 ' CG ' ' HB3' ' A' ' 21' ' ' CYS . 94.9 m-85 -110.32 125.48 53.22 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -76.96 139.11 40.02 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.624 -178.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.13 155.18 41.94 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 120.889 0.376 . . . . 0.0 111.603 -177.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.494 ' HB3' ' HG2' ' A' ' 12' ' ' ARG . 42.0 t -137.29 139.95 41.24 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 36.4 pt -105.67 151.82 7.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -173.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.547 ' O ' ' HB2' ' A' ' 76' ' ' GLU . . . -151.35 160.26 43.86 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.7 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.547 ' HB2' ' O ' ' A' ' 75' ' ' ALA . 39.5 mm-40 . . . . . 0 C--O 1.251 1.148 0 C-N-CA 123.3 0.64 . . . . 0.0 110.879 -178.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.622 0 CA-C-O 120.632 0.253 . . . . 0.0 110.375 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -123.56 166.29 16.08 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.524 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -67.64 149.74 49.66 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.622 0.248 . . . . 0.0 110.356 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -66.71 116.88 8.1 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.021 0.438 . . . . 0.0 110.966 -178.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -65.24 -37.84 88.49 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.663 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.5 m -107.77 150.58 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.587 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.98 147.27 42.44 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.103 0.478 . . . . 0.0 111.885 -175.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 53.9 p -119.35 150.15 40.64 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.715 176.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.429 ' OG ' HD21 ' A' ' 58' ' ' LEU . 87.5 p -155.34 160.35 40.66 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.314 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 41.2 p -127.77 146.09 50.7 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.538 176.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.5 m -128.92 146.19 34.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.459 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 38.5 ptt180 -106.67 140.99 38.65 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.535 HG12 ' SG ' ' A' ' 21' ' ' CYS . 7.8 tp -120.08 131.51 72.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-O 121.679 0.752 . . . . 0.0 112.424 -173.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 65.7 tp -124.67 118.19 25.93 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.52 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -170.01 169.32 42.09 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 119.938 -1.125 . . . . 0.0 112.733 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 79.3 mtm -64.09 -42.81 96.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.786 0.327 . . . . 0.0 111.377 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.7 p -132.52 122.54 25.01 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.193 0.52 . . . . 0.0 111.57 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.402 ' O ' HG23 ' A' ' 22' ' ' VAL . 44.1 t -63.6 -41.9 98.28 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.141 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.8 mp0 -61.51 -40.42 94.54 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.295 -176.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.7 m -62.84 -45.59 91.9 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -177.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.535 ' SG ' HG12 ' A' ' 13' ' ' ILE . 26.7 p -68.71 -35.66 77.46 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.178 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 18' ' ' CYS . 67.6 t -62.91 -44.32 99.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-O 121.114 0.483 . . . . 0.0 109.759 178.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -64.81 -40.13 94.71 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.012 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.6 m -62.74 -46.65 87.08 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.376 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.547 ' HB ' ' CG2' ' A' ' 65' ' ' ILE . 8.1 tp -69.9 -31.94 49.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.009 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -58.84 -42.81 90.16 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.316 -178.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -59.3 -53.57 56.75 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.418 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 24.0 ttm180 -67.14 -47.15 71.93 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.118 -178.224 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.578 ' O ' HD11 ' A' ' 35' ' ' ILE . 18.5 tt -65.76 -41.43 90.29 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.987 -175.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 86.6 p -66.33 -30.09 70.42 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-O 121.062 0.458 . . . . 0.0 110.488 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -70.62 -27.09 63.81 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.841 177.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 28' ' ' ARG . 89.9 mt -91.72 137.63 32.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.189 0.518 . . . . 0.0 111.775 -178.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -86.72 151.62 23.24 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.841 177.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.58 8.22 12.71 Favored Glycine 0 C--O 1.238 0.369 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.658 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.578 HD11 ' O ' ' A' ' 29' ' ' ILE . 79.8 mt -81.67 121.98 35.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 83.6 mt -94.24 -54.77 6.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.0 t -149.06 124.21 10.12 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.97 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.429 ' SD ' HD13 ' A' ' 29' ' ' ILE . 27.2 ttt -121.24 113.58 20.16 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.125 177.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -133.29 145.68 50.69 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.139 178.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.45 126.51 74.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.222 0.534 . . . . 0.0 110.089 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.8 m -93.65 91.99 7.31 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.152 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.8 mt -63.54 -35.98 82.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.603 0.716 . . . . 0.0 109.235 178.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -62.84 -40.28 96.95 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.844 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -90.33 -12.19 38.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.046 -177.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.5 29.69 69.64 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.379 -0.915 . . . . 0.0 111.471 -177.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 90.1 p -151.06 163.66 38.25 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.48 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -119.07 145.83 45.59 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.533 0.206 . . . . 0.0 110.82 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.3 m -112.93 121.95 46.18 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.0 t -120.49 123.19 69.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-O 120.884 0.373 . . . . 0.0 110.371 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -109.2 119.38 39.35 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 176.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -150.77 166.68 29.72 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.697 -170.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.9 t -92.05 110.82 46.62 Favored Pre-proline 0 N--CA 1.444 -0.755 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 173.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 37.6 Cg_endo -64.27 -21.72 67.02 Favored 'Trans proline' 0 N--CA 1.475 0.427 0 C-N-CA 122.88 2.387 . . . . 0.0 113.467 -175.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.5 t -64.37 -42.71 96.04 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.173 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.8 p -95.11 -35.71 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 12.2 p -130.14 149.89 34.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -177.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 29.6 p -134.01 163.06 30.39 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.19 0.519 . . . . 0.0 111.663 -175.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.446 ' HA ' HG22 ' A' ' 61' ' ' VAL . 98.6 mt -70.8 -22.53 62.34 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.982 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -61.73 -42.3 98.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.07 0.462 . . . . 0.0 110.14 -179.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -65.15 -40.89 95.01 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.182 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.497 ' HB ' HD11 ' A' ' 25' ' ' ILE . 32.7 m -72.71 -36.4 52.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.53 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 95.6 m -64.18 -39.51 94.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.665 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 66.3 m170 -64.31 -39.94 94.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.314 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -60.83 -43.79 97.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.606 -177.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.547 ' CG2' ' HB ' ' A' ' 25' ' ' ILE . 27.2 pt -87.04 -37.87 11.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -178.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -62.94 -40.71 99.62 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.888 -0.673 . . . . 0.0 113.137 -178.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -70.13 -14.91 62.86 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 26.3 mmt -85.11 2.34 43.88 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.907 0.384 . . . . 0.0 110.817 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.48 -9.2 71.73 Favored Glycine 0 CA--C 1.507 -0.407 0 C-N-CA 121.066 -0.587 . . . . 0.0 112.188 179.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.459 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 96.8 m-85 -80.89 143.57 32.61 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -106.25 128.31 53.87 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.643 -177.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 12' ' ' ARG . . . -147.31 151.23 36.24 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.466 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.8 p -136.77 153.63 50.78 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.903 0.382 . . . . 0.0 111.341 178.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 81.3 mt -90.98 131.86 37.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.908 -174.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -133.67 126.54 31.02 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.454 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 . . . . . 0 C--N 1.314 -0.97 0 CA-C-O 118.062 -0.97 . . . . 0.0 110.657 179.691 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.615 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.6 -130.74 46.33 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.14 -177.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.436 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 63.0 m170 -90.11 152.67 21.02 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.84 0.352 . . . . 0.0 110.247 -179.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 96.2 mmm -70.84 -37.9 73.18 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.911 0.386 . . . . 0.0 111.026 175.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -67.0 -40.01 87.26 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.087 178.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.436 ' O ' ' HB2' ' A' ' 3' ' ' HIS . 7.6 p -139.45 125.89 23.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.066 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.409 ' H ' ' HD3' ' A' ' 53' ' ' PRO . . . -108.77 134.55 51.32 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.287 0.565 . . . . 0.0 112.27 -173.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 50.5 p -123.97 140.5 52.92 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.976 174.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 91.3 p -158.46 166.85 31.2 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.019 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 2.1 p -110.32 148.48 31.85 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 175.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 91.1 t -131.01 126.89 60.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.425 ' NE ' ' HB2' ' A' ' 73' ' ' SER . 37.9 ptt180 -87.8 144.62 26.51 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.6 HG12 ' SG ' ' A' ' 21' ' ' CYS . 7.4 tp -129.61 130.3 66.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-O 121.163 0.506 . . . . 0.0 111.134 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 62.0 tp -129.47 124.22 33.48 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.478 178.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -165.18 176.25 40.9 Favored Glycine 0 N--CA 1.435 -1.425 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.157 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 61.0 tpp -61.52 -47.91 83.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.884 0.373 . . . . 0.0 111.024 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 65.9 m -130.4 125.16 33.84 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.119 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.8 t -63.23 -43.59 97.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.396 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -61.52 -38.76 88.57 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.528 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.0 m -60.47 -44.21 96.12 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -177.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.6 ' SG ' HG12 ' A' ' 13' ' ' ILE . 25.6 p -70.99 -36.95 72.68 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.235 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.9 t -63.18 -44.53 99.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-O 121.123 0.487 . . . . 0.0 109.764 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -64.41 -40.38 95.67 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.878 178.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.639 ' O ' ' HD3' ' A' ' 28' ' ' ARG . 68.9 m -62.11 -45.04 95.23 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.38 -178.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.468 ' HB ' ' HB ' ' A' ' 65' ' ' ILE . 17.9 tt -70.93 -33.77 53.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.849 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -60.22 -48.01 83.54 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.934 -177.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -61.55 -46.69 88.86 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.887 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.639 ' HD3' ' O ' ' A' ' 24' ' ' SER . 10.9 mpt_? -70.41 -41.75 72.53 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.754 -177.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.6 ' O ' HD11 ' A' ' 35' ' ' ILE . 16.6 tt -70.66 -39.81 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.163 -177.342 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 79.5 p -66.06 -28.33 68.76 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 120.988 0.423 . . . . 0.0 110.515 178.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -67.96 -28.76 67.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.793 175.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.4 tp -86.95 118.66 26.48 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.655 177.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -78.58 142.9 36.94 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.949 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.22 8.86 11.03 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.815 -178.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.6 HD11 ' O ' ' A' ' 29' ' ' ILE . 90.0 mt -70.75 125.12 28.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.642 ' HB ' ' O ' ' A' ' 50' ' ' LYS . 47.9 mm -88.21 -63.85 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.1 t -161.82 140.11 9.21 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.805 177.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.435 ' HG2' HG12 ' A' ' 49' ' ' VAL . 18.8 tmm? -137.27 126.37 24.46 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 176.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -125.14 115.68 20.84 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.2 p -103.16 122.32 55.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-O 121.172 0.51 . . . . 0.0 110.296 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.4 m -96.89 99.95 11.49 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 97.1 mt -63.9 -38.89 92.75 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.937 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -63.69 -40.25 96.32 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.978 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -77.1 -30.01 55.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.9 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.68 20.17 71.8 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -175.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.0 t -146.5 150.36 35.43 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -178.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -119.53 148.77 42.9 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 120.804 0.335 . . . . 0.0 111.735 -177.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.2 m -108.35 124.48 50.41 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.691 ' HB ' ' CE2' ' A' ' 51' ' ' TYR . 33.6 m -119.32 149.6 21.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.621 -176.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.642 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 65.3 tttm -140.05 106.36 5.27 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.691 ' CE2' ' HB ' ' A' ' 49' ' ' VAL . 42.2 m-85 -138.37 161.92 35.73 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -177.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 64.8 t -88.34 110.41 36.09 Favored Pre-proline 0 N--CA 1.439 -1.0 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 172.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 36.2 Cg_endo -64.21 -23.48 66.35 Favored 'Trans proline' 0 CA--C 1.514 -0.489 0 C-N-CA 122.592 2.195 . . . . 0.0 112.341 -176.133 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 61.9 m -62.95 -42.0 99.68 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 177.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.5 t -75.1 -48.42 32.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.826 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 7.5 p -146.68 139.54 19.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.954 -178.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.416 ' SG ' ' HB2' ' A' ' 60' ' ' GLN . 26.5 p -83.51 153.71 24.26 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.107 0.479 . . . . 0.0 111.196 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.1 mt -66.06 -37.26 85.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.759 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -60.04 -40.61 89.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.436 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.416 ' HB2' ' SG ' ' A' ' 57' ' ' CYS . 1.0 OUTLIER -62.14 -41.02 97.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.192 0.52 . . . . 0.0 109.633 179.12 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 73.9 t -63.41 -44.24 98.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.084 178.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 49.6 t -60.42 -41.52 94.14 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.146 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -61.07 -41.4 96.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.367 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -61.08 -41.65 97.04 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 -176.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.468 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 20.3 tt -76.89 -38.25 28.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.94 178.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.6 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -64.35 -38.49 95.9 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-N 115.699 -0.682 . . . . 0.0 113.702 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -58.1 -35.8 71.97 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.275 0.63 . . . . 0.0 112.081 -175.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 15.7 tpt -57.76 -25.82 61.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.786 -178.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 123.66 6.19 7.36 Favored Glycine 0 CA--C 1.5 -0.901 0 C-N-CA 120.229 -0.986 . . . . 0.0 112.188 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.6 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 65.2 m-85 -110.16 135.96 50.13 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -89.33 121.59 31.75 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.236 0.541 . . . . 0.0 111.751 -174.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.54 135.72 54.16 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.126 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.425 ' HB2' ' NE ' ' A' ' 12' ' ' ARG . 45.5 m -131.62 144.78 51.3 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.6 tt -69.45 128.18 32.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 121.47 0.652 . . . . 0.0 110.902 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -97.74 134.51 40.81 Favored 'General case' 0 C--O 1.261 1.673 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.657 177.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 . . . . . 0 C--O 1.249 1.058 0 O-C-N 124.832 1.333 . . . . 0.0 110.658 -176.155 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.702 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.86 32.14 73.51 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.663 -0.78 . . . . 0.0 111.358 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -61.75 132.15 52.23 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.041 0.448 . . . . 0.0 111.339 -176.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -139.21 155.1 48.04 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.94 178.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -64.8 -38.74 92.01 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -176.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.9 t -102.47 120.77 52.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -113.58 139.57 48.89 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 120.893 0.378 . . . . 0.0 111.23 -177.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 67.6 p -121.61 148.21 44.84 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.097 178.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.2 t -158.31 157.0 31.61 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 73.5 p -117.1 142.06 47.48 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 120.799 0.333 . . . . 0.0 110.335 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.9 m -131.89 145.8 34.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.364 178.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 45.8 ptt85 -108.86 142.95 38.71 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 175.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.7 pt -118.26 142.98 30.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-O 121.458 0.647 . . . . 0.0 112.006 -175.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.2 tp -110.12 118.44 36.41 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.728 177.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.44 140.04 4.15 Favored Glycine 0 N--CA 1.434 -1.495 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.349 179.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 95.9 mmm -67.97 -37.71 81.85 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.233 0.539 . . . . 0.0 109.924 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.0 p -111.22 58.16 0.62 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.883 177.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 26.3 p -59.56 -30.66 68.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.767 -175.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -64.49 -33.99 77.18 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.741 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.3 t -66.41 -45.34 80.29 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.439 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.531 ' HB3' ' CD1' ' A' ' 70' ' ' PHE . 28.4 p -66.05 -35.06 79.51 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.267 -177.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 69.9 t -61.81 -45.71 98.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -65.43 -42.24 92.66 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.947 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.3 m -63.97 -42.9 97.12 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.287 -178.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 21' ' ' CYS . 46.9 pt -78.56 -27.12 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.401 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -61.77 -39.45 91.68 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -59.98 -43.13 95.32 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.693 176.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -64.26 -43.31 95.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.185 0.517 . . . . 0.0 110.277 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.41 -46.25 96.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.603 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 88.1 p -64.62 -28.38 69.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.71 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -72.78 -27.35 61.94 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.927 0.394 . . . . 0.0 110.573 177.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.3 tt -81.74 123.88 29.13 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -83.38 147.48 27.87 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.778 0.323 . . . . 0.0 111.417 -177.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.31 7.67 56.93 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.774 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.8 pt -75.0 139.29 19.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.772 0.32 . . . . 0.0 111.176 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.621 ' HB ' ' O ' ' A' ' 50' ' ' LYS . 42.1 mm -89.19 -79.84 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.954 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 82.2 p -168.61 166.68 11.82 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.788 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -156.99 159.11 37.72 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 175.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -129.69 132.78 46.75 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 69.8 t -116.21 125.68 73.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 120.827 0.346 . . . . 0.0 110.789 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.6 t -103.34 102.48 12.43 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 177.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.6 tp -62.4 -42.72 99.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.765 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.2 -45.45 94.54 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.459 -178.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -74.96 -29.69 61.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.411 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.65 16.14 78.15 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.0 m -129.48 152.39 49.07 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.342 -0.429 . . . . 0.0 110.144 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -128.39 149.35 50.57 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.544 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.7 m -113.41 126.6 55.53 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.489 ' HB ' ' CE2' ' A' ' 51' ' ' TYR . 27.5 m -114.29 146.39 18.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.466 -177.463 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.621 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 87.6 tttt -132.2 104.17 6.63 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.489 ' CE2' ' HB ' ' A' ' 49' ' ' VAL . 84.5 m-85 -141.52 160.11 40.84 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 120.995 0.426 . . . . 0.0 111.853 -176.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.8 m -98.66 112.45 62.6 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.518 176.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -56.17 -26.62 61.54 Favored 'Trans proline' 0 N--CA 1.48 0.686 0 C-N-CA 123.265 2.643 . . . . 0.0 112.162 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.2 t -61.08 -42.27 98.2 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.274 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.9 t -101.22 -40.28 7.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -177.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.4 HG13 ' HB3' ' A' ' 51' ' ' TYR . 7.5 p -130.2 139.65 50.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.162 0.506 . . . . 0.0 111.488 -177.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.418 ' SG ' ' HB3' ' A' ' 59' ' ' GLN . 42.6 t -93.16 121.89 34.98 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.434 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.3 mp -63.76 -37.45 87.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.607 178.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.418 ' HB3' ' SG ' ' A' ' 57' ' ' CYS . 57.5 tp60 -60.76 -39.31 88.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.679 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -62.89 -38.56 91.39 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.32 178.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 75.6 t -60.83 -42.68 93.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.675 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 42.6 t -60.22 -39.61 87.23 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.937 176.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -64.15 -35.12 79.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.383 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -60.57 -42.24 96.25 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.484 -178.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.456 ' HB ' HG21 ' A' ' 25' ' ' ILE . 20.2 tt -76.55 -37.55 29.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 120.294 -0.563 . . . . 0.0 111.318 178.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.48 -44.24 97.88 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.452 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -67.18 -31.48 71.91 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.284 0.564 . . . . 0.0 110.297 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 50.1 tpp -59.23 -29.18 67.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.217 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 119.35 5.39 11.44 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.479 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.531 ' CD1' ' HB3' ' A' ' 21' ' ' CYS . 89.5 m-85 -112.78 131.04 55.86 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 120.977 0.418 . . . . 0.0 110.577 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -85.55 134.99 34.0 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.191 -177.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -133.19 147.6 52.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.836 0.35 . . . . 0.0 111.337 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.6 t -119.14 132.67 56.01 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 15.2 tt -103.49 134.19 45.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.502 0.668 . . . . 0.0 111.977 -175.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 76' ' ' GLU . . . -135.22 157.5 46.75 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.867 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.407 ' HB3' ' O ' ' A' ' 75' ' ' ALA . 43.2 tt0 . . . . . 0 C--O 1.245 0.854 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.628 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.919 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.24 -129.97 48.31 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.993 -0.623 . . . . 0.0 112.066 -178.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -81.77 124.81 29.96 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 63.3 mtt -87.13 97.29 10.67 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.172 0.51 . . . . 0.0 110.327 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.1 pm0 -77.28 161.02 28.44 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.377 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.6 t -105.32 119.3 54.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 120.895 0.379 . . . . 0.0 110.107 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 50' ' ' LYS . . . -121.43 123.94 43.3 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.494 179.211 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.8 p -125.62 151.82 45.99 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.055 0.455 . . . . 0.0 110.684 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.5 t -158.27 146.35 18.53 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.9 178.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 41.9 p -111.5 109.95 20.14 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 175.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.7 p -92.34 115.43 31.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 40.1 ptt180 -82.22 148.04 28.64 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.223 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.8 131.07 70.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-O 121.049 0.452 . . . . 0.0 110.861 -176.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.9 tt -115.16 115.11 26.21 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -171.25 151.91 16.79 Favored Glycine 0 N--CA 1.434 -1.492 0 C-N-CA 120.211 -0.995 . . . . 0.0 112.596 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 23.0 ptt? -74.98 -23.99 58.37 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 122.756 0.422 . . . . 0.0 111.295 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.5 p -122.48 85.57 2.44 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.284 0.564 . . . . 0.0 109.636 177.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.4 m -63.83 -39.98 95.52 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.303 -176.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.504 ' HA ' HG12 ' A' ' 22' ' ' VAL . 98.7 mt-30 -64.38 -41.0 96.93 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -175.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.0 p -64.9 -41.43 95.61 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.776 -177.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.598 ' HB3' ' CD2' ' A' ' 70' ' ' PHE . 20.3 p -74.46 -39.16 62.7 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.504 HG12 ' HA ' ' A' ' 19' ' ' GLN . 9.0 p -68.5 -37.68 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.61 -178.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -64.36 -40.76 96.5 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.978 0.418 . . . . 0.0 110.052 176.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.2 m -61.9 -44.72 96.22 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.671 -178.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.593 HD12 ' HB ' ' A' ' 65' ' ' ILE . 16.2 tt -74.19 -38.65 48.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.726 -0.389 . . . . 0.0 111.425 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.07 -44.29 96.99 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 120.85 0.357 . . . . 0.0 110.948 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -60.73 -44.08 97.1 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.586 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.568 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 99.4 mtt180 -65.33 -46.07 81.77 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.169 -177.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.541 HG22 HD12 ' A' ' 35' ' ' ILE . 98.0 mt -65.96 -44.8 92.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.092 -178.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.426 ' HA ' HG21 ' A' ' 35' ' ' ILE . 77.8 p -64.03 -34.58 78.32 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.032 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -71.81 -26.78 62.55 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.094 0.473 . . . . 0.0 110.74 177.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 28' ' ' ARG . 93.3 mt -82.9 142.32 31.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.543 178.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -76.79 141.21 40.83 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.16 -8.04 18.59 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.876 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.541 HD12 HG22 ' A' ' 29' ' ' ILE . 7.2 tt -75.24 110.1 9.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 176.043 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.9 mt -84.27 -51.19 14.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.278 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.9 t -160.38 145.75 14.89 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.522 177.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.414 ' HG3' HG12 ' A' ' 49' ' ' VAL . 27.3 ttt -135.85 132.16 36.26 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.088 179.271 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -130.34 130.82 44.94 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 178.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.1 t -103.92 120.36 53.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 120.836 0.35 . . . . 0.0 110.397 -178.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 51.0 m -119.73 96.46 5.2 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-O 121.467 0.651 . . . . 0.0 110.63 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.4 -35.41 80.82 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.259 -178.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -61.65 -39.63 92.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.535 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -76.76 -22.68 53.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.139 176.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.56 21.75 68.66 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 89.9 p -149.33 164.93 33.49 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 121.058 0.456 . . . . 0.0 111.326 -177.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.55 137.44 52.58 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 65.3 m -104.56 125.64 50.91 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.806 -177.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.414 HG12 ' HG3' ' A' ' 38' ' ' MET . 27.0 m -129.25 150.03 34.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-O 120.883 0.373 . . . . 0.0 111.369 -179.255 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 14.3 ptmm? -131.45 135.71 47.36 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 173.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -157.2 171.45 20.41 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.95 -169.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.6 t -94.16 114.25 62.77 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 173.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -52.99 -39.1 80.36 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 C-N-CA 123.628 2.886 . . . . 0.0 114.97 -174.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.8 m -69.02 -41.98 77.01 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.898 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.9 t -70.71 -43.51 77.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.708 -176.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 30.9 m -128.65 148.65 33.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.047 0.451 . . . . 0.0 110.766 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.533 ' SG ' ' HB2' ' A' ' 59' ' ' GLN . 43.5 t -102.23 128.32 48.8 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.563 -177.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.492 ' HG ' HD13 ' A' ' 74' ' ' ILE . 56.7 tp -61.51 -38.12 86.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.317 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.533 ' HB2' ' SG ' ' A' ' 57' ' ' CYS . 80.6 mt-30 -60.33 -39.53 87.4 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.524 178.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.698 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 97.8 mt-30 -61.75 -39.39 91.42 Favored 'General case' 0 C--O 1.214 -0.783 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.879 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.435 HG13 HD11 ' A' ' 25' ' ' ILE . 73.2 t -59.4 -46.3 92.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.243 -178.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 42.3 t -61.12 -42.36 98.4 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.089 177.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -67.42 -37.58 83.26 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.3 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.698 ' HG2' ' O ' ' A' ' 60' ' ' GLN . 20.0 mm-40 -61.0 -41.46 96.55 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.958 0.409 . . . . 0.0 111.013 -175.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.593 ' HB ' HD12 ' A' ' 25' ' ' ILE . 18.8 tt -82.52 -33.11 10.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.664 177.06 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.85 -40.84 98.78 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.798 -0.637 . . . . 0.0 114.025 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -72.8 -11.4 60.59 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 117.797 0.799 . . . . 0.0 110.961 -177.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 16.4 tpt -66.02 -28.6 68.99 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.764 176.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 116.52 9.14 11.69 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.806 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.598 ' CD2' ' HB3' ' A' ' 21' ' ' CYS . 98.3 m-85 -117.79 145.29 44.63 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -84.71 133.16 34.39 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.48 -177.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 12' ' ' ARG . . . -147.71 150.2 33.86 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.934 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 86.0 p -140.69 158.92 43.27 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.615 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.492 HD13 ' HG ' ' A' ' 58' ' ' LEU . 91.4 mt -91.2 122.69 42.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.053 -177.137 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -133.17 160.93 35.79 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 C--N 1.305 -1.35 0 CA-C-O 118.133 -0.937 . . . . 0.0 110.595 178.663 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.741 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 91.61 -1.72 76.05 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.668 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -89.73 143.79 26.51 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 110.27 -0.271 . . . . 0.0 110.27 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.8 mmt -99.11 154.28 18.24 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.072 0.463 . . . . 0.0 112.243 -175.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.489 ' O ' ' HD2' ' A' ' 53' ' ' PRO . 30.0 pt20 -63.74 -18.95 64.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.458 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.455 HG13 ' HG3' ' A' ' 5' ' ' GLN . 25.0 m -128.66 150.85 34.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.006 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -143.79 152.85 41.75 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.76 0.314 . . . . 0.0 110.61 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 82.7 p -127.3 154.91 44.34 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.613 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.444 ' HB3' HG13 ' A' ' 49' ' ' VAL . 14.8 t -159.02 164.2 35.72 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 53.1 p -118.11 144.68 45.45 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.5 p -143.71 129.47 15.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 120.921 0.391 . . . . 0.0 111.098 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 15.8 ptm180 -89.06 146.92 24.53 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.6 mp -111.43 120.63 62.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 59.5 tp -114.71 112.71 23.26 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.991 0.424 . . . . 0.0 110.559 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -167.41 157.59 30.06 Favored Glycine 0 N--CA 1.44 -1.068 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.197 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 59.6 ttm -64.6 -43.02 95.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.992 0.425 . . . . 0.0 110.813 178.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.1 p -113.01 108.33 17.19 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.792 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 23.8 p -69.88 -41.23 75.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.105 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -63.94 -41.53 97.59 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.836 0.351 . . . . 0.0 111.035 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.6 t -61.5 -46.37 90.25 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.835 -177.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.461 ' HB3' ' CG ' ' A' ' 70' ' ' PHE . 20.1 p -67.33 -44.11 79.9 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.565 -178.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 73.7 t -62.79 -46.09 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.557 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.66 -44.86 95.19 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.2 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.4 m -63.49 -43.4 97.38 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.254 -177.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.464 HG21 ' HB ' ' A' ' 65' ' ' ILE . 46.3 pt -74.32 -29.18 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.765 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -60.78 -41.98 96.63 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.052 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -60.99 -45.26 95.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.264 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -63.09 -42.37 99.61 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.181 0.515 . . . . 0.0 109.9 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.556 ' O ' HD11 ' A' ' 35' ' ' ILE . 92.9 mt -61.44 -46.22 97.04 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.716 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.693 178.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 85.2 p -63.97 -23.21 67.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.856 0.36 . . . . 0.0 111.539 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -92.46 -6.08 50.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.892 0.377 . . . . 0.0 110.768 177.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 67.7 tp -103.3 128.04 50.46 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.159 178.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -85.44 153.94 22.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.689 0.28 . . . . 0.0 111.09 176.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.42 8.83 22.64 Favored Glycine 0 C--O 1.239 0.427 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -177.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.556 HD11 ' O ' ' A' ' 29' ' ' ILE . 74.9 mt -72.65 123.63 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 115.19 -0.505 . . . . 0.0 110.871 -177.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 80.5 mt -101.23 -68.15 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 172.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.541 ' O ' ' HB3' ' A' ' 50' ' ' LYS . 34.7 t -166.1 140.14 4.36 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.748 177.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.7 ttt -136.23 127.69 28.58 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 176.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.496 ' HE3' ' OG ' ' A' ' 37' ' ' SER . 34.4 mmtp -119.53 129.47 54.7 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.3 t -106.47 118.47 54.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.5 m -98.86 98.12 9.24 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.921 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.1 tp -62.49 -42.05 99.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.393 -179.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -62.0 -41.19 97.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.281 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -75.83 -30.33 58.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.591 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.45 15.05 79.11 Favored Glycine 0 N--CA 1.454 -0.142 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -176.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 12' ' ' ARG . 39.8 t -145.12 150.59 37.07 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -178.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.57 151.44 47.92 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.808 0.337 . . . . 0.0 111.043 -177.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.4 p -95.15 125.44 39.8 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.295 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.444 HG13 ' HB3' ' A' ' 9' ' ' SER . 3.0 p -105.91 118.66 53.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.281 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.541 ' HB3' ' O ' ' A' ' 37' ' ' SER . 60.1 tttm -136.33 104.3 5.57 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.621 0.724 . . . . 0.0 109.968 -176.201 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.538 ' CD2' ' HA ' ' A' ' 35' ' ' ILE . 87.0 m-85 -139.43 162.96 33.77 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.329 -176.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 54.6 t -74.94 114.85 38.84 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 37.2 Cg_endo -65.02 -18.59 62.47 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.081 2.521 . . . . 0.0 112.327 -177.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 61.4 m -61.6 -39.36 90.92 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.659 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.459 HG23 HG23 ' A' ' 56' ' ' VAL . 18.8 m -116.69 -25.76 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -178.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 96.9 t -127.28 128.93 70.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.728 0.299 . . . . 0.0 110.77 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.524 ' SG ' ' HB2' ' A' ' 60' ' ' GLN . 25.9 p -105.96 161.55 14.36 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 178.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.59 -40.24 96.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.446 -177.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -63.27 -37.4 87.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.281 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.524 ' HB2' ' SG ' ' A' ' 57' ' ' CYS . 54.7 tt0 -59.92 -45.78 91.49 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.287 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.457 ' HA ' ' OE1' ' A' ' 64' ' ' GLN . 75.1 t -63.14 -42.34 96.18 Favored 'Isoleucine or valine' 0 C--O 1.25 1.128 0 CA-C-O 121.768 0.794 . . . . 0.0 110.309 178.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 43.3 t -58.47 -35.49 72.25 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.191 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.406 ' HB2' ' O ' ' A' ' 60' ' ' GLN . 58.8 m170 -60.24 -43.98 95.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.182 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.473 ' O ' ' HG2' ' A' ' 68' ' ' MET . 25.7 mp0 -63.05 -42.23 99.68 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.929 -177.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.464 ' HB ' HG21 ' A' ' 25' ' ' ILE . 19.9 tt -71.3 -37.83 67.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.072 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.32 -39.85 98.29 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.9 -0.591 . . . . 0.0 113.36 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -80.15 -5.99 56.98 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 117.446 0.623 . . . . 0.0 111.555 -177.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 23.1 mmt -83.72 -3.16 57.56 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.038 0.447 . . . . 0.0 110.447 176.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.67 8.1 62.52 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.282 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.461 ' CG ' ' HB3' ' A' ' 21' ' ' CYS . 99.2 m-85 -113.4 143.06 45.12 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 120.979 0.419 . . . . 0.0 110.292 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -101.1 148.04 25.53 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.99 -175.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.92 151.48 35.92 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.114 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.41 ' HB2' ' HG2' ' A' ' 12' ' ' ARG . 60.7 m -123.53 141.51 51.93 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 176.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.0 tt -117.33 141.27 36.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 121.111 0.481 . . . . 0.0 111.337 -174.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 76' ' ' GLU . . . -138.08 154.71 49.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.604 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.446 ' HB3' ' O ' ' A' ' 75' ' ' ALA . 34.8 tt0 . . . . . 0 N--CA 1.474 0.758 0 C-N-CA 123.636 0.775 . . . . 0.0 109.926 -175.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.757 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -78.91 171.46 55.11 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.576 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -73.56 141.75 46.66 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.549 0.214 . . . . 0.0 110.693 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 64.3 mtt 57.48 27.03 13.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.399 -178.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 -75.09 112.95 11.86 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 121.213 0.53 . . . . 0.0 110.096 178.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 70.4 t -101.99 118.78 49.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -127.59 149.6 50.09 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.005 0.431 . . . . 0.0 111.21 -177.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 56.4 p -103.57 156.02 18.09 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.821 178.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.6 t -154.34 143.95 21.55 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 62.5 p -118.59 144.02 46.4 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.12 123.22 55.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-O 120.91 0.386 . . . . 0.0 110.489 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.519 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 39.7 ptt180 -90.08 151.2 21.73 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.084 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.9 pt -126.58 144.5 36.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-O 121.187 0.517 . . . . 0.0 111.775 -177.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.9 tp -131.21 113.66 14.12 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.331 177.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -176.23 160.3 28.02 Favored Glycine 0 N--CA 1.439 -1.135 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 96.1 mmm -68.17 -40.24 82.36 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.854 0.359 . . . . 0.0 110.857 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.8 p -110.14 80.25 1.29 Allowed 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.448 0.642 . . . . 0.0 110.478 177.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.41 ' O ' HG23 ' A' ' 22' ' ' VAL . 21.8 p -67.02 -34.55 77.96 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.479 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -63.28 -39.44 94.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.11 0.481 . . . . 0.0 110.295 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.0 t -60.67 -45.73 93.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.579 -178.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 27.7 p -70.01 -33.29 71.82 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.365 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 18' ' ' CYS . 67.1 t -63.27 -45.11 99.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-O 121.412 0.625 . . . . 0.0 109.464 177.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -67.14 -35.18 79.17 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.327 177.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.3 t -60.19 -46.59 89.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.619 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.523 HD12 ' HB ' ' A' ' 65' ' ' ILE . 18.8 tt -70.99 -29.25 36.29 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.892 177.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -57.85 -49.35 76.98 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.214 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -62.52 -42.83 99.77 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.121 178.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.5 tpt180 -64.27 -47.61 78.88 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.496 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.561 HG21 ' SD ' ' A' ' 38' ' ' MET . 19.5 tt -71.01 -36.71 64.6 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.696 -177.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 77.6 p -67.72 -25.41 65.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.36 . . . . 0.0 111.257 177.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -85.37 -12.05 53.08 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.12 0.486 . . . . 0.0 110.231 175.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 64.9 tp -84.18 122.93 29.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.511 175.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -83.38 152.98 24.79 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 120.994 0.425 . . . . 0.0 111.587 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.51 6.01 64.59 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.441 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 39.7 pt -69.15 126.79 29.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 121.337 0.589 . . . . 0.0 111.576 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' A' ' 50' ' ' LYS . 86.3 mt -82.09 -61.81 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.492 -179.138 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.421 ' OG ' ' HE2' ' A' ' 50' ' ' LYS . 87.1 p -159.43 154.34 24.78 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.993 178.222 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.561 ' SD ' HG21 ' A' ' 29' ' ' ILE . 27.0 ttt -140.79 134.45 30.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.843 177.111 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -133.59 148.94 51.62 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.1 p -126.31 134.01 67.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 C-N-CA 119.796 -0.762 . . . . 0.0 111.792 -178.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.5 m -108.66 85.75 2.16 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.327 -0.852 . . . . 0.0 108.843 177.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.9 tp -61.64 -43.09 99.5 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.32 -176.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -70.11 -28.18 65.18 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.063 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -84.92 -12.42 53.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.649 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.4 28.03 71.84 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.88 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 79.6 p -148.2 161.02 42.31 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.076 0.465 . . . . 0.0 111.454 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.75 149.2 42.41 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.839 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.7 m -117.12 126.39 52.75 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.3 p -129.32 139.31 52.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 120.868 0.366 . . . . 0.0 110.761 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.444 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 39.6 ttpt -119.07 119.14 33.35 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -153.91 164.02 39.09 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.992 -173.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.7 t -84.87 112.28 41.75 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 177.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.43 -22.2 65.89 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.797 2.331 . . . . 0.0 112.656 -176.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.5 t -63.89 -42.99 97.34 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.655 178.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.476 HG12 HG23 ' A' ' 56' ' ' VAL . 98.9 t -73.39 -51.59 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.909 -178.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.476 HG23 HG12 ' A' ' 55' ' ' VAL . 98.6 t -131.56 130.65 62.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.331 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 31.5 p -73.76 159.47 32.9 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.634 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.3 mp -68.62 -24.32 64.55 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.839 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -61.02 -42.41 98.41 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.102 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.536 ' O ' ' HG3' ' A' ' 64' ' ' GLN . 87.3 mm-40 -65.69 -39.25 91.08 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.342 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.83 -45.6 98.34 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 CA-C-O 121.245 0.545 . . . . 0.0 110.06 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 47.5 t -60.74 -41.96 96.42 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.188 177.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -61.67 -38.29 87.23 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.025 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.536 ' HG3' ' O ' ' A' ' 60' ' ' GLN . 98.7 mt-30 -59.35 -42.73 92.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.465 0.174 . . . . 0.0 111.269 -176.15 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.523 ' HB ' HD12 ' A' ' 25' ' ' ILE . 21.2 tt -85.95 -38.68 12.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.874 178.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.94 -35.54 92.2 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.911 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -54.44 -28.14 42.07 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.879 0.872 . . . . 0.0 111.658 -178.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 15.8 tpt -59.62 -29.23 67.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.076 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 119.13 8.13 9.7 Favored Glycine 0 CA--C 1.506 -0.511 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.492 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -114.84 145.11 42.51 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -72.94 135.94 45.12 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.087 0.47 . . . . 0.0 111.12 -178.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 12' ' ' ARG . . . -146.94 146.54 30.15 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.141 178.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 39.6 t -142.12 140.5 32.5 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.761 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 42.9 pt -91.58 145.06 7.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.522 -177.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.48 145.64 29.22 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.267 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 . . . . . 0 C--O 1.251 1.162 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.085 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.674 0 CA-C-O 120.799 0.333 . . . . 0.0 110.386 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -133.3 169.37 22.69 Favored Glycine 0 N--CA 1.438 -1.182 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.607 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -90.66 130.91 36.62 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 120.873 0.368 . . . . 0.0 110.499 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 67.4 ttp -60.73 -48.76 80.35 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.878 -176.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -151.4 -50.26 0.12 Allowed 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.469 -0.493 . . . . 0.0 111.945 -177.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.9 t -108.52 126.45 65.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-O 120.931 0.396 . . . . 0.0 110.684 -177.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -133.82 147.56 51.23 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.09 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 54.9 p -123.08 143.23 50.11 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 175.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 87.7 p -155.63 162.03 40.69 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.333 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.1 p -109.03 125.51 52.16 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.59 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.92 122.58 70.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 17.8 ptp180 -78.99 141.94 37.05 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.208 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.775 ' HB ' ' SG ' ' A' ' 21' ' ' CYS . 19.8 pt -116.06 106.51 20.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-O 121.672 0.749 . . . . 0.0 110.519 -178.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.8 tp -114.1 128.74 56.52 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.826 -175.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 176.25 -149.29 9.73 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.213 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 66.5 mtt -60.88 -43.18 98.81 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.472 0.654 . . . . 0.0 109.272 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.573 HG23 ' H ' ' A' ' 20' ' ' SER . 11.5 t -163.82 159.41 21.16 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.411 177.04 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.486 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 98.3 m -63.55 -39.03 93.35 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 120.645 0.26 . . . . 0.0 111.487 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -59.6 -45.2 92.62 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -177.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.573 ' H ' HG23 ' A' ' 17' ' ' THR . 81.0 p -69.11 -41.61 77.18 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.95 -177.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.775 ' SG ' ' HB ' ' A' ' 13' ' ' ILE . 26.0 p -72.26 -35.35 68.74 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.3 p -69.78 -33.92 58.34 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.556 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.625 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -62.28 -42.16 99.1 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.454 0.645 . . . . 0.0 109.319 176.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.6 t -59.58 -49.78 76.42 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.401 -177.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.8 tt -74.55 -32.8 30.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.811 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.4 tm-20 -60.84 -47.68 85.28 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.342 -175.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -62.54 -44.4 96.45 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.502 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.452 ' HA ' ' NE ' ' A' ' 28' ' ' ARG . 4.2 mmp_? -67.52 -43.72 80.11 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.266 -177.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 16.9 tt -72.9 -32.77 41.34 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.6 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.998 -177.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.8 t -64.76 -41.49 95.85 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 120.938 0.399 . . . . 0.0 110.404 177.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -68.64 -26.22 65.22 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.788 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.534 HD21 HG21 ' A' ' 56' ' ' VAL . 57.7 tp -96.23 122.18 38.82 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.025 0.441 . . . . 0.0 110.962 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -68.73 150.01 48.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.871 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.43 -1.97 16.08 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 121.065 -0.588 . . . . 0.0 111.973 -178.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.8 tt -95.82 130.22 44.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 175.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 83.9 mt -92.52 -57.7 4.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 81.5 p -163.71 164.4 23.85 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.281 178.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -154.12 147.7 25.17 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 120.925 0.393 . . . . 0.0 110.271 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -128.87 141.57 51.24 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.5 t -110.05 128.73 66.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -174.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.1 t -113.54 102.03 9.91 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 121.17 0.51 . . . . 0.0 109.998 177.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.97 -36.48 83.43 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.089 178.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -60.62 -44.56 96.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.141 -178.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -85.85 -12.63 50.28 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.11 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.14 26.9 73.64 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.333 -179.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 87.1 p -146.01 161.98 38.88 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.046 0.451 . . . . 0.0 110.823 -177.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.1 142.72 50.08 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.336 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 87.4 m -95.8 119.14 33.78 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 65.7 t -114.77 126.74 72.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 120.997 0.427 . . . . 0.0 111.394 -176.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -103.11 106.43 16.95 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 176.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -135.63 166.34 23.45 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.027 -170.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.5 t -106.07 101.67 35.37 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.027 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.51 -25.87 80.14 Favored 'Trans proline' 0 N--CA 1.48 0.68 0 C-N-CA 123.369 2.713 . . . . 0.0 112.565 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 43.9 t -61.76 -41.33 97.54 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.941 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.447 HG12 HG13 ' A' ' 56' ' ' VAL . 77.8 t -65.51 -62.11 1.39 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.534 HG21 HD21 ' A' ' 32' ' ' LEU . 34.7 m -140.04 159.64 26.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.65 175.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.432 ' SG ' ' HG3' ' A' ' 60' ' ' GLN . 31.8 p -76.07 154.48 35.58 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.029 0.442 . . . . 0.0 110.313 178.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.6 mt -70.97 -19.19 62.58 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.223 179.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -61.45 -42.15 98.31 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.374 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.446 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 97.7 mt-30 -64.28 -39.51 94.08 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.999 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 78.6 t -62.01 -45.48 98.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 CA-C-O 121.265 0.555 . . . . 0.0 109.768 178.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 42.6 t -61.92 -38.73 89.51 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.882 176.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 58.3 m170 -63.07 -36.86 84.97 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.191 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 60' ' ' GLN . 86.5 mm-40 -59.52 -43.55 93.41 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.808 0.337 . . . . 0.0 110.919 -178.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.537 HD11 ' HB2' ' A' ' 21' ' ' CYS . 18.0 tt -76.69 -36.19 26.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.901 178.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -62.81 -42.25 99.72 Favored Glycine 0 CA--C 1.522 0.514 0 CA-C-N 116.07 -0.514 . . . . 0.0 113.478 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -66.47 -22.05 66.19 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 26.4 mmt -83.52 0.56 45.99 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.527 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.45 9.33 57.9 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.513 -0.851 . . . . 0.0 113.531 177.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.491 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 90.2 m-85 -112.51 140.68 47.06 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.985 0.393 . . . . 0.0 110.092 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -90.47 140.24 29.91 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.886 0.374 . . . . 0.0 110.856 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 12' ' ' ARG . . . -147.27 150.41 34.76 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.135 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.8 t -143.64 136.46 27.43 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.142 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 83.8 mt -91.4 127.1 43.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.457 -178.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.03 160.67 37.03 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.113 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.534 -0.746 . . . . 0.0 110.941 178.856 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.3 t . . . . . 0 N--CA 1.449 -0.518 0 CA-C-O 120.991 0.424 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.24 133.82 45.22 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.891 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 63.0 p -109.37 146.45 34.4 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.512 ' OG ' HG13 ' A' ' 74' ' ' ILE . 37.2 t -159.07 147.08 17.81 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.538 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 17.1 p -113.27 108.93 17.94 Favored 'General case' 0 N--CA 1.418 -2.041 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 172.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.4 p -95.64 124.79 48.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.339 -177.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 54.8 ptt85 -75.46 142.56 42.92 Favored 'General case' 0 CA--C 1.505 -0.758 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.574 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 47.1 mm -115.12 119.2 61.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.6 tp -124.05 117.18 24.12 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.978 0.418 . . . . 0.0 110.474 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -175.24 154.28 17.61 Favored Glycine 0 N--CA 1.434 -1.464 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.476 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 98.8 mtp -65.35 -40.19 93.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.963 0.411 . . . . 0.0 110.9 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.0 p -111.12 84.83 2.0 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.383 0.611 . . . . 0.0 110.38 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.507 ' O ' HG23 ' A' ' 22' ' ' VAL . 42.2 t -61.38 -44.27 97.44 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.017 -177.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -61.35 -39.92 92.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.943 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.6 m -62.67 -44.2 96.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.59 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.505 ' HB3' ' CD2' ' A' ' 70' ' ' PHE . 29.6 p -73.02 -33.81 65.96 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.476 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 18' ' ' CYS . 63.0 t -62.79 -43.57 98.86 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -60.69 -44.41 96.56 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.997 177.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.0 t -61.64 -50.02 74.2 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.556 -178.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.7 tt -71.63 -36.83 61.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -61.68 -44.0 97.78 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.829 0.347 . . . . 0.0 110.693 -177.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -64.73 -47.3 78.79 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.281 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -64.58 -42.56 95.54 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.914 -176.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.639 HD13 ' SD ' ' A' ' 38' ' ' MET . 19.6 tt -69.7 -35.14 64.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.957 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 79.0 p -71.26 -22.06 62.02 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.926 0.393 . . . . 0.0 110.634 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -70.76 -27.92 64.29 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 174.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.6 mt -75.0 128.99 36.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.851 176.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.0 mtpt -86.6 153.58 21.68 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.374 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.23 8.1 57.9 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.323 -0.942 . . . . 0.0 111.862 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 33.1 pt -69.52 137.74 23.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.993 0.425 . . . . 0.0 111.819 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -96.77 -71.98 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.695 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.7 t -169.89 149.88 3.78 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-O 120.769 0.319 . . . . 0.0 111.051 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.639 ' SD ' HD13 ' A' ' 29' ' ' ILE . 28.9 ptm -153.4 159.53 42.41 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 177.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -141.1 123.45 15.78 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.989 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 79.9 t -92.52 119.29 39.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 175.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.8 m -109.21 112.07 24.02 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.042 0.448 . . . . 0.0 111.117 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.2 mt -66.2 -37.63 86.05 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.795 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -61.9 -41.81 98.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.775 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -77.22 -27.91 53.61 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.948 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.51 15.99 80.04 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -175.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 87.7 p -148.68 165.54 31.06 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.14 -0.53 . . . . 0.0 109.982 -177.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.515 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -118.5 139.44 51.43 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.708 0.289 . . . . 0.0 111.291 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.8 m -89.13 119.69 29.86 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 8' ' ' THR . 99.8 t -114.64 124.48 71.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.499 -174.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.428 ' HG2' HG22 ' A' ' 8' ' ' THR . 51.5 mtmt -126.96 103.96 7.76 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 174.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -143.86 158.71 43.51 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.587 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.8 t -82.52 114.27 50.51 Favored Pre-proline 0 N--CA 1.437 -1.125 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 173.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -61.44 -28.09 83.32 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.921 2.414 . . . . 0.0 113.787 -173.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.2 p -70.19 -39.74 75.05 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 120.809 0.338 . . . . 0.0 110.899 177.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 84.7 t -75.67 -50.81 22.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 121.128 0.49 . . . . 0.0 110.67 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 69.7 t -128.58 123.72 60.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.162 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.66 ' SG ' ' HG2' ' A' ' 60' ' ' GLN . 27.7 p -88.49 144.42 26.36 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.898 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.4 mp -68.56 -26.8 65.59 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.092 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 -60.35 -41.14 93.02 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.66 ' HG2' ' SG ' ' A' ' 57' ' ' CYS . 85.4 mm-40 -63.98 -38.43 91.07 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.387 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 71.6 t -60.98 -46.74 96.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 121.391 0.615 . . . . 0.0 109.55 178.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 43.0 t -62.55 -39.61 94.18 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.76 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -59.6 -45.17 92.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.947 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 60' ' ' GLN . 98.2 mt-30 -60.75 -44.01 97.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.65 -175.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.0 tt -81.41 -37.19 15.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.856 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.8 -41.73 99.81 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.782 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.99 -28.73 70.0 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 122.37 0.268 . . . . 0.0 111.37 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 16.1 tpt -61.75 -29.79 70.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.719 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.69 5.06 12.6 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.515 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.505 ' CD2' ' HB3' ' A' ' 21' ' ' CYS . 95.1 m-85 -111.48 152.02 27.94 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -94.97 134.69 37.37 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.37 0.605 . . . . 0.0 111.818 -176.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 12' ' ' ARG . . . -140.82 145.59 36.47 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.687 176.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.9 t -139.88 138.65 35.86 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.243 -0.583 . . . . 0.0 111.445 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.512 HG13 ' OG ' ' A' ' 9' ' ' SER . 14.7 tt -78.23 137.02 22.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.12 -0.945 . . . . 0.0 112.158 -178.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -152.11 159.48 43.64 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 176.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.308 -1.228 0 CA-C-O 118.577 -0.725 . . . . 0.0 109.976 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 N--CA 1.445 -0.687 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.453 ' HB3' ' HD3' ' A' ' 53' ' ' PRO . . . -120.73 140.18 52.01 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 120.979 0.418 . . . . 0.0 110.592 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 44.5 p -120.77 145.77 47.19 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.393 177.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.9 t -140.88 142.47 34.5 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.6 p -108.64 133.88 52.13 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 121.307 0.575 . . . . 0.0 110.759 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.445 HG12 ' HA ' ' A' ' 74' ' ' ILE . 33.6 m -126.85 150.53 32.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.457 ' HG2' ' HB3' ' A' ' 73' ' ' SER . 16.6 ptm180 -107.06 147.24 30.21 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.55 HG21 ' SG ' ' A' ' 21' ' ' CYS . 85.0 mt -119.56 125.86 74.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.546 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.8 tp -119.6 115.84 24.81 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -171.02 154.88 23.56 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.976 -0.63 . . . . 0.0 111.642 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 68.6 mtt -67.66 -40.14 84.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.923 0.392 . . . . 0.0 110.978 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.2 p -104.45 89.59 3.27 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.713 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 95.5 m -64.06 -40.57 96.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.238 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -64.88 -39.14 93.08 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.462 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.0 m -62.63 -43.74 98.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.712 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.55 ' SG ' HG21 ' A' ' 13' ' ' ILE . 16.0 p -70.19 -39.87 74.96 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.597 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 65.5 t -63.22 -44.13 99.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-O 121.087 0.47 . . . . 0.0 110.108 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -64.46 -40.88 96.54 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.41 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.5 m -62.36 -42.9 99.77 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.978 -0.556 . . . . 0.0 112.012 -178.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.552 ' CG2' ' HB ' ' A' ' 65' ' ' ILE . 47.1 pt -72.02 -34.94 52.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 C-N-CA 120.064 -0.655 . . . . 0.0 110.161 178.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -60.97 -44.43 97.36 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.909 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -61.82 -50.06 73.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.082 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -68.67 -41.86 78.7 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.165 -0.471 . . . . 0.0 112.192 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 94.0 mt -64.41 -42.61 95.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-O 120.668 0.27 . . . . 0.0 111.035 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 41.4 t -60.24 -41.5 93.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.023 0.44 . . . . 0.0 110.26 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -68.49 -27.9 66.54 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.094 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.5 tp -70.33 131.95 44.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.705 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -86.1 152.55 22.77 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.69 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.89 5.98 73.0 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.687 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.407 ' HA ' ' CD2' ' A' ' 51' ' ' TYR . 46.4 pt -72.55 138.19 21.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.908 0.385 . . . . 0.0 111.316 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.2 mm -96.79 -67.05 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.481 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.7 t -162.39 152.83 16.9 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.279 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -139.27 148.22 42.73 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -134.79 142.47 46.71 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.68 140.05 50.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 120.967 0.413 . . . . 0.0 111.134 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.9 m -119.38 101.75 8.18 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.67 -44.83 95.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.845 -176.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -61.68 -44.28 97.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.462 -178.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -76.93 -24.82 52.39 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.742 -178.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.13 17.53 79.53 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.326 -177.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 60.1 m -125.17 151.61 45.58 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 120.882 0.372 . . . . 0.0 110.591 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -128.71 149.14 50.82 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.047 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.6 m -116.2 125.41 52.23 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 63.1 t -114.47 124.97 71.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 120.84 0.352 . . . . 0.0 110.545 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -105.88 107.7 18.83 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.65 ' CE1' ' HB ' ' A' ' 56' ' ' VAL . 34.4 t80 -152.93 152.74 31.81 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -175.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.4 t -80.64 114.02 44.51 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.453 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 46.9 Cg_endo -66.26 -22.28 53.62 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.066 2.511 . . . . 0.0 113.852 -174.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 79.8 p -65.28 -33.36 75.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.718 0.294 . . . . 0.0 111.271 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.446 HG12 HG23 ' A' ' 56' ' ' VAL . 45.9 t -84.06 -61.9 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.907 0.384 . . . . 0.0 110.174 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.65 ' HB ' ' CE1' ' A' ' 51' ' ' TYR . 88.7 t -128.76 127.49 66.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.096 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 30.3 p -76.81 155.79 32.79 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.343 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.35 -16.13 61.87 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.838 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -61.5 -42.2 98.44 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.195 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.511 ' OE1' HG13 ' A' ' 56' ' ' VAL . 98.6 mt-30 -65.13 -37.94 89.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.531 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 77.8 t -61.28 -40.95 87.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-O 121.352 0.596 . . . . 0.0 109.728 177.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.523 ' SG ' ' HB ' ' A' ' 74' ' ' ILE . 92.7 m -61.08 -38.96 88.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.569 177.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -67.94 -28.77 67.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.452 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -61.93 -42.18 98.8 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.739 0.304 . . . . 0.0 110.503 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.552 ' HB ' ' CG2' ' A' ' 25' ' ' ILE . 18.8 tt -79.7 -38.94 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 120.754 0.311 . . . . 0.0 111.565 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -62.39 -39.08 97.31 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.156 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -59.09 -39.0 80.85 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.152 0.501 . . . . 0.0 110.472 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 17.0 tpt -62.01 -29.09 70.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.127 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.15 8.54 10.38 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.677 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.52 ' CG ' ' HB3' ' A' ' 21' ' ' CYS . 97.5 m-85 -106.29 150.02 26.36 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.687 0.28 . . . . 0.0 110.286 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -93.13 138.87 31.16 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.584 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.88 149.13 31.7 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.642 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.457 ' HB3' ' HG2' ' A' ' 12' ' ' ARG . 48.3 t -127.86 138.93 52.86 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.523 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 13.5 tt -100.27 139.21 22.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.226 0.536 . . . . 0.0 111.681 -176.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.45 159.45 44.02 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.42 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.442 ' H ' ' CD ' ' A' ' 76' ' ' GLU . 1.2 pm0 . . . . . 0 C--N 1.3 -1.575 0 CA-C-O 118.47 -0.776 . . . . 0.0 109.709 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 68.2 t . . . . . 0 N--CA 1.442 -0.844 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.62 128.53 45.73 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.004 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 76.3 p -118.47 147.45 43.6 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.699 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.9 p -159.98 168.09 26.44 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.336 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.6 p -113.0 129.59 56.44 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.5 p -109.57 123.34 65.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-O 121.026 0.441 . . . . 0.0 110.364 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -83.26 147.45 27.97 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.647 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 85.9 mt -114.68 123.6 70.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.891 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 69.6 tp -117.92 118.47 32.08 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.938 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -175.45 157.95 24.87 Favored Glycine 0 N--CA 1.432 -1.617 0 C-N-CA 119.692 -1.242 . . . . 0.0 113.151 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 66.4 ttp -61.93 -47.16 86.14 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 120.915 0.388 . . . . 0.0 110.202 177.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.6 m -118.21 107.23 13.68 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.426 ' O ' HG23 ' A' ' 22' ' ' VAL . 47.9 t -64.22 -40.19 95.54 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.09 -178.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -60.35 -39.83 88.57 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.757 -176.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 63.7 m -62.3 -46.29 89.4 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 120.959 0.409 . . . . 0.0 111.518 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.595 ' HB3' ' CD2' ' A' ' 70' ' ' PHE . 16.4 p -73.64 -36.36 65.41 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.926 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 18' ' ' CYS . 57.0 t -62.18 -42.79 96.56 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.541 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -60.56 -40.61 92.25 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.518 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.3 t -59.99 -48.66 80.79 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.875 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.457 HD11 HG13 ' A' ' 61' ' ' VAL . 17.3 tt -76.49 -39.42 33.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.018 -178.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.1 tp10 -60.33 -47.59 85.4 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.914 0.388 . . . . 0.0 111.281 -175.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.64 -51.15 66.43 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.978 -177.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.558 ' HD2' ' HG2' ' A' ' 64' ' ' GLN . 44.4 ttm180 -63.89 -45.42 89.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.852 -177.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 15.3 tt -68.53 -31.22 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.312 -176.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 73.7 m -63.78 -38.77 92.33 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.081 0.467 . . . . 0.0 110.076 176.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -68.18 -27.8 66.72 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.877 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.4 mt -84.68 137.32 33.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.755 0.788 . . . . 0.0 112.753 -178.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.561 ' N ' ' HD2' ' A' ' 33' ' ' LYS . 9.9 mptt -87.75 155.04 20.1 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.39 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.53 7.4 39.73 Favored Glycine 0 C--O 1.239 0.422 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.94 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.2 pt -91.39 132.91 34.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 86.3 mt -97.63 -59.45 3.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.935 0.398 . . . . 0.0 110.728 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.3 t -152.34 141.21 21.08 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.162 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 28.5 ptm -145.27 146.96 31.87 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.759 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -135.52 124.7 24.49 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.908 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 65.7 t -106.6 116.05 49.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 176.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.8 m -109.64 104.68 13.73 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.083 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.8 mt -64.4 -36.65 84.84 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.72 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.7 mp0 -63.61 -41.29 98.32 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.74 -178.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -83.85 -27.34 28.76 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.316 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.86 20.64 77.73 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -177.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.7 m -137.63 155.91 48.64 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 122.371 0.268 . . . . 0.0 110.592 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -121.92 141.8 50.93 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.398 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.1 m -85.38 124.36 31.9 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.664 HG13 ' CE2' ' A' ' 51' ' ' TYR . 97.4 t -107.26 119.29 56.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.053 -176.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -145.56 102.83 3.74 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 173.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.664 ' CE2' HG13 ' A' ' 49' ' ' VAL . 24.7 m-85 -141.69 165.78 26.54 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -177.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.6 t -78.1 114.22 40.3 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 175.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -62.87 -25.91 74.46 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.894 2.396 . . . . 0.0 112.861 -175.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.3 m -64.46 -39.08 93.14 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.925 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.6 t -94.84 -49.43 12.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.125 -178.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.1 t -114.45 126.63 72.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.328 -177.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 25.2 p -103.89 149.9 24.67 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.651 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.5 mp -64.32 -38.06 89.71 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.507 -176.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -62.6 -40.79 98.05 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -176.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.599 ' O ' ' HG3' ' A' ' 64' ' ' GLN . 85.4 mm-40 -64.72 -37.1 86.44 Favored 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 121.119 -0.233 . . . . 0.0 111.18 176.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.457 HG13 HD11 ' A' ' 25' ' ' ILE . 77.2 t -59.29 -43.43 89.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-O 121.17 0.509 . . . . 0.0 109.636 178.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 96.3 m -62.49 -39.09 92.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.97 177.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 63.8 m170 -67.3 -36.35 81.32 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.157 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.599 ' HG3' ' O ' ' A' ' 60' ' ' GLN . 99.2 mt-30 -60.02 -42.91 95.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.536 -176.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.419 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 19.8 tt -81.11 -35.07 14.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.114 178.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -67.14 -24.2 73.24 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.935 -0.575 . . . . 0.0 113.629 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.1 -36.59 77.78 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.847 0.356 . . . . 0.0 111.087 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 16.5 tpt -62.41 -28.93 70.13 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.533 178.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.89 5.13 18.29 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.38 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.595 ' CD2' ' HB3' ' A' ' 21' ' ' CYS . 99.0 m-85 -104.83 142.67 34.32 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.776 0.322 . . . . 0.0 110.661 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -80.88 147.81 30.2 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.404 -177.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.97 148.93 31.29 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.197 176.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 39.8 t -143.61 142.11 30.91 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.38 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 88.7 mt -86.27 128.58 39.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.198 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -138.35 148.43 44.54 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.481 177.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 . . . . . 0 C--N 1.307 -1.282 0 CA-C-O 118.393 -0.813 . . . . 0.0 110.307 -179.818 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.0 t . . . . . 0 CA--C 1.516 -0.342 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -112.31 143.58 43.16 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.954 0.406 . . . . 0.0 111.388 -176.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.587 HG22 ' HG2' ' A' ' 50' ' ' LYS . 71.7 p -109.32 140.86 42.46 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.9 t -150.64 143.02 24.32 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.048 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.58 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 71.3 p -115.09 122.99 47.83 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.8 m -107.21 125.69 63.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.329 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.519 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 16.2 ptp180 -77.79 135.29 37.96 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 85.4 mt -117.57 127.52 74.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-O 120.977 0.418 . . . . 0.0 111.63 -174.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.0 tt -115.13 119.4 36.29 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.107 177.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -165.73 173.42 41.37 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.943 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 79.2 mtm -63.81 -44.91 91.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.32 0.581 . . . . 0.0 110.134 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.0 p -134.91 128.8 33.26 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.748 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.551 ' O ' HG23 ' A' ' 22' ' ' VAL . 51.5 t -62.61 -49.56 74.74 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -176.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -62.61 -40.88 98.35 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -174.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.6 t -62.83 -47.16 84.58 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.675 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.5 p -70.75 -33.29 70.65 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.698 0.285 . . . . 0.0 110.967 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 18' ' ' CYS . 52.7 t -61.91 -45.62 98.29 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.018 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 176.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -64.34 -36.28 83.62 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.493 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 41.1 t -59.24 -48.69 80.67 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.281 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.8 tt -78.51 -28.86 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.448 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -59.2 -46.33 88.73 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.28 -176.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -61.17 -45.09 96.03 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.962 0.41 . . . . 0.0 110.689 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -67.22 -45.75 75.87 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.505 -176.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.3 tp -72.47 -34.63 49.0 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 78.8 p -65.82 -36.32 83.15 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.817 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -70.6 -27.29 63.98 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.283 176.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -77.96 125.18 28.96 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.918 0.389 . . . . 0.0 110.169 176.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -81.51 152.48 27.29 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.316 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 115.81 -0.91 21.53 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.17 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.9 tt -108.73 124.19 65.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.25 0.547 . . . . 0.0 109.98 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 49.7 mm -71.38 -49.43 47.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.029 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.7 t -159.81 150.26 18.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.76 -177.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 26.3 ttt -127.33 119.56 26.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.143 178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -131.03 146.38 52.36 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 110.289 -0.264 . . . . 0.0 110.289 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.5 HG21 HG11 ' A' ' 22' ' ' VAL . 66.4 t -123.91 129.73 74.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 120.757 0.313 . . . . 0.0 111.67 -175.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.3 t -106.85 105.3 15.26 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 177.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 60.0 tp -64.48 -40.83 96.41 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.679 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -62.07 -40.91 97.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.732 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -76.26 -29.11 57.34 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.667 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.83 20.31 63.71 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.978 -0.629 . . . . 0.0 111.629 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 89.3 p -143.91 166.22 25.55 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 120.93 0.395 . . . . 0.0 110.542 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.58 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -117.52 133.77 55.59 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.469 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.1 m -98.88 121.24 40.57 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.6 m -127.96 149.34 32.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 CA-C-O 121.408 0.623 . . . . 0.0 111.509 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.587 ' HG2' HG22 ' A' ' 8' ' ' THR . 62.3 mttp -116.04 123.88 49.06 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 175.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -150.7 165.46 33.37 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.504 -174.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.5 t -100.16 110.28 59.18 Favored Pre-proline 0 N--CA 1.438 -1.056 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.041 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -55.82 -27.13 60.8 Favored 'Trans proline' 0 N--CA 1.483 0.866 0 C-N-CA 123.62 2.88 . . . . 0.0 112.676 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.2 m -62.03 -39.22 91.59 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.845 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 51.8 t -89.05 -47.52 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.998 -177.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 31.8 m -123.25 160.2 26.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.614 0.245 . . . . 0.0 110.904 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 31.2 p -134.89 167.32 21.12 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.948 0.404 . . . . 0.0 111.541 -176.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 68.6 tp -61.07 -44.33 97.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.856 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -60.03 -42.31 94.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.515 -177.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.563 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 64.7 tt0 -61.66 -45.81 92.41 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.609 178.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.0 t -63.97 -46.59 93.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 CA-C-O 121.2 0.524 . . . . 0.0 110.751 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 48.5 t -60.82 -40.07 91.37 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.927 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -60.36 -41.38 93.58 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.414 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.563 ' HG2' ' O ' ' A' ' 60' ' ' GLN . 87.0 mm-40 -60.56 -45.7 92.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.143 -176.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.3 tt -83.22 -35.78 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.869 0.366 . . . . 0.0 111.752 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.59 -39.8 97.86 Favored Glycine 0 CA--C 1.505 -0.536 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.42 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -60.42 -39.37 87.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.952 0.406 . . . . 0.0 110.324 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 14.8 tpt -63.47 -30.67 71.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.485 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 116.64 7.93 12.96 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.334 -0.936 . . . . 0.0 113.301 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -114.53 141.6 47.52 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -99.31 133.35 43.74 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -172.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 12' ' ' ARG . . . -130.89 139.03 50.06 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.474 176.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.6 m -127.57 143.59 51.16 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.689 0.281 . . . . 0.0 110.938 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.2 tt -74.13 142.32 14.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -175.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.434 ' HB2' ' NH2' ' A' ' 12' ' ' ARG . . . -143.05 125.63 15.83 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.45 172.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 . . . . . 0 C--N 1.307 -1.244 0 CA-C-O 118.771 -0.633 . . . . 0.0 111.435 -178.579 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 N--CA 1.441 -0.9 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -129.9 143.2 50.68 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 120.954 0.407 . . . . 0.0 111.136 -178.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.1 p -107.96 129.34 55.12 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.024 177.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.424 ' O ' HG22 ' A' ' 49' ' ' VAL . 46.8 t -140.71 143.78 35.22 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 22.4 p -109.62 119.71 40.25 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.929 177.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 74' ' ' ILE . 33.5 m -102.61 135.89 37.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.408 ' HG2' ' HB3' ' A' ' 73' ' ' SER . 24.1 ptt180 -83.74 150.9 25.52 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.642 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 86.4 mt -112.52 121.35 64.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 63.4 tp -122.56 108.08 12.72 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -167.23 156.19 27.8 Favored Glycine 0 N--CA 1.431 -1.656 0 C-N-CA 119.932 -1.127 . . . . 0.0 113.069 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 79.5 mtm -64.6 -40.28 95.23 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.92 0.39 . . . . 0.0 110.346 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 35.5 m -121.85 103.87 9.16 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.468 ' O ' HG23 ' A' ' 22' ' ' VAL . 91.5 m -65.4 -40.23 93.16 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.051 -177.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -62.72 -39.79 95.15 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -176.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.0 m -62.38 -44.56 96.16 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.553 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.651 ' HB3' ' CD2' ' A' ' 70' ' ' PHE . 24.7 p -71.73 -37.05 70.64 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.416 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 18' ' ' CYS . 59.4 t -62.65 -45.18 99.46 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.001 178.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 66.3 tttp -62.86 -42.73 99.86 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.275 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 74.5 m -60.78 -43.01 98.63 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.67 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.0 tt -76.52 -41.16 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.396 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -62.71 -49.36 75.4 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -63.71 -46.42 85.52 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.046 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.0 ttp180 -67.17 -42.72 83.81 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.522 HG12 ' OH ' ' A' ' 51' ' ' TYR . 11.2 tp -67.55 -36.44 76.24 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.687 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.882 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 79.0 p -73.17 -20.71 60.84 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.17 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -71.64 -27.91 63.4 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 174.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 64.1 tp -93.29 119.3 32.28 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.388 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -80.66 152.41 28.48 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 120.994 0.426 . . . . 0.0 111.069 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 115.3 1.67 21.86 Favored Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -175.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.522 HD11 ' HB2' ' A' ' 38' ' ' MET . 4.1 tt -91.92 122.25 43.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 123.132 0.573 . . . . 0.0 110.426 178.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.1 tt -82.7 -42.8 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.822 177.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.492 ' HB3' ' HD2' ' A' ' 50' ' ' LYS . 35.3 t -160.67 145.62 14.35 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 120.123 -0.631 . . . . 0.0 112.248 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.577 ' SD ' HG12 ' A' ' 49' ' ' VAL . 14.4 tpt -134.41 129.81 35.89 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.851 177.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -135.05 129.05 33.44 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.6 p -129.77 137.61 56.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 120.811 0.339 . . . . 0.0 110.862 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.1 t -117.62 117.9 30.64 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.979 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.8 tp -66.66 -41.62 87.9 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.863 176.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -61.07 -48.93 79.42 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.587 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -77.02 -25.02 52.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.69 -178.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.33 29.8 69.85 Favored Glycine 0 CA--C 1.505 -0.591 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.9 t -149.12 152.85 36.84 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -119.36 138.17 53.24 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.987 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 71.6 m -102.67 122.6 44.77 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.667 ' HB ' ' CE2' ' A' ' 51' ' ' TYR . 33.3 m -120.72 149.91 23.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -174.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.492 ' HD2' ' HB3' ' A' ' 37' ' ' SER . 69.0 mttm -125.0 108.2 11.6 Favored 'General case' 0 C--O 1.245 0.858 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.749 175.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.667 ' CE2' ' HB ' ' A' ' 49' ' ' VAL . 80.8 m-85 -136.44 148.78 47.92 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.03 0.443 . . . . 0.0 111.434 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 66.5 t -87.61 115.41 62.8 Favored Pre-proline 0 N--CA 1.438 -1.049 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 171.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -59.4 -28.62 88.04 Favored 'Trans proline' 0 N--CA 1.475 0.398 0 C-N-CA 122.819 2.346 . . . . 0.0 113.765 -173.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.0 p -77.05 -14.29 59.84 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.907 0.384 . . . . 0.0 111.473 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 49.0 t -104.4 -59.19 3.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.105 0.479 . . . . 0.0 109.892 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 66.7 t -126.3 124.16 65.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.491 ' SG ' ' HG3' ' A' ' 60' ' ' GLN . 31.2 p -93.48 159.28 15.31 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.208 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.8 mt -62.91 -36.67 84.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.66 -178.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -61.11 -40.03 92.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.734 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.491 ' HG3' ' SG ' ' A' ' 57' ' ' CYS . 95.5 mt-30 -63.08 -41.25 99.38 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.074 0.464 . . . . 0.0 110.369 177.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 70.2 t -63.26 -44.24 99.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.119 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 92.5 m -62.59 -39.51 93.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.967 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -61.75 -39.67 92.4 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.547 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.42 ' HG3' ' O ' ' A' ' 60' ' ' GLN . 99.1 mt-30 -60.3 -42.34 95.32 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.41 -176.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.2 tt -81.77 -40.73 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-O 120.787 0.327 . . . . 0.0 111.604 178.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -62.31 -37.01 93.88 Favored Glycine 0 C--N 1.335 0.473 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.626 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -56.35 -36.14 68.44 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 123.91 0.884 . . . . 0.0 111.594 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 14.2 tpt -63.44 -28.58 70.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.246 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.81 9.62 9.83 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.495 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.651 ' CD2' ' HB3' ' A' ' 21' ' ' CYS . 98.4 m-85 -113.79 141.82 46.83 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -82.78 146.85 28.74 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.485 0.66 . . . . 0.0 112.592 -176.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.44 151.09 35.86 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.981 -1.008 . . . . 0.0 108.923 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 36.6 t -138.19 140.48 39.8 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.891 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.455 ' HA ' HG12 ' A' ' 11' ' ' VAL . 85.7 mt -81.55 128.63 38.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.066 -178.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -142.95 159.96 41.25 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.435 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 119.132 -0.461 . . . . 0.0 111.403 -179.692 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.9 t . . . . . 0 N--CA 1.449 -0.509 0 CA-C-O 120.908 0.385 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 50' ' ' LYS . . . -117.24 131.82 56.76 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 176.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.573 HG22 ' HG2' ' A' ' 50' ' ' LYS . 66.4 p -111.82 135.04 52.96 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.8 t -157.57 152.15 25.13 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 40.7 p -111.93 142.39 44.4 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-O 121.037 0.446 . . . . 0.0 110.042 178.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.3 p -133.14 127.33 54.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.137 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 40.6 ptt180 -94.53 142.61 27.24 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.595 -0.442 . . . . 0.0 109.815 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 85.3 mt -110.13 127.13 67.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.782 -177.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 63.0 tp -112.87 115.2 28.08 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.219 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -172.83 148.54 10.58 Favored Glycine 0 N--CA 1.438 -1.229 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 68.3 mtt -65.94 -41.05 91.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.972 0.415 . . . . 0.0 110.794 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.7 m -100.76 85.26 2.86 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.489 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 93.7 m -63.45 -40.13 96.32 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.495 -175.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -62.83 -42.21 99.64 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -177.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.9 m -67.34 -41.1 85.75 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.504 ' HB3' ' CG ' ' A' ' 70' ' ' PHE . 18.6 p -68.79 -39.96 79.86 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.572 -179.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.476 ' O ' ' HG3' ' A' ' 26' ' ' GLU . 67.3 t -63.07 -46.0 97.27 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.282 0 CA-C-O 121.13 0.49 . . . . 0.0 109.804 178.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.46 -44.13 97.64 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.793 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.459 ' HB3' ' HG3' ' A' ' 68' ' ' MET . 67.2 m -62.95 -46.43 87.79 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.067 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.9 tt -66.25 -33.62 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.207 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 22' ' ' VAL . 49.4 mt-10 -62.33 -44.03 97.45 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.627 178.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -65.93 -45.46 81.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.149 0.499 . . . . 0.0 110.812 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.534 ' HB3' ' HG2' ' A' ' 64' ' ' GLN . 26.5 mmt85 -64.18 -43.32 95.47 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.239 -178.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.591 HG21 ' SD ' ' A' ' 38' ' ' MET . 19.1 tt -70.62 -32.95 51.25 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.303 0 CA-C-O 120.952 0.406 . . . . 0.0 110.264 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.5 t -62.41 -38.86 91.3 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.575 176.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -66.79 -30.37 70.55 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.886 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 93.7 mt -75.82 129.12 36.51 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.164 0.507 . . . . 0.0 110.451 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -85.49 153.35 22.52 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.294 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.02 7.96 48.94 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.583 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.497 ' HA ' ' CB ' ' A' ' 51' ' ' TYR . 48.0 pt -94.78 138.68 20.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.868 0.366 . . . . 0.0 110.662 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.3 mm -99.48 -61.78 2.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.114 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.5 m -146.57 154.13 41.16 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.615 0.245 . . . . 0.0 110.965 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.591 ' SD ' HG21 ' A' ' 29' ' ' ILE . 27.8 ttt -145.6 132.45 20.12 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.583 178.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -126.26 128.34 47.02 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 176.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.8 t -107.2 123.62 62.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-O 120.79 0.329 . . . . 0.0 110.366 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.5 m -98.6 99.38 10.51 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.9 mt -64.19 -40.23 95.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.089 -175.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -69.27 -38.57 78.44 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.075 0.464 . . . . 0.0 110.91 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -74.66 -29.96 61.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.806 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.82 15.14 81.2 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -177.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 12' ' ' ARG . 49.0 m -131.48 154.25 48.93 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.39 -0.405 . . . . 0.0 110.133 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -125.41 143.49 50.96 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.978 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 85.1 m -102.01 125.26 48.66 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.6 m -117.69 147.28 21.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 121.023 0.439 . . . . 0.0 111.512 -177.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.573 ' HG2' HG22 ' A' ' 8' ' ' THR . 99.7 mttt -133.17 112.94 12.15 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.444 177.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.497 ' CB ' ' HA ' ' A' ' 35' ' ' ILE . 35.9 p90 -159.28 170.62 21.47 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.13 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.0 t -80.61 114.94 51.84 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 38.9 Cg_endo -65.97 -23.34 54.38 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.696 2.264 . . . . 0.0 112.218 -178.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.4 m -65.77 -39.36 90.94 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.619 177.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 66.0 t -74.42 -51.11 24.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.017 0.437 . . . . 0.0 110.483 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 17.8 m -137.08 149.02 26.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.434 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.582 ' SG ' ' HB2' ' A' ' 60' ' ' GLN . 24.9 p -99.65 172.24 7.41 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.871 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.484 HD23 ' OH ' ' A' ' 51' ' ' TYR . 96.5 mt -64.84 -40.89 95.9 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.718 0.771 . . . . 0.0 110.332 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -68.27 -26.71 65.8 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.462 178.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.582 ' HB2' ' SG ' ' A' ' 57' ' ' CYS . 59.6 tp60 -60.41 -45.93 91.85 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.381 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.54 ' HA ' ' OE1' ' A' ' 64' ' ' GLN . 31.8 m -74.33 -26.43 20.49 Favored 'Isoleucine or valine' 0 C--O 1.248 0.989 0 CA-C-O 121.387 0.613 . . . . 0.0 110.722 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 98.1 m -61.64 -36.45 80.82 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.104 176.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -60.48 -40.5 91.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.933 -178.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.54 ' OE1' ' HA ' ' A' ' 61' ' ' VAL . 28.6 mp0 -64.57 -41.0 96.56 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 120.4 -0.52 . . . . 0.0 112.235 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.4 tt -72.67 -36.82 54.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.525 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.23 -38.39 96.12 Favored Glycine 0 C--N 1.339 0.702 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 176.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -57.63 -36.83 72.34 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.358 0.663 . . . . 0.0 110.896 178.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.459 ' HG3' ' HB3' ' A' ' 24' ' ' SER . 95.9 mmm -74.72 -8.05 55.2 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.526 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.57 9.91 59.65 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.617 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.504 ' CG ' ' HB3' ' A' ' 21' ' ' CYS . 98.7 m-85 -111.7 147.52 35.39 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -105.95 151.32 24.74 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.184 0.516 . . . . 0.0 111.91 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -144.72 148.62 34.4 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.456 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.7 t -123.6 132.6 53.91 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.937 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 84.4 mt -78.96 130.93 35.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.235 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -144.51 155.31 43.63 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.283 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 . . . . . 0 C--O 1.256 1.432 0 CA-C-O 118.568 -0.729 . . . . 0.0 109.377 178.388 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 CA--C 1.507 -0.702 0 CA-C-O 121.003 0.43 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -104.79 131.35 52.36 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.646 -178.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 61.2 p -117.65 142.86 46.73 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.2 t -158.89 152.55 23.1 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.274 -0.571 . . . . 0.0 110.029 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 20.8 p -102.43 141.23 35.58 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 177.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.3 p -134.78 135.16 53.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.522 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -95.22 151.9 18.83 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.3 pt -115.11 138.8 44.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 110.127 -0.324 . . . . 0.0 110.127 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.2 tp -126.0 117.89 24.19 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.143 0.497 . . . . 0.0 110.774 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.82 157.77 16.31 Favored Glycine 0 N--CA 1.437 -1.264 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 95.3 mmm -69.02 -39.48 79.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.145 0.498 . . . . 0.0 110.059 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.2 p -99.74 79.07 2.2 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 121.509 0.671 . . . . 0.0 109.879 176.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.545 ' O ' HG23 ' A' ' 22' ' ' VAL . 96.4 m -62.39 -43.16 99.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.986 -176.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -64.99 -38.95 92.66 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.862 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.0 t -61.23 -45.93 92.5 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.451 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 29.3 p -67.53 -32.19 72.81 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.516 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 18' ' ' CYS . 53.7 t -62.97 -43.63 99.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.615 176.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -61.87 -43.79 98.13 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.456 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.6 m -61.76 -44.94 95.9 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.809 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.7 tp -72.5 -35.34 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 121.171 -0.212 . . . . 0.0 111.324 178.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -59.46 -47.11 86.76 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.878 0.37 . . . . 0.0 110.955 -177.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -62.92 -51.14 68.1 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.065 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.56 ' HG3' ' NE2' ' A' ' 64' ' ' GLN . 29.9 tpt180 -68.99 -40.82 78.54 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.568 -174.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.404 ' O ' HD13 ' A' ' 35' ' ' ILE . 18.9 tt -65.64 -33.83 66.28 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.086 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 73.5 m -63.64 -35.06 79.27 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.783 175.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -67.4 -26.24 66.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.097 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.428 HD11 ' NE2' ' A' ' 64' ' ' GLN . 92.1 mt -74.56 136.52 42.1 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.973 0.416 . . . . 0.0 110.852 176.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -86.75 149.92 24.52 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.393 177.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.84 7.97 54.78 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.064 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.404 HD13 ' O ' ' A' ' 29' ' ' ILE . 47.7 pt -94.02 139.49 18.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 120.881 0.372 . . . . 0.0 110.22 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 89.2 mt -99.38 -58.56 3.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.819 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.1 t -158.47 147.53 19.07 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.079 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.42 ' HG3' HG12 ' A' ' 49' ' ' VAL . 65.5 ttp -141.74 130.04 22.32 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.115 175.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -120.12 127.0 52.11 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.3 t -111.47 119.99 61.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.1 m -100.97 106.34 17.65 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 97.0 mt -63.61 -38.68 92.03 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.979 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -63.67 -41.08 98.22 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.931 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -77.29 -27.33 52.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.174 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.27 18.78 73.42 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.216 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 78.7 p -144.69 159.03 43.49 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 120.881 0.372 . . . . 0.0 111.177 -178.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -128.33 155.65 44.32 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.23 -178.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.9 m -113.32 127.54 56.18 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 8' ' ' THR . 35.9 m -116.99 148.28 19.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 120.826 0.346 . . . . 0.0 111.218 -178.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -142.68 114.87 8.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.459 177.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.449 ' OH ' HD23 ' A' ' 58' ' ' LEU . 39.4 p90 -158.89 166.84 30.93 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.06 -178.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.12 116.27 63.38 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.647 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 43.4 Cg_endo -65.78 -20.42 58.87 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.086 2.524 . . . . 0.0 114.053 -175.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.6 p -65.71 -38.11 88.29 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.695 0.283 . . . . 0.0 111.439 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.9 m -100.4 -26.98 3.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 79.8 t -125.35 124.86 68.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 176.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.564 ' SG ' ' HG3' ' A' ' 60' ' ' GLN . 31.2 p -103.29 168.65 9.03 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.001 -178.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.449 HD23 ' OH ' ' A' ' 51' ' ' TYR . 96.0 mt -64.18 -38.2 90.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.533 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -61.74 -41.06 97.17 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.014 -177.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.564 ' HG3' ' SG ' ' A' ' 57' ' ' CYS . 96.0 mt-30 -62.07 -45.56 92.97 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.47 -178.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 72.6 t -64.22 -46.93 92.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 CA-C-O 121.075 0.464 . . . . 0.0 111.048 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 44.6 t -62.16 -43.37 98.97 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.135 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -62.53 -41.33 98.8 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.779 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.56 ' NE2' ' HG3' ' A' ' 28' ' ' ARG . 99.6 mt-30 -61.2 -43.55 98.7 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 121.207 -0.197 . . . . 0.0 111.334 -176.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.0 tt -77.85 -38.02 24.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.119 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -62.82 -40.21 98.95 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.604 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -62.61 -26.93 68.86 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 122.989 0.516 . . . . 0.0 110.781 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.476 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 36.6 mmt -71.4 -8.97 57.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.666 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.77 5.86 58.47 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.377 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.479 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 99.1 m-85 -110.55 138.56 46.78 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -88.42 140.6 29.3 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.735 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -139.62 138.36 36.09 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.13 177.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.3 m -118.63 139.38 51.59 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.4 tt -118.56 139.91 44.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-O 121.128 0.489 . . . . 0.0 111.499 -174.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.44 160.41 42.12 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.108 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 . . . . . 0 C--O 1.252 1.214 0 CA-C-O 118.512 -0.756 . . . . 0.0 109.744 177.887 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 N--CA 1.44 -0.931 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -117.19 127.34 54.01 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 40.1 p -119.78 144.78 47.11 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.087 177.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.3 t -158.09 153.1 25.36 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.86 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 34.9 p -110.07 142.14 41.93 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 176.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 73' ' ' SER . 6.8 p -127.35 122.98 60.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-O 121.044 0.449 . . . . 0.0 110.192 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 36.3 ptt180 -91.44 146.2 24.0 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.208 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.2 pt -121.09 133.92 66.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 121.207 0.527 . . . . 0.0 112.008 -176.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 62.0 tp -135.56 129.41 32.94 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.069 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.21 -172.65 44.73 Favored Glycine 0 N--CA 1.438 -1.192 0 C-N-CA 119.58 -1.295 . . . . 0.0 112.811 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -61.8 -42.17 98.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.911 0.386 . . . . 0.0 110.913 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.472 ' HB ' ' OG ' ' A' ' 20' ' ' SER . 63.6 m -139.84 118.08 12.01 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.115 177.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.463 ' O ' HG23 ' A' ' 22' ' ' VAL . 95.1 m -67.47 -39.77 85.28 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.558 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -63.37 -41.91 98.84 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.613 -177.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.472 ' OG ' ' HB ' ' A' ' 17' ' ' THR . 78.9 p -69.71 -39.12 77.07 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.437 ' HB3' ' CG ' ' A' ' 70' ' ' PHE . 29.7 p -67.08 -34.03 76.78 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.544 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 18' ' ' CYS . 63.3 t -63.12 -44.84 99.68 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -63.09 -40.45 97.68 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.212 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.2 m -62.73 -46.22 89.09 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.637 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.9 tt -74.29 -35.62 40.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.012 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -60.65 -44.51 96.32 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.918 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -60.83 -51.3 69.91 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.207 -176.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -65.29 -46.35 80.74 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.452 HD13 ' SD ' ' A' ' 38' ' ' MET . 19.0 tt -65.8 -33.11 61.4 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.52 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.724 -177.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.5 m -65.55 -41.54 92.89 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.236 0.541 . . . . 0.0 110.338 177.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -71.13 -27.22 63.42 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.257 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 62.5 tp -81.86 117.23 21.96 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 121.306 0.574 . . . . 0.0 109.532 178.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -86.46 154.66 20.97 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.123 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.415 ' HA3' HG11 ' A' ' 55' ' ' VAL . . . 117.8 -6.3 15.9 Favored Glycine 0 C--N 1.314 -0.644 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -176.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.7 mp -102.05 112.67 36.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.3 tt -72.12 -38.45 63.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -176.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.5 m -151.34 145.31 25.21 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.838 0.352 . . . . 0.0 111.478 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.452 ' SD ' HD13 ' A' ' 29' ' ' ILE . 63.4 ttp -145.69 127.75 15.59 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -134.97 144.43 47.4 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.0 129.16 76.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 121.379 0.609 . . . . 0.0 111.428 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.6 p -100.47 98.07 8.72 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.703 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 99.4 mt -63.89 -39.16 93.54 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.371 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -65.45 -23.47 66.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.151 0.5 . . . . 0.0 111.115 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 -88.56 -27.82 21.14 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.135 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.34 19.67 71.21 Favored Glycine 0 C--O 1.236 0.272 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -176.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.0 t -145.0 154.88 43.01 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.24 -0.48 . . . . 0.0 109.733 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -118.36 149.73 40.7 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.584 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.7 m -112.86 126.83 55.88 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 8' ' ' THR . 12.7 p -123.72 137.37 57.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 121.013 0.435 . . . . 0.0 110.815 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -124.81 117.96 25.31 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 56.2 p90 -151.62 165.4 34.44 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.957 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.4 t -77.12 121.66 85.02 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 174.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -59.95 -28.38 86.99 Favored 'Trans proline' 0 N--CA 1.476 0.498 0 C-N-CA 122.814 2.343 . . . . 0.0 113.866 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.2 m -85.25 -9.43 57.74 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 120.752 0.31 . . . . 0.0 111.707 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.415 HG11 ' HA3' ' A' ' 34' ' ' GLY . 65.7 t -99.15 -42.33 10.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.712 0.291 . . . . 0.0 111.539 -178.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 63.5 t -125.36 137.16 58.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.746 -177.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.403 ' SG ' ' HB2' ' A' ' 60' ' ' GLN . 28.9 p -105.91 156.18 18.61 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.792 0.329 . . . . 0.0 110.872 178.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.471 HD13 HG21 ' A' ' 74' ' ' ILE . 87.9 mt -63.73 -39.86 95.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.085 -178.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -63.51 -36.87 85.19 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -177.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.426 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 23.8 tm0? -58.95 -45.28 90.86 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 121.224 -0.19 . . . . 0.0 110.796 -177.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.8 m -75.3 -33.47 28.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.216 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 95.4 m -63.64 -39.89 95.5 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-O 121.099 0.476 . . . . 0.0 110.179 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -63.33 -38.14 89.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.856 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' A' ' 60' ' ' GLN . 19.6 mm100 -62.7 -43.52 98.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.499 -177.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.5 tt -83.0 -40.25 16.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 120.797 0.332 . . . . 0.0 111.714 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.566 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -62.89 -40.78 99.69 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 116.119 -0.491 . . . . 0.0 113.426 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -61.39 -35.3 77.11 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.974 0.416 . . . . 0.0 111.282 -178.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 35.9 mmt -68.62 -8.05 38.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.703 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.39 11.15 39.59 Favored Glycine 0 CA--C 1.506 -0.499 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.713 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.566 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 96.2 m-85 -108.03 146.16 32.94 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -102.49 131.23 49.32 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.91 0.386 . . . . 0.0 110.899 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 12' ' ' ARG . . . -143.28 144.36 32.09 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 13.4 p -133.9 153.72 51.56 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.306 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.471 HG21 HD13 ' A' ' 58' ' ' LEU . 49.8 mm -95.01 130.54 43.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.208 -174.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.0 151.5 51.47 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.134 176.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 C--N 1.309 -1.163 0 CA-C-O 119.024 -0.512 . . . . 0.0 110.595 -178.945 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 31.8 m . . . . . 0 N--CA 1.443 -0.801 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.4 134.31 55.02 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.632 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 67.9 p -117.65 147.14 43.17 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 175.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 76' ' ' GLU . 87.4 p -158.85 158.21 33.01 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.149 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 31.9 p -115.36 114.38 25.05 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 175.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.505 HG22 HG12 ' A' ' 74' ' ' ILE . 70.7 t -107.62 123.51 63.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.2 -176.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -91.48 143.2 26.85 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.497 -177.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 82.7 mt -120.18 130.48 74.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.364 -176.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.46 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 7.4 tt -112.32 120.49 41.89 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 176.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -166.14 179.49 40.22 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.272 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 94.7 mmm -63.18 -41.41 99.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.745 0.307 . . . . 0.0 111.294 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.0 t -152.17 150.36 29.77 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 120.993 0.425 . . . . 0.0 110.652 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.456 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 93.1 m -64.01 -38.78 92.33 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.67 -178.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -59.22 -47.42 85.41 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -172.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.2 p -70.52 -40.93 73.21 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -177.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.456 ' SG ' ' HA ' ' A' ' 18' ' ' CYS . 25.4 p -72.71 -42.74 63.85 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -177.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.414 ' O ' ' HG3' ' A' ' 26' ' ' GLU . 66.9 t -64.18 -45.58 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.86 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 73.6 mmtt -64.41 -38.95 92.84 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.328 -0.549 . . . . 0.0 112.061 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.6 m -62.22 -43.97 97.63 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.279 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.439 ' O ' HG22 ' A' ' 29' ' ' ILE . 10.9 tp -72.86 -37.62 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.547 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 22' ' ' VAL . 44.4 mt-10 -61.97 -41.43 98.01 Favored 'General case' 0 C--N 1.349 0.558 0 C-N-CA 120.944 -0.303 . . . . 0.0 111.513 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -61.07 -50.26 74.01 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -176.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -65.93 -44.96 83.56 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.439 HG22 ' O ' ' A' ' 25' ' ' ILE . 19.7 tt -72.17 -32.68 44.08 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 CA-C-O 120.797 0.332 . . . . 0.0 111.372 -177.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.2 t -63.66 -39.67 94.93 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -68.56 -27.09 65.77 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.377 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 98.5 mt -83.68 118.34 23.8 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.556 -0.457 . . . . 0.0 110.427 176.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -85.71 153.94 21.98 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.606 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.13 7.48 14.62 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.453 -177.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.412 ' HA ' ' CB ' ' A' ' 51' ' ' TYR . 46.7 pt -102.79 139.02 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 86.8 mt -83.82 -56.96 4.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.173 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 78.6 p -155.14 157.42 37.41 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.256 -178.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 77.9 mtm -138.03 142.35 40.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.331 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -131.3 149.52 52.53 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 175.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.9 p -138.48 131.7 40.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-O 121.187 0.518 . . . . 0.0 111.385 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.1 m -116.19 103.99 11.08 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.76 -41.63 97.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.346 -176.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -64.02 -39.93 95.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.156 0.503 . . . . 0.0 110.997 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -73.11 -29.89 63.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.323 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.35 17.66 73.28 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.749 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 88.4 p -142.2 158.58 43.57 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 120.893 0.378 . . . . 0.0 110.455 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -124.48 144.7 49.94 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.85 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.1 m -103.65 123.35 46.83 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 8' ' ' THR . 29.7 m -126.67 149.41 31.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.446 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -134.95 115.33 13.44 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.468 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.412 ' CB ' ' HA ' ' A' ' 35' ' ' ILE . 51.6 p90 -161.97 170.93 18.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.237 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.5 t -82.88 116.32 63.46 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 36.7 Cg_endo -64.76 -23.88 62.41 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.71 2.273 . . . . 0.0 113.515 -176.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.5 t -64.88 -42.88 94.45 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.271 177.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 96.5 t -67.78 -49.47 69.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.137 0.494 . . . . 0.0 110.043 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 63.0 t -128.35 119.84 51.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.657 ' SG ' ' HB2' ' A' ' 60' ' ' GLN . 30.4 p -83.12 154.46 24.33 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.472 -178.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.482 ' HB3' ' CD1' ' A' ' 74' ' ' ILE . 98.9 mt -62.48 -37.99 88.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.544 -178.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -63.11 -39.43 94.66 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.535 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.657 ' HB2' ' SG ' ' A' ' 57' ' ' CYS . 14.2 tm0? -65.0 -38.89 92.44 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 77.3 t -61.58 -44.05 98.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.298 0.571 . . . . 0.0 110.171 178.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 44.0 t -60.49 -40.32 90.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.191 176.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.468 ' HB3' ' O ' ' A' ' 60' ' ' GLN . 53.7 t-80 -60.18 -39.36 86.2 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.872 177.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -59.9 -46.17 90.18 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.373 -177.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.3 tt -82.04 -33.65 11.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.09 -39.66 97.43 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.455 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -61.75 -37.94 86.14 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.838 0.351 . . . . 0.0 111.082 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 16.4 tpt -61.97 -30.04 70.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.04 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.94 6.94 18.26 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.61 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -112.55 136.92 51.51 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.46 ' HG3' ' HB3' ' A' ' 14' ' ' LEU . 12.0 pt-20 -95.88 144.55 26.12 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.009 0.433 . . . . 0.0 110.649 -178.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.89 152.36 37.46 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.381 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 78.3 p -132.1 149.36 52.42 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.45 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.505 HG12 HG22 ' A' ' 11' ' ' VAL . 81.6 mt -94.4 125.26 47.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.891 -175.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -126.33 149.83 48.91 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.008 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 9' ' ' SER . 41.8 tt0 . . . . . 0 C--O 1.249 1.078 0 C-N-CA 123.167 0.587 . . . . 0.0 111.125 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 CA--C 1.508 -0.651 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -139.07 148.77 43.77 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.06 0.457 . . . . 0.0 110.614 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 72.3 p -125.34 156.18 39.11 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.7 p -156.5 159.06 38.25 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 123.266 0.354 . . . . 0.0 110.078 176.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.2 p -117.93 139.21 51.47 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 73' ' ' SER . 6.7 p -132.14 123.81 51.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.234 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -77.96 143.51 37.55 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.503 HD12 ' SG ' ' A' ' 21' ' ' CYS . 37.6 pt -115.76 123.02 70.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 60.4 tp -122.82 119.36 30.35 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.063 0.458 . . . . 0.0 111.545 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.49 167.95 37.64 Favored Glycine 0 N--CA 1.438 -1.229 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 178.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 99.0 mtp -64.51 -39.32 93.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.954 0.407 . . . . 0.0 111.208 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.6 p -109.49 113.46 26.28 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.104 0.478 . . . . 0.0 111.196 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.509 ' O ' HG23 ' A' ' 22' ' ' VAL . 23.7 p -70.93 -44.9 65.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.851 -178.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.415 ' O ' ' HG3' ' A' ' 23' ' ' LYS . 98.3 mt-30 -64.73 -37.9 89.15 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.555 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.2 t -60.55 -45.25 94.58 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.241 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.503 ' SG ' HD12 ' A' ' 13' ' ' ILE . 26.9 p -69.56 -32.57 71.44 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.836 178.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 18' ' ' CYS . 61.5 t -63.64 -43.67 98.22 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-O 121.214 0.531 . . . . 0.0 109.631 176.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 19' ' ' GLN . 98.6 mttt -61.86 -39.34 91.53 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.752 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.403 ' HB3' ' HG3' ' A' ' 68' ' ' MET . 70.9 m -62.72 -43.23 99.34 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.716 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.439 ' CG2' ' HB ' ' A' ' 65' ' ' ILE . 46.1 pt -81.63 -39.24 16.8 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.886 0 C-N-CA 120.386 -0.525 . . . . 0.0 112.292 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -62.67 -44.87 95.16 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.155 -176.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -61.85 -51.73 67.03 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.206 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.56 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 97.7 mtt180 -70.11 -41.21 74.29 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -176.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 92.1 mt -63.45 -44.19 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.683 0.278 . . . . 0.0 111.166 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 81.1 p -63.2 -33.78 76.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.833 0.349 . . . . 0.0 110.936 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -70.98 -25.76 62.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.417 176.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 28' ' ' ARG . 99.3 mt -70.43 146.61 50.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.133 0.492 . . . . 0.0 111.316 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -86.57 130.88 34.33 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.46 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.5 7.76 25.71 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.799 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.7 tp -84.88 123.39 39.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.05 0.453 . . . . 0.0 110.821 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 86.6 mt -93.58 -60.68 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.011 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 85.9 p -161.51 164.26 29.74 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.64 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 28.5 ptm -151.31 155.54 38.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.904 0.383 . . . . 0.0 110.883 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -143.73 138.67 29.0 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.692 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 67.0 t -106.9 124.33 62.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 120.941 0.4 . . . . 0.0 110.506 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.5 t -99.24 108.09 20.57 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.101 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.11 -33.47 73.53 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.426 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -61.48 -45.48 94.06 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.256 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -93.14 -12.69 29.77 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.646 -0.421 . . . . 0.0 111.686 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.83 26.95 73.78 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.1 m -135.69 158.17 45.05 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.389 -0.406 . . . . 0.0 110.447 -177.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.44 143.59 47.42 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 85.7 m -110.03 127.8 55.04 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.1 p -127.57 134.73 64.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 121.181 0.515 . . . . 0.0 111.283 -178.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -104.48 114.99 29.58 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 175.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.473 ' O ' ' HD3' ' A' ' 53' ' ' PRO . 16.1 t80 -142.79 165.27 27.85 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.612 -170.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.9 t -107.12 98.21 21.29 Favored Pre-proline 0 C--N 1.319 -0.744 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 51' ' ' TYR . 45.9 Cg_exo -60.66 -25.08 80.17 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.294 2.663 . . . . 0.0 111.971 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.8 m -62.26 -41.06 98.11 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.792 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 76.5 t -65.5 -49.69 76.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-O 121.192 0.52 . . . . 0.0 109.847 177.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.3 p -155.85 147.13 12.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.654 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 29.8 p -68.87 156.22 38.83 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.295 0.569 . . . . 0.0 112.406 -176.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.0 mt -77.2 -12.32 59.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.425 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -58.32 -37.89 76.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.954 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.514 ' O ' ' HG3' ' A' ' 64' ' ' GLN . 16.8 mm100 -61.57 -39.88 92.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.011 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.2 t -61.74 -45.11 99.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.744 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 43.0 t -60.73 -40.54 92.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.96 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 44.7 m170 -64.63 -37.16 86.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.703 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.514 ' HG3' ' O ' ' A' ' 60' ' ' GLN . 98.5 mt-30 -60.87 -44.29 97.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.119 -0.492 . . . . 0.0 112.008 -177.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.52 HD13 ' HB2' ' A' ' 72' ' ' ALA . 20.1 tt -76.32 -38.41 33.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.597 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.13 -37.89 95.24 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 177.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -58.12 -36.89 73.59 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.25 0.62 . . . . 0.0 111.132 177.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.403 ' HG3' ' HB3' ' A' ' 24' ' ' SER . 97.8 mmm -79.91 1.93 25.36 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.87 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.31 19.39 58.86 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.871 -0.68 . . . . 0.0 113.897 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -114.64 135.79 53.76 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 177.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -83.08 140.07 32.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.721 0.296 . . . . 0.0 110.56 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.52 ' HB2' HD13 ' A' ' 65' ' ' ILE . . . -148.23 149.72 32.43 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.175 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 65.9 m -133.92 133.97 42.08 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.181 177.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 85.9 mt -100.28 125.87 53.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.258 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -138.67 148.37 43.93 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.419 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.466 -0.778 . . . . 0.0 109.313 179.239 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -129.69 128.55 42.77 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.98 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.608 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 63.0 p -126.32 136.99 53.42 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.116 177.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.4 t -159.43 162.91 35.78 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 59.3 p -106.05 136.71 45.25 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.273 0.558 . . . . 0.0 111.077 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.32 123.61 70.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 177.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -80.61 141.15 35.29 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -178.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.2 pt -109.68 126.86 66.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-O 121.332 0.586 . . . . 0.0 111.369 -177.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.4 tp -126.26 117.8 23.81 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -165.47 160.46 33.85 Favored Glycine 0 N--CA 1.422 -2.27 0 C-N-CA 120.07 -1.062 . . . . 0.0 111.495 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.6 mmt -65.41 -39.67 92.45 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.3 p -122.33 105.94 10.64 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.722 176.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.9 m -63.63 -40.15 96.16 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.712 -177.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -62.93 -40.71 98.45 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.79 0.329 . . . . 0.0 110.471 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.4 m -62.81 -44.65 95.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.79 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.405 ' HB3' ' CD1' ' A' ' 70' ' ' PHE . 27.9 p -67.14 -38.28 85.25 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.128 -178.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 78.8 t -64.86 -45.02 96.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-O 121.128 0.489 . . . . 0.0 109.828 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -63.52 -43.14 98.03 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.925 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.492 ' HB3' ' HG3' ' A' ' 68' ' ' MET . 68.8 m -62.44 -42.79 99.71 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.825 -178.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.428 HD12 ' HB ' ' A' ' 65' ' ' ILE . 17.9 tt -72.56 -37.65 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.41 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -60.83 -45.94 92.49 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.228 0.537 . . . . 0.0 109.956 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -60.7 -49.71 76.43 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.366 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 44.4 ttt180 -66.02 -43.69 86.91 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.237 -177.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 87.9 mt -63.68 -39.87 86.97 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.799 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.861 177.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 69.3 m -59.72 -37.24 78.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.98 0.419 . . . . 0.0 110.384 178.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -68.59 -26.5 65.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.994 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.0 mp -97.71 150.01 21.67 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.31 0.576 . . . . 0.0 112.105 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -75.58 154.66 36.61 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.793 178.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.95 2.05 45.59 Favored Glycine 0 CA--C 1.505 -0.543 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.971 177.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.8 tt -72.62 108.13 3.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.253 0.549 . . . . 0.0 110.794 178.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' A' ' 50' ' ' LYS . 46.0 mm -101.88 -71.47 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.816 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 52.2 m -155.65 158.41 38.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.752 0.31 . . . . 0.0 111.242 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.8 ptm -148.74 148.53 30.11 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.242 175.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.52 ' HB3' ' HB ' ' A' ' 48' ' ' THR . 55.1 tttp -117.36 112.0 20.11 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.317 176.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.7 p -118.79 114.43 44.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-O 121.409 0.623 . . . . 0.0 110.008 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.7 m -124.98 127.01 46.36 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.02 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 93.8 mt -63.29 -39.07 93.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.225 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -61.75 -39.32 91.19 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.258 0.552 . . . . 0.0 110.365 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -72.56 -30.11 64.14 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.465 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.66 14.94 80.87 Favored Glycine 0 C--O 1.236 0.255 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.036 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 89.7 p -156.17 164.4 38.42 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.56 134.78 55.07 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.926 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' A' ' 39' ' ' LYS . 53.4 m -94.54 124.32 38.5 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 177.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.608 ' O ' ' HA ' ' A' ' 8' ' ' THR . 28.9 m -107.86 142.0 21.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.457 -177.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.461 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 87.7 tttt -131.58 104.58 7.03 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.478 -0.783 . . . . 0.0 108.926 178.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.523 ' CE2' ' HB ' ' A' ' 49' ' ' VAL . 64.5 m-85 -140.25 160.38 40.09 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.967 -177.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.0 t -80.44 117.08 66.08 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.612 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 30.1 Cg_endo -62.28 -25.83 76.92 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.142 2.561 . . . . 0.0 113.096 -176.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.8 t -62.94 -41.57 99.53 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.054 0.454 . . . . 0.0 110.334 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.1 t -87.53 -49.81 14.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.3 -177.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.612 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 28.5 m -132.82 161.68 41.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.484 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 31.1 p -133.74 169.72 16.63 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 120.679 0.276 . . . . 0.0 110.899 -178.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.1 mt -62.6 -38.59 90.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.51 -177.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -60.32 -44.49 95.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.43 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.495 ' O ' ' HG3' ' A' ' 64' ' ' GLN . 97.0 mt-30 -64.42 -41.06 96.82 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.104 178.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 73.6 t -62.08 -46.13 97.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 CA-C-O 121.133 0.492 . . . . 0.0 110.353 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.504 ' SG ' ' HB ' ' A' ' 74' ' ' ILE . 93.8 m -62.78 -39.71 95.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.848 178.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -62.47 -41.64 98.92 Favored 'General case' 0 C--O 1.206 -1.226 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.052 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 60' ' ' GLN . 78.5 mt-30 -60.39 -42.42 95.87 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -175.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.428 ' HB ' HD12 ' A' ' 25' ' ' ILE . 17.4 tt -76.77 -40.95 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.571 178.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.578 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -63.33 -38.33 96.26 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 121.334 -0.46 . . . . 0.0 112.381 178.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -58.72 -33.59 70.38 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 124.261 1.024 . . . . 0.0 110.509 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.492 ' HG3' ' HB3' ' A' ' 24' ' ' SER . 96.6 mmm -79.09 -1.32 35.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.936 -178.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.17 15.55 44.26 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.149 -1.024 . . . . 0.0 113.589 177.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.578 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 99.3 m-85 -113.8 145.86 40.79 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.788 0.328 . . . . 0.0 110.354 178.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -88.52 130.75 35.16 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 120.983 0.421 . . . . 0.0 111.028 -178.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.46 140.2 24.85 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.644 178.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.7 m -127.0 141.49 51.78 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.1 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.504 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 10.2 tp -98.33 136.32 29.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 120.859 0.361 . . . . 0.0 110.498 -177.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -154.43 159.35 41.02 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.23 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 . . . . . 0 C--O 1.252 1.198 0 CA-C-O 118.152 -0.928 . . . . 0.0 110.721 179.094 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.7 t . . . . . 0 N--CA 1.439 -1.006 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.01 134.11 44.5 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.137 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 69.8 p -123.73 137.52 54.68 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.855 178.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 72.7 m -147.11 157.3 43.56 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.448 178.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 38.4 p -110.01 139.23 45.35 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 177.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.453 ' CG2' ' HB1' ' A' ' 72' ' ' ALA . 7.0 p -129.74 119.69 48.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-O 120.967 0.413 . . . . 0.0 110.205 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.526 ' HG2' ' HB2' ' A' ' 73' ' ' SER . 9.2 ptm180 -82.21 148.79 28.24 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.9 pt -112.81 142.66 24.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 121.278 0.561 . . . . 0.0 111.123 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 67.1 tp -132.69 119.74 20.78 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.166 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.414 ' HA3' ' HD1' ' A' ' 70' ' ' PHE . . . 178.41 174.41 44.64 Favored Glycine 0 N--CA 1.436 -1.305 0 C-N-CA 119.27 -1.443 . . . . 0.0 113.831 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 28.1 ttt -62.06 -48.13 81.6 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 122.987 0.515 . . . . 0.0 111.426 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.4 p -128.86 119.34 24.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.066 0.46 . . . . 0.0 111.297 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.8 m -65.47 -39.02 91.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.118 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -63.42 -39.47 94.58 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.449 -177.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.8 m -62.67 -43.73 98.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.543 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.0 p -71.83 -39.65 69.64 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -178.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.7 m -69.99 -33.02 53.57 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 120.291 -0.563 . . . . 0.0 111.051 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -71.09 -42.28 69.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.111 0.482 . . . . 0.0 110.863 177.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.5 m -62.73 -43.55 98.51 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.041 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.574 ' HB ' ' CG2' ' A' ' 65' ' ' ILE . 19.3 tt -71.56 -29.71 35.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.618 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -59.63 -45.16 92.8 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.559 -177.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -61.97 -50.8 70.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.795 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.514 HH11 ' HA ' ' A' ' 64' ' ' GLN . 99.4 mtt180 -65.47 -39.95 92.57 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -177.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.444 HG23 HG21 ' A' ' 35' ' ' ILE . 27.6 mm -60.99 -44.56 98.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.99 0.424 . . . . 0.0 110.328 176.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.7 t -62.54 -39.93 95.18 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.385 178.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -68.56 -28.78 67.26 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.006 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 64.4 tp -100.38 118.13 35.99 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.133 0.492 . . . . 0.0 111.478 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -83.22 153.05 24.92 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.056 178.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.501 ' HA3' HG11 ' A' ' 55' ' ' VAL . . . 118.29 -11.4 12.86 Favored Glycine 0 CA--C 1.499 -0.91 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -176.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.444 HG21 HG23 ' A' ' 29' ' ' ILE . 12.6 tt -108.42 110.43 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 173.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.14 -47.03 95.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.864 -174.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 85.0 p -158.85 160.57 36.33 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.479 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 28.0 ttt -146.69 129.87 16.54 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.554 177.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -121.3 139.76 52.98 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.6 m -116.52 140.27 39.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 120.873 0.368 . . . . 0.0 110.894 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.6 t -119.64 106.81 12.53 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.778 178.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.8 mp -64.65 -39.72 94.17 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.271 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -62.3 -44.98 95.26 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.501 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -75.71 -28.68 58.68 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.048 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.21 25.62 65.83 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -176.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 12' ' ' ARG . 45.4 t -145.32 150.98 37.59 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.079 -0.56 . . . . 0.0 110.034 -176.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.04 145.88 45.51 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.361 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 87.2 m -105.82 126.02 51.67 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 8' ' ' THR . 23.7 m -110.6 138.3 39.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-O 120.966 0.412 . . . . 0.0 110.382 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -128.43 108.08 10.26 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -149.19 165.99 30.17 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.029 0.442 . . . . 0.0 112.035 -171.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 52.1 t -79.72 119.8 77.99 Favored Pre-proline 0 C--N 1.319 -0.741 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 174.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -60.68 -32.21 92.92 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.649 2.232 . . . . 0.0 113.281 -174.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.6 t -65.06 -41.93 94.67 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.001 0.429 . . . . 0.0 110.934 178.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.501 HG11 ' HA3' ' A' ' 34' ' ' GLY . 60.0 t -81.42 -46.04 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -175.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 74.0 t -114.75 133.88 59.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -173.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 29.1 p -109.25 147.95 31.77 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.285 177.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.494 HD13 HG21 ' A' ' 74' ' ' ILE . 87.1 mt -64.56 -40.3 95.32 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -176.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -62.6 -39.72 94.65 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -177.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.446 HE21 ' HB3' ' A' ' 60' ' ' GLN . 1.1 tm0? -61.85 -41.6 98.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.961 0.41 . . . . 0.0 109.999 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.428 HG13 HD11 ' A' ' 25' ' ' ILE . 76.4 t -63.31 -44.49 99.12 Favored 'Isoleucine or valine' 0 C--O 1.247 0.924 0 CA-C-O 121.47 0.652 . . . . 0.0 110.403 177.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 97.2 m -61.65 -38.31 87.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.15 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 61.4 m170 -66.87 -26.17 66.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.088 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.514 ' HA ' HH11 ' A' ' 28' ' ' ARG . 78.8 mt-30 -60.73 -43.65 97.63 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 120.79 0.328 . . . . 0.0 110.432 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.638 HD11 ' HB2' ' A' ' 72' ' ' ALA . 36.6 pt -87.65 -25.89 5.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.251 176.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -61.5 -35.96 91.86 Favored Glycine 0 N--CA 1.453 -0.22 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.467 178.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -58.83 -37.43 76.41 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.856 0.36 . . . . 0.0 110.935 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 26.4 mmt -79.63 1.2 27.08 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.733 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.9 10.3 60.1 Favored Glycine 0 CA--C 1.508 -0.404 0 C-N-CA 120.604 -0.808 . . . . 0.0 113.035 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.458 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 72.2 m-85 -98.84 139.14 34.95 Favored 'General case' 0 C--N 1.315 -0.901 0 O-C-N 122.645 -0.326 . . . . 0.0 110.235 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -100.75 151.15 22.01 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.353 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.638 ' HB2' HD11 ' A' ' 65' ' ' ILE . . . -144.93 156.69 44.12 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 120.782 0.325 . . . . 0.0 111.242 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.526 ' HB2' ' HG2' ' A' ' 12' ' ' ARG . 40.4 m -129.19 146.8 51.04 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.494 HG21 HD13 ' A' ' 58' ' ' LEU . 84.2 mt -101.95 127.18 55.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.238 0.542 . . . . 0.0 111.947 -174.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -128.52 157.14 42.0 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.135 177.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 . . . . . 0 C--O 1.242 0.678 0 C-N-CA 123.37 0.668 . . . . 0.0 110.283 -176.985 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.473 HG11 HD12 ' A' ' 36' ' ' ILE . 61.8 t . . . . . 0 N--CA 1.433 -1.295 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.78 148.05 25.36 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.768 -175.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.8 p -100.64 136.05 41.11 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.174 176.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.3 m -126.8 145.86 50.47 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 120.704 0.288 . . . . 0.0 110.227 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 46.5 p -117.16 140.1 49.94 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.347 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.91 126.76 38.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.447 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.494 ' HG2' ' HB3' ' A' ' 73' ' ' SER . 14.7 ptm180 -83.42 149.17 26.84 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.721 HG21 ' SG ' ' A' ' 21' ' ' CYS . 86.0 mt -123.1 130.51 74.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -176.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.7 tp -131.61 119.07 20.93 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -173.42 -177.27 42.53 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.247 -0.977 . . . . 0.0 112.403 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 66.8 mtt -63.78 -43.22 97.01 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.6 m -136.6 116.91 13.58 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.633 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.416 ' O ' HG23 ' A' ' 22' ' ' VAL . 94.1 m -65.57 -40.23 92.56 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.729 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -62.82 -40.87 98.74 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -177.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.9 m -62.5 -44.27 96.79 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -177.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.721 ' SG ' HG21 ' A' ' 13' ' ' ILE . 24.5 p -71.38 -35.73 71.18 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.64 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 18' ' ' CYS . 59.0 t -62.76 -44.22 99.33 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 177.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.96 -40.25 97.14 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.114 177.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.7 t -60.63 -47.64 85.32 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.295 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.6 pt -74.25 -29.4 24.63 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.899 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -59.53 -48.83 80.13 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -65.41 -51.18 62.09 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.306 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -62.27 -50.71 70.61 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-O 121.192 0.52 . . . . 0.0 111.631 -174.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.448 ' CG2' HD12 ' A' ' 35' ' ' ILE . 37.4 mm -62.83 -41.98 94.63 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.929 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.752 179.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 73.2 m -60.56 -38.81 85.74 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -68.52 -27.17 65.87 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.035 177.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 60.5 tp -87.25 129.69 34.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.148 0.499 . . . . 0.0 110.966 177.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -70.81 151.88 44.33 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.354 177.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.95 -4.97 18.55 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.881 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.448 HD12 ' CG2' ' A' ' 29' ' ' ILE . 9.3 tt -96.14 138.32 21.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.84 0.353 . . . . 0.0 110.899 178.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.473 HD12 HG11 ' A' ' 6' ' ' VAL . 86.4 mt -113.02 -53.31 5.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.793 176.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.9 m -137.52 151.72 48.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.889 0.376 . . . . 0.0 111.694 -177.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.45 ' HG3' HG12 ' A' ' 49' ' ' VAL . 60.6 ttm -139.14 131.21 27.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.394 176.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -128.79 124.54 35.7 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.9 m -126.61 140.0 50.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.381 -179.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.4 t -134.74 108.3 7.91 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.973 177.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.5 mp -66.5 -32.57 74.01 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.643 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -61.74 -39.92 93.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.283 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -75.41 -27.39 59.01 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.06 0.457 . . . . 0.0 110.14 176.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.2 15.47 81.0 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 -177.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 12' ' ' ARG . 51.1 m -135.13 153.69 51.91 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 121.085 0.469 . . . . 0.0 110.627 -178.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.66 139.19 51.91 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.498 178.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 79.6 m -115.18 125.5 53.48 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.45 HG12 ' HG3' ' A' ' 38' ' ' MET . 31.5 m -125.58 148.05 30.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.977 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -124.1 116.53 22.92 Favored 'General case' 0 C--O 1.245 0.838 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.58 ' CD2' ' HB ' ' A' ' 56' ' ' VAL . 55.3 p90 -152.61 166.15 32.99 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.474 -173.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.8 t -77.5 117.99 69.09 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.03 -30.37 82.85 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.769 2.313 . . . . 0.0 113.546 -175.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.3 t -64.78 -44.19 90.8 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.039 0.447 . . . . 0.0 110.828 178.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 90.9 t -72.7 -47.17 51.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.71 -177.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.58 ' HB ' ' CD2' ' A' ' 51' ' ' TYR . 58.3 t -112.63 126.3 70.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.093 -177.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 60' ' ' GLN . 28.6 p -100.92 158.35 16.05 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 120.989 0.423 . . . . 0.0 111.473 -178.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.3 mt -63.41 -39.12 93.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.576 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -62.19 -39.93 94.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.671 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.49 ' HB2' ' SG ' ' A' ' 57' ' ' CYS . 64.9 tt0 -61.16 -46.55 90.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.627 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.5 t -61.93 -44.44 98.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.625 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 93.3 m -61.66 -41.46 97.56 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.089 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -66.04 -41.13 91.28 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.759 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.489 ' HG3' ' O ' ' A' ' 60' ' ' GLN . 95.6 mt-30 -60.87 -42.24 97.51 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.985 -175.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.0 tt -84.04 -41.23 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.98 -40.18 98.99 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 116.303 -0.408 . . . . 0.0 113.501 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -60.51 -35.82 76.88 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.936 0.398 . . . . 0.0 110.571 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 26.5 mmt -69.76 -11.95 61.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.468 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.98 12.21 32.44 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.394 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.529 ' CG ' ' HB3' ' A' ' 21' ' ' CYS . 94.9 m-85 -110.32 125.48 53.22 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -76.96 139.11 40.02 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.624 -178.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.13 155.18 41.94 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 120.889 0.376 . . . . 0.0 111.603 -177.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.494 ' HB3' ' HG2' ' A' ' 12' ' ' ARG . 42.0 t -137.29 139.95 41.24 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 36.4 pt -105.67 151.82 7.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -173.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.547 ' O ' ' HB2' ' A' ' 76' ' ' GLU . . . -151.35 160.26 43.86 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.7 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.547 ' HB2' ' O ' ' A' ' 75' ' ' ALA . 39.5 mm-40 . . . . . 0 C--O 1.251 1.148 0 C-N-CA 123.3 0.64 . . . . 0.0 110.879 -178.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.5 m . . . . . 0 N--CA 1.439 -0.979 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.98 147.27 42.44 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.103 0.478 . . . . 0.0 111.885 -175.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 53.9 p -119.35 150.15 40.64 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.715 176.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.429 ' OG ' HD21 ' A' ' 58' ' ' LEU . 87.5 p -155.34 160.35 40.66 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.314 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 41.2 p -127.77 146.09 50.7 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.538 176.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.5 m -128.92 146.19 34.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.459 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 38.5 ptt180 -106.67 140.99 38.65 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.535 HG12 ' SG ' ' A' ' 21' ' ' CYS . 7.8 tp -120.08 131.51 72.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-O 121.679 0.752 . . . . 0.0 112.424 -173.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 65.7 tp -124.67 118.19 25.93 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.52 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -170.01 169.32 42.09 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 119.938 -1.125 . . . . 0.0 112.733 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 79.3 mtm -64.09 -42.81 96.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.786 0.327 . . . . 0.0 111.377 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.7 p -132.52 122.54 25.01 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.193 0.52 . . . . 0.0 111.57 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.402 ' O ' HG23 ' A' ' 22' ' ' VAL . 44.1 t -63.6 -41.9 98.28 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.141 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.8 mp0 -61.51 -40.42 94.54 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.295 -176.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.7 m -62.84 -45.59 91.9 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -177.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.535 ' SG ' HG12 ' A' ' 13' ' ' ILE . 26.7 p -68.71 -35.66 77.46 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.178 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 18' ' ' CYS . 67.6 t -62.91 -44.32 99.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-O 121.114 0.483 . . . . 0.0 109.759 178.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -64.81 -40.13 94.71 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.012 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.6 m -62.74 -46.65 87.08 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.376 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.547 ' HB ' ' CG2' ' A' ' 65' ' ' ILE . 8.1 tp -69.9 -31.94 49.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.009 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -58.84 -42.81 90.16 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.316 -178.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -59.3 -53.57 56.75 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.418 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 24.0 ttm180 -67.14 -47.15 71.93 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.118 -178.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.578 ' O ' HD11 ' A' ' 35' ' ' ILE . 18.5 tt -65.76 -41.43 90.29 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.987 -175.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 86.6 p -66.33 -30.09 70.42 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-O 121.062 0.458 . . . . 0.0 110.488 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -70.62 -27.09 63.81 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.841 177.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 28' ' ' ARG . 89.9 mt -91.72 137.63 32.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.189 0.518 . . . . 0.0 111.775 -178.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -86.72 151.62 23.24 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.841 177.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.58 8.22 12.71 Favored Glycine 0 C--O 1.238 0.369 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.658 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.578 HD11 ' O ' ' A' ' 29' ' ' ILE . 79.8 mt -81.67 121.98 35.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 83.6 mt -94.24 -54.77 6.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.0 t -149.06 124.21 10.12 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.97 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.429 ' SD ' HD13 ' A' ' 29' ' ' ILE . 27.2 ttt -121.24 113.58 20.16 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.125 177.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -133.29 145.68 50.69 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.139 178.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.45 126.51 74.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.222 0.534 . . . . 0.0 110.089 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.8 m -93.65 91.99 7.31 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.152 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.8 mt -63.54 -35.98 82.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.603 0.716 . . . . 0.0 109.235 178.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -62.84 -40.28 96.95 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.844 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -90.33 -12.19 38.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.046 -177.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.5 29.69 69.64 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.379 -0.915 . . . . 0.0 111.471 -177.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 90.1 p -151.06 163.66 38.25 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.48 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -119.07 145.83 45.59 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.533 0.206 . . . . 0.0 110.82 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.3 m -112.93 121.95 46.18 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.0 t -120.49 123.19 69.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-O 120.884 0.373 . . . . 0.0 110.371 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -109.2 119.38 39.35 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 176.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -150.77 166.68 29.72 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.697 -170.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.9 t -92.05 110.82 46.62 Favored Pre-proline 0 N--CA 1.444 -0.755 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 173.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 37.6 Cg_endo -64.27 -21.72 67.02 Favored 'Trans proline' 0 N--CA 1.475 0.427 0 C-N-CA 122.88 2.387 . . . . 0.0 113.467 -175.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.5 t -64.37 -42.71 96.04 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.173 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.8 p -95.11 -35.71 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 12.2 p -130.14 149.89 34.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -177.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 29.6 p -134.01 163.06 30.39 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.19 0.519 . . . . 0.0 111.663 -175.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.446 ' HA ' HG22 ' A' ' 61' ' ' VAL . 98.6 mt -70.8 -22.53 62.34 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.982 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -61.73 -42.3 98.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.07 0.462 . . . . 0.0 110.14 -179.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -65.15 -40.89 95.01 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.182 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.497 ' HB ' HD11 ' A' ' 25' ' ' ILE . 32.7 m -72.71 -36.4 52.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.53 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 95.6 m -64.18 -39.51 94.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.665 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 66.3 m170 -64.31 -39.94 94.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.314 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -60.83 -43.79 97.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.606 -177.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.547 ' CG2' ' HB ' ' A' ' 25' ' ' ILE . 27.2 pt -87.04 -37.87 11.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -178.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -62.94 -40.71 99.62 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.888 -0.673 . . . . 0.0 113.137 -178.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -70.13 -14.91 62.86 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 26.3 mmt -85.11 2.34 43.88 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.907 0.384 . . . . 0.0 110.817 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.48 -9.2 71.73 Favored Glycine 0 CA--C 1.507 -0.407 0 C-N-CA 121.066 -0.587 . . . . 0.0 112.188 179.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.459 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 96.8 m-85 -80.89 143.57 32.61 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -106.25 128.31 53.87 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.643 -177.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 12' ' ' ARG . . . -147.31 151.23 36.24 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.466 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.8 p -136.77 153.63 50.78 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.903 0.382 . . . . 0.0 111.341 178.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 81.3 mt -90.98 131.86 37.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.908 -174.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -133.67 126.54 31.02 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.454 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 . . . . . 0 C--N 1.314 -0.97 0 CA-C-O 118.062 -0.97 . . . . 0.0 110.657 179.691 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.455 -0.212 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.409 ' H ' ' HD3' ' A' ' 53' ' ' PRO . . . -108.77 134.55 51.32 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.287 0.565 . . . . 0.0 112.27 -173.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 50.5 p -123.97 140.5 52.92 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.976 174.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 91.3 p -158.46 166.85 31.2 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.019 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 2.1 p -110.32 148.48 31.85 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 175.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 91.1 t -131.01 126.89 60.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.425 ' NE ' ' HB2' ' A' ' 73' ' ' SER . 37.9 ptt180 -87.8 144.62 26.51 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.6 HG12 ' SG ' ' A' ' 21' ' ' CYS . 7.4 tp -129.61 130.3 66.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-O 121.163 0.506 . . . . 0.0 111.134 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 62.0 tp -129.47 124.22 33.48 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.478 178.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -165.18 176.25 40.9 Favored Glycine 0 N--CA 1.435 -1.425 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.157 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 61.0 tpp -61.52 -47.91 83.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.884 0.373 . . . . 0.0 111.024 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 65.9 m -130.4 125.16 33.84 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.119 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.8 t -63.23 -43.59 97.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.396 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -61.52 -38.76 88.57 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.528 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.0 m -60.47 -44.21 96.12 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -177.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.6 ' SG ' HG12 ' A' ' 13' ' ' ILE . 25.6 p -70.99 -36.95 72.68 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.235 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.9 t -63.18 -44.53 99.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-O 121.123 0.487 . . . . 0.0 109.764 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -64.41 -40.38 95.67 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.878 178.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.639 ' O ' ' HD3' ' A' ' 28' ' ' ARG . 68.9 m -62.11 -45.04 95.23 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.38 -178.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.468 ' HB ' ' HB ' ' A' ' 65' ' ' ILE . 17.9 tt -70.93 -33.77 53.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.849 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -60.22 -48.01 83.54 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.934 -177.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -61.55 -46.69 88.86 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.887 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.639 ' HD3' ' O ' ' A' ' 24' ' ' SER . 10.9 mpt_? -70.41 -41.75 72.53 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.754 -177.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.6 ' O ' HD11 ' A' ' 35' ' ' ILE . 16.6 tt -70.66 -39.81 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.163 -177.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 79.5 p -66.06 -28.33 68.76 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 120.988 0.423 . . . . 0.0 110.515 178.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -67.96 -28.76 67.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.793 175.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.4 tp -86.95 118.66 26.48 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.655 177.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -78.58 142.9 36.94 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.949 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.22 8.86 11.03 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.815 -178.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.6 HD11 ' O ' ' A' ' 29' ' ' ILE . 90.0 mt -70.75 125.12 28.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.642 ' HB ' ' O ' ' A' ' 50' ' ' LYS . 47.9 mm -88.21 -63.85 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.1 t -161.82 140.11 9.21 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.805 177.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.435 ' HG2' HG12 ' A' ' 49' ' ' VAL . 18.8 tmm? -137.27 126.37 24.46 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 176.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -125.14 115.68 20.84 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.2 p -103.16 122.32 55.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-O 121.172 0.51 . . . . 0.0 110.296 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.4 m -96.89 99.95 11.49 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 97.1 mt -63.9 -38.89 92.75 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.937 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -63.69 -40.25 96.32 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.978 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -77.1 -30.01 55.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.9 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.68 20.17 71.8 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -175.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.0 t -146.5 150.36 35.43 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -178.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -119.53 148.77 42.9 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 120.804 0.335 . . . . 0.0 111.735 -177.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.2 m -108.35 124.48 50.41 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.691 ' HB ' ' CE2' ' A' ' 51' ' ' TYR . 33.6 m -119.32 149.6 21.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.621 -176.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.642 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 65.3 tttm -140.05 106.36 5.27 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.691 ' CE2' ' HB ' ' A' ' 49' ' ' VAL . 42.2 m-85 -138.37 161.92 35.73 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -177.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 64.8 t -88.34 110.41 36.09 Favored Pre-proline 0 N--CA 1.439 -1.0 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 172.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 36.2 Cg_endo -64.21 -23.48 66.35 Favored 'Trans proline' 0 CA--C 1.514 -0.489 0 C-N-CA 122.592 2.195 . . . . 0.0 112.341 -176.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 61.9 m -62.95 -42.0 99.68 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 177.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.5 t -75.1 -48.42 32.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.826 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 7.5 p -146.68 139.54 19.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.954 -178.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.416 ' SG ' ' HB2' ' A' ' 60' ' ' GLN . 26.5 p -83.51 153.71 24.26 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.107 0.479 . . . . 0.0 111.196 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.1 mt -66.06 -37.26 85.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.759 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -60.04 -40.61 89.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.436 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.416 ' HB2' ' SG ' ' A' ' 57' ' ' CYS . 1.0 OUTLIER -62.14 -41.02 97.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.192 0.52 . . . . 0.0 109.633 179.12 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 73.9 t -63.41 -44.24 98.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.084 178.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 49.6 t -60.42 -41.52 94.14 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.146 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -61.07 -41.4 96.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.367 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -61.08 -41.65 97.04 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 -176.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.468 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 20.3 tt -76.89 -38.25 28.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.94 178.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.6 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -64.35 -38.49 95.9 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-N 115.699 -0.682 . . . . 0.0 113.702 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -58.1 -35.8 71.97 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.275 0.63 . . . . 0.0 112.081 -175.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 15.7 tpt -57.76 -25.82 61.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.786 -178.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 123.66 6.19 7.36 Favored Glycine 0 CA--C 1.5 -0.901 0 C-N-CA 120.229 -0.986 . . . . 0.0 112.188 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.6 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 65.2 m-85 -110.16 135.96 50.13 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -89.33 121.59 31.75 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.236 0.541 . . . . 0.0 111.751 -174.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.54 135.72 54.16 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.126 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.425 ' HB2' ' NE ' ' A' ' 12' ' ' ARG . 45.5 m -131.62 144.78 51.3 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.6 tt -69.45 128.18 32.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 121.47 0.652 . . . . 0.0 110.902 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -97.74 134.51 40.81 Favored 'General case' 0 C--O 1.261 1.673 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.657 177.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 . . . . . 0 C--O 1.249 1.058 0 O-C-N 124.832 1.333 . . . . 0.0 110.658 -176.155 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.9 t . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -113.58 139.57 48.89 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 120.893 0.378 . . . . 0.0 111.23 -177.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 67.6 p -121.61 148.21 44.84 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.097 178.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.2 t -158.31 157.0 31.61 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 73.5 p -117.1 142.06 47.48 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 120.799 0.333 . . . . 0.0 110.335 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.9 m -131.89 145.8 34.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.364 178.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 45.8 ptt85 -108.86 142.95 38.71 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 175.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.7 pt -118.26 142.98 30.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-O 121.458 0.647 . . . . 0.0 112.006 -175.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.2 tp -110.12 118.44 36.41 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.728 177.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.44 140.04 4.15 Favored Glycine 0 N--CA 1.434 -1.495 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.349 179.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 95.9 mmm -67.97 -37.71 81.85 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.233 0.539 . . . . 0.0 109.924 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.0 p -111.22 58.16 0.62 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.883 177.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 26.3 p -59.56 -30.66 68.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.767 -175.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -64.49 -33.99 77.18 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.741 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.3 t -66.41 -45.34 80.29 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.439 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.531 ' HB3' ' CD1' ' A' ' 70' ' ' PHE . 28.4 p -66.05 -35.06 79.51 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.267 -177.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 69.9 t -61.81 -45.71 98.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -65.43 -42.24 92.66 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.947 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.3 m -63.97 -42.9 97.12 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.287 -178.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 21' ' ' CYS . 46.9 pt -78.56 -27.12 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.401 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -61.77 -39.45 91.68 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -59.98 -43.13 95.32 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.693 176.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -64.26 -43.31 95.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.185 0.517 . . . . 0.0 110.277 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.41 -46.25 96.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.603 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 88.1 p -64.62 -28.38 69.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.71 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -72.78 -27.35 61.94 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.927 0.394 . . . . 0.0 110.573 177.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.3 tt -81.74 123.88 29.13 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -83.38 147.48 27.87 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.778 0.323 . . . . 0.0 111.417 -177.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.31 7.67 56.93 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.774 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.8 pt -75.0 139.29 19.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.772 0.32 . . . . 0.0 111.176 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.621 ' HB ' ' O ' ' A' ' 50' ' ' LYS . 42.1 mm -89.19 -79.84 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.954 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 82.2 p -168.61 166.68 11.82 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.788 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -156.99 159.11 37.72 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 175.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -129.69 132.78 46.75 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 69.8 t -116.21 125.68 73.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 120.827 0.346 . . . . 0.0 110.789 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.6 t -103.34 102.48 12.43 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 177.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.6 tp -62.4 -42.72 99.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.765 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.2 -45.45 94.54 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.459 -178.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -74.96 -29.69 61.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.411 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.65 16.14 78.15 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.0 m -129.48 152.39 49.07 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.342 -0.429 . . . . 0.0 110.144 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -128.39 149.35 50.57 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.544 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.7 m -113.41 126.6 55.53 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.489 ' HB ' ' CE2' ' A' ' 51' ' ' TYR . 27.5 m -114.29 146.39 18.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.466 -177.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.621 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 87.6 tttt -132.2 104.17 6.63 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.489 ' CE2' ' HB ' ' A' ' 49' ' ' VAL . 84.5 m-85 -141.52 160.11 40.84 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 120.995 0.426 . . . . 0.0 111.853 -176.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.8 m -98.66 112.45 62.6 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.518 176.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -56.17 -26.62 61.54 Favored 'Trans proline' 0 N--CA 1.48 0.686 0 C-N-CA 123.265 2.643 . . . . 0.0 112.162 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.2 t -61.08 -42.27 98.2 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.274 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.9 t -101.22 -40.28 7.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -177.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.4 HG13 ' HB3' ' A' ' 51' ' ' TYR . 7.5 p -130.2 139.65 50.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.162 0.506 . . . . 0.0 111.488 -177.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.418 ' SG ' ' HB3' ' A' ' 59' ' ' GLN . 42.6 t -93.16 121.89 34.98 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.434 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.3 mp -63.76 -37.45 87.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.607 178.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.418 ' HB3' ' SG ' ' A' ' 57' ' ' CYS . 57.5 tp60 -60.76 -39.31 88.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.679 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -62.89 -38.56 91.39 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.32 178.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 75.6 t -60.83 -42.68 93.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.675 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 42.6 t -60.22 -39.61 87.23 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.937 176.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -64.15 -35.12 79.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.383 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -60.57 -42.24 96.25 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.484 -178.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.456 ' HB ' HG21 ' A' ' 25' ' ' ILE . 20.2 tt -76.55 -37.55 29.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 120.294 -0.563 . . . . 0.0 111.318 178.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.48 -44.24 97.88 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.452 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -67.18 -31.48 71.91 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.284 0.564 . . . . 0.0 110.297 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 50.1 tpp -59.23 -29.18 67.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.217 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 119.35 5.39 11.44 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.479 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.531 ' CD1' ' HB3' ' A' ' 21' ' ' CYS . 89.5 m-85 -112.78 131.04 55.86 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 120.977 0.418 . . . . 0.0 110.577 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -85.55 134.99 34.0 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.191 -177.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -133.19 147.6 52.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.836 0.35 . . . . 0.0 111.337 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.6 t -119.14 132.67 56.01 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 15.2 tt -103.49 134.19 45.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.502 0.668 . . . . 0.0 111.977 -175.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 76' ' ' GLU . . . -135.22 157.5 46.75 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.867 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.407 ' HB3' ' O ' ' A' ' 75' ' ' ALA . 43.2 tt0 . . . . . 0 C--O 1.245 0.854 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.628 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.6 t . . . . . 0 N--CA 1.443 -0.811 0 CA-C-O 120.895 0.379 . . . . 0.0 110.107 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 50' ' ' LYS . . . -121.43 123.94 43.3 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.494 179.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.8 p -125.62 151.82 45.99 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.055 0.455 . . . . 0.0 110.684 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.5 t -158.27 146.35 18.53 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.9 178.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 41.9 p -111.5 109.95 20.14 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 175.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.7 p -92.34 115.43 31.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 40.1 ptt180 -82.22 148.04 28.64 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.223 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.8 131.07 70.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-O 121.049 0.452 . . . . 0.0 110.861 -176.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.9 tt -115.16 115.11 26.21 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -171.25 151.91 16.79 Favored Glycine 0 N--CA 1.434 -1.492 0 C-N-CA 120.211 -0.995 . . . . 0.0 112.596 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 23.0 ptt? -74.98 -23.99 58.37 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 122.756 0.422 . . . . 0.0 111.295 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.5 p -122.48 85.57 2.44 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.284 0.564 . . . . 0.0 109.636 177.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.4 m -63.83 -39.98 95.52 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.303 -176.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.504 ' HA ' HG12 ' A' ' 22' ' ' VAL . 98.7 mt-30 -64.38 -41.0 96.93 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -175.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.0 p -64.9 -41.43 95.61 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.776 -177.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.598 ' HB3' ' CD2' ' A' ' 70' ' ' PHE . 20.3 p -74.46 -39.16 62.7 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.504 HG12 ' HA ' ' A' ' 19' ' ' GLN . 9.0 p -68.5 -37.68 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.61 -178.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -64.36 -40.76 96.5 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.978 0.418 . . . . 0.0 110.052 176.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.2 m -61.9 -44.72 96.22 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.671 -178.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.593 HD12 ' HB ' ' A' ' 65' ' ' ILE . 16.2 tt -74.19 -38.65 48.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.726 -0.389 . . . . 0.0 111.425 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.07 -44.29 96.99 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 120.85 0.357 . . . . 0.0 110.948 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -60.73 -44.08 97.1 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.586 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.587 ' HD3' ' NE2' ' A' ' 64' ' ' GLN . 99.4 mtt180 -65.33 -46.07 81.77 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.169 -177.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.541 HG22 HD12 ' A' ' 35' ' ' ILE . 98.0 mt -65.96 -44.8 92.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.092 -178.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.426 ' HA ' HG21 ' A' ' 35' ' ' ILE . 77.8 p -64.03 -34.58 78.32 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.032 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -71.81 -26.78 62.55 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.094 0.473 . . . . 0.0 110.74 177.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 28' ' ' ARG . 93.3 mt -82.9 142.32 31.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.543 178.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -76.79 141.21 40.83 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.16 -8.04 18.59 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.876 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.541 HD12 HG22 ' A' ' 29' ' ' ILE . 7.2 tt -75.24 110.1 9.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 176.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.9 mt -84.27 -51.19 14.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.278 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.9 t -160.38 145.75 14.89 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.522 177.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.414 ' HG3' HG12 ' A' ' 49' ' ' VAL . 27.3 ttt -135.85 132.16 36.26 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.088 179.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -130.34 130.82 44.94 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 178.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.1 t -103.92 120.36 53.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 120.836 0.35 . . . . 0.0 110.397 -178.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 51.0 m -119.73 96.46 5.2 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-O 121.467 0.651 . . . . 0.0 110.63 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.4 -35.41 80.82 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.259 -178.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -61.65 -39.63 92.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.535 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -76.76 -22.68 53.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.139 176.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.56 21.75 68.66 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 89.9 p -149.33 164.93 33.49 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 121.058 0.456 . . . . 0.0 111.326 -177.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.55 137.44 52.58 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 65.3 m -104.56 125.64 50.91 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.806 -177.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.414 HG12 ' HG3' ' A' ' 38' ' ' MET . 27.0 m -129.25 150.03 34.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-O 120.883 0.373 . . . . 0.0 111.369 -179.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 14.3 ptmm? -131.45 135.71 47.36 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 173.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -157.2 171.45 20.41 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.95 -169.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.6 t -94.16 114.25 62.77 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 173.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -52.99 -39.1 80.36 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 C-N-CA 123.628 2.886 . . . . 0.0 114.97 -174.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.8 m -69.02 -41.98 77.01 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.898 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.9 t -70.71 -43.51 77.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.708 -176.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 30.9 m -128.65 148.65 33.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.047 0.451 . . . . 0.0 110.766 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.533 ' SG ' ' HB2' ' A' ' 59' ' ' GLN . 43.5 t -102.23 128.32 48.8 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.563 -177.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.492 ' HG ' HD13 ' A' ' 74' ' ' ILE . 56.7 tp -61.51 -38.12 86.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.317 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.533 ' HB2' ' SG ' ' A' ' 57' ' ' CYS . 80.6 mt-30 -60.33 -39.53 87.4 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.524 178.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.698 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 97.8 mt-30 -61.75 -39.39 91.42 Favored 'General case' 0 C--O 1.214 -0.783 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.879 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.435 HG13 HD11 ' A' ' 25' ' ' ILE . 73.2 t -59.4 -46.3 92.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.243 -178.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 42.3 t -61.12 -42.36 98.4 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.089 177.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -67.42 -37.58 83.26 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.3 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.698 ' HG2' ' O ' ' A' ' 60' ' ' GLN . 13.6 mm100 -61.0 -41.46 96.55 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.958 0.409 . . . . 0.0 111.013 -175.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.593 ' HB ' HD12 ' A' ' 25' ' ' ILE . 18.8 tt -82.52 -33.11 10.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.664 177.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.85 -40.84 98.78 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.798 -0.637 . . . . 0.0 114.025 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -72.8 -11.4 60.59 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 117.797 0.799 . . . . 0.0 110.961 -177.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 16.4 tpt -66.02 -28.6 68.99 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.764 176.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 116.52 9.14 11.69 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.806 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.598 ' CD2' ' HB3' ' A' ' 21' ' ' CYS . 98.3 m-85 -117.79 145.29 44.63 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -84.71 133.16 34.39 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.48 -177.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 12' ' ' ARG . . . -147.71 150.2 33.86 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.934 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 86.0 p -140.69 158.92 43.27 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.615 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.492 HD13 ' HG ' ' A' ' 58' ' ' LEU . 91.4 mt -91.2 122.69 42.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.053 -177.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -133.17 160.93 35.79 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 C--N 1.305 -1.35 0 CA-C-O 118.133 -0.937 . . . . 0.0 110.595 178.663 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.0 m . . . . . 0 N--CA 1.449 -0.521 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -143.79 152.85 41.75 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.76 0.314 . . . . 0.0 110.61 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 82.7 p -127.3 154.91 44.34 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.613 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.444 ' HB3' HG13 ' A' ' 49' ' ' VAL . 14.8 t -159.02 164.2 35.72 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 53.1 p -118.11 144.68 45.45 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.5 p -143.71 129.47 15.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 120.921 0.391 . . . . 0.0 111.098 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 15.8 ptm180 -89.06 146.92 24.53 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.6 mp -111.43 120.63 62.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 59.5 tp -114.71 112.71 23.26 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.991 0.424 . . . . 0.0 110.559 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -167.41 157.59 30.06 Favored Glycine 0 N--CA 1.44 -1.068 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.197 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 59.6 ttm -64.6 -43.02 95.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.992 0.425 . . . . 0.0 110.813 178.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.1 p -113.01 108.33 17.19 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.792 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 23.8 p -69.88 -41.23 75.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.105 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -63.94 -41.53 97.59 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.836 0.351 . . . . 0.0 111.035 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.6 t -61.5 -46.37 90.25 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.835 -177.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.461 ' HB3' ' CG ' ' A' ' 70' ' ' PHE . 20.1 p -67.33 -44.11 79.9 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.565 -178.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 73.7 t -62.79 -46.09 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.557 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.66 -44.86 95.19 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.2 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.4 m -63.49 -43.4 97.38 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.254 -177.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.464 HG21 ' HB ' ' A' ' 65' ' ' ILE . 46.3 pt -74.32 -29.18 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.765 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -60.78 -41.98 96.63 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.052 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -60.99 -45.26 95.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.264 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -63.09 -42.37 99.61 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.181 0.515 . . . . 0.0 109.9 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.556 ' O ' HD11 ' A' ' 35' ' ' ILE . 92.9 mt -61.44 -46.22 97.04 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.716 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.693 178.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 85.2 p -63.97 -23.21 67.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.856 0.36 . . . . 0.0 111.539 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -92.46 -6.08 50.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.892 0.377 . . . . 0.0 110.768 177.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 67.7 tp -103.3 128.04 50.46 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.159 178.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -85.44 153.94 22.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.689 0.28 . . . . 0.0 111.09 176.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.42 8.83 22.64 Favored Glycine 0 C--O 1.239 0.427 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -177.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.556 HD11 ' O ' ' A' ' 29' ' ' ILE . 74.9 mt -72.65 123.63 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 115.19 -0.505 . . . . 0.0 110.871 -177.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 80.5 mt -101.23 -68.15 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 172.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.541 ' O ' ' HB3' ' A' ' 50' ' ' LYS . 34.7 t -166.1 140.14 4.36 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.748 177.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.7 ttt -136.23 127.69 28.58 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 176.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.496 ' HE3' ' OG ' ' A' ' 37' ' ' SER . 34.4 mmtp -119.53 129.47 54.7 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.3 t -106.47 118.47 54.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.5 m -98.86 98.12 9.24 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.921 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.1 tp -62.49 -42.05 99.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.393 -179.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -62.0 -41.19 97.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.281 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -75.83 -30.33 58.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.591 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.45 15.05 79.11 Favored Glycine 0 N--CA 1.454 -0.142 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -176.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 12' ' ' ARG . 39.8 t -145.12 150.59 37.07 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -178.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.57 151.44 47.92 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.808 0.337 . . . . 0.0 111.043 -177.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.4 p -95.15 125.44 39.8 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.295 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.444 HG13 ' HB3' ' A' ' 9' ' ' SER . 3.0 p -105.91 118.66 53.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.281 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.541 ' HB3' ' O ' ' A' ' 37' ' ' SER . 60.1 tttm -136.33 104.3 5.57 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.621 0.724 . . . . 0.0 109.968 -176.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.538 ' CD2' ' HA ' ' A' ' 35' ' ' ILE . 87.0 m-85 -139.43 162.96 33.77 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.329 -176.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 54.6 t -74.94 114.85 38.84 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 37.2 Cg_endo -65.02 -18.59 62.47 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.081 2.521 . . . . 0.0 112.327 -177.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 61.4 m -61.6 -39.36 90.92 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.659 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.459 HG23 HG23 ' A' ' 56' ' ' VAL . 18.8 m -116.69 -25.76 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -178.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 96.9 t -127.28 128.93 70.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.728 0.299 . . . . 0.0 110.77 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.524 ' SG ' ' HB2' ' A' ' 60' ' ' GLN . 25.9 p -105.96 161.55 14.36 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 178.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.59 -40.24 96.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.446 -177.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -63.27 -37.4 87.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.281 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.524 ' HB2' ' SG ' ' A' ' 57' ' ' CYS . 54.7 tt0 -59.92 -45.78 91.49 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.287 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.457 ' HA ' ' OE1' ' A' ' 64' ' ' GLN . 75.1 t -63.14 -42.34 96.18 Favored 'Isoleucine or valine' 0 C--O 1.25 1.128 0 CA-C-O 121.768 0.794 . . . . 0.0 110.309 178.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 43.3 t -58.47 -35.49 72.25 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.191 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.406 ' HB2' ' O ' ' A' ' 60' ' ' GLN . 58.8 m170 -60.24 -43.98 95.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.182 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.473 ' O ' ' HG2' ' A' ' 68' ' ' MET . 25.7 mp0 -63.05 -42.23 99.68 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.929 -177.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.464 ' HB ' HG21 ' A' ' 25' ' ' ILE . 19.9 tt -71.3 -37.83 67.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.072 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.32 -39.85 98.29 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.9 -0.591 . . . . 0.0 113.36 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -80.15 -5.99 56.98 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 117.446 0.623 . . . . 0.0 111.555 -177.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 23.1 mmt -83.72 -3.16 57.56 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.038 0.447 . . . . 0.0 110.447 176.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.67 8.1 62.52 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.282 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.461 ' CG ' ' HB3' ' A' ' 21' ' ' CYS . 99.2 m-85 -113.4 143.06 45.12 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 120.979 0.419 . . . . 0.0 110.292 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -101.1 148.04 25.53 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.99 -175.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.92 151.48 35.92 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.114 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.41 ' HB2' ' HG2' ' A' ' 12' ' ' ARG . 60.7 m -123.53 141.51 51.93 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 176.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.0 tt -117.33 141.27 36.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 121.111 0.481 . . . . 0.0 111.337 -174.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 76' ' ' GLU . . . -138.08 154.71 49.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.604 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.446 ' HB3' ' O ' ' A' ' 75' ' ' ALA . 34.8 tt0 . . . . . 0 N--CA 1.474 0.758 0 C-N-CA 123.636 0.775 . . . . 0.0 109.926 -175.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 70.4 t . . . . . 0 N--CA 1.432 -1.329 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -127.59 149.6 50.09 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.005 0.431 . . . . 0.0 111.21 -177.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 56.4 p -103.57 156.02 18.09 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.821 178.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.6 t -154.34 143.95 21.55 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 62.5 p -118.59 144.02 46.4 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.12 123.22 55.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-O 120.91 0.386 . . . . 0.0 110.489 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.519 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 39.7 ptt180 -90.08 151.2 21.73 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.084 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.9 pt -126.58 144.5 36.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-O 121.187 0.517 . . . . 0.0 111.775 -177.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.9 tp -131.21 113.66 14.12 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.331 177.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -176.23 160.3 28.02 Favored Glycine 0 N--CA 1.439 -1.135 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 96.1 mmm -68.17 -40.24 82.36 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.854 0.359 . . . . 0.0 110.857 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.8 p -110.14 80.25 1.29 Allowed 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.448 0.642 . . . . 0.0 110.478 177.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.41 ' O ' HG23 ' A' ' 22' ' ' VAL . 21.8 p -67.02 -34.55 77.96 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.479 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -63.28 -39.44 94.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.11 0.481 . . . . 0.0 110.295 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.0 t -60.67 -45.73 93.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.579 -178.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 27.7 p -70.01 -33.29 71.82 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.365 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 18' ' ' CYS . 67.1 t -63.27 -45.11 99.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-O 121.412 0.625 . . . . 0.0 109.464 177.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -67.14 -35.18 79.17 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.327 177.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.3 t -60.19 -46.59 89.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.619 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.523 HD12 ' HB ' ' A' ' 65' ' ' ILE . 18.8 tt -70.99 -29.25 36.29 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.892 177.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -57.85 -49.35 76.98 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.214 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -62.52 -42.83 99.77 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.121 178.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.5 tpt180 -64.27 -47.61 78.88 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.496 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.561 HG21 ' SD ' ' A' ' 38' ' ' MET . 19.5 tt -71.01 -36.71 64.6 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.696 -177.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 77.6 p -67.72 -25.41 65.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.36 . . . . 0.0 111.257 177.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -85.37 -12.05 53.08 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.12 0.486 . . . . 0.0 110.231 175.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 64.9 tp -84.18 122.93 29.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.511 175.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -83.38 152.98 24.79 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 120.994 0.425 . . . . 0.0 111.587 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.51 6.01 64.59 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.441 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 39.7 pt -69.15 126.79 29.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 121.337 0.589 . . . . 0.0 111.576 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' A' ' 50' ' ' LYS . 86.3 mt -82.09 -61.81 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.492 -179.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.421 ' OG ' ' HE2' ' A' ' 50' ' ' LYS . 87.1 p -159.43 154.34 24.78 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.993 178.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.561 ' SD ' HG21 ' A' ' 29' ' ' ILE . 27.0 ttt -140.79 134.45 30.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.843 177.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -133.59 148.94 51.62 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.1 p -126.31 134.01 67.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 C-N-CA 119.796 -0.762 . . . . 0.0 111.792 -178.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.5 m -108.66 85.75 2.16 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.327 -0.852 . . . . 0.0 108.843 177.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.9 tp -61.64 -43.09 99.5 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.32 -176.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -70.11 -28.18 65.18 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.063 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -84.92 -12.42 53.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.649 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.4 28.03 71.84 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.88 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 79.6 p -148.2 161.02 42.31 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.076 0.465 . . . . 0.0 111.454 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.75 149.2 42.41 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.839 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.7 m -117.12 126.39 52.75 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.3 p -129.32 139.31 52.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 120.868 0.366 . . . . 0.0 110.761 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.444 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 39.6 ttpt -119.07 119.14 33.35 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -153.91 164.02 39.09 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.992 -173.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.7 t -84.87 112.28 41.75 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 177.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.43 -22.2 65.89 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.797 2.331 . . . . 0.0 112.656 -176.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.5 t -63.89 -42.99 97.34 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.655 178.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.476 HG12 HG23 ' A' ' 56' ' ' VAL . 98.9 t -73.39 -51.59 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.909 -178.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.476 HG23 HG12 ' A' ' 55' ' ' VAL . 98.6 t -131.56 130.65 62.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.331 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 31.5 p -73.76 159.47 32.9 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.634 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.3 mp -68.62 -24.32 64.55 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.839 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -61.02 -42.41 98.41 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.102 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.536 ' O ' ' HG3' ' A' ' 64' ' ' GLN . 87.3 mm-40 -65.69 -39.25 91.08 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.342 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.83 -45.6 98.34 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 CA-C-O 121.245 0.545 . . . . 0.0 110.06 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 47.5 t -60.74 -41.96 96.42 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.188 177.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -61.67 -38.29 87.23 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.025 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.536 ' HG3' ' O ' ' A' ' 60' ' ' GLN . 98.7 mt-30 -59.35 -42.73 92.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.465 0.174 . . . . 0.0 111.269 -176.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.523 ' HB ' HD12 ' A' ' 25' ' ' ILE . 21.2 tt -85.95 -38.68 12.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.874 178.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.94 -35.54 92.2 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.911 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -54.44 -28.14 42.07 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.879 0.872 . . . . 0.0 111.658 -178.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 15.8 tpt -59.62 -29.23 67.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.076 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 119.13 8.13 9.7 Favored Glycine 0 CA--C 1.506 -0.511 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.492 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -114.84 145.11 42.51 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -72.94 135.94 45.12 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.087 0.47 . . . . 0.0 111.12 -178.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 12' ' ' ARG . . . -146.94 146.54 30.15 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.141 178.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 39.6 t -142.12 140.5 32.5 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.761 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 42.9 pt -91.58 145.06 7.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.522 -177.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.48 145.64 29.22 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.267 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 . . . . . 0 C--O 1.251 1.162 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.085 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.9 t . . . . . 0 N--CA 1.45 -0.465 0 CA-C-O 120.931 0.396 . . . . 0.0 110.684 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -133.82 147.56 51.23 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.09 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 54.9 p -123.08 143.23 50.11 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 175.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 87.7 p -155.63 162.03 40.69 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.333 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.1 p -109.03 125.51 52.16 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.59 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.92 122.58 70.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 17.8 ptp180 -78.99 141.94 37.05 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.208 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.775 ' HB ' ' SG ' ' A' ' 21' ' ' CYS . 19.8 pt -116.06 106.51 20.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-O 121.672 0.749 . . . . 0.0 110.519 -178.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.8 tp -114.1 128.74 56.52 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.826 -175.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 176.25 -149.29 9.73 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.213 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 66.5 mtt -60.88 -43.18 98.81 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.472 0.654 . . . . 0.0 109.272 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.573 HG23 ' H ' ' A' ' 20' ' ' SER . 11.5 t -163.82 159.41 21.16 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.411 177.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.486 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 98.3 m -63.55 -39.03 93.35 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 120.645 0.26 . . . . 0.0 111.487 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -59.6 -45.2 92.62 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -177.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.573 ' H ' HG23 ' A' ' 17' ' ' THR . 81.0 p -69.11 -41.61 77.18 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.95 -177.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.775 ' SG ' ' HB ' ' A' ' 13' ' ' ILE . 26.0 p -72.26 -35.35 68.74 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.3 p -69.78 -33.92 58.34 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.556 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.625 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -62.28 -42.16 99.1 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.454 0.645 . . . . 0.0 109.319 176.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.6 t -59.58 -49.78 76.42 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.401 -177.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.8 tt -74.55 -32.8 30.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.811 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.4 tm-20 -60.84 -47.68 85.28 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.342 -175.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -62.54 -44.4 96.45 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.502 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.452 ' HA ' ' NE ' ' A' ' 28' ' ' ARG . 4.2 mmp_? -67.52 -43.72 80.11 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.266 -177.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 16.9 tt -72.9 -32.77 41.34 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.6 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.998 -177.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.8 t -64.76 -41.49 95.85 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 120.938 0.399 . . . . 0.0 110.404 177.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -68.64 -26.22 65.22 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.788 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.534 HD21 HG21 ' A' ' 56' ' ' VAL . 57.7 tp -96.23 122.18 38.82 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.025 0.441 . . . . 0.0 110.962 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -68.73 150.01 48.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.871 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.43 -1.97 16.08 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 121.065 -0.588 . . . . 0.0 111.973 -178.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.8 tt -95.82 130.22 44.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 175.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 83.9 mt -92.52 -57.7 4.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 81.5 p -163.71 164.4 23.85 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.281 178.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -154.12 147.7 25.17 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 120.925 0.393 . . . . 0.0 110.271 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -128.87 141.57 51.24 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.5 t -110.05 128.73 66.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -174.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.1 t -113.54 102.03 9.91 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 121.17 0.51 . . . . 0.0 109.998 177.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.97 -36.48 83.43 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.089 178.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -60.62 -44.56 96.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.141 -178.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -85.85 -12.63 50.28 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.11 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.14 26.9 73.64 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.333 -179.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 87.1 p -146.01 161.98 38.88 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.046 0.451 . . . . 0.0 110.823 -177.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.1 142.72 50.08 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.336 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 87.4 m -95.8 119.14 33.78 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 65.7 t -114.77 126.74 72.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 120.997 0.427 . . . . 0.0 111.394 -176.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -103.11 106.43 16.95 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 176.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -135.63 166.34 23.45 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.027 -170.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.5 t -106.07 101.67 35.37 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.027 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.51 -25.87 80.14 Favored 'Trans proline' 0 N--CA 1.48 0.68 0 C-N-CA 123.369 2.713 . . . . 0.0 112.565 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 43.9 t -61.76 -41.33 97.54 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.941 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.447 HG12 HG13 ' A' ' 56' ' ' VAL . 77.8 t -65.51 -62.11 1.39 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.534 HG21 HD21 ' A' ' 32' ' ' LEU . 34.7 m -140.04 159.64 26.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.65 175.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.432 ' SG ' ' HG3' ' A' ' 60' ' ' GLN . 31.8 p -76.07 154.48 35.58 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.029 0.442 . . . . 0.0 110.313 178.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.6 mt -70.97 -19.19 62.58 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.223 179.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -61.45 -42.15 98.31 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.374 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.446 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 97.7 mt-30 -64.28 -39.51 94.08 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.999 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 78.6 t -62.01 -45.48 98.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 CA-C-O 121.265 0.555 . . . . 0.0 109.768 178.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 42.6 t -61.92 -38.73 89.51 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.882 176.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 58.3 m170 -63.07 -36.86 84.97 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.191 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 60' ' ' GLN . 86.5 mm-40 -59.52 -43.55 93.41 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.808 0.337 . . . . 0.0 110.919 -178.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.537 HD11 ' HB2' ' A' ' 21' ' ' CYS . 18.0 tt -76.69 -36.19 26.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.901 178.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -62.81 -42.25 99.72 Favored Glycine 0 CA--C 1.522 0.514 0 CA-C-N 116.07 -0.514 . . . . 0.0 113.478 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -66.47 -22.05 66.19 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 26.4 mmt -83.52 0.56 45.99 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.527 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.45 9.33 57.9 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.513 -0.851 . . . . 0.0 113.531 177.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.491 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 90.2 m-85 -112.51 140.68 47.06 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.985 0.393 . . . . 0.0 110.092 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -90.47 140.24 29.91 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.886 0.374 . . . . 0.0 110.856 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 12' ' ' ARG . . . -147.27 150.41 34.76 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.135 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.8 t -143.64 136.46 27.43 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.142 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 83.8 mt -91.4 127.1 43.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.457 -178.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.03 160.67 37.03 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.113 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.534 -0.746 . . . . 0.0 110.941 178.856 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.474 0 CA-C-O 120.551 0.215 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -61.97 -40.62 99.13 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 121.295 -0.479 . . . . 0.0 112.811 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.402 ' HB2' ' HG3' ' A' ' 53' ' ' PRO . 86.4 m-70 -71.71 136.6 47.28 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 78.7 mtm -64.08 -42.03 97.09 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -175.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.443 ' O ' ' HD2' ' A' ' 53' ' ' PRO . 60.9 tp60 -140.0 -71.9 0.38 Allowed 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.799 -177.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.3 t -109.26 127.57 65.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 120.991 0.424 . . . . 0.0 110.663 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.24 133.82 45.22 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.891 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 63.0 p -109.37 146.45 34.4 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.512 ' OG ' HG13 ' A' ' 74' ' ' ILE . 37.2 t -159.07 147.08 17.81 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.538 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 17.1 p -113.27 108.93 17.94 Favored 'General case' 0 N--CA 1.418 -2.041 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 172.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.4 p -95.64 124.79 48.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.339 -177.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 54.8 ptt85 -75.46 142.56 42.92 Favored 'General case' 0 CA--C 1.505 -0.758 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.574 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 47.1 mm -115.12 119.2 61.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.6 tp -124.05 117.18 24.12 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.978 0.418 . . . . 0.0 110.474 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -175.24 154.28 17.61 Favored Glycine 0 N--CA 1.434 -1.464 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.476 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 98.8 mtp -65.35 -40.19 93.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.963 0.411 . . . . 0.0 110.9 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.0 p -111.12 84.83 2.0 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.383 0.611 . . . . 0.0 110.38 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.507 ' O ' HG23 ' A' ' 22' ' ' VAL . 42.2 t -61.38 -44.27 97.44 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.017 -177.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -61.35 -39.92 92.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.943 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.6 m -62.67 -44.2 96.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.59 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.505 ' HB3' ' CD2' ' A' ' 70' ' ' PHE . 29.6 p -73.02 -33.81 65.96 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.476 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 18' ' ' CYS . 63.0 t -62.79 -43.57 98.86 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -60.69 -44.41 96.56 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.997 177.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.0 t -61.64 -50.02 74.2 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.556 -178.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.7 tt -71.63 -36.83 61.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -61.68 -44.0 97.78 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.829 0.347 . . . . 0.0 110.693 -177.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -64.73 -47.3 78.79 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.281 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -64.58 -42.56 95.54 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.914 -176.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.639 HD13 ' SD ' ' A' ' 38' ' ' MET . 19.6 tt -69.7 -35.14 64.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.957 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 79.0 p -71.26 -22.06 62.02 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.926 0.393 . . . . 0.0 110.634 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -70.76 -27.92 64.29 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 174.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.6 mt -75.0 128.99 36.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.851 176.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.0 mtpt -86.6 153.58 21.68 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.374 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.23 8.1 57.9 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.323 -0.942 . . . . 0.0 111.862 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 33.1 pt -69.52 137.74 23.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.993 0.425 . . . . 0.0 111.819 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -96.77 -71.98 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.695 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.7 t -169.89 149.88 3.78 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-O 120.769 0.319 . . . . 0.0 111.051 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.639 ' SD ' HD13 ' A' ' 29' ' ' ILE . 28.9 ptm -153.4 159.53 42.41 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 177.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -141.1 123.45 15.78 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.989 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 79.9 t -92.52 119.29 39.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 175.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.8 m -109.21 112.07 24.02 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.042 0.448 . . . . 0.0 111.117 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.2 mt -66.2 -37.63 86.05 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.795 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -61.9 -41.81 98.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.775 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -77.22 -27.91 53.61 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.948 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.51 15.99 80.04 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -175.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 87.7 p -148.68 165.54 31.06 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.14 -0.53 . . . . 0.0 109.982 -177.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.515 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -118.5 139.44 51.43 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.708 0.289 . . . . 0.0 111.291 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.8 m -89.13 119.69 29.86 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 8' ' ' THR . 99.8 t -114.64 124.48 71.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.499 -174.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.428 ' HG2' HG22 ' A' ' 8' ' ' THR . 51.5 mtmt -126.96 103.96 7.76 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 174.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -143.86 158.71 43.51 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.587 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.8 t -82.52 114.27 50.51 Favored Pre-proline 0 N--CA 1.437 -1.125 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 173.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.443 ' HD2' ' O ' ' A' ' 5' ' ' GLN . 29.0 Cg_endo -61.44 -28.09 83.32 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.921 2.414 . . . . 0.0 113.787 -173.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.2 p -70.19 -39.74 75.05 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 120.809 0.338 . . . . 0.0 110.899 177.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 84.7 t -75.67 -50.81 22.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 121.128 0.49 . . . . 0.0 110.67 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 69.7 t -128.58 123.72 60.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.162 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.66 ' SG ' ' HG2' ' A' ' 60' ' ' GLN . 27.7 p -88.49 144.42 26.36 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.898 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.4 mp -68.56 -26.8 65.59 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.092 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 -60.35 -41.14 93.02 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.66 ' HG2' ' SG ' ' A' ' 57' ' ' CYS . 85.4 mm-40 -63.98 -38.43 91.07 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.387 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 71.6 t -60.98 -46.74 96.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 121.391 0.615 . . . . 0.0 109.55 178.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 43.0 t -62.55 -39.61 94.18 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.76 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -59.6 -45.17 92.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.947 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 60' ' ' GLN . 98.2 mt-30 -60.75 -44.01 97.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.65 -175.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.0 tt -81.41 -37.19 15.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.856 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.8 -41.73 99.81 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.782 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.99 -28.73 70.0 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 122.37 0.268 . . . . 0.0 111.37 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 16.1 tpt -61.75 -29.79 70.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.719 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.69 5.06 12.6 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.515 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.505 ' CD2' ' HB3' ' A' ' 21' ' ' CYS . 95.1 m-85 -111.48 152.02 27.94 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -94.97 134.69 37.37 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.37 0.605 . . . . 0.0 111.818 -176.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 12' ' ' ARG . . . -140.82 145.59 36.47 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.687 176.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.9 t -139.88 138.65 35.86 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.243 -0.583 . . . . 0.0 111.445 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.512 HG13 ' OG ' ' A' ' 9' ' ' SER . 14.7 tt -78.23 137.02 22.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.12 -0.945 . . . . 0.0 112.158 -178.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -152.11 159.48 43.64 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 176.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.308 -1.228 0 CA-C-O 118.577 -0.725 . . . . 0.0 109.976 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.769 0 CA-C-O 120.961 0.41 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -87.48 -173.03 48.14 Favored Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.544 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -89.96 126.81 35.88 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 43.4 tpp -63.37 -41.69 98.83 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.136 0.493 . . . . 0.0 110.063 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -94.65 122.27 37.07 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.572 177.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.1 m -128.01 150.5 33.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.142 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.453 ' HB3' ' HD3' ' A' ' 53' ' ' PRO . . . -120.73 140.18 52.01 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 120.979 0.418 . . . . 0.0 110.592 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 44.5 p -120.77 145.77 47.19 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.393 177.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.9 t -140.88 142.47 34.5 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.6 p -108.64 133.88 52.13 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 121.307 0.575 . . . . 0.0 110.759 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.445 HG12 ' HA ' ' A' ' 74' ' ' ILE . 33.6 m -126.85 150.53 32.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.457 ' HG2' ' HB3' ' A' ' 73' ' ' SER . 16.6 ptm180 -107.06 147.24 30.21 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.55 HG21 ' SG ' ' A' ' 21' ' ' CYS . 85.0 mt -119.56 125.86 74.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.546 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.8 tp -119.6 115.84 24.81 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -171.02 154.88 23.56 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.976 -0.63 . . . . 0.0 111.642 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 68.6 mtt -67.66 -40.14 84.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.923 0.392 . . . . 0.0 110.978 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.2 p -104.45 89.59 3.27 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.713 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 95.5 m -64.06 -40.57 96.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.238 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -64.88 -39.14 93.08 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.462 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.0 m -62.63 -43.74 98.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.712 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.55 ' SG ' HG21 ' A' ' 13' ' ' ILE . 16.0 p -70.19 -39.87 74.96 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.597 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 65.5 t -63.22 -44.13 99.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-O 121.087 0.47 . . . . 0.0 110.108 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -64.46 -40.88 96.54 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.41 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.5 m -62.36 -42.9 99.77 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.978 -0.556 . . . . 0.0 112.012 -178.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.552 ' CG2' ' HB ' ' A' ' 65' ' ' ILE . 47.1 pt -72.02 -34.94 52.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 C-N-CA 120.064 -0.655 . . . . 0.0 110.161 178.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -60.97 -44.43 97.36 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.909 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -61.82 -50.06 73.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.082 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -68.67 -41.86 78.7 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.165 -0.471 . . . . 0.0 112.192 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 94.0 mt -64.41 -42.61 95.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-O 120.668 0.27 . . . . 0.0 111.035 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 41.4 t -60.24 -41.5 93.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.023 0.44 . . . . 0.0 110.26 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -68.49 -27.9 66.54 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.094 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.5 tp -70.33 131.95 44.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.705 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -86.1 152.55 22.77 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.69 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.89 5.98 73.0 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.687 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.407 ' HA ' ' CD2' ' A' ' 51' ' ' TYR . 46.4 pt -72.55 138.19 21.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.908 0.385 . . . . 0.0 111.316 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.2 mm -96.79 -67.05 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.481 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.7 t -162.39 152.83 16.9 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.279 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -139.27 148.22 42.73 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -134.79 142.47 46.71 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.68 140.05 50.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 120.967 0.413 . . . . 0.0 111.134 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.9 m -119.38 101.75 8.18 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.67 -44.83 95.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.845 -176.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -61.68 -44.28 97.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.462 -178.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -76.93 -24.82 52.39 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.742 -178.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.13 17.53 79.53 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.326 -177.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 60.1 m -125.17 151.61 45.58 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 120.882 0.372 . . . . 0.0 110.591 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -128.71 149.14 50.82 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.047 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.6 m -116.2 125.41 52.23 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 63.1 t -114.47 124.97 71.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 120.84 0.352 . . . . 0.0 110.545 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -105.88 107.7 18.83 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.65 ' CE1' ' HB ' ' A' ' 56' ' ' VAL . 34.4 t80 -152.93 152.74 31.81 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -175.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.4 t -80.64 114.02 44.51 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.453 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 46.9 Cg_endo -66.26 -22.28 53.62 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.066 2.511 . . . . 0.0 113.852 -174.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 79.8 p -65.28 -33.36 75.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.718 0.294 . . . . 0.0 111.271 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.446 HG12 HG23 ' A' ' 56' ' ' VAL . 45.9 t -84.06 -61.9 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.907 0.384 . . . . 0.0 110.174 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.65 ' HB ' ' CE1' ' A' ' 51' ' ' TYR . 88.7 t -128.76 127.49 66.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.096 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 30.3 p -76.81 155.79 32.79 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.343 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.35 -16.13 61.87 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.838 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -61.5 -42.2 98.44 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.195 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.511 ' OE1' HG13 ' A' ' 56' ' ' VAL . 98.6 mt-30 -65.13 -37.94 89.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.531 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 77.8 t -61.28 -40.95 87.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-O 121.352 0.596 . . . . 0.0 109.728 177.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.523 ' SG ' ' HB ' ' A' ' 74' ' ' ILE . 92.7 m -61.08 -38.96 88.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.569 177.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -67.94 -28.77 67.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.452 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -61.93 -42.18 98.8 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.739 0.304 . . . . 0.0 110.503 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.552 ' HB ' ' CG2' ' A' ' 25' ' ' ILE . 18.8 tt -79.7 -38.94 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 120.754 0.311 . . . . 0.0 111.565 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -62.39 -39.08 97.31 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.156 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -59.09 -39.0 80.85 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.152 0.501 . . . . 0.0 110.472 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 17.0 tpt -62.01 -29.09 70.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.127 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.15 8.54 10.38 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.677 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.52 ' CG ' ' HB3' ' A' ' 21' ' ' CYS . 97.5 m-85 -106.29 150.02 26.36 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.687 0.28 . . . . 0.0 110.286 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -93.13 138.87 31.16 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.584 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.88 149.13 31.7 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.642 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.457 ' HB3' ' HG2' ' A' ' 12' ' ' ARG . 48.3 t -127.86 138.93 52.86 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.523 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 13.5 tt -100.27 139.21 22.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.226 0.536 . . . . 0.0 111.681 -176.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.45 159.45 44.02 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.42 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.442 ' H ' ' CD ' ' A' ' 76' ' ' GLU . 1.2 pm0 . . . . . 0 C--N 1.3 -1.575 0 CA-C-O 118.47 -0.776 . . . . 0.0 109.709 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.578 0 CA-C-O 120.756 0.313 . . . . 0.0 110.482 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -138.59 148.87 20.25 Favored Glycine 0 N--CA 1.433 -1.566 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.901 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -71.63 137.52 47.99 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 71.9 mtm -94.92 107.25 19.28 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -78.89 117.7 20.23 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 68.2 t -117.79 127.15 75.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.618 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.62 128.53 45.73 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.004 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 76.3 p -118.47 147.45 43.6 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.699 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.9 p -159.98 168.09 26.44 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.336 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.6 p -113.0 129.59 56.44 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.5 p -109.57 123.34 65.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-O 121.026 0.441 . . . . 0.0 110.364 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -83.26 147.45 27.97 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.647 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 85.9 mt -114.68 123.6 70.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.891 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 69.6 tp -117.92 118.47 32.08 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.938 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -175.45 157.95 24.87 Favored Glycine 0 N--CA 1.432 -1.617 0 C-N-CA 119.692 -1.242 . . . . 0.0 113.151 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 66.4 ttp -61.93 -47.16 86.14 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 120.915 0.388 . . . . 0.0 110.202 177.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.6 m -118.21 107.23 13.68 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.426 ' O ' HG23 ' A' ' 22' ' ' VAL . 47.9 t -64.22 -40.19 95.54 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.09 -178.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -60.35 -39.83 88.57 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.757 -176.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 63.7 m -62.3 -46.29 89.4 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 120.959 0.409 . . . . 0.0 111.518 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.595 ' HB3' ' CD2' ' A' ' 70' ' ' PHE . 16.4 p -73.64 -36.36 65.41 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.926 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 18' ' ' CYS . 57.0 t -62.18 -42.79 96.56 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.541 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -60.56 -40.61 92.25 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.518 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.3 t -59.99 -48.66 80.79 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.875 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.457 HD11 HG13 ' A' ' 61' ' ' VAL . 17.3 tt -76.49 -39.42 33.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.018 -178.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.1 tp10 -60.33 -47.59 85.4 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.914 0.388 . . . . 0.0 111.281 -175.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.64 -51.15 66.43 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.978 -177.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.558 ' HD2' ' HG2' ' A' ' 64' ' ' GLN . 44.4 ttm180 -63.89 -45.42 89.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.852 -177.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 15.3 tt -68.53 -31.22 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.312 -176.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 73.7 m -63.78 -38.77 92.33 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.081 0.467 . . . . 0.0 110.076 176.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -68.18 -27.8 66.72 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.877 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.4 mt -84.68 137.32 33.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.755 0.788 . . . . 0.0 112.753 -178.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.561 ' N ' ' HD2' ' A' ' 33' ' ' LYS . 9.9 mptt -87.75 155.04 20.1 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.39 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.53 7.4 39.73 Favored Glycine 0 C--O 1.239 0.422 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.94 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.2 pt -91.39 132.91 34.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 86.3 mt -97.63 -59.45 3.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.935 0.398 . . . . 0.0 110.728 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.3 t -152.34 141.21 21.08 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.162 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 28.5 ptm -145.27 146.96 31.87 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.759 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -135.52 124.7 24.49 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.908 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 65.7 t -106.6 116.05 49.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 176.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.8 m -109.64 104.68 13.73 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.083 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.8 mt -64.4 -36.65 84.84 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.72 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.7 mp0 -63.61 -41.29 98.32 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.74 -178.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -83.85 -27.34 28.76 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.316 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.86 20.64 77.73 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -177.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.7 m -137.63 155.91 48.64 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 122.371 0.268 . . . . 0.0 110.592 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -121.92 141.8 50.93 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.398 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.1 m -85.38 124.36 31.9 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.664 HG13 ' CE2' ' A' ' 51' ' ' TYR . 97.4 t -107.26 119.29 56.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.053 -176.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -145.56 102.83 3.74 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 173.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.664 ' CE2' HG13 ' A' ' 49' ' ' VAL . 24.7 m-85 -141.69 165.78 26.54 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -177.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.6 t -78.1 114.22 40.3 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 175.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -62.87 -25.91 74.46 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.894 2.396 . . . . 0.0 112.861 -175.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.3 m -64.46 -39.08 93.14 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.925 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.6 t -94.84 -49.43 12.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.125 -178.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.1 t -114.45 126.63 72.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.328 -177.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 25.2 p -103.89 149.9 24.67 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.651 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.5 mp -64.32 -38.06 89.71 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.507 -176.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -62.6 -40.79 98.05 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -176.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.599 ' O ' ' HG3' ' A' ' 64' ' ' GLN . 85.4 mm-40 -64.72 -37.1 86.44 Favored 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 121.119 -0.233 . . . . 0.0 111.18 176.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.457 HG13 HD11 ' A' ' 25' ' ' ILE . 77.2 t -59.29 -43.43 89.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-O 121.17 0.509 . . . . 0.0 109.636 178.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 96.3 m -62.49 -39.09 92.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.97 177.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 63.8 m170 -67.3 -36.35 81.32 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.157 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.599 ' HG3' ' O ' ' A' ' 60' ' ' GLN . 99.2 mt-30 -60.02 -42.91 95.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.536 -176.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.419 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 19.8 tt -81.11 -35.07 14.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.114 178.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -67.14 -24.2 73.24 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.935 -0.575 . . . . 0.0 113.629 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.1 -36.59 77.78 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.847 0.356 . . . . 0.0 111.087 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 16.5 tpt -62.41 -28.93 70.13 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.533 178.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.89 5.13 18.29 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.38 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.595 ' CD2' ' HB3' ' A' ' 21' ' ' CYS . 99.0 m-85 -104.83 142.67 34.32 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.776 0.322 . . . . 0.0 110.661 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -80.88 147.81 30.2 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.404 -177.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.97 148.93 31.29 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.197 176.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 39.8 t -143.61 142.11 30.91 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.38 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 88.7 mt -86.27 128.58 39.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.198 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -138.35 148.43 44.54 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.481 177.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 . . . . . 0 C--N 1.307 -1.282 0 CA-C-O 118.393 -0.813 . . . . 0.0 110.307 -179.818 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.656 0 CA-C-O 120.765 0.317 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 155.24 -161.99 30.74 Favored Glycine 0 N--CA 1.436 -1.309 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.604 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.8 m170 -68.97 137.09 53.46 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.3 mtt -70.72 -27.97 64.38 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.758 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -66.59 -40.73 89.05 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.853 0.359 . . . . 0.0 110.772 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.0 t -130.7 108.7 15.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 175.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -112.31 143.58 43.16 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.954 0.406 . . . . 0.0 111.388 -176.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.587 HG22 ' HG2' ' A' ' 50' ' ' LYS . 71.7 p -109.32 140.86 42.46 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.9 t -150.64 143.02 24.32 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.048 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.58 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 71.3 p -115.09 122.99 47.83 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.8 m -107.21 125.69 63.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.329 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.519 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 16.2 ptp180 -77.79 135.29 37.96 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 85.4 mt -117.57 127.52 74.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-O 120.977 0.418 . . . . 0.0 111.63 -174.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.0 tt -115.13 119.4 36.29 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.107 177.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -165.73 173.42 41.37 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.943 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 79.2 mtm -63.81 -44.91 91.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.32 0.581 . . . . 0.0 110.134 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.0 p -134.91 128.8 33.26 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.748 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.551 ' O ' HG23 ' A' ' 22' ' ' VAL . 51.5 t -62.61 -49.56 74.74 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -176.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -62.61 -40.88 98.35 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -174.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.6 t -62.83 -47.16 84.58 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.675 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.5 p -70.75 -33.29 70.65 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.698 0.285 . . . . 0.0 110.967 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 18' ' ' CYS . 52.7 t -61.91 -45.62 98.29 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.018 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 176.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -64.34 -36.28 83.62 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.493 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 41.1 t -59.24 -48.69 80.67 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.281 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.8 tt -78.51 -28.86 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.448 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -59.2 -46.33 88.73 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.28 -176.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -61.17 -45.09 96.03 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.962 0.41 . . . . 0.0 110.689 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -67.22 -45.75 75.87 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.505 -176.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.3 tp -72.47 -34.63 49.0 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 78.8 p -65.82 -36.32 83.15 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.817 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -70.6 -27.29 63.98 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.283 176.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -77.96 125.18 28.96 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.918 0.389 . . . . 0.0 110.169 176.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -81.51 152.48 27.29 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.316 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 115.81 -0.91 21.53 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.17 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.9 tt -108.73 124.19 65.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.25 0.547 . . . . 0.0 109.98 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 49.7 mm -71.38 -49.43 47.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.029 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.7 t -159.81 150.26 18.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.76 -177.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 26.3 ttt -127.33 119.56 26.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.143 178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -131.03 146.38 52.36 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 110.289 -0.264 . . . . 0.0 110.289 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.5 HG21 HG11 ' A' ' 22' ' ' VAL . 66.4 t -123.91 129.73 74.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 120.757 0.313 . . . . 0.0 111.67 -175.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.3 t -106.85 105.3 15.26 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 177.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 60.0 tp -64.48 -40.83 96.41 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.679 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -62.07 -40.91 97.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.732 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -76.26 -29.11 57.34 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.667 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.83 20.31 63.71 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.978 -0.629 . . . . 0.0 111.629 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 89.3 p -143.91 166.22 25.55 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 120.93 0.395 . . . . 0.0 110.542 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.58 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -117.52 133.77 55.59 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.469 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.1 m -98.88 121.24 40.57 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.6 m -127.96 149.34 32.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 CA-C-O 121.408 0.623 . . . . 0.0 111.509 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.587 ' HG2' HG22 ' A' ' 8' ' ' THR . 62.3 mttp -116.04 123.88 49.06 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 175.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -150.7 165.46 33.37 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.504 -174.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.5 t -100.16 110.28 59.18 Favored Pre-proline 0 N--CA 1.438 -1.056 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.041 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -55.82 -27.13 60.8 Favored 'Trans proline' 0 N--CA 1.483 0.866 0 C-N-CA 123.62 2.88 . . . . 0.0 112.676 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.2 m -62.03 -39.22 91.59 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.845 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 51.8 t -89.05 -47.52 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.998 -177.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 31.8 m -123.25 160.2 26.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.614 0.245 . . . . 0.0 110.904 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 31.2 p -134.89 167.32 21.12 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.948 0.404 . . . . 0.0 111.541 -176.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 68.6 tp -61.07 -44.33 97.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.856 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -60.03 -42.31 94.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.515 -177.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.563 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 64.7 tt0 -61.66 -45.81 92.41 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.609 178.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.0 t -63.97 -46.59 93.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 CA-C-O 121.2 0.524 . . . . 0.0 110.751 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 48.5 t -60.82 -40.07 91.37 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.927 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -60.36 -41.38 93.58 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.414 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.563 ' HG2' ' O ' ' A' ' 60' ' ' GLN . 87.0 mm-40 -60.56 -45.7 92.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.143 -176.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.3 tt -83.22 -35.78 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.869 0.366 . . . . 0.0 111.752 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.59 -39.8 97.86 Favored Glycine 0 CA--C 1.505 -0.536 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.42 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -60.42 -39.37 87.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.952 0.406 . . . . 0.0 110.324 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 14.8 tpt -63.47 -30.67 71.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.485 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 116.64 7.93 12.96 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.334 -0.936 . . . . 0.0 113.301 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -114.53 141.6 47.52 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -99.31 133.35 43.74 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -172.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 12' ' ' ARG . . . -130.89 139.03 50.06 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.474 176.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.6 m -127.57 143.59 51.16 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.689 0.281 . . . . 0.0 110.938 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.2 tt -74.13 142.32 14.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -175.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.434 ' HB2' ' NH2' ' A' ' 12' ' ' ARG . . . -143.05 125.63 15.83 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.45 172.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 . . . . . 0 C--N 1.307 -1.244 0 CA-C-O 118.771 -0.633 . . . . 0.0 111.435 -178.579 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.671 0 CA-C-O 120.404 0.145 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 57.52 -131.03 51.85 Favored Glycine 0 C--N 1.338 0.642 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -90.1 129.43 36.39 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.0 mtt -103.08 120.07 40.01 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.193 0.521 . . . . 0.0 111.194 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -116.19 126.64 53.92 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.507 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.7 p -141.51 138.37 32.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 176.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -129.9 143.2 50.68 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 120.954 0.407 . . . . 0.0 111.136 -178.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.1 p -107.96 129.34 55.12 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.024 177.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.424 ' O ' HG22 ' A' ' 49' ' ' VAL . 46.8 t -140.71 143.78 35.22 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 22.4 p -109.62 119.71 40.25 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.929 177.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 74' ' ' ILE . 33.5 m -102.61 135.89 37.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.408 ' HG2' ' HB3' ' A' ' 73' ' ' SER . 24.1 ptt180 -83.74 150.9 25.52 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.642 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 86.4 mt -112.52 121.35 64.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 63.4 tp -122.56 108.08 12.72 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -167.23 156.19 27.8 Favored Glycine 0 N--CA 1.431 -1.656 0 C-N-CA 119.932 -1.127 . . . . 0.0 113.069 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 79.5 mtm -64.6 -40.28 95.23 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.92 0.39 . . . . 0.0 110.346 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 35.5 m -121.85 103.87 9.16 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.468 ' O ' HG23 ' A' ' 22' ' ' VAL . 91.5 m -65.4 -40.23 93.16 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.051 -177.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -62.72 -39.79 95.15 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -176.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.0 m -62.38 -44.56 96.16 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.553 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.651 ' HB3' ' CD2' ' A' ' 70' ' ' PHE . 24.7 p -71.73 -37.05 70.64 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.416 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 18' ' ' CYS . 59.4 t -62.65 -45.18 99.46 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.001 178.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 66.3 tttp -62.86 -42.73 99.86 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.275 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 74.5 m -60.78 -43.01 98.63 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.67 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.0 tt -76.52 -41.16 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.396 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -62.71 -49.36 75.4 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -63.71 -46.42 85.52 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.046 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.0 ttp180 -67.17 -42.72 83.81 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.522 HG12 ' OH ' ' A' ' 51' ' ' TYR . 11.2 tp -67.55 -36.44 76.24 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.687 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.882 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 79.0 p -73.17 -20.71 60.84 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.17 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -71.64 -27.91 63.4 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 174.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 64.1 tp -93.29 119.3 32.28 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.388 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -80.66 152.41 28.48 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 120.994 0.426 . . . . 0.0 111.069 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 115.3 1.67 21.86 Favored Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -175.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.522 HD11 ' HB2' ' A' ' 38' ' ' MET . 4.1 tt -91.92 122.25 43.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 123.132 0.573 . . . . 0.0 110.426 178.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.1 tt -82.7 -42.8 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.822 177.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.492 ' HB3' ' HD2' ' A' ' 50' ' ' LYS . 35.3 t -160.67 145.62 14.35 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 120.123 -0.631 . . . . 0.0 112.248 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.577 ' SD ' HG12 ' A' ' 49' ' ' VAL . 14.4 tpt -134.41 129.81 35.89 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.851 177.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -135.05 129.05 33.44 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.6 p -129.77 137.61 56.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 120.811 0.339 . . . . 0.0 110.862 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.1 t -117.62 117.9 30.64 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.979 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.8 tp -66.66 -41.62 87.9 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.863 176.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -61.07 -48.93 79.42 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.587 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -77.02 -25.02 52.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.69 -178.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.33 29.8 69.85 Favored Glycine 0 CA--C 1.505 -0.591 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.9 t -149.12 152.85 36.84 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -119.36 138.17 53.24 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.987 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 71.6 m -102.67 122.6 44.77 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.667 ' HB ' ' CE2' ' A' ' 51' ' ' TYR . 33.3 m -120.72 149.91 23.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -174.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.492 ' HD2' ' HB3' ' A' ' 37' ' ' SER . 69.0 mttm -125.0 108.2 11.6 Favored 'General case' 0 C--O 1.245 0.858 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.749 175.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.667 ' CE2' ' HB ' ' A' ' 49' ' ' VAL . 80.8 m-85 -136.44 148.78 47.92 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.03 0.443 . . . . 0.0 111.434 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 66.5 t -87.61 115.41 62.8 Favored Pre-proline 0 N--CA 1.438 -1.049 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 171.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -59.4 -28.62 88.04 Favored 'Trans proline' 0 N--CA 1.475 0.398 0 C-N-CA 122.819 2.346 . . . . 0.0 113.765 -173.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.0 p -77.05 -14.29 59.84 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.907 0.384 . . . . 0.0 111.473 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 49.0 t -104.4 -59.19 3.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.105 0.479 . . . . 0.0 109.892 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 66.7 t -126.3 124.16 65.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.491 ' SG ' ' HG3' ' A' ' 60' ' ' GLN . 31.2 p -93.48 159.28 15.31 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.208 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.8 mt -62.91 -36.67 84.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.66 -178.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -61.11 -40.03 92.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.734 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.491 ' HG3' ' SG ' ' A' ' 57' ' ' CYS . 95.5 mt-30 -63.08 -41.25 99.38 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.074 0.464 . . . . 0.0 110.369 177.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 70.2 t -63.26 -44.24 99.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.119 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 92.5 m -62.59 -39.51 93.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.967 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -61.75 -39.67 92.4 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.547 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.42 ' HG3' ' O ' ' A' ' 60' ' ' GLN . 99.1 mt-30 -60.3 -42.34 95.32 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.41 -176.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.2 tt -81.77 -40.73 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-O 120.787 0.327 . . . . 0.0 111.604 178.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -62.31 -37.01 93.88 Favored Glycine 0 C--N 1.335 0.473 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.626 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -56.35 -36.14 68.44 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 123.91 0.884 . . . . 0.0 111.594 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 14.2 tpt -63.44 -28.58 70.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.246 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.81 9.62 9.83 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.495 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.651 ' CD2' ' HB3' ' A' ' 21' ' ' CYS . 98.4 m-85 -113.79 141.82 46.83 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -82.78 146.85 28.74 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.485 0.66 . . . . 0.0 112.592 -176.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.44 151.09 35.86 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.981 -1.008 . . . . 0.0 108.923 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 36.6 t -138.19 140.48 39.8 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.891 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.455 ' HA ' HG12 ' A' ' 11' ' ' VAL . 85.7 mt -81.55 128.63 38.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.066 -178.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -142.95 159.96 41.25 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.435 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 119.132 -0.461 . . . . 0.0 111.403 -179.692 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.86 0 CA-C-O 120.744 0.307 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 136.74 -20.34 3.46 Favored Glycine 0 C--N 1.316 -0.532 0 C-N-CA 120.913 -0.661 . . . . 0.0 111.508 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -90.76 137.88 32.02 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 98.4 mmm 68.43 177.12 0.26 Allowed 'General case' 0 N--CA 1.471 0.588 0 O-C-N 123.716 0.635 . . . . 0.0 110.668 -176.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 62.9 18.95 11.22 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.071 0.548 . . . . 0.0 111.579 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.9 t -126.35 122.78 62.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 120.908 0.385 . . . . 0.0 110.957 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 50' ' ' LYS . . . -117.24 131.82 56.76 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 176.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.573 HG22 ' HG2' ' A' ' 50' ' ' LYS . 66.4 p -111.82 135.04 52.96 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.8 t -157.57 152.15 25.13 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 40.7 p -111.93 142.39 44.4 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-O 121.037 0.446 . . . . 0.0 110.042 178.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.3 p -133.14 127.33 54.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.137 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 40.6 ptt180 -94.53 142.61 27.24 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.595 -0.442 . . . . 0.0 109.815 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 85.3 mt -110.13 127.13 67.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.782 -177.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 63.0 tp -112.87 115.2 28.08 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.219 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -172.83 148.54 10.58 Favored Glycine 0 N--CA 1.438 -1.229 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 68.3 mtt -65.94 -41.05 91.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.972 0.415 . . . . 0.0 110.794 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.7 m -100.76 85.26 2.86 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.489 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 93.7 m -63.45 -40.13 96.32 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.495 -175.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -62.83 -42.21 99.64 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -177.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.9 m -67.34 -41.1 85.75 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.504 ' HB3' ' CG ' ' A' ' 70' ' ' PHE . 18.6 p -68.79 -39.96 79.86 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.572 -179.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.476 ' O ' ' HG3' ' A' ' 26' ' ' GLU . 67.3 t -63.07 -46.0 97.27 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.282 0 CA-C-O 121.13 0.49 . . . . 0.0 109.804 178.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.46 -44.13 97.64 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.793 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.459 ' HB3' ' HG3' ' A' ' 68' ' ' MET . 67.2 m -62.95 -46.43 87.79 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.067 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.9 tt -66.25 -33.62 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.207 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 22' ' ' VAL . 49.4 mt-10 -62.33 -44.03 97.45 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.627 178.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -65.93 -45.46 81.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.149 0.499 . . . . 0.0 110.812 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.534 ' HB3' ' HG2' ' A' ' 64' ' ' GLN . 26.5 mmt85 -64.18 -43.32 95.47 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.239 -178.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.591 HG21 ' SD ' ' A' ' 38' ' ' MET . 19.1 tt -70.62 -32.95 51.25 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.303 0 CA-C-O 120.952 0.406 . . . . 0.0 110.264 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.5 t -62.41 -38.86 91.3 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.575 176.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -66.79 -30.37 70.55 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.886 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 93.7 mt -75.82 129.12 36.51 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.164 0.507 . . . . 0.0 110.451 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -85.49 153.35 22.52 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.294 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.02 7.96 48.94 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.583 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.497 ' HA ' ' CB ' ' A' ' 51' ' ' TYR . 48.0 pt -94.78 138.68 20.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.868 0.366 . . . . 0.0 110.662 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.3 mm -99.48 -61.78 2.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.114 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.5 m -146.57 154.13 41.16 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.615 0.245 . . . . 0.0 110.965 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.591 ' SD ' HG21 ' A' ' 29' ' ' ILE . 27.8 ttt -145.6 132.45 20.12 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.583 178.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -126.26 128.34 47.02 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 176.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.8 t -107.2 123.62 62.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-O 120.79 0.329 . . . . 0.0 110.366 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.5 m -98.6 99.38 10.51 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.9 mt -64.19 -40.23 95.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.089 -175.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -69.27 -38.57 78.44 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.075 0.464 . . . . 0.0 110.91 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -74.66 -29.96 61.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.806 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.82 15.14 81.2 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -177.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 12' ' ' ARG . 49.0 m -131.48 154.25 48.93 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.39 -0.405 . . . . 0.0 110.133 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -125.41 143.49 50.96 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.978 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 85.1 m -102.01 125.26 48.66 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.6 m -117.69 147.28 21.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 121.023 0.439 . . . . 0.0 111.512 -177.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.573 ' HG2' HG22 ' A' ' 8' ' ' THR . 99.7 mttt -133.17 112.94 12.15 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.444 177.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.497 ' CB ' ' HA ' ' A' ' 35' ' ' ILE . 35.9 p90 -159.28 170.62 21.47 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.13 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.0 t -80.61 114.94 51.84 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 38.9 Cg_endo -65.97 -23.34 54.38 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.696 2.264 . . . . 0.0 112.218 -178.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.4 m -65.77 -39.36 90.94 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.619 177.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 66.0 t -74.42 -51.11 24.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.017 0.437 . . . . 0.0 110.483 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 17.8 m -137.08 149.02 26.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.434 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.582 ' SG ' ' HB2' ' A' ' 60' ' ' GLN . 24.9 p -99.65 172.24 7.41 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.871 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.484 HD23 ' OH ' ' A' ' 51' ' ' TYR . 96.5 mt -64.84 -40.89 95.9 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.718 0.771 . . . . 0.0 110.332 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -68.27 -26.71 65.8 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.462 178.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.582 ' HB2' ' SG ' ' A' ' 57' ' ' CYS . 59.6 tp60 -60.41 -45.93 91.85 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.381 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.54 ' HA ' ' OE1' ' A' ' 64' ' ' GLN . 31.8 m -74.33 -26.43 20.49 Favored 'Isoleucine or valine' 0 C--O 1.248 0.989 0 CA-C-O 121.387 0.613 . . . . 0.0 110.722 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 98.1 m -61.64 -36.45 80.82 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.104 176.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -60.48 -40.5 91.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.933 -178.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.54 ' OE1' ' HA ' ' A' ' 61' ' ' VAL . 28.6 mp0 -64.57 -41.0 96.56 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 120.4 -0.52 . . . . 0.0 112.235 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.4 tt -72.67 -36.82 54.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.525 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.23 -38.39 96.12 Favored Glycine 0 C--N 1.339 0.702 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 176.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -57.63 -36.83 72.34 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.358 0.663 . . . . 0.0 110.896 178.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.459 ' HG3' ' HB3' ' A' ' 24' ' ' SER . 95.9 mmm -74.72 -8.05 55.2 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.526 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.57 9.91 59.65 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.617 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.504 ' CG ' ' HB3' ' A' ' 21' ' ' CYS . 98.7 m-85 -111.7 147.52 35.39 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -105.95 151.32 24.74 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.184 0.516 . . . . 0.0 111.91 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -144.72 148.62 34.4 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.456 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.7 t -123.6 132.6 53.91 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.937 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 84.4 mt -78.96 130.93 35.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.235 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -144.51 155.31 43.63 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.283 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 . . . . . 0 C--O 1.256 1.432 0 CA-C-O 118.568 -0.729 . . . . 0.0 109.377 178.388 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.825 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.23 173.87 52.49 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.219 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.7 p80 -69.56 147.73 50.38 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 117.128 0.464 . . . . 0.0 111.198 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -107.15 130.23 54.73 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.379 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 89.7 mm-40 -105.66 131.28 53.22 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.4 m -117.16 150.39 19.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-O 121.003 0.43 . . . . 0.0 111.075 -175.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -104.79 131.35 52.36 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.646 -178.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 61.2 p -117.65 142.86 46.73 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.2 t -158.89 152.55 23.1 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.274 -0.571 . . . . 0.0 110.029 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 20.8 p -102.43 141.23 35.58 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 177.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.3 p -134.78 135.16 53.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.522 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -95.22 151.9 18.83 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.3 pt -115.11 138.8 44.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 110.127 -0.324 . . . . 0.0 110.127 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.2 tp -126.0 117.89 24.19 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.143 0.497 . . . . 0.0 110.774 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.82 157.77 16.31 Favored Glycine 0 N--CA 1.437 -1.264 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 95.3 mmm -69.02 -39.48 79.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.145 0.498 . . . . 0.0 110.059 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.2 p -99.74 79.07 2.2 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 121.509 0.671 . . . . 0.0 109.879 176.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.545 ' O ' HG23 ' A' ' 22' ' ' VAL . 96.4 m -62.39 -43.16 99.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.986 -176.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -64.99 -38.95 92.66 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.862 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.0 t -61.23 -45.93 92.5 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.451 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 29.3 p -67.53 -32.19 72.81 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.516 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 18' ' ' CYS . 53.7 t -62.97 -43.63 99.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.615 176.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -61.87 -43.79 98.13 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.456 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.6 m -61.76 -44.94 95.9 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.809 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.7 tp -72.5 -35.34 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 121.171 -0.212 . . . . 0.0 111.324 178.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -59.46 -47.11 86.76 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.878 0.37 . . . . 0.0 110.955 -177.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -62.92 -51.14 68.1 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.065 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.56 ' HG3' ' NE2' ' A' ' 64' ' ' GLN . 29.9 tpt180 -68.99 -40.82 78.54 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.568 -174.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.404 ' O ' HD13 ' A' ' 35' ' ' ILE . 18.9 tt -65.64 -33.83 66.28 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.086 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 73.5 m -63.64 -35.06 79.27 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.783 175.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -67.4 -26.24 66.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.097 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.428 HD11 ' NE2' ' A' ' 64' ' ' GLN . 92.1 mt -74.56 136.52 42.1 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.973 0.416 . . . . 0.0 110.852 176.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -86.75 149.92 24.52 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.393 177.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.84 7.97 54.78 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.064 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.404 HD13 ' O ' ' A' ' 29' ' ' ILE . 47.7 pt -94.02 139.49 18.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 120.881 0.372 . . . . 0.0 110.22 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 89.2 mt -99.38 -58.56 3.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.819 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.1 t -158.47 147.53 19.07 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.079 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.42 ' HG3' HG12 ' A' ' 49' ' ' VAL . 65.5 ttp -141.74 130.04 22.32 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.115 175.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -120.12 127.0 52.11 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.3 t -111.47 119.99 61.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.1 m -100.97 106.34 17.65 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 97.0 mt -63.61 -38.68 92.03 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.979 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -63.67 -41.08 98.22 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.931 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -77.29 -27.33 52.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.174 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.27 18.78 73.42 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.216 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 78.7 p -144.69 159.03 43.49 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 120.881 0.372 . . . . 0.0 111.177 -178.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -128.33 155.65 44.32 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.23 -178.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.9 m -113.32 127.54 56.18 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 8' ' ' THR . 35.9 m -116.99 148.28 19.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 120.826 0.346 . . . . 0.0 111.218 -178.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -142.68 114.87 8.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.459 177.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.449 ' OH ' HD23 ' A' ' 58' ' ' LEU . 39.4 p90 -158.89 166.84 30.93 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.06 -178.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.12 116.27 63.38 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.647 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 43.4 Cg_endo -65.78 -20.42 58.87 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.086 2.524 . . . . 0.0 114.053 -175.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.6 p -65.71 -38.11 88.29 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.695 0.283 . . . . 0.0 111.439 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.9 m -100.4 -26.98 3.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 79.8 t -125.35 124.86 68.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 176.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.564 ' SG ' ' HG3' ' A' ' 60' ' ' GLN . 31.2 p -103.29 168.65 9.03 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.001 -178.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.449 HD23 ' OH ' ' A' ' 51' ' ' TYR . 96.0 mt -64.18 -38.2 90.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.533 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -61.74 -41.06 97.17 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.014 -177.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.564 ' HG3' ' SG ' ' A' ' 57' ' ' CYS . 96.0 mt-30 -62.07 -45.56 92.97 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.47 -178.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 72.6 t -64.22 -46.93 92.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 CA-C-O 121.075 0.464 . . . . 0.0 111.048 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 44.6 t -62.16 -43.37 98.97 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.135 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -62.53 -41.33 98.8 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.779 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.56 ' NE2' ' HG3' ' A' ' 28' ' ' ARG . 99.6 mt-30 -61.2 -43.55 98.7 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 121.207 -0.197 . . . . 0.0 111.334 -176.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.0 tt -77.85 -38.02 24.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.119 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -62.82 -40.21 98.95 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.604 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -62.61 -26.93 68.86 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 122.989 0.516 . . . . 0.0 110.781 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.476 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 36.6 mmt -71.4 -8.97 57.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.666 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.77 5.86 58.47 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.377 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.479 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 99.1 m-85 -110.55 138.56 46.78 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -88.42 140.6 29.3 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.735 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -139.62 138.36 36.09 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.13 177.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.3 m -118.63 139.38 51.59 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.4 tt -118.56 139.91 44.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-O 121.128 0.489 . . . . 0.0 111.499 -174.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.44 160.41 42.12 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.108 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 . . . . . 0 C--O 1.252 1.214 0 CA-C-O 118.512 -0.756 . . . . 0.0 109.744 177.887 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.553 0 CA-C-O 120.63 0.253 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.61 -56.33 4.47 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 121.234 -0.508 . . . . 0.0 114.111 176.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 65.1 m170 -65.21 127.35 31.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.741 0.305 . . . . 0.0 111.447 -175.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 67.3 mtt 54.49 29.47 11.27 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.52 0.728 . . . . 0.0 112.62 177.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -64.68 -33.34 75.73 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.326 0.584 . . . . 0.0 110.327 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.1 m -134.03 150.79 31.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.031 177.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -117.19 127.34 54.01 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 40.1 p -119.78 144.78 47.11 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.087 177.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.3 t -158.09 153.1 25.36 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.86 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 34.9 p -110.07 142.14 41.93 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 176.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 73' ' ' SER . 6.8 p -127.35 122.98 60.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-O 121.044 0.449 . . . . 0.0 110.192 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 36.3 ptt180 -91.44 146.2 24.0 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.208 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.2 pt -121.09 133.92 66.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 121.207 0.527 . . . . 0.0 112.008 -176.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 62.0 tp -135.56 129.41 32.94 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.069 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.21 -172.65 44.73 Favored Glycine 0 N--CA 1.438 -1.192 0 C-N-CA 119.58 -1.295 . . . . 0.0 112.811 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -61.8 -42.17 98.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.911 0.386 . . . . 0.0 110.913 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.472 ' HB ' ' OG ' ' A' ' 20' ' ' SER . 63.6 m -139.84 118.08 12.01 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.115 177.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.463 ' O ' HG23 ' A' ' 22' ' ' VAL . 95.1 m -67.47 -39.77 85.28 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.558 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -63.37 -41.91 98.84 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.613 -177.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.472 ' OG ' ' HB ' ' A' ' 17' ' ' THR . 78.9 p -69.71 -39.12 77.07 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.437 ' HB3' ' CG ' ' A' ' 70' ' ' PHE . 29.7 p -67.08 -34.03 76.78 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.544 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 18' ' ' CYS . 63.3 t -63.12 -44.84 99.68 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -63.09 -40.45 97.68 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.212 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.2 m -62.73 -46.22 89.09 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.637 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.9 tt -74.29 -35.62 40.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.012 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -60.65 -44.51 96.32 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.918 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -60.83 -51.3 69.91 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.207 -176.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -65.29 -46.35 80.74 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.452 HD13 ' SD ' ' A' ' 38' ' ' MET . 19.0 tt -65.8 -33.11 61.4 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.52 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.724 -177.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.5 m -65.55 -41.54 92.89 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.236 0.541 . . . . 0.0 110.338 177.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -71.13 -27.22 63.42 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.257 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 62.5 tp -81.86 117.23 21.96 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 121.306 0.574 . . . . 0.0 109.532 178.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -86.46 154.66 20.97 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.123 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.415 ' HA3' HG11 ' A' ' 55' ' ' VAL . . . 117.8 -6.3 15.9 Favored Glycine 0 C--N 1.314 -0.644 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -176.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.7 mp -102.05 112.67 36.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.3 tt -72.12 -38.45 63.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -176.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.5 m -151.34 145.31 25.21 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.838 0.352 . . . . 0.0 111.478 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.452 ' SD ' HD13 ' A' ' 29' ' ' ILE . 63.4 ttp -145.69 127.75 15.59 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -134.97 144.43 47.4 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.0 129.16 76.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 121.379 0.609 . . . . 0.0 111.428 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.6 p -100.47 98.07 8.72 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.703 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 99.4 mt -63.89 -39.16 93.54 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.371 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -65.45 -23.47 66.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.151 0.5 . . . . 0.0 111.115 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 -88.56 -27.82 21.14 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.135 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.34 19.67 71.21 Favored Glycine 0 C--O 1.236 0.272 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -176.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.0 t -145.0 154.88 43.01 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.24 -0.48 . . . . 0.0 109.733 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -118.36 149.73 40.7 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.584 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.7 m -112.86 126.83 55.88 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 8' ' ' THR . 12.7 p -123.72 137.37 57.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 121.013 0.435 . . . . 0.0 110.815 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -124.81 117.96 25.31 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 56.2 p90 -151.62 165.4 34.44 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.957 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.4 t -77.12 121.66 85.02 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 174.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -59.95 -28.38 86.99 Favored 'Trans proline' 0 N--CA 1.476 0.498 0 C-N-CA 122.814 2.343 . . . . 0.0 113.866 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.2 m -85.25 -9.43 57.74 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 120.752 0.31 . . . . 0.0 111.707 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.415 HG11 ' HA3' ' A' ' 34' ' ' GLY . 65.7 t -99.15 -42.33 10.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.712 0.291 . . . . 0.0 111.539 -178.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 63.5 t -125.36 137.16 58.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.746 -177.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.403 ' SG ' ' HB2' ' A' ' 60' ' ' GLN . 28.9 p -105.91 156.18 18.61 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.792 0.329 . . . . 0.0 110.872 178.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.471 HD13 HG21 ' A' ' 74' ' ' ILE . 87.9 mt -63.73 -39.86 95.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.085 -178.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -63.51 -36.87 85.19 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -177.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.426 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 23.8 tm0? -58.95 -45.28 90.86 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 121.224 -0.19 . . . . 0.0 110.796 -177.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.8 m -75.3 -33.47 28.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.216 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 95.4 m -63.64 -39.89 95.5 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-O 121.099 0.476 . . . . 0.0 110.179 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -63.33 -38.14 89.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.856 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' A' ' 60' ' ' GLN . 19.6 mm100 -62.7 -43.52 98.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.499 -177.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.5 tt -83.0 -40.25 16.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 120.797 0.332 . . . . 0.0 111.714 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.566 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -62.89 -40.78 99.69 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 116.119 -0.491 . . . . 0.0 113.426 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -61.39 -35.3 77.11 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.974 0.416 . . . . 0.0 111.282 -178.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 35.9 mmt -68.62 -8.05 38.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.703 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.39 11.15 39.59 Favored Glycine 0 CA--C 1.506 -0.499 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.713 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.566 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 96.2 m-85 -108.03 146.16 32.94 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -102.49 131.23 49.32 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.91 0.386 . . . . 0.0 110.899 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 12' ' ' ARG . . . -143.28 144.36 32.09 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 13.4 p -133.9 153.72 51.56 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.306 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.471 HG21 HD13 ' A' ' 58' ' ' LEU . 49.8 mm -95.01 130.54 43.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.208 -174.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.0 151.5 51.47 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.134 176.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 C--N 1.309 -1.163 0 CA-C-O 119.024 -0.512 . . . . 0.0 110.595 -178.945 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.796 0 CA-C-O 120.739 0.304 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -137.04 147.52 19.28 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.386 -0.911 . . . . 0.0 111.94 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -88.41 130.06 35.27 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.007 0.432 . . . . 0.0 111.166 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 98.2 mmm -67.47 -39.17 85.26 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.489 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -98.98 105.57 17.73 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.426 0.631 . . . . 0.0 111.944 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 31.8 m -132.68 150.76 33.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.075 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.4 134.31 55.02 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.632 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 67.9 p -117.65 147.14 43.17 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 175.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 76' ' ' GLU . 87.4 p -158.85 158.21 33.01 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.149 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 31.9 p -115.36 114.38 25.05 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 175.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.505 HG22 HG12 ' A' ' 74' ' ' ILE . 70.7 t -107.62 123.51 63.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.2 -176.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -91.48 143.2 26.85 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.497 -177.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 82.7 mt -120.18 130.48 74.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.364 -176.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.46 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 7.4 tt -112.32 120.49 41.89 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 176.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -166.14 179.49 40.22 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.272 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 94.7 mmm -63.18 -41.41 99.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.745 0.307 . . . . 0.0 111.294 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.0 t -152.17 150.36 29.77 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 120.993 0.425 . . . . 0.0 110.652 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.456 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 93.1 m -64.01 -38.78 92.33 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.67 -178.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -59.22 -47.42 85.41 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -172.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.2 p -70.52 -40.93 73.21 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -177.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.456 ' SG ' ' HA ' ' A' ' 18' ' ' CYS . 25.4 p -72.71 -42.74 63.85 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -177.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.414 ' O ' ' HG3' ' A' ' 26' ' ' GLU . 66.9 t -64.18 -45.58 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.86 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 73.6 mmtt -64.41 -38.95 92.84 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.328 -0.549 . . . . 0.0 112.061 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.6 m -62.22 -43.97 97.63 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.279 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.439 ' O ' HG22 ' A' ' 29' ' ' ILE . 10.9 tp -72.86 -37.62 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.547 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 22' ' ' VAL . 44.4 mt-10 -61.97 -41.43 98.01 Favored 'General case' 0 C--N 1.349 0.558 0 C-N-CA 120.944 -0.303 . . . . 0.0 111.513 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -61.07 -50.26 74.01 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -176.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -65.93 -44.96 83.56 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.439 HG22 ' O ' ' A' ' 25' ' ' ILE . 19.7 tt -72.17 -32.68 44.08 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 CA-C-O 120.797 0.332 . . . . 0.0 111.372 -177.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.2 t -63.66 -39.67 94.93 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -68.56 -27.09 65.77 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.377 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 98.5 mt -83.68 118.34 23.8 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.556 -0.457 . . . . 0.0 110.427 176.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -85.71 153.94 21.98 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.606 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.13 7.48 14.62 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.453 -177.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.412 ' HA ' ' CB ' ' A' ' 51' ' ' TYR . 46.7 pt -102.79 139.02 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 86.8 mt -83.82 -56.96 4.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.173 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 78.6 p -155.14 157.42 37.41 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.256 -178.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 77.9 mtm -138.03 142.35 40.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.331 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -131.3 149.52 52.53 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 175.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.9 p -138.48 131.7 40.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-O 121.187 0.518 . . . . 0.0 111.385 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.1 m -116.19 103.99 11.08 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.76 -41.63 97.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.346 -176.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -64.02 -39.93 95.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.156 0.503 . . . . 0.0 110.997 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -73.11 -29.89 63.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.323 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.35 17.66 73.28 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.749 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 88.4 p -142.2 158.58 43.57 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 120.893 0.378 . . . . 0.0 110.455 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -124.48 144.7 49.94 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.85 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.1 m -103.65 123.35 46.83 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 8' ' ' THR . 29.7 m -126.67 149.41 31.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.446 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -134.95 115.33 13.44 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.468 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.412 ' CB ' ' HA ' ' A' ' 35' ' ' ILE . 51.6 p90 -161.97 170.93 18.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.237 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.5 t -82.88 116.32 63.46 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 36.7 Cg_endo -64.76 -23.88 62.41 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.71 2.273 . . . . 0.0 113.515 -176.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.5 t -64.88 -42.88 94.45 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.271 177.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 96.5 t -67.78 -49.47 69.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.137 0.494 . . . . 0.0 110.043 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 63.0 t -128.35 119.84 51.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.657 ' SG ' ' HB2' ' A' ' 60' ' ' GLN . 30.4 p -83.12 154.46 24.33 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.472 -178.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.482 ' HB3' ' CD1' ' A' ' 74' ' ' ILE . 98.9 mt -62.48 -37.99 88.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.544 -178.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -63.11 -39.43 94.66 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.535 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.657 ' HB2' ' SG ' ' A' ' 57' ' ' CYS . 14.2 tm0? -65.0 -38.89 92.44 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 77.3 t -61.58 -44.05 98.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.298 0.571 . . . . 0.0 110.171 178.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 44.0 t -60.49 -40.32 90.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.191 176.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.468 ' HB3' ' O ' ' A' ' 60' ' ' GLN . 53.7 t-80 -60.18 -39.36 86.2 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.872 177.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -59.9 -46.17 90.18 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.373 -177.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.3 tt -82.04 -33.65 11.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.09 -39.66 97.43 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.455 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -61.75 -37.94 86.14 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.838 0.351 . . . . 0.0 111.082 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 16.4 tpt -61.97 -30.04 70.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.04 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.94 6.94 18.26 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.61 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -112.55 136.92 51.51 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.46 ' HG3' ' HB3' ' A' ' 14' ' ' LEU . 12.0 pt-20 -95.88 144.55 26.12 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.009 0.433 . . . . 0.0 110.649 -178.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.89 152.36 37.46 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.381 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 78.3 p -132.1 149.36 52.42 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.45 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.505 HG12 HG22 ' A' ' 11' ' ' VAL . 81.6 mt -94.4 125.26 47.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.891 -175.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -126.33 149.83 48.91 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.008 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 9' ' ' SER . 41.8 tt0 . . . . . 0 C--O 1.249 1.078 0 C-N-CA 123.167 0.587 . . . . 0.0 111.125 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.636 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.03 137.1 13.68 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.518 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -90.49 127.85 36.36 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.07 0.462 . . . . 0.0 111.622 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.55 ' HG3' HG13 ' A' ' 6' ' ' VAL . 15.0 tpt -140.96 128.89 21.84 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.481 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -91.37 103.33 15.98 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.233 0.54 . . . . 0.0 111.218 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.55 HG13 ' HG3' ' A' ' 4' ' ' MET . 27.6 m -133.17 150.41 32.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.511 177.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -139.07 148.77 43.77 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.06 0.457 . . . . 0.0 110.614 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 72.3 p -125.34 156.18 39.11 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.7 p -156.5 159.06 38.25 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 123.266 0.354 . . . . 0.0 110.078 176.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.2 p -117.93 139.21 51.47 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 73' ' ' SER . 6.7 p -132.14 123.81 51.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.234 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -77.96 143.51 37.55 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.503 HD12 ' SG ' ' A' ' 21' ' ' CYS . 37.6 pt -115.76 123.02 70.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 60.4 tp -122.82 119.36 30.35 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.063 0.458 . . . . 0.0 111.545 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.49 167.95 37.64 Favored Glycine 0 N--CA 1.438 -1.229 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 178.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 99.0 mtp -64.51 -39.32 93.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.954 0.407 . . . . 0.0 111.208 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.6 p -109.49 113.46 26.28 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.104 0.478 . . . . 0.0 111.196 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.509 ' O ' HG23 ' A' ' 22' ' ' VAL . 23.7 p -70.93 -44.9 65.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.851 -178.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.415 ' O ' ' HG3' ' A' ' 23' ' ' LYS . 98.3 mt-30 -64.73 -37.9 89.15 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.555 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.2 t -60.55 -45.25 94.58 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.241 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.503 ' SG ' HD12 ' A' ' 13' ' ' ILE . 26.9 p -69.56 -32.57 71.44 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.836 178.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 18' ' ' CYS . 61.5 t -63.64 -43.67 98.22 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-O 121.214 0.531 . . . . 0.0 109.631 176.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 19' ' ' GLN . 98.6 mttt -61.86 -39.34 91.53 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.752 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.403 ' HB3' ' HG3' ' A' ' 68' ' ' MET . 70.9 m -62.72 -43.23 99.34 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.716 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.439 ' CG2' ' HB ' ' A' ' 65' ' ' ILE . 46.1 pt -81.63 -39.24 16.8 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.886 0 C-N-CA 120.386 -0.525 . . . . 0.0 112.292 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -62.67 -44.87 95.16 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.155 -176.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -61.85 -51.73 67.03 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.206 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.56 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 97.7 mtt180 -70.11 -41.21 74.29 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -176.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 92.1 mt -63.45 -44.19 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.683 0.278 . . . . 0.0 111.166 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 81.1 p -63.2 -33.78 76.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.833 0.349 . . . . 0.0 110.936 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -70.98 -25.76 62.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.417 176.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 28' ' ' ARG . 99.3 mt -70.43 146.61 50.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.133 0.492 . . . . 0.0 111.316 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -86.57 130.88 34.33 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.46 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.5 7.76 25.71 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.799 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.7 tp -84.88 123.39 39.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.05 0.453 . . . . 0.0 110.821 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 86.6 mt -93.58 -60.68 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.011 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 85.9 p -161.51 164.26 29.74 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.64 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 28.5 ptm -151.31 155.54 38.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.904 0.383 . . . . 0.0 110.883 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -143.73 138.67 29.0 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.692 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 67.0 t -106.9 124.33 62.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 120.941 0.4 . . . . 0.0 110.506 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.5 t -99.24 108.09 20.57 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.101 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.11 -33.47 73.53 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.426 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -61.48 -45.48 94.06 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.256 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -93.14 -12.69 29.77 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.646 -0.421 . . . . 0.0 111.686 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.83 26.95 73.78 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.1 m -135.69 158.17 45.05 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.389 -0.406 . . . . 0.0 110.447 -177.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.44 143.59 47.42 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 85.7 m -110.03 127.8 55.04 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.1 p -127.57 134.73 64.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 121.181 0.515 . . . . 0.0 111.283 -178.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -104.48 114.99 29.58 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 175.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.473 ' O ' ' HD3' ' A' ' 53' ' ' PRO . 16.1 t80 -142.79 165.27 27.85 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.612 -170.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.9 t -107.12 98.21 21.29 Favored Pre-proline 0 C--N 1.319 -0.744 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 51' ' ' TYR . 45.9 Cg_exo -60.66 -25.08 80.17 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.294 2.663 . . . . 0.0 111.971 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.8 m -62.26 -41.06 98.11 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.792 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 76.5 t -65.5 -49.69 76.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-O 121.192 0.52 . . . . 0.0 109.847 177.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.3 p -155.85 147.13 12.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.654 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 29.8 p -68.87 156.22 38.83 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.295 0.569 . . . . 0.0 112.406 -176.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.0 mt -77.2 -12.32 59.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.425 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -58.32 -37.89 76.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.954 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.514 ' O ' ' HG3' ' A' ' 64' ' ' GLN . 16.8 mm100 -61.57 -39.88 92.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.011 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.2 t -61.74 -45.11 99.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.744 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 43.0 t -60.73 -40.54 92.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.96 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 44.7 m170 -64.63 -37.16 86.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.703 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.514 ' HG3' ' O ' ' A' ' 60' ' ' GLN . 98.5 mt-30 -60.87 -44.29 97.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.119 -0.492 . . . . 0.0 112.008 -177.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.52 HD13 ' HB2' ' A' ' 72' ' ' ALA . 20.1 tt -76.32 -38.41 33.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.597 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.13 -37.89 95.24 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 177.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -58.12 -36.89 73.59 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.25 0.62 . . . . 0.0 111.132 177.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.403 ' HG3' ' HB3' ' A' ' 24' ' ' SER . 97.8 mmm -79.91 1.93 25.36 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.87 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.31 19.39 58.86 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.871 -0.68 . . . . 0.0 113.897 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -114.64 135.79 53.76 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 177.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -83.08 140.07 32.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.721 0.296 . . . . 0.0 110.56 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.52 ' HB2' HD13 ' A' ' 65' ' ' ILE . . . -148.23 149.72 32.43 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.175 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 65.9 m -133.92 133.97 42.08 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.181 177.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 85.9 mt -100.28 125.87 53.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.258 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -138.67 148.37 43.93 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.419 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.466 -0.778 . . . . 0.0 109.313 179.239 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -62.0 -44.88 97.19 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 121.039 -0.6 . . . . 0.0 113.3 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.8 p80 -90.23 164.91 14.22 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.453 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.9 tpt -122.17 91.14 3.44 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.807 0.336 . . . . 0.0 110.812 177.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 52.86 28.46 6.5 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.2 p -145.63 135.58 18.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -129.69 128.55 42.77 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.98 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.608 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 63.0 p -126.32 136.99 53.42 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.116 177.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.4 t -159.43 162.91 35.78 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 59.3 p -106.05 136.71 45.25 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.273 0.558 . . . . 0.0 111.077 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.32 123.61 70.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 177.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -80.61 141.15 35.29 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -178.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.2 pt -109.68 126.86 66.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-O 121.332 0.586 . . . . 0.0 111.369 -177.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.4 tp -126.26 117.8 23.81 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -165.47 160.46 33.85 Favored Glycine 0 N--CA 1.422 -2.27 0 C-N-CA 120.07 -1.062 . . . . 0.0 111.495 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.6 mmt -65.41 -39.67 92.45 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.3 p -122.33 105.94 10.64 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.722 176.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.9 m -63.63 -40.15 96.16 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.712 -177.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -62.93 -40.71 98.45 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.79 0.329 . . . . 0.0 110.471 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.4 m -62.81 -44.65 95.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.79 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.405 ' HB3' ' CD1' ' A' ' 70' ' ' PHE . 27.9 p -67.14 -38.28 85.25 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.128 -178.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 78.8 t -64.86 -45.02 96.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-O 121.128 0.489 . . . . 0.0 109.828 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -63.52 -43.14 98.03 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.925 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.492 ' HB3' ' HG3' ' A' ' 68' ' ' MET . 68.8 m -62.44 -42.79 99.71 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.825 -178.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.428 HD12 ' HB ' ' A' ' 65' ' ' ILE . 17.9 tt -72.56 -37.65 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.41 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -60.83 -45.94 92.49 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.228 0.537 . . . . 0.0 109.956 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -60.7 -49.71 76.43 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.366 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 44.4 ttt180 -66.02 -43.69 86.91 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.237 -177.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 87.9 mt -63.68 -39.87 86.97 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.799 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.861 177.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 69.3 m -59.72 -37.24 78.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.98 0.419 . . . . 0.0 110.384 178.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -68.59 -26.5 65.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.994 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.0 mp -97.71 150.01 21.67 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.31 0.576 . . . . 0.0 112.105 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -75.58 154.66 36.61 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.793 178.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.95 2.05 45.59 Favored Glycine 0 CA--C 1.505 -0.543 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.971 177.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.8 tt -72.62 108.13 3.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.253 0.549 . . . . 0.0 110.794 178.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' A' ' 50' ' ' LYS . 46.0 mm -101.88 -71.47 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.816 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 52.2 m -155.65 158.41 38.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.752 0.31 . . . . 0.0 111.242 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.8 ptm -148.74 148.53 30.11 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.242 175.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.52 ' HB3' ' HB ' ' A' ' 48' ' ' THR . 55.1 tttp -117.36 112.0 20.11 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.317 176.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.7 p -118.79 114.43 44.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-O 121.409 0.623 . . . . 0.0 110.008 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.7 m -124.98 127.01 46.36 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.02 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 93.8 mt -63.29 -39.07 93.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.225 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -61.75 -39.32 91.19 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.258 0.552 . . . . 0.0 110.365 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -72.56 -30.11 64.14 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.465 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.66 14.94 80.87 Favored Glycine 0 C--O 1.236 0.255 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.036 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 89.7 p -156.17 164.4 38.42 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.56 134.78 55.07 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.926 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' A' ' 39' ' ' LYS . 53.4 m -94.54 124.32 38.5 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 177.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.608 ' O ' ' HA ' ' A' ' 8' ' ' THR . 28.9 m -107.86 142.0 21.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.457 -177.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.461 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 87.7 tttt -131.58 104.58 7.03 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.478 -0.783 . . . . 0.0 108.926 178.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.523 ' CE2' ' HB ' ' A' ' 49' ' ' VAL . 64.5 m-85 -140.25 160.38 40.09 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.967 -177.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.0 t -80.44 117.08 66.08 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.612 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 30.1 Cg_endo -62.28 -25.83 76.92 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.142 2.561 . . . . 0.0 113.096 -176.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.8 t -62.94 -41.57 99.53 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.054 0.454 . . . . 0.0 110.334 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.1 t -87.53 -49.81 14.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.3 -177.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.612 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 28.5 m -132.82 161.68 41.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.484 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 31.1 p -133.74 169.72 16.63 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 120.679 0.276 . . . . 0.0 110.899 -178.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.1 mt -62.6 -38.59 90.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.51 -177.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -60.32 -44.49 95.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.43 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.495 ' O ' ' HG3' ' A' ' 64' ' ' GLN . 97.0 mt-30 -64.42 -41.06 96.82 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.104 178.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 73.6 t -62.08 -46.13 97.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 CA-C-O 121.133 0.492 . . . . 0.0 110.353 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.504 ' SG ' ' HB ' ' A' ' 74' ' ' ILE . 93.8 m -62.78 -39.71 95.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.848 178.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -62.47 -41.64 98.92 Favored 'General case' 0 C--O 1.206 -1.226 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.052 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 60' ' ' GLN . 78.5 mt-30 -60.39 -42.42 95.87 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -175.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.428 ' HB ' HD12 ' A' ' 25' ' ' ILE . 17.4 tt -76.77 -40.95 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.571 178.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.578 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -63.33 -38.33 96.26 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 121.334 -0.46 . . . . 0.0 112.381 178.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -58.72 -33.59 70.38 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 124.261 1.024 . . . . 0.0 110.509 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.492 ' HG3' ' HB3' ' A' ' 24' ' ' SER . 96.6 mmm -79.09 -1.32 35.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.936 -178.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.17 15.55 44.26 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.149 -1.024 . . . . 0.0 113.589 177.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.578 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 99.3 m-85 -113.8 145.86 40.79 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.788 0.328 . . . . 0.0 110.354 178.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -88.52 130.75 35.16 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 120.983 0.421 . . . . 0.0 111.028 -178.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.46 140.2 24.85 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.644 178.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.7 m -127.0 141.49 51.78 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.1 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.504 ' HB ' ' SG ' ' A' ' 62' ' ' CYS . 10.2 tp -98.33 136.32 29.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 120.859 0.361 . . . . 0.0 110.498 -177.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -154.43 159.35 41.02 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.23 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 . . . . . 0 C--O 1.252 1.198 0 CA-C-O 118.152 -0.928 . . . . 0.0 110.721 179.094 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.569 ' HA ' ' OE1' ' A' ' 5' ' ' GLN . . . . . . . . 0 N--CA 1.467 0.39 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -157.86 174.91 35.21 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.117 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -83.69 129.0 34.95 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.7 ttt 55.04 48.66 19.29 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -176.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.569 ' OE1' ' HA ' ' A' ' 1' ' ' ALA . 53.6 tt0 -70.67 123.79 22.73 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.576 -177.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.7 t -126.7 129.27 71.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.875 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.01 134.11 44.5 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.137 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 69.8 p -123.73 137.52 54.68 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.855 178.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 72.7 m -147.11 157.3 43.56 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.448 178.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 38.4 p -110.01 139.23 45.35 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 177.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.453 ' CG2' ' HB1' ' A' ' 72' ' ' ALA . 7.0 p -129.74 119.69 48.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-O 120.967 0.413 . . . . 0.0 110.205 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.526 ' HG2' ' HB2' ' A' ' 73' ' ' SER . 9.2 ptm180 -82.21 148.79 28.24 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.9 pt -112.81 142.66 24.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 121.278 0.561 . . . . 0.0 111.123 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 67.1 tp -132.69 119.74 20.78 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.166 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.414 ' HA3' ' HD1' ' A' ' 70' ' ' PHE . . . 178.41 174.41 44.64 Favored Glycine 0 N--CA 1.436 -1.305 0 C-N-CA 119.27 -1.443 . . . . 0.0 113.831 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 28.1 ttt -62.06 -48.13 81.6 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 122.987 0.515 . . . . 0.0 111.426 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.4 p -128.86 119.34 24.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.066 0.46 . . . . 0.0 111.297 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.8 m -65.47 -39.02 91.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.118 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -63.42 -39.47 94.58 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.449 -177.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.8 m -62.67 -43.73 98.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.543 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.0 p -71.83 -39.65 69.64 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -178.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.7 m -69.99 -33.02 53.57 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 120.291 -0.563 . . . . 0.0 111.051 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -71.09 -42.28 69.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.111 0.482 . . . . 0.0 110.863 177.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.5 m -62.73 -43.55 98.51 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.041 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.574 ' HB ' ' CG2' ' A' ' 65' ' ' ILE . 19.3 tt -71.56 -29.71 35.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.618 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -59.63 -45.16 92.8 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.559 -177.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -61.97 -50.8 70.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.795 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.514 HH11 ' HA ' ' A' ' 64' ' ' GLN . 99.4 mtt180 -65.47 -39.95 92.57 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -177.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.444 HG23 HG21 ' A' ' 35' ' ' ILE . 27.6 mm -60.99 -44.56 98.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.99 0.424 . . . . 0.0 110.328 176.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.7 t -62.54 -39.93 95.18 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.385 178.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -68.56 -28.78 67.26 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.006 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 64.4 tp -100.38 118.13 35.99 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.133 0.492 . . . . 0.0 111.478 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -83.22 153.05 24.92 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.056 178.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.501 ' HA3' HG11 ' A' ' 55' ' ' VAL . . . 118.29 -11.4 12.86 Favored Glycine 0 CA--C 1.499 -0.91 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -176.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.444 HG21 HG23 ' A' ' 29' ' ' ILE . 12.6 tt -108.42 110.43 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 173.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.14 -47.03 95.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.864 -174.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 85.0 p -158.85 160.57 36.33 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.479 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 28.0 ttt -146.69 129.87 16.54 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.554 177.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -121.3 139.76 52.98 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.6 m -116.52 140.27 39.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 120.873 0.368 . . . . 0.0 110.894 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.6 t -119.64 106.81 12.53 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.778 178.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.8 mp -64.65 -39.72 94.17 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.271 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -62.3 -44.98 95.26 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.501 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -75.71 -28.68 58.68 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.048 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.21 25.62 65.83 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -176.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 12' ' ' ARG . 45.4 t -145.32 150.98 37.59 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.079 -0.56 . . . . 0.0 110.034 -176.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.04 145.88 45.51 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.361 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 87.2 m -105.82 126.02 51.67 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 8' ' ' THR . 23.7 m -110.6 138.3 39.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-O 120.966 0.412 . . . . 0.0 110.382 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -128.43 108.08 10.26 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -149.19 165.99 30.17 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.029 0.442 . . . . 0.0 112.035 -171.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 52.1 t -79.72 119.8 77.99 Favored Pre-proline 0 C--N 1.319 -0.741 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 174.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -60.68 -32.21 92.92 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.649 2.232 . . . . 0.0 113.281 -174.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.6 t -65.06 -41.93 94.67 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.001 0.429 . . . . 0.0 110.934 178.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.501 HG11 ' HA3' ' A' ' 34' ' ' GLY . 60.0 t -81.42 -46.04 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -175.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 74.0 t -114.75 133.88 59.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -173.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 29.1 p -109.25 147.95 31.77 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.285 177.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.494 HD13 HG21 ' A' ' 74' ' ' ILE . 87.1 mt -64.56 -40.3 95.32 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -176.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -62.6 -39.72 94.65 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -177.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.446 HE21 ' HB3' ' A' ' 60' ' ' GLN . 1.1 tm0? -61.85 -41.6 98.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.961 0.41 . . . . 0.0 109.999 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.428 HG13 HD11 ' A' ' 25' ' ' ILE . 76.4 t -63.31 -44.49 99.12 Favored 'Isoleucine or valine' 0 C--O 1.247 0.924 0 CA-C-O 121.47 0.652 . . . . 0.0 110.403 177.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 97.2 m -61.65 -38.31 87.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.15 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 61.4 m170 -66.87 -26.17 66.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.088 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.514 ' HA ' HH11 ' A' ' 28' ' ' ARG . 78.8 mt-30 -60.73 -43.65 97.63 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 120.79 0.328 . . . . 0.0 110.432 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.638 HD11 ' HB2' ' A' ' 72' ' ' ALA . 36.6 pt -87.65 -25.89 5.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.251 176.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -61.5 -35.96 91.86 Favored Glycine 0 N--CA 1.453 -0.22 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.467 178.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -58.83 -37.43 76.41 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.856 0.36 . . . . 0.0 110.935 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 26.4 mmt -79.63 1.2 27.08 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.733 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.9 10.3 60.1 Favored Glycine 0 CA--C 1.508 -0.404 0 C-N-CA 120.604 -0.808 . . . . 0.0 113.035 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.458 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 72.2 m-85 -98.84 139.14 34.95 Favored 'General case' 0 C--N 1.315 -0.901 0 O-C-N 122.645 -0.326 . . . . 0.0 110.235 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -100.75 151.15 22.01 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.353 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.638 ' HB2' HD11 ' A' ' 65' ' ' ILE . . . -144.93 156.69 44.12 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 120.782 0.325 . . . . 0.0 111.242 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.526 ' HB2' ' HG2' ' A' ' 12' ' ' ARG . 40.4 m -129.19 146.8 51.04 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.494 HG21 HD13 ' A' ' 58' ' ' LEU . 84.2 mt -101.95 127.18 55.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.238 0.542 . . . . 0.0 111.947 -174.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -128.52 157.14 42.0 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.135 177.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 . . . . . 0 C--O 1.242 0.678 0 C-N-CA 123.37 0.668 . . . . 0.0 110.283 -176.985 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.01 137.13 29.5 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.233 -0.984 . . . . 0.0 110.896 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -91.78 124.35 35.85 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.997 0.427 . . . . 0.0 111.12 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 98.5 mmm -89.51 138.14 31.72 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.263 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -85.34 137.27 33.06 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.629 -0.429 . . . . 0.0 110.263 178.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.473 HG11 HD12 ' A' ' 36' ' ' ILE . 61.8 t -95.29 120.31 44.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.78 148.05 25.36 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.768 -175.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.8 p -100.64 136.05 41.11 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.174 176.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.3 m -126.8 145.86 50.47 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 120.704 0.288 . . . . 0.0 110.227 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 46.5 p -117.16 140.1 49.94 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.347 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.91 126.76 38.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.447 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.494 ' HG2' ' HB3' ' A' ' 73' ' ' SER . 14.7 ptm180 -83.42 149.17 26.84 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.721 HG21 ' SG ' ' A' ' 21' ' ' CYS . 86.0 mt -123.1 130.51 74.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -176.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.7 tp -131.61 119.07 20.93 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -173.42 -177.27 42.53 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.247 -0.977 . . . . 0.0 112.403 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 66.8 mtt -63.78 -43.22 97.01 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.6 m -136.6 116.91 13.58 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.633 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.416 ' O ' HG23 ' A' ' 22' ' ' VAL . 94.1 m -65.57 -40.23 92.56 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.729 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -62.82 -40.87 98.74 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -177.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.9 m -62.5 -44.27 96.79 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -177.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.721 ' SG ' HG21 ' A' ' 13' ' ' ILE . 24.5 p -71.38 -35.73 71.18 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.64 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 18' ' ' CYS . 59.0 t -62.76 -44.22 99.33 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 177.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.96 -40.25 97.14 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.114 177.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.7 t -60.63 -47.64 85.32 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.295 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.6 pt -74.25 -29.4 24.63 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.899 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -59.53 -48.83 80.13 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -65.41 -51.18 62.09 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.306 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -62.27 -50.71 70.61 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-O 121.192 0.52 . . . . 0.0 111.631 -174.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.448 ' CG2' HD12 ' A' ' 35' ' ' ILE . 37.4 mm -62.83 -41.98 94.63 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.929 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.752 179.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 73.2 m -60.56 -38.81 85.74 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -68.52 -27.17 65.87 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.035 177.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 60.5 tp -87.25 129.69 34.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.148 0.499 . . . . 0.0 110.966 177.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -70.81 151.88 44.33 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.354 177.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.95 -4.97 18.55 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.881 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.448 HD12 ' CG2' ' A' ' 29' ' ' ILE . 9.3 tt -96.14 138.32 21.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.84 0.353 . . . . 0.0 110.899 178.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.473 HD12 HG11 ' A' ' 6' ' ' VAL . 86.4 mt -113.02 -53.31 5.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.793 176.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.9 m -137.52 151.72 48.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.889 0.376 . . . . 0.0 111.694 -177.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.45 ' HG3' HG12 ' A' ' 49' ' ' VAL . 60.6 ttm -139.14 131.21 27.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.394 176.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -128.79 124.54 35.7 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.9 m -126.61 140.0 50.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.381 -179.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.4 t -134.74 108.3 7.91 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.973 177.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.5 mp -66.5 -32.57 74.01 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.643 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -61.74 -39.92 93.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.283 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -75.41 -27.39 59.01 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.06 0.457 . . . . 0.0 110.14 176.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.2 15.47 81.0 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 -177.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 12' ' ' ARG . 51.1 m -135.13 153.69 51.91 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 121.085 0.469 . . . . 0.0 110.627 -178.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.66 139.19 51.91 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.498 178.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 79.6 m -115.18 125.5 53.48 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.45 HG12 ' HG3' ' A' ' 38' ' ' MET . 31.5 m -125.58 148.05 30.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.977 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -124.1 116.53 22.92 Favored 'General case' 0 C--O 1.245 0.838 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.58 ' CD2' ' HB ' ' A' ' 56' ' ' VAL . 55.3 p90 -152.61 166.15 32.99 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.474 -173.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.8 t -77.5 117.99 69.09 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.03 -30.37 82.85 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.769 2.313 . . . . 0.0 113.546 -175.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.3 t -64.78 -44.19 90.8 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.039 0.447 . . . . 0.0 110.828 178.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 90.9 t -72.7 -47.17 51.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.71 -177.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.58 ' HB ' ' CD2' ' A' ' 51' ' ' TYR . 58.3 t -112.63 126.3 70.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.093 -177.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 60' ' ' GLN . 28.6 p -100.92 158.35 16.05 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 120.989 0.423 . . . . 0.0 111.473 -178.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.3 mt -63.41 -39.12 93.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.576 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -62.19 -39.93 94.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.671 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.49 ' HB2' ' SG ' ' A' ' 57' ' ' CYS . 64.9 tt0 -61.16 -46.55 90.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.627 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.5 t -61.93 -44.44 98.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.625 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 93.3 m -61.66 -41.46 97.56 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.089 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -66.04 -41.13 91.28 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.759 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.489 ' HG3' ' O ' ' A' ' 60' ' ' GLN . 95.6 mt-30 -60.87 -42.24 97.51 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.985 -175.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.0 tt -84.04 -41.23 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.98 -40.18 98.99 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 116.303 -0.408 . . . . 0.0 113.501 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -60.51 -35.82 76.88 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.936 0.398 . . . . 0.0 110.571 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 26.5 mmt -69.76 -11.95 61.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.468 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.98 12.21 32.44 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.394 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.529 ' CG ' ' HB3' ' A' ' 21' ' ' CYS . 94.9 m-85 -110.32 125.48 53.22 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -76.96 139.11 40.02 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.624 -178.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.13 155.18 41.94 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 120.889 0.376 . . . . 0.0 111.603 -177.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.494 ' HB3' ' HG2' ' A' ' 12' ' ' ARG . 42.0 t -137.29 139.95 41.24 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 36.4 pt -105.67 151.82 7.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -173.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.547 ' O ' ' HB2' ' A' ' 76' ' ' GLU . . . -151.35 160.26 43.86 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.7 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.547 ' HB2' ' O ' ' A' ' 75' ' ' ALA . 39.5 mm-40 . . . . . 0 C--O 1.251 1.148 0 C-N-CA 123.3 0.64 . . . . 0.0 110.879 -178.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.622 0 CA-C-O 120.632 0.253 . . . . 0.0 110.375 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -123.56 166.29 16.08 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.524 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -67.64 149.74 49.66 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.622 0.248 . . . . 0.0 110.356 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -66.71 116.88 8.1 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.021 0.438 . . . . 0.0 110.966 -178.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -65.24 -37.84 88.49 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.663 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.5 m -107.77 150.58 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.587 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.98 147.27 42.44 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.103 0.478 . . . . 0.0 111.885 -175.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 53.9 p -119.35 150.15 40.64 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.715 176.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.429 ' OG ' HD21 ' A' ' 58' ' ' LEU . 87.5 p -155.34 160.35 40.66 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.314 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 41.2 p -127.77 146.09 50.7 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.538 176.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.5 m -128.92 146.19 34.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.459 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 38.5 ptt180 -106.67 140.99 38.65 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.535 HG12 ' SG ' ' A' ' 21' ' ' CYS . 7.8 tp -120.08 131.51 72.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-O 121.679 0.752 . . . . 0.0 112.424 -173.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 65.7 tp -124.67 118.19 25.93 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.52 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -170.01 169.32 42.09 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 119.938 -1.125 . . . . 0.0 112.733 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 79.3 mtm -64.09 -42.81 96.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.786 0.327 . . . . 0.0 111.377 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.7 p -132.52 122.54 25.01 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.193 0.52 . . . . 0.0 111.57 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.402 ' O ' HG23 ' A' ' 22' ' ' VAL . 44.1 t -63.6 -41.9 98.28 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.141 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.8 mp0 -61.51 -40.42 94.54 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.295 -176.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.7 m -62.84 -45.59 91.9 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -177.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.535 ' SG ' HG12 ' A' ' 13' ' ' ILE . 26.7 p -68.71 -35.66 77.46 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.178 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 18' ' ' CYS . 67.6 t -62.91 -44.32 99.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-O 121.114 0.483 . . . . 0.0 109.759 178.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -64.81 -40.13 94.71 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.012 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.6 m -62.74 -46.65 87.08 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.376 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.547 ' HB ' ' CG2' ' A' ' 65' ' ' ILE . 8.1 tp -69.9 -31.94 49.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.009 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -58.84 -42.81 90.16 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.316 -178.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -59.3 -53.57 56.75 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.418 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 24.0 ttm180 -67.14 -47.15 71.93 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.118 -178.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.578 ' O ' HD11 ' A' ' 35' ' ' ILE . 18.5 tt -65.76 -41.43 90.29 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.987 -175.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 86.6 p -66.33 -30.09 70.42 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-O 121.062 0.458 . . . . 0.0 110.488 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -70.62 -27.09 63.81 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.841 177.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 28' ' ' ARG . 89.9 mt -91.72 137.63 32.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.189 0.518 . . . . 0.0 111.775 -178.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -86.72 151.62 23.24 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.841 177.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.58 8.22 12.71 Favored Glycine 0 C--O 1.238 0.369 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.658 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.578 HD11 ' O ' ' A' ' 29' ' ' ILE . 79.8 mt -81.67 121.98 35.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 83.6 mt -94.24 -54.77 6.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.0 t -149.06 124.21 10.12 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.97 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.429 ' SD ' HD13 ' A' ' 29' ' ' ILE . 27.2 ttt -121.24 113.58 20.16 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.125 177.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -133.29 145.68 50.69 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.139 178.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.45 126.51 74.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.222 0.534 . . . . 0.0 110.089 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.8 m -93.65 91.99 7.31 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.152 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.8 mt -63.54 -35.98 82.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.603 0.716 . . . . 0.0 109.235 178.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -62.84 -40.28 96.95 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.844 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -90.33 -12.19 38.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.046 -177.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.5 29.69 69.64 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.379 -0.915 . . . . 0.0 111.471 -177.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 90.1 p -151.06 163.66 38.25 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.48 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -119.07 145.83 45.59 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.533 0.206 . . . . 0.0 110.82 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.3 m -112.93 121.95 46.18 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.0 t -120.49 123.19 69.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-O 120.884 0.373 . . . . 0.0 110.371 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -109.2 119.38 39.35 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 176.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -150.77 166.68 29.72 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.697 -170.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.9 t -92.05 110.82 46.62 Favored Pre-proline 0 N--CA 1.444 -0.755 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 173.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 37.6 Cg_endo -64.27 -21.72 67.02 Favored 'Trans proline' 0 N--CA 1.475 0.427 0 C-N-CA 122.88 2.387 . . . . 0.0 113.467 -175.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.5 t -64.37 -42.71 96.04 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.173 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.8 p -95.11 -35.71 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 12.2 p -130.14 149.89 34.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -177.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 29.6 p -134.01 163.06 30.39 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.19 0.519 . . . . 0.0 111.663 -175.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.446 ' HA ' HG22 ' A' ' 61' ' ' VAL . 98.6 mt -70.8 -22.53 62.34 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.982 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -61.73 -42.3 98.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.07 0.462 . . . . 0.0 110.14 -179.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -65.15 -40.89 95.01 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.182 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.497 ' HB ' HD11 ' A' ' 25' ' ' ILE . 32.7 m -72.71 -36.4 52.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.53 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 95.6 m -64.18 -39.51 94.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.665 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 66.3 m170 -64.31 -39.94 94.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.314 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -60.83 -43.79 97.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.606 -177.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.547 ' CG2' ' HB ' ' A' ' 25' ' ' ILE . 27.2 pt -87.04 -37.87 11.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -178.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -62.94 -40.71 99.62 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.888 -0.673 . . . . 0.0 113.137 -178.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -70.13 -14.91 62.86 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 26.3 mmt -85.11 2.34 43.88 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.907 0.384 . . . . 0.0 110.817 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.48 -9.2 71.73 Favored Glycine 0 CA--C 1.507 -0.407 0 C-N-CA 121.066 -0.587 . . . . 0.0 112.188 179.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.459 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 96.8 m-85 -80.89 143.57 32.61 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -106.25 128.31 53.87 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.643 -177.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 12' ' ' ARG . . . -147.31 151.23 36.24 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.466 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.8 p -136.77 153.63 50.78 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.903 0.382 . . . . 0.0 111.341 178.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 81.3 mt -90.98 131.86 37.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.908 -174.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -133.67 126.54 31.02 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.454 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 . . . . . 0 C--N 1.314 -0.97 0 CA-C-O 118.062 -0.97 . . . . 0.0 110.657 179.691 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.615 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.6 -130.74 46.33 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.14 -177.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.436 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 63.0 m170 -90.11 152.67 21.02 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.84 0.352 . . . . 0.0 110.247 -179.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 96.2 mmm -70.84 -37.9 73.18 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.911 0.386 . . . . 0.0 111.026 175.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -67.0 -40.01 87.26 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.087 178.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.436 ' O ' ' HB2' ' A' ' 3' ' ' HIS . 7.6 p -139.45 125.89 23.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.409 ' H ' ' HD3' ' A' ' 53' ' ' PRO . . . -108.77 134.55 51.32 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.287 0.565 . . . . 0.0 112.27 -173.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 50.5 p -123.97 140.5 52.92 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.976 174.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 91.3 p -158.46 166.85 31.2 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.019 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 2.1 p -110.32 148.48 31.85 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 175.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 91.1 t -131.01 126.89 60.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.425 ' NE ' ' HB2' ' A' ' 73' ' ' SER . 37.9 ptt180 -87.8 144.62 26.51 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.6 HG12 ' SG ' ' A' ' 21' ' ' CYS . 7.4 tp -129.61 130.3 66.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-O 121.163 0.506 . . . . 0.0 111.134 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 62.0 tp -129.47 124.22 33.48 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.478 178.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -165.18 176.25 40.9 Favored Glycine 0 N--CA 1.435 -1.425 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.157 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 61.0 tpp -61.52 -47.91 83.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.884 0.373 . . . . 0.0 111.024 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 65.9 m -130.4 125.16 33.84 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.119 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.8 t -63.23 -43.59 97.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.396 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -61.52 -38.76 88.57 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.528 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.0 m -60.47 -44.21 96.12 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -177.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.6 ' SG ' HG12 ' A' ' 13' ' ' ILE . 25.6 p -70.99 -36.95 72.68 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.235 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.9 t -63.18 -44.53 99.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-O 121.123 0.487 . . . . 0.0 109.764 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -64.41 -40.38 95.67 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.878 178.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.639 ' O ' ' HD3' ' A' ' 28' ' ' ARG . 68.9 m -62.11 -45.04 95.23 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.38 -178.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.468 ' HB ' ' HB ' ' A' ' 65' ' ' ILE . 17.9 tt -70.93 -33.77 53.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.849 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -60.22 -48.01 83.54 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.934 -177.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -61.55 -46.69 88.86 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.887 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.639 ' HD3' ' O ' ' A' ' 24' ' ' SER . 10.9 mpt_? -70.41 -41.75 72.53 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.754 -177.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.6 ' O ' HD11 ' A' ' 35' ' ' ILE . 16.6 tt -70.66 -39.81 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.163 -177.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 79.5 p -66.06 -28.33 68.76 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 120.988 0.423 . . . . 0.0 110.515 178.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -67.96 -28.76 67.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.793 175.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.4 tp -86.95 118.66 26.48 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.655 177.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -78.58 142.9 36.94 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.949 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.22 8.86 11.03 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.815 -178.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.6 HD11 ' O ' ' A' ' 29' ' ' ILE . 90.0 mt -70.75 125.12 28.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.642 ' HB ' ' O ' ' A' ' 50' ' ' LYS . 47.9 mm -88.21 -63.85 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.1 t -161.82 140.11 9.21 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.805 177.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.435 ' HG2' HG12 ' A' ' 49' ' ' VAL . 18.8 tmm? -137.27 126.37 24.46 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 176.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -125.14 115.68 20.84 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.2 p -103.16 122.32 55.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-O 121.172 0.51 . . . . 0.0 110.296 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.4 m -96.89 99.95 11.49 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 97.1 mt -63.9 -38.89 92.75 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.937 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -63.69 -40.25 96.32 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.978 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -77.1 -30.01 55.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.9 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.68 20.17 71.8 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -175.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.0 t -146.5 150.36 35.43 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -178.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 10' ' ' THR . . . -119.53 148.77 42.9 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 120.804 0.335 . . . . 0.0 111.735 -177.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.2 m -108.35 124.48 50.41 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.691 ' HB ' ' CE2' ' A' ' 51' ' ' TYR . 33.6 m -119.32 149.6 21.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.621 -176.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.642 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 65.3 tttm -140.05 106.36 5.27 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.691 ' CE2' ' HB ' ' A' ' 49' ' ' VAL . 42.2 m-85 -138.37 161.92 35.73 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -177.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 64.8 t -88.34 110.41 36.09 Favored Pre-proline 0 N--CA 1.439 -1.0 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 172.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 36.2 Cg_endo -64.21 -23.48 66.35 Favored 'Trans proline' 0 CA--C 1.514 -0.489 0 C-N-CA 122.592 2.195 . . . . 0.0 112.341 -176.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 61.9 m -62.95 -42.0 99.68 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 177.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.5 t -75.1 -48.42 32.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.826 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 7.5 p -146.68 139.54 19.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.954 -178.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.416 ' SG ' ' HB2' ' A' ' 60' ' ' GLN . 26.5 p -83.51 153.71 24.26 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.107 0.479 . . . . 0.0 111.196 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.1 mt -66.06 -37.26 85.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.759 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -60.04 -40.61 89.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.436 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.416 ' HB2' ' SG ' ' A' ' 57' ' ' CYS . 1.0 OUTLIER -62.14 -41.02 97.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.192 0.52 . . . . 0.0 109.633 179.12 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 73.9 t -63.41 -44.24 98.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.084 178.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 49.6 t -60.42 -41.52 94.14 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.146 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -61.07 -41.4 96.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.367 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -61.08 -41.65 97.04 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 -176.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.468 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 20.3 tt -76.89 -38.25 28.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.94 178.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.6 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -64.35 -38.49 95.9 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-N 115.699 -0.682 . . . . 0.0 113.702 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -58.1 -35.8 71.97 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.275 0.63 . . . . 0.0 112.081 -175.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 15.7 tpt -57.76 -25.82 61.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.786 -178.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 123.66 6.19 7.36 Favored Glycine 0 CA--C 1.5 -0.901 0 C-N-CA 120.229 -0.986 . . . . 0.0 112.188 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.6 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 65.2 m-85 -110.16 135.96 50.13 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -89.33 121.59 31.75 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.236 0.541 . . . . 0.0 111.751 -174.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.54 135.72 54.16 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.126 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.425 ' HB2' ' NE ' ' A' ' 12' ' ' ARG . 45.5 m -131.62 144.78 51.3 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.6 tt -69.45 128.18 32.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 121.47 0.652 . . . . 0.0 110.902 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -97.74 134.51 40.81 Favored 'General case' 0 C--O 1.261 1.673 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.657 177.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 . . . . . 0 C--O 1.249 1.058 0 O-C-N 124.832 1.333 . . . . 0.0 110.658 -176.155 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.702 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.86 32.14 73.51 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.663 -0.78 . . . . 0.0 111.358 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -61.75 132.15 52.23 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.041 0.448 . . . . 0.0 111.339 -176.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -139.21 155.1 48.04 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.94 178.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -64.8 -38.74 92.01 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -176.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.9 t -102.47 120.77 52.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -113.58 139.57 48.89 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 120.893 0.378 . . . . 0.0 111.23 -177.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 67.6 p -121.61 148.21 44.84 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.097 178.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.2 t -158.31 157.0 31.61 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 73.5 p -117.1 142.06 47.48 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 120.799 0.333 . . . . 0.0 110.335 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.9 m -131.89 145.8 34.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.364 178.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 45.8 ptt85 -108.86 142.95 38.71 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 175.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.7 pt -118.26 142.98 30.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-O 121.458 0.647 . . . . 0.0 112.006 -175.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.2 tp -110.12 118.44 36.41 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.728 177.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.44 140.04 4.15 Favored Glycine 0 N--CA 1.434 -1.495 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.349 179.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 95.9 mmm -67.97 -37.71 81.85 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.233 0.539 . . . . 0.0 109.924 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.0 p -111.22 58.16 0.62 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.883 177.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 26.3 p -59.56 -30.66 68.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.767 -175.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -64.49 -33.99 77.18 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.741 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.3 t -66.41 -45.34 80.29 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.439 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.531 ' HB3' ' CD1' ' A' ' 70' ' ' PHE . 28.4 p -66.05 -35.06 79.51 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.267 -177.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 69.9 t -61.81 -45.71 98.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -65.43 -42.24 92.66 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.947 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.3 m -63.97 -42.9 97.12 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.287 -178.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 21' ' ' CYS . 46.9 pt -78.56 -27.12 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.401 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -61.77 -39.45 91.68 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -59.98 -43.13 95.32 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.693 176.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -64.26 -43.31 95.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.185 0.517 . . . . 0.0 110.277 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.41 -46.25 96.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.603 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 88.1 p -64.62 -28.38 69.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.71 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -72.78 -27.35 61.94 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.927 0.394 . . . . 0.0 110.573 177.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.3 tt -81.74 123.88 29.13 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -83.38 147.48 27.87 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.778 0.323 . . . . 0.0 111.417 -177.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.31 7.67 56.93 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.774 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.8 pt -75.0 139.29 19.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.772 0.32 . . . . 0.0 111.176 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.621 ' HB ' ' O ' ' A' ' 50' ' ' LYS . 42.1 mm -89.19 -79.84 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.954 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 82.2 p -168.61 166.68 11.82 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.788 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -156.99 159.11 37.72 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 175.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -129.69 132.78 46.75 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 69.8 t -116.21 125.68 73.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 120.827 0.346 . . . . 0.0 110.789 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.6 t -103.34 102.48 12.43 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 177.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.6 tp -62.4 -42.72 99.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.765 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.2 -45.45 94.54 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.459 -178.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -74.96 -29.69 61.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.411 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.65 16.14 78.15 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.0 m -129.48 152.39 49.07 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.342 -0.429 . . . . 0.0 110.144 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -128.39 149.35 50.57 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.544 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.7 m -113.41 126.6 55.53 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.489 ' HB ' ' CE2' ' A' ' 51' ' ' TYR . 27.5 m -114.29 146.39 18.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.466 -177.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.621 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 87.6 tttt -132.2 104.17 6.63 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.489 ' CE2' ' HB ' ' A' ' 49' ' ' VAL . 84.5 m-85 -141.52 160.11 40.84 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 120.995 0.426 . . . . 0.0 111.853 -176.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.8 m -98.66 112.45 62.6 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.518 176.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -56.17 -26.62 61.54 Favored 'Trans proline' 0 N--CA 1.48 0.686 0 C-N-CA 123.265 2.643 . . . . 0.0 112.162 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.2 t -61.08 -42.27 98.2 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.274 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.9 t -101.22 -40.28 7.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -177.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.4 HG13 ' HB3' ' A' ' 51' ' ' TYR . 7.5 p -130.2 139.65 50.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.162 0.506 . . . . 0.0 111.488 -177.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.418 ' SG ' ' HB3' ' A' ' 59' ' ' GLN . 42.6 t -93.16 121.89 34.98 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.434 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.3 mp -63.76 -37.45 87.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.607 178.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.418 ' HB3' ' SG ' ' A' ' 57' ' ' CYS . 57.5 tp60 -60.76 -39.31 88.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.679 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -62.89 -38.56 91.39 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.32 178.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 75.6 t -60.83 -42.68 93.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.675 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 42.6 t -60.22 -39.61 87.23 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.937 176.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -64.15 -35.12 79.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.383 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -60.57 -42.24 96.25 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.484 -178.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.456 ' HB ' HG21 ' A' ' 25' ' ' ILE . 20.2 tt -76.55 -37.55 29.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 120.294 -0.563 . . . . 0.0 111.318 178.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.48 -44.24 97.88 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.452 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -67.18 -31.48 71.91 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.284 0.564 . . . . 0.0 110.297 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 50.1 tpp -59.23 -29.18 67.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.217 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 119.35 5.39 11.44 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.479 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.531 ' CD1' ' HB3' ' A' ' 21' ' ' CYS . 89.5 m-85 -112.78 131.04 55.86 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 120.977 0.418 . . . . 0.0 110.577 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -85.55 134.99 34.0 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.191 -177.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -133.19 147.6 52.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.836 0.35 . . . . 0.0 111.337 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.6 t -119.14 132.67 56.01 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 15.2 tt -103.49 134.19 45.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.502 0.668 . . . . 0.0 111.977 -175.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 76' ' ' GLU . . . -135.22 157.5 46.75 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.867 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.407 ' HB3' ' O ' ' A' ' 75' ' ' ALA . 43.2 tt0 . . . . . 0 C--O 1.245 0.854 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.628 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.919 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.24 -129.97 48.31 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.993 -0.623 . . . . 0.0 112.066 -178.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -81.77 124.81 29.96 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 63.3 mtt -87.13 97.29 10.67 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.172 0.51 . . . . 0.0 110.327 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.1 pm0 -77.28 161.02 28.44 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.377 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.6 t -105.32 119.3 54.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 120.895 0.379 . . . . 0.0 110.107 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 50' ' ' LYS . . . -121.43 123.94 43.3 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.494 179.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.8 p -125.62 151.82 45.99 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.055 0.455 . . . . 0.0 110.684 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.5 t -158.27 146.35 18.53 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.9 178.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 41.9 p -111.5 109.95 20.14 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 175.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.7 p -92.34 115.43 31.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 40.1 ptt180 -82.22 148.04 28.64 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.223 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.8 131.07 70.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-O 121.049 0.452 . . . . 0.0 110.861 -176.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.9 tt -115.16 115.11 26.21 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -171.25 151.91 16.79 Favored Glycine 0 N--CA 1.434 -1.492 0 C-N-CA 120.211 -0.995 . . . . 0.0 112.596 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 23.0 ptt? -74.98 -23.99 58.37 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 122.756 0.422 . . . . 0.0 111.295 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.5 p -122.48 85.57 2.44 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.284 0.564 . . . . 0.0 109.636 177.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.4 m -63.83 -39.98 95.52 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.303 -176.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.504 ' HA ' HG12 ' A' ' 22' ' ' VAL . 98.7 mt-30 -64.38 -41.0 96.93 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -175.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.0 p -64.9 -41.43 95.61 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.776 -177.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.598 ' HB3' ' CD2' ' A' ' 70' ' ' PHE . 20.3 p -74.46 -39.16 62.7 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.504 HG12 ' HA ' ' A' ' 19' ' ' GLN . 9.0 p -68.5 -37.68 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.61 -178.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -64.36 -40.76 96.5 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.978 0.418 . . . . 0.0 110.052 176.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.2 m -61.9 -44.72 96.22 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.671 -178.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.593 HD12 ' HB ' ' A' ' 65' ' ' ILE . 16.2 tt -74.19 -38.65 48.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.726 -0.389 . . . . 0.0 111.425 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.07 -44.29 96.99 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 120.85 0.357 . . . . 0.0 110.948 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -60.73 -44.08 97.1 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.586 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.587 ' HD3' ' NE2' ' A' ' 64' ' ' GLN . 99.4 mtt180 -65.33 -46.07 81.77 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.169 -177.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.541 HG22 HD12 ' A' ' 35' ' ' ILE . 98.0 mt -65.96 -44.8 92.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.092 -178.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.426 ' HA ' HG21 ' A' ' 35' ' ' ILE . 77.8 p -64.03 -34.58 78.32 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.032 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -71.81 -26.78 62.55 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.094 0.473 . . . . 0.0 110.74 177.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 28' ' ' ARG . 93.3 mt -82.9 142.32 31.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.543 178.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -76.79 141.21 40.83 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.16 -8.04 18.59 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.876 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.541 HD12 HG22 ' A' ' 29' ' ' ILE . 7.2 tt -75.24 110.1 9.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 176.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.9 mt -84.27 -51.19 14.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.278 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.9 t -160.38 145.75 14.89 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.522 177.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.414 ' HG3' HG12 ' A' ' 49' ' ' VAL . 27.3 ttt -135.85 132.16 36.26 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.088 179.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -130.34 130.82 44.94 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 178.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.1 t -103.92 120.36 53.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 120.836 0.35 . . . . 0.0 110.397 -178.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 51.0 m -119.73 96.46 5.2 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-O 121.467 0.651 . . . . 0.0 110.63 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.4 -35.41 80.82 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.259 -178.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -61.65 -39.63 92.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.535 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -76.76 -22.68 53.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.139 176.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.56 21.75 68.66 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 89.9 p -149.33 164.93 33.49 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 121.058 0.456 . . . . 0.0 111.326 -177.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.55 137.44 52.58 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 65.3 m -104.56 125.64 50.91 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.806 -177.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.414 HG12 ' HG3' ' A' ' 38' ' ' MET . 27.0 m -129.25 150.03 34.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-O 120.883 0.373 . . . . 0.0 111.369 -179.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 14.3 ptmm? -131.45 135.71 47.36 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 173.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -157.2 171.45 20.41 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.95 -169.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.6 t -94.16 114.25 62.77 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 173.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -52.99 -39.1 80.36 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 C-N-CA 123.628 2.886 . . . . 0.0 114.97 -174.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.8 m -69.02 -41.98 77.01 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.898 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.9 t -70.71 -43.51 77.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.708 -176.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 30.9 m -128.65 148.65 33.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.047 0.451 . . . . 0.0 110.766 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.533 ' SG ' ' HB2' ' A' ' 59' ' ' GLN . 43.5 t -102.23 128.32 48.8 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.563 -177.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.492 ' HG ' HD13 ' A' ' 74' ' ' ILE . 56.7 tp -61.51 -38.12 86.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.317 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.533 ' HB2' ' SG ' ' A' ' 57' ' ' CYS . 80.6 mt-30 -60.33 -39.53 87.4 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.524 178.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.698 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 97.8 mt-30 -61.75 -39.39 91.42 Favored 'General case' 0 C--O 1.214 -0.783 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.879 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.435 HG13 HD11 ' A' ' 25' ' ' ILE . 73.2 t -59.4 -46.3 92.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.243 -178.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 42.3 t -61.12 -42.36 98.4 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.089 177.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -67.42 -37.58 83.26 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.3 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.698 ' HG2' ' O ' ' A' ' 60' ' ' GLN . 13.6 mm100 -61.0 -41.46 96.55 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.958 0.409 . . . . 0.0 111.013 -175.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.593 ' HB ' HD12 ' A' ' 25' ' ' ILE . 18.8 tt -82.52 -33.11 10.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.664 177.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.85 -40.84 98.78 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.798 -0.637 . . . . 0.0 114.025 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -72.8 -11.4 60.59 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 117.797 0.799 . . . . 0.0 110.961 -177.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 16.4 tpt -66.02 -28.6 68.99 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.764 176.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 116.52 9.14 11.69 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.806 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.598 ' CD2' ' HB3' ' A' ' 21' ' ' CYS . 98.3 m-85 -117.79 145.29 44.63 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -84.71 133.16 34.39 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.48 -177.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 12' ' ' ARG . . . -147.71 150.2 33.86 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.934 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 86.0 p -140.69 158.92 43.27 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.615 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.492 HD13 ' HG ' ' A' ' 58' ' ' LEU . 91.4 mt -91.2 122.69 42.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.053 -177.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -133.17 160.93 35.79 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 C--N 1.305 -1.35 0 CA-C-O 118.133 -0.937 . . . . 0.0 110.595 178.663 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.741 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 91.61 -1.72 76.05 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.668 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -89.73 143.79 26.51 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 110.27 -0.271 . . . . 0.0 110.27 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.8 mmt -99.11 154.28 18.24 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.072 0.463 . . . . 0.0 112.243 -175.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.489 ' O ' ' HD2' ' A' ' 53' ' ' PRO . 30.0 pt20 -63.74 -18.95 64.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.458 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.455 HG13 ' HG3' ' A' ' 5' ' ' GLN . 25.0 m -128.66 150.85 34.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.006 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -143.79 152.85 41.75 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.76 0.314 . . . . 0.0 110.61 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 82.7 p -127.3 154.91 44.34 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.613 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.444 ' HB3' HG13 ' A' ' 49' ' ' VAL . 14.8 t -159.02 164.2 35.72 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 53.1 p -118.11 144.68 45.45 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.5 p -143.71 129.47 15.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 120.921 0.391 . . . . 0.0 111.098 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 15.8 ptm180 -89.06 146.92 24.53 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.6 mp -111.43 120.63 62.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 59.5 tp -114.71 112.71 23.26 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.991 0.424 . . . . 0.0 110.559 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -167.41 157.59 30.06 Favored Glycine 0 N--CA 1.44 -1.068 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.197 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 59.6 ttm -64.6 -43.02 95.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.992 0.425 . . . . 0.0 110.813 178.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.1 p -113.01 108.33 17.19 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.792 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 23.8 p -69.88 -41.23 75.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.105 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -63.94 -41.53 97.59 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.836 0.351 . . . . 0.0 111.035 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.6 t -61.5 -46.37 90.25 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.835 -177.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.461 ' HB3' ' CG ' ' A' ' 70' ' ' PHE . 20.1 p -67.33 -44.11 79.9 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.565 -178.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 73.7 t -62.79 -46.09 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.557 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.66 -44.86 95.19 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.2 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.4 m -63.49 -43.4 97.38 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.254 -177.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.464 HG21 ' HB ' ' A' ' 65' ' ' ILE . 46.3 pt -74.32 -29.18 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.765 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -60.78 -41.98 96.63 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.052 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -60.99 -45.26 95.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.264 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -63.09 -42.37 99.61 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.181 0.515 . . . . 0.0 109.9 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.556 ' O ' HD11 ' A' ' 35' ' ' ILE . 92.9 mt -61.44 -46.22 97.04 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.716 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.693 178.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 85.2 p -63.97 -23.21 67.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.856 0.36 . . . . 0.0 111.539 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -92.46 -6.08 50.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.892 0.377 . . . . 0.0 110.768 177.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 67.7 tp -103.3 128.04 50.46 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.159 178.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -85.44 153.94 22.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.689 0.28 . . . . 0.0 111.09 176.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.42 8.83 22.64 Favored Glycine 0 C--O 1.239 0.427 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -177.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.556 HD11 ' O ' ' A' ' 29' ' ' ILE . 74.9 mt -72.65 123.63 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 115.19 -0.505 . . . . 0.0 110.871 -177.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 80.5 mt -101.23 -68.15 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 172.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.541 ' O ' ' HB3' ' A' ' 50' ' ' LYS . 34.7 t -166.1 140.14 4.36 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.748 177.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.7 ttt -136.23 127.69 28.58 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 176.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.496 ' HE3' ' OG ' ' A' ' 37' ' ' SER . 34.4 mmtp -119.53 129.47 54.7 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.3 t -106.47 118.47 54.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.5 m -98.86 98.12 9.24 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.921 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.1 tp -62.49 -42.05 99.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.393 -179.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -62.0 -41.19 97.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.281 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -75.83 -30.33 58.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.591 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.45 15.05 79.11 Favored Glycine 0 N--CA 1.454 -0.142 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -176.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 12' ' ' ARG . 39.8 t -145.12 150.59 37.07 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -178.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.57 151.44 47.92 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.808 0.337 . . . . 0.0 111.043 -177.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.4 p -95.15 125.44 39.8 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.295 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.444 HG13 ' HB3' ' A' ' 9' ' ' SER . 3.0 p -105.91 118.66 53.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.281 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.541 ' HB3' ' O ' ' A' ' 37' ' ' SER . 60.1 tttm -136.33 104.3 5.57 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.621 0.724 . . . . 0.0 109.968 -176.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.538 ' CD2' ' HA ' ' A' ' 35' ' ' ILE . 87.0 m-85 -139.43 162.96 33.77 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.329 -176.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 54.6 t -74.94 114.85 38.84 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 37.2 Cg_endo -65.02 -18.59 62.47 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.081 2.521 . . . . 0.0 112.327 -177.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 61.4 m -61.6 -39.36 90.92 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.659 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.459 HG23 HG23 ' A' ' 56' ' ' VAL . 18.8 m -116.69 -25.76 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -178.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 96.9 t -127.28 128.93 70.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.728 0.299 . . . . 0.0 110.77 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.524 ' SG ' ' HB2' ' A' ' 60' ' ' GLN . 25.9 p -105.96 161.55 14.36 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 178.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.59 -40.24 96.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.446 -177.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -63.27 -37.4 87.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.281 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.524 ' HB2' ' SG ' ' A' ' 57' ' ' CYS . 54.7 tt0 -59.92 -45.78 91.49 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.287 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.457 ' HA ' ' OE1' ' A' ' 64' ' ' GLN . 75.1 t -63.14 -42.34 96.18 Favored 'Isoleucine or valine' 0 C--O 1.25 1.128 0 CA-C-O 121.768 0.794 . . . . 0.0 110.309 178.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 43.3 t -58.47 -35.49 72.25 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.191 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.406 ' HB2' ' O ' ' A' ' 60' ' ' GLN . 58.8 m170 -60.24 -43.98 95.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.182 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.473 ' O ' ' HG2' ' A' ' 68' ' ' MET . 25.7 mp0 -63.05 -42.23 99.68 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.929 -177.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.464 ' HB ' HG21 ' A' ' 25' ' ' ILE . 19.9 tt -71.3 -37.83 67.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.072 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.32 -39.85 98.29 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.9 -0.591 . . . . 0.0 113.36 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -80.15 -5.99 56.98 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 117.446 0.623 . . . . 0.0 111.555 -177.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 23.1 mmt -83.72 -3.16 57.56 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.038 0.447 . . . . 0.0 110.447 176.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.67 8.1 62.52 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.282 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.461 ' CG ' ' HB3' ' A' ' 21' ' ' CYS . 99.2 m-85 -113.4 143.06 45.12 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 120.979 0.419 . . . . 0.0 110.292 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -101.1 148.04 25.53 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.99 -175.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.92 151.48 35.92 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.114 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.41 ' HB2' ' HG2' ' A' ' 12' ' ' ARG . 60.7 m -123.53 141.51 51.93 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 176.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.0 tt -117.33 141.27 36.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 121.111 0.481 . . . . 0.0 111.337 -174.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 76' ' ' GLU . . . -138.08 154.71 49.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.604 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.446 ' HB3' ' O ' ' A' ' 75' ' ' ALA . 34.8 tt0 . . . . . 0 N--CA 1.474 0.758 0 C-N-CA 123.636 0.775 . . . . 0.0 109.926 -175.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.757 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -78.91 171.46 55.11 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.576 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -73.56 141.75 46.66 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.549 0.214 . . . . 0.0 110.693 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 64.3 mtt 57.48 27.03 13.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.399 -178.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 -75.09 112.95 11.86 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 121.213 0.53 . . . . 0.0 110.096 178.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 70.4 t -101.99 118.78 49.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -127.59 149.6 50.09 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.005 0.431 . . . . 0.0 111.21 -177.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 56.4 p -103.57 156.02 18.09 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.821 178.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.6 t -154.34 143.95 21.55 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 62.5 p -118.59 144.02 46.4 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.12 123.22 55.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-O 120.91 0.386 . . . . 0.0 110.489 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.519 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 39.7 ptt180 -90.08 151.2 21.73 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.084 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.9 pt -126.58 144.5 36.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-O 121.187 0.517 . . . . 0.0 111.775 -177.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.9 tp -131.21 113.66 14.12 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.331 177.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -176.23 160.3 28.02 Favored Glycine 0 N--CA 1.439 -1.135 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 96.1 mmm -68.17 -40.24 82.36 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.854 0.359 . . . . 0.0 110.857 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.8 p -110.14 80.25 1.29 Allowed 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.448 0.642 . . . . 0.0 110.478 177.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.41 ' O ' HG23 ' A' ' 22' ' ' VAL . 21.8 p -67.02 -34.55 77.96 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.479 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -63.28 -39.44 94.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.11 0.481 . . . . 0.0 110.295 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.0 t -60.67 -45.73 93.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.579 -178.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 27.7 p -70.01 -33.29 71.82 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.365 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 18' ' ' CYS . 67.1 t -63.27 -45.11 99.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-O 121.412 0.625 . . . . 0.0 109.464 177.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -67.14 -35.18 79.17 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.327 177.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.3 t -60.19 -46.59 89.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.619 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.523 HD12 ' HB ' ' A' ' 65' ' ' ILE . 18.8 tt -70.99 -29.25 36.29 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.892 177.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -57.85 -49.35 76.98 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.214 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -62.52 -42.83 99.77 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.121 178.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.5 tpt180 -64.27 -47.61 78.88 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.496 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.561 HG21 ' SD ' ' A' ' 38' ' ' MET . 19.5 tt -71.01 -36.71 64.6 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.696 -177.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 77.6 p -67.72 -25.41 65.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.36 . . . . 0.0 111.257 177.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -85.37 -12.05 53.08 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.12 0.486 . . . . 0.0 110.231 175.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 64.9 tp -84.18 122.93 29.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.511 175.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -83.38 152.98 24.79 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 120.994 0.425 . . . . 0.0 111.587 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.51 6.01 64.59 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.441 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 39.7 pt -69.15 126.79 29.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 121.337 0.589 . . . . 0.0 111.576 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' A' ' 50' ' ' LYS . 86.3 mt -82.09 -61.81 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.492 -179.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.421 ' OG ' ' HE2' ' A' ' 50' ' ' LYS . 87.1 p -159.43 154.34 24.78 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.993 178.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.561 ' SD ' HG21 ' A' ' 29' ' ' ILE . 27.0 ttt -140.79 134.45 30.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.843 177.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -133.59 148.94 51.62 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.1 p -126.31 134.01 67.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 C-N-CA 119.796 -0.762 . . . . 0.0 111.792 -178.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.5 m -108.66 85.75 2.16 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.327 -0.852 . . . . 0.0 108.843 177.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.9 tp -61.64 -43.09 99.5 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.32 -176.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -70.11 -28.18 65.18 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.063 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -84.92 -12.42 53.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.649 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.4 28.03 71.84 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.88 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 79.6 p -148.2 161.02 42.31 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.076 0.465 . . . . 0.0 111.454 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.75 149.2 42.41 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.839 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.7 m -117.12 126.39 52.75 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.3 p -129.32 139.31 52.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 120.868 0.366 . . . . 0.0 110.761 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.444 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 39.6 ttpt -119.07 119.14 33.35 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -153.91 164.02 39.09 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.992 -173.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.7 t -84.87 112.28 41.75 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 177.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.43 -22.2 65.89 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.797 2.331 . . . . 0.0 112.656 -176.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.5 t -63.89 -42.99 97.34 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.655 178.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.476 HG12 HG23 ' A' ' 56' ' ' VAL . 98.9 t -73.39 -51.59 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.909 -178.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.476 HG23 HG12 ' A' ' 55' ' ' VAL . 98.6 t -131.56 130.65 62.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.331 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 31.5 p -73.76 159.47 32.9 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.634 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.3 mp -68.62 -24.32 64.55 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.839 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -61.02 -42.41 98.41 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.102 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.536 ' O ' ' HG3' ' A' ' 64' ' ' GLN . 87.3 mm-40 -65.69 -39.25 91.08 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.342 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.83 -45.6 98.34 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 CA-C-O 121.245 0.545 . . . . 0.0 110.06 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 47.5 t -60.74 -41.96 96.42 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.188 177.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -61.67 -38.29 87.23 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.025 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.536 ' HG3' ' O ' ' A' ' 60' ' ' GLN . 98.7 mt-30 -59.35 -42.73 92.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.465 0.174 . . . . 0.0 111.269 -176.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.523 ' HB ' HD12 ' A' ' 25' ' ' ILE . 21.2 tt -85.95 -38.68 12.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.874 178.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.94 -35.54 92.2 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.911 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -54.44 -28.14 42.07 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.879 0.872 . . . . 0.0 111.658 -178.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 15.8 tpt -59.62 -29.23 67.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.076 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 119.13 8.13 9.7 Favored Glycine 0 CA--C 1.506 -0.511 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.492 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -114.84 145.11 42.51 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -72.94 135.94 45.12 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.087 0.47 . . . . 0.0 111.12 -178.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 12' ' ' ARG . . . -146.94 146.54 30.15 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.141 178.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 39.6 t -142.12 140.5 32.5 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.761 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 42.9 pt -91.58 145.06 7.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.522 -177.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.48 145.64 29.22 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.267 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 . . . . . 0 C--O 1.251 1.162 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.085 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.674 0 CA-C-O 120.799 0.333 . . . . 0.0 110.386 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -133.3 169.37 22.69 Favored Glycine 0 N--CA 1.438 -1.182 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.607 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -90.66 130.91 36.62 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 120.873 0.368 . . . . 0.0 110.499 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 67.4 ttp -60.73 -48.76 80.35 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.878 -176.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -151.4 -50.26 0.12 Allowed 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.469 -0.493 . . . . 0.0 111.945 -177.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.9 t -108.52 126.45 65.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-O 120.931 0.396 . . . . 0.0 110.684 -177.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -133.82 147.56 51.23 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.09 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 54.9 p -123.08 143.23 50.11 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 175.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 87.7 p -155.63 162.03 40.69 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.333 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.1 p -109.03 125.51 52.16 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.59 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.92 122.58 70.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 17.8 ptp180 -78.99 141.94 37.05 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.208 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.775 ' HB ' ' SG ' ' A' ' 21' ' ' CYS . 19.8 pt -116.06 106.51 20.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-O 121.672 0.749 . . . . 0.0 110.519 -178.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.8 tp -114.1 128.74 56.52 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.826 -175.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 176.25 -149.29 9.73 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.213 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 66.5 mtt -60.88 -43.18 98.81 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.472 0.654 . . . . 0.0 109.272 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.573 HG23 ' H ' ' A' ' 20' ' ' SER . 11.5 t -163.82 159.41 21.16 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.411 177.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.486 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 98.3 m -63.55 -39.03 93.35 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 120.645 0.26 . . . . 0.0 111.487 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -59.6 -45.2 92.62 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -177.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.573 ' H ' HG23 ' A' ' 17' ' ' THR . 81.0 p -69.11 -41.61 77.18 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.95 -177.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.775 ' SG ' ' HB ' ' A' ' 13' ' ' ILE . 26.0 p -72.26 -35.35 68.74 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.3 p -69.78 -33.92 58.34 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.556 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.625 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -62.28 -42.16 99.1 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.454 0.645 . . . . 0.0 109.319 176.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.6 t -59.58 -49.78 76.42 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.401 -177.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.8 tt -74.55 -32.8 30.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.811 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.4 tm-20 -60.84 -47.68 85.28 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.342 -175.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -62.54 -44.4 96.45 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.502 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.452 ' HA ' ' NE ' ' A' ' 28' ' ' ARG . 4.2 mmp_? -67.52 -43.72 80.11 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.266 -177.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 16.9 tt -72.9 -32.77 41.34 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.6 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.998 -177.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.8 t -64.76 -41.49 95.85 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 120.938 0.399 . . . . 0.0 110.404 177.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -68.64 -26.22 65.22 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.788 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.534 HD21 HG21 ' A' ' 56' ' ' VAL . 57.7 tp -96.23 122.18 38.82 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.025 0.441 . . . . 0.0 110.962 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -68.73 150.01 48.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.871 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.43 -1.97 16.08 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 121.065 -0.588 . . . . 0.0 111.973 -178.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.8 tt -95.82 130.22 44.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 175.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 83.9 mt -92.52 -57.7 4.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 81.5 p -163.71 164.4 23.85 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.281 178.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -154.12 147.7 25.17 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 120.925 0.393 . . . . 0.0 110.271 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -128.87 141.57 51.24 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.5 t -110.05 128.73 66.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -174.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.1 t -113.54 102.03 9.91 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 121.17 0.51 . . . . 0.0 109.998 177.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.97 -36.48 83.43 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.089 178.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -60.62 -44.56 96.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.141 -178.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -85.85 -12.63 50.28 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.11 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.14 26.9 73.64 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.333 -179.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 87.1 p -146.01 161.98 38.88 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.046 0.451 . . . . 0.0 110.823 -177.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.1 142.72 50.08 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.336 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 87.4 m -95.8 119.14 33.78 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 65.7 t -114.77 126.74 72.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 120.997 0.427 . . . . 0.0 111.394 -176.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -103.11 106.43 16.95 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 176.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -135.63 166.34 23.45 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.027 -170.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.5 t -106.07 101.67 35.37 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.027 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.51 -25.87 80.14 Favored 'Trans proline' 0 N--CA 1.48 0.68 0 C-N-CA 123.369 2.713 . . . . 0.0 112.565 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 43.9 t -61.76 -41.33 97.54 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.941 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.447 HG12 HG13 ' A' ' 56' ' ' VAL . 77.8 t -65.51 -62.11 1.39 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.534 HG21 HD21 ' A' ' 32' ' ' LEU . 34.7 m -140.04 159.64 26.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.65 175.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.432 ' SG ' ' HG3' ' A' ' 60' ' ' GLN . 31.8 p -76.07 154.48 35.58 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.029 0.442 . . . . 0.0 110.313 178.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.6 mt -70.97 -19.19 62.58 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.223 179.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -61.45 -42.15 98.31 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.374 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.446 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 97.7 mt-30 -64.28 -39.51 94.08 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.999 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 78.6 t -62.01 -45.48 98.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 CA-C-O 121.265 0.555 . . . . 0.0 109.768 178.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 42.6 t -61.92 -38.73 89.51 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.882 176.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 58.3 m170 -63.07 -36.86 84.97 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.191 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 60' ' ' GLN . 86.5 mm-40 -59.52 -43.55 93.41 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.808 0.337 . . . . 0.0 110.919 -178.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.537 HD11 ' HB2' ' A' ' 21' ' ' CYS . 18.0 tt -76.69 -36.19 26.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.901 178.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 70' ' ' PHE . . . -62.81 -42.25 99.72 Favored Glycine 0 CA--C 1.522 0.514 0 CA-C-N 116.07 -0.514 . . . . 0.0 113.478 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -66.47 -22.05 66.19 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 26.4 mmt -83.52 0.56 45.99 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.527 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.45 9.33 57.9 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.513 -0.851 . . . . 0.0 113.531 177.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.491 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 90.2 m-85 -112.51 140.68 47.06 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.985 0.393 . . . . 0.0 110.092 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -90.47 140.24 29.91 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.886 0.374 . . . . 0.0 110.856 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 12' ' ' ARG . . . -147.27 150.41 34.76 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.135 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.8 t -143.64 136.46 27.43 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.142 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 83.8 mt -91.4 127.1 43.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.457 -178.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.03 160.67 37.03 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.113 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.534 -0.746 . . . . 0.0 110.941 178.856 . . . . . . . . 0 0 . 1 stop_ save_